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ABSTRACT 
Internationally publicized impacts upon human health associated with exposure to 
potentially harmful elements (PHE) have been reported globally. Particular concern has 
surrounded the exposure to Pb indicated by the presence of highly elevated 
concentrations of Pb in blood and hair samples amongst internally displaced populations 
(IDPs) in Mitrovica, Kosovo, following the Kosovan War (Runow, 2005). The exposure risk 
to humans depends in part on the potential of the PHE to mobilise from its matrices in the 
human digestive and respiratory systems (bioaccessibility) and enter the blood stream 
(bioavailability). This study utilizes physiologically based in-vitro extraction methods to 
assess the bioaccessibility of PHEs in surface soils and metallurgical waste in Mitrovica 
and assesses the potential daily ingestion of soil-bound PHEs (As, Cd, Cu, Mn, Pb, and 
Zn) and inhalation (Pb) of particulate matter < 10 µm (PM10).  
A total of 63 samples (52 surface soils and 11 mine/smelter waste) were selected based 
on PHE loadings and their spatial distribution.  For the in-vitro oral bioaccessibility 0.3 g 
subsamples were analysed using the UBM method (adopted by BARGE, Wragg et al., 
2009). The mean bioaccessibility of Cd, Pb and Zn in the gastric phase is 51 %, 57 % and 
41 %, respectively, compared to 18 %, 16% and 14%, respectively, in the gastric-intestinal 
phase. The trend with As and Cu data is less consistent across the sample locations, with 
a mean of 20 % and 22 % in the gastric phase and 22 % and 26 % bioaccessibility in the 
gastric-intestinal phase, respectively. To investigate the role of mineralogy in 
understanding the bioaccessibility data subsamples (< 250 µm) were submitted to the 
British Geological Survey, Nottingham, for X-ray diffraction (XRD) analyses. Samples 
associated with lower bioaccessibilities typically contain a number of XRD-identifiable 
primary and secondary mineral phases, particularly As- and Pb-bearing arseninian pyrite, 
beudantite, galena and cerrusite.  For the inhalation bioaccessibility, PM10 subsamples 
were extracted from 33 samples using a locally developed laboratory based wet method. 
The 0.3 g PM10 subsamples were analysed using a new tracheobronchial fluid and 
protocol developed as part of this study. The bioaccessibility of Pb for all the 33 samples 
tested ranged from 0.02 to 11 % and it is consistent with a range (0.17 to 11 %) previously 
reported by Harris and Silberman (1988) for Pb bioaccessibility in inhalable particulates (< 
22 µm) using canine serum.  
Quantification of the potential human exposure risk associated with the inhalation and 
ingestion of soil-associated PHEs indicates the likely possibility of local populations 
exceeding the recommended tolerable daily intake of Pb. IEUBK model (USEPA, 2007) 
predicted mean blood Pb concentrations for children based on bioaccessible (ingestion) 
data are above the CDC level of concern (10 µg/dL). 
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Chapter 1: Introduction, aims and objectives 
1.1 General introduction 
Potentially harmful elements (PHEs) are those elements thought to inflict harmful effects 
to human health, if exposure occurs (Plant et al., 2001; Costa et al., 2012). They include 
elements such as As, Cd, Cr, Mn, Pb and Zn (EC, 2001; Costa et al., 2012; DEFRA, 
2011a). Human induced enrichment of PHEs in environmental media to concentrations 
beyond ‘safe’ levels is an issue of global concern. PHEs in environmental media, like 
sediments and soil, can accumulate over time (EC, 2001) and may be remobilized by 
humans, wind, rain, flood, and lightening. Assessment of the fate and health effects of 
PHEs in environmental matrices based solely on total recoverable concentrations is no 
longer scientifically justified (Stewart et al., 2003; Landner and Reuther, 2004; Pospescu 
et al., 2012). To minimize the uncertainties and better understand the assessment of 
potential health effects due to PHEs in the environment, the total recoverable 
concentrations are now studied in conjunction with different environmental matrices, 
exposure pathways, sequential extractions, in vitro bioaccessibility, in vitro and in vivo 
bioavailability, chemical speciation, particle size and dose-response effects (Berglund et 
al., 2001; Hursthouse et al., 2001; Caussy et al., 2003; Gal et al., 2006; Ramsey, 2009; 
Scheckel et al., 2009; Meunier et al., 2010; Pospescu et al., 2012).  
1.1.1 Occurrence of PHEs in solid environmental matrices 
In the environment PHEs occur at very high concentrations principally in ore deposits (e.g. 
massive sulphide, metal-bearing veinlets and Pb-Zn-Ag skarns deposits (Hedenquist and 
Lowenstern, 1994; Montac, 2007). The mining and refinement of subsurface ore bodies 
for pure metals and metalloids has brought PHEs into close contact with humans. 
Possible agents and sources of environmental redistribution of PHEs from the mining and 
refinement processes are mine water, particulate emissions, uncontained mine tailings 
and smelter wastes (Nriagu and Pacyna, 1988). Other significant sources of PHEs in the 
environment includes coal combustion, oil combustion, firewood combustion, refuse 
2 
 
incineration, cement production, wastewater, sewage sludge, manufacturing processes 
and others (Nriagu and Pacyna, 1988; Senesi et al., 1999).  The PHEs released from the 
listed sources are discharged into the atmosphere, water bodies and deposited on soils. 
Apart from serving as reserviour for household, commercial and agricultural wastes the 
soil also serves as a sink for atmospheric pollutants (Fowler et al., 1999; Hernandez et al., 
2003; Nygard et al., 2012). This study’s focus is soil and soil-like matrices. 
1.1.2 Metallurgic processes and pollution 
Processes involved in the extraction of metals from ores have been identified as 
significant sources of potentially harmful elements (PHEs) within the environment (e.g. 
Bacon and Dinev, 2005; Schulin et al., 2007; Martínez-López et al., 2008). Mining, 
smelting and other metal refining processes only extract a small fraction of  the ore 
(Dudka et al., 1995). The undesired side-products are mostly abandoned in the open and 
they leave a legacy of spoil heaps that can impact the local environment (Tordoff et al., 
2000). The metalliferous wastes are classed as coarse waste rock (20-200 mm diameter) 
or tailings (< 2mm) and the later are liable to surface compaction and weathering (Tordoff 
et al., 2000).  
Mine and smelter waste are usually redistributed from their original dumps to other sites 
by fluvial transport through adjourning streams, washout during seasonal heavy rainfall 
and aeolian resuspension/transportation of fine mineral particulates (Castro-Larragoitia et 
al., 1997; Razo et al., 2003). Consequently even very distal places from the dump site can 
become contaminated by the waste materials (Castro-Larragoitia et al., 1997). Another 
significant implication of the redistribution of the waste is the masking of the surface soil 
geological signatures of affected sites with minerals phases in the mine and smelter 
wastes (Castro-Larragoitia et al., 1997). Source apportionment investigation at the chosen 
study site (Mitrovica, Kosovo) have indicated similar lead isotope ratios (206Pb/207Pb) 
between metalliferous waste and adjoining surface soils (Prathumratana et al., 2008) and 
the surface soil geochemistry has been altered (Frese et al., 2004). 
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1.1.3 Mineralogy of PHEs 
Mineralogical analysis of metal mine wastes has revealed some major groups of metal 
and arsenic bearing minerals like sulphides (XnSm), iron-arsenic oxides (Fe-As-O), iron 
oxides/hydroxides/oxyhydroxides (Fe-O), manganese oxyhydroxide (Mn-O), and iron 
oxyhydroxysulphates (Fe-S-O) (Hudson-Edwards et al., 1996; 1999; Roussel et al., 2000). 
The Fe-As-O and Fe-S-O phases are major hosts of As, Cu, Pb and Zn elements whilst 
the Fe-O and Mn-O are rich in As, Cd, Cu and Zn (Hudson-Edwards et al., 1996; 1999; 
Roussel et al., 2000). The sulphides include minerals like galena, pyrite, chalcopyrite, 
arsenopyrite and sphalerite, whilst the Fe-O is associated with goethite and minor 
amounts of As, Cu, Pb and Zn (Hudson-Edwards et al., 1996; 1999).  
1.1.4 Human health risk assessment methods 
Risk assessment estimates the severity of harm to human and other receptors that may 
result from exposure to chemicals present in the environment (Zakrezewski, 2002). The 
main components of human health risk assessment procedures are development of a site 
conceptual model, exposure assessment, toxicity assessment, risk characterization, 
modelling and uncertainty analysis (USEPA, 1994; Ferguson, 1999; DETR, 2000; ICPS, 
2004). The site conceptual model is a tool that links sources of contaminants and 
pathways for a given site; exposure assessment identifies likely receptors and estimates 
intake dose; toxicity assessment involves the identification of potential adverse health 
effects; risk characterization involves prediction of health effect and severity based on 
exposure and toxicity data; and, the uncertainty analysis process involves identification of 
likely sources of uncertainty during risk estimation (USEPA, 1989, 1994; Ferguson, 1999; 
DETR, 2000; EA, 2009; ICPS, 2004).  The risk characterisation step quantifies risk for a 
given PHE by the comparison of projected intake and toxicity values (USEPA, 1989). 
A tiered approach (DETR, 2000) for assessing risk to humans and ecosystems has been 
developed by the Environment Agency and the Department for Environment, Food and 
Rural Affairs (DEFRA). In this tiered approach there are three levels of assessment; tier 1, 
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tier 2 and tier 3. Tier 1-Risk screening: involves hazard identification, preliminary risk 
screening and the development of a site conceptual model with the aid of desk study and 
site reconnaissance. Tier 2-Generic Quantitative Risk Assessment: involves the 
identification of the consequences of the hazard noted at Tier 1. At this stage soil generic 
soil screening values are used to assess risk to human health based on the land use 
scenario applicable at the site. Tier 3 involves the generation of site specific risk criteria 
(e.g. bioaccessibility). Here the attempt is to minimize uncertainties that might exist due to 
peculiarity of site and interspecies differences. The bioaccessibility testing protocol which 
aims at eliminating differences that exist between test animals applied in the process of 
obtaining Health Criteria Values (HCVs) and humans (Nathanail and McCaffrey, 2003) is 
an emerging testing tool. 
Risk assessment models are mathematical equations or computational software 
developed to generate risk tools employed in assessment of contaminated sites and, 
examples include the Scotland and Northern Ireland Forum for Environmental Research 
(SNIFFER) model (SNIFFER, 2003), the Society for Environmental Geochemistry and 
Health (SEGH) UK Pb model (Wixson and Davies, 1994), Contaminated Land Exposure 
Assessment (CLEA) model (Environment Agency, 2002a), and the Integrated Exposure 
Uptake Biokinetic (IEUBK) model (White et al., 1998). The appropriateness of a model for 
a specific study depends on desired output, PHE of interest and available input data. At 
sites where soil and human blood Pb loading are elevated the Integrated Exposure 
Uptake Biokinetic (IEUBK) model developed by United States Environmental Protection 
Agency for estimating blood lead concentration in children between the age brackets of 6 
months to 7 years has been shown to be highly relevant (USEPA, 1994) (e.g. Rieuwerts 
et al., 2000; Yu et al., 2006). This physiologically based model is a stand alone, PC 
compactable software package, capable of calculating the probability of a child’s blood 
level exceeding levels of concern (10 µg / dL) and predicting changes in exposure media 
that can translate to lower blood levels (USEPA, 1994).  
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1.1.5 Exposure to PHEs and associated health effects 
Exposure is defined as the concentration of a xenobiotic that reaches a target organ or 
population at a specified frequency (IPCS, 2004). The PHEs at their point and diffuse 
sources may be exposed to humans through inhalation, ingestion and dermal absorption 
exposure pathways (Lioy, 1990; Abrahams, 2002; EA, 2009a). Humans are exposed to 
these contaminants through soil, soil-like matrices and the food chain. Though soil PHEs 
exposure to humans is strongly associated with the oral ingestion route, studies by Roels 
et al. (1978) and Schmitt et al. (1979) have highlighted the resuspension and subsequent 
inhalation as important factors for exposure in children. Also, in an epidemiological study 
investigating contributions of ambient air Pb, soil Pb, age, occupation of parents and 
dustiness of the home to children’s blood Pb levels the strongest positive (0.74) 
correlation was for ambient air Pb (Yankel et al., 1977).  
The concentrations of PHEs found in plants and animal tissues in case studies have 
suggested they depend on loadings in sediment, soil and soil-like matrices at the sites of 
interest (Wilkinson et al., 2003). In humans PHEs have the capacity to bioaccumulate in 
blood, hair, teeth and breast milk (Gallercher et al., 1984; Sonawane, 1995; Nowak and 
Kozlowski, 1998; Bjerregaard and Hansen, 2000). The presence of these PHEs (As, Cd, 
Cr, Ni, Mn and Pb) in human tissues and systemic circulation can induce toxic effects 
(Plumlee et al., 2006). Arsenic, Mn and Pb have been found to be neurotoxic to children 
as mixtures or individual chemicals (Hu et al., 2007). Most health effects associated with 
exposure of PHEs to humans through inhalation and ingestion have been reviewed by 
Plumlee and Ziegler (2005) and the summary of health effects associated with the six 
elements of interest in this study is provided in Table 1.1.   
When these PHEs (xenobiotics) enter the human body through ingestion and inhalation 
they get in contact with the lymphatic system which drains into the blood stream. The 
PHEs in the blood stream may be biotransformed before translocation to receptor sites 
(Zakrzewski, 2002). The distribution of the xenobiotics between the plasma and tissue 
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depends on the availability of free solutes (Zakrzewski, 2002). But the amount of a 
xenobiotic that will be free through inhalation and ingestion will depend on the fraction of 
the chemical dissolvable by respiratory tract and gastrointestinal fluids. Since toxicity of 
xenobiotics may depend on the soluble fraction, the relevance of studies targeted at 
estimating bioaccessible fractions of PHEs from environmental media cannot be over 
emphasized.  
Table1.1: Health effects associated with excess exposure of PHEs to human (Plumlee 
and Ziegler, 2005)   
Element Health effects 
As Systemic hypotension, liver necrosis, kidney failure, skin cancer 
and seizures 
Cd GI tract distress, liver and kidney damage, obstructive lung 
disease and cancer 
Cu Hemolysis and hyperglycemia 
Mn Manganism, Mn-pneumonitis and liver cirrhosis 
Pb Reduction in IQ, renal failure, gastrointestinal tract distress, 
anaemia and hypertension  
Zn Metal fume fever and hyperchronic anaemia  
 
1.1.6 Inhalable particulate matter 
Ambient air quality guidelines provide guidance to policy makers with a tool for reducing 
health effects resulting from air pollution. Though such guidance are based on strong 
scientific evidence knowledge gaps still exist (WHO, 2006). It is known that in spite of 
lower particulate matter (PM) concentrations recorded in some regions of the world 
adverse health effects are still associated with air pollutants (WHO, 2006) and this may be 
due to complex nature of ambient PM. Englert (2004) in a review of epidemiological 
studies relating to fine particles and human health listed the following as some 
unanswered questions based on current knowledge: 
 Which is the health relevant particle size fraction? 
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 What is the concentration (exposure)-response relationship for a specific health 
endpoint? 
 What are the effect of modifiers? 
 What is the composition of PM? 
For the health relevant particle size fraction several size fractions have been suggested 
and investigated but the PM10, PM2.5 and PM0.1 are the most relevant fractions for 
respiratory risk (Vineis et al., 2004; Ajmone-Marsan et al., 2008) and studies on systemic 
deposition of inhaled steroids have indicated the ultra fine particles may be actually 
exhaled rather than deposited in the respiratory tract (Edsbacker and Johansson, 2006). 
The coarse fraction (PM10) has shown strong association with asthma symptoms and 
mortality for respiratory diseases including lung cancer related deaths (Abbey et al., 1999; 
Pope et al., 2002; Weinmayr et al., 2010). Similarly, a study of PM10 elemental 
composition and acute respiratory health effects in European children (PEACE project) 
has observed that the PM10 composition significantly influences its ability to cause 
respiratory health effects (Roemer et al., 2000). The composition of PM10 also varies from 
city to city dependant on the sources of local and regional contributors (Roemer et al., 
2000; Ajmone-Marsan et al., 2008). There is consensus among environmental health 
researchers that the understanding of health effects of PM on human requires accurate 
assessment of human exposure concentration of the harmful constituents of PM (Mckone 
et al., 2008). 
Chemical categories of inhalable particles that are toxic include organic compounds, 
inorganic fibres, inorganic acids, silicates and metals (Miller et al., 1979; Countess et al., 
1980; Harrison and Jones, 1995; Pakkanen et al., 2001; Paoletti et al., 2002; Sun et al., 
2004; Moreno et al., 2007). Regulatory agencies, considering the complexity of ambient 
PM have also provided guidelines for individual pollutants (e.g. Pb of particular relevance 
in the Kosovo case study) in the ambient PM, yet nonindustrial cases of Pb poisoning are 
still being reported, as is the case at Mitrovica (Brown et al., 2010).  
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1.1.7 Research gap in the application of bioaccessibility protocols 
Existing human health risk assessment tools for contaminated land management 
assumes that people are exposed to total soil concentrations, and that the physiology of 
test animals approximates that of humans. However, due to certain physiological 
disparities between animal and humans, estimated risks are usually associated with 
uncertainties. An accurate risk assessment for a PHE needs to account for its 
bioavailability in site-specific soil (Ruby et al., 1999). Initial bioavailability (oral absorption 
fraction) studies for PHEs in soil have been based on in vivo studies in animals, but the 
approach is no longer attractive and the present desire is for the development of in vitro 
extraction tests that are predictive of PHEs site-specific bioavailability from soil (Ruby et 
al., 1999). The physiologically based extraction test (PBET) is a typical example of an in 
vitro test protocol for predicting the bioavailability of PHEs from solid matrix but in vivo 
bioavailability studies involving animal models are still relevant (Ruby et al., 1996; Ruby et 
al., 1999). The PBET estimates bioavailability for the purpose of exposure assessment in 
the absence of in vivo animal data (Ruby et al., 1996). The PBET method is employed to 
determine the oral bioaccessibility of PHEs in solid matrices.  
By 2002 published bioaccessibility methods included the Simple Bioaccessibility 
Extraction Test (SBET) by the British Geological Survey (BGS, United Kingdom), the DIN 
method by Ruhr-Universitat Bochum (RUB, Germany), the in vitro Digestion Model by the 
National Institute of Public Health and Environment (RIVM, Netherlands), and the 
Simulator of Human Intestinal Microbial Ecosystem of Infants (SHIME) by LabMET (RUG) 
/ VITO (Belgium) and TNO Gastrointestinal Model (TIM) by TNO Nutrition (TNO, 
Netherlands) (Oomen et al., 2002). A questionnaire and interview based study on the use 
bioaccessibility for risk-based regulation of contaminated land using local authority 
contaminated land officers in England indicates that bioaccesibility testing is perceived as 
a relevant and future tool for site specific study (Latawiec et al., 2010). The study 
recommends the provision of authoritative guidance capable of providing uniform scientific 
criteria for development decisions and the need for data on successful bioaccessibility 
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studies to help instil confidence in management and application of the protocol. The 
Environment Agency’s science update on the use of bioaccessibility testing in risk 
assessment of contaminated land highlighted potential in the use of bioaccessibility for 
site-specific risk assessments studies but also indicated the absence of certified reference 
material, lack of consensus on procedures and quality control protocol as limitations (EA, 
2005). The update emphasized the need for bioaccessibility test that can better 
approximate physiological processes in human biologic systems and suggested possible 
uncertainties, since validations are sometimes based on in vivo rat and pig data (EA, 
2005). Wragg and Cave (2003) in their critical review of existing in vitro methods for 
estimating bioaccessibility of selected PHEs in soils identified similar research gaps but 
also emphasized the need for further investigations focused on identifying how different 
soil matrices influence the bioaccessibility of PHEs. The BioAccessibility Research Group 
Europe (BARGE) has developed a robust methodology for estimating more scientifically 
realistic bioavailability factors to be applied in general and site-specific risk assessments 
(Wragg et al., 2009).  
Solid-phase (mineralogy) can also influence the mobility of PHEs in solid environmental 
matrices through in situ chemical transformations, precipitation and sorption processes 
(Stewart et al., 2003; Romero et al., 2007). Mobilization of PHEs in synthetic biologic 
fluids is suggested to be under the influence of mineralogy (Roussel et al., 2000, Plumlee 
et al., 2006, Jamieson et al., 2007, Bosso et al., 2008, Meunier et al., 2010), therefore 
interpretation of oral and inhalation bioaccessibility data obtained from different solid 
environmental media requires mineralogy data. Harris and White (2008) have highlighted 
how mineralogy data facilitates the interpretation of bioaccessibility data. Consistent with 
these observations and suggestions mineralogy analysis was conducted in parallel with 
the bioaccessibility tests in this study. 
For samples having predominantly inhalable particle size fractions it has been suggested 
that the most appropriate test be inhalation bioaccessibility, since for such samples 
inhalation is potentially the most harmful exposure route (Broadway et al., 2010). In some 
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studies both ingestible and inhalable soil size fractions have been extracted with 
simulated gut fluid (e.g. Colombo et al., 2008; Smith et al., 2009; Turner et al., 2009). To 
also account for risk due to exposure via the respiratory tract some workers (e.g. Twining 
et al., 2005; Broadway et al., 2010) now conduct both oral and inhalation bioaccessibility 
tests on samples. However, the extracellular in vitro extraction fluids for inhalation route 
have not undergone the kind of ordered evolution experience by synthetic gastrointestinal 
fluid. Most studies have used Gamble’s solution (e.g. Stopford et al., 2003; Mildader et al., 
2007; Broadway et al., 2010) or a modified version of it (Christensen et al., 1994; Gray et 
al., 2010; Drysdale et al., 2012). In most of the fluids used in published works citrates and 
acetate have been used in place of proteins and organic acids with some authors citing 
possible implications (e.g. Collier et al. (1992) observed increased dissolution rate for 
cobalt oxide with higher citrate concentrations in the fluid make-up). For the inhalation 
pathway no standard robust bioaccessibility protocol has been adopted; variations in 
particle size, extraction time, solid / liquid ratio and extractant recipe exist in literature. 
There are data gaps on the influence of resuspended surface dust in point source 
exposure assessment and generic ambient conditions (Hursthouse and Kowalczyk, 2008). 
Respiratory tract bioaccessibility is typically not incorporated into risk assessment models 
(e.g. CLEA and SNIFFER models). Mattson (1994) has suggested researchers involved in 
inhalation risk assessment need awareness about the compartments present in animal 
respiratory tract and formulate artificial fluids based on the specific region being simulated. 
Existing in vitro respiratory tract fluids do not typically account for distinct compartments 
(i.e. upper and lower respiratory tract) in the respiratory system. 
Existing in vitro bioaccessibility models designed to mimic in vivo physiological conditions 
following ingestion of soil contaminants contain minerals, lipids, proteins, carbohydrates 
and water but existing in vitro respiratory tract fluids employed for bioaccessibility assays 
(e.g. Stopford et al., 2003; Mildader et al., 2007; Broadway et al., 2010; Christensen et al., 
1994; Gray et al., 2010; Drysdale et al., 2012) indicate exclusion of proteins, 
carbohydrates, organic acids and in some cases lipids. In vivo composition of respiratory 
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tract lining fluids in addition to minerals also contains surfactant lipids, lubricating proteins 
and antioxidant proteins (Ringer et al., 1987; Ringer et al., 1988; Cross et al., 1994; 
Samet and Cheng, 1994; Schenkel et al., 1995; Vliet et al., 1999; Schock et al., 2004). 
The absence of some molecular groupings in existing in vitro respiratory tract fluids may 
introduce uncertainties into the data. More research is required on the development and 
testing of simulated lung fluids for inhalation bioaccessibility and for the integration of 
environmental data with physiologically based biokinetic models to generate data on the 
migration and distribution of environmental pollutants within human body while 
simultaneously validating such models (Hursthouse and Kowalczyk, 2008). Such data are 
needed to facilitate the understanding of the chemical processes that influence the 
release, mobilization and final environmental fate of PHEs (Ramsey, 2009).  
1.2 Aims and objectives of the research 
The overall aim of this thesis was to investigate inhalation and oral (UBM) protocols and 
their roles in human health risk assessment. 
An overview of the research objectives are shown in Figure 1.1. The figure highlights two  
Figure 1.1: Overview of the research objectives in this study 
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distinct solid matrices (soil and mine waste) and the inhalable particulates (< 10 µm) 
investigated. The objectives set for this thesis are summarized as:  
a) To optimize a method for PM10 extraction (Chapter 2) 
b) To evaluate the application of in vitro oral bioaccessibility testing using the UBM 
method (Wragg et al., 2009) and the indicative role of mineralogy in 
gastrointestinal dissolution of PHEs  (Chapter 3) 
c) To conduct a critical review of published literature and formulate an in vitro 
tracheobronchial fluid and develop an inhalation bioaccessibility protocol for 
particulate Pb (Chapter 4) 
d) To evaluate the application of the developed in vitro inhalation bioaccessibility 
protocol (Chapter 5) 
e) To predict childhood blood Pb concentrations with the PBPK (IEUBK) model based 
on model default and site-specific bioavailability (bioaccessibility) inputs (Chapter 
6) 
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Chapter 2: Standard Methods and Instrumentation 
2.1 General Introduction 
Soil evaluation involves several steps including understanding the intended use of land, 
identification of relevant soil quality parameters, site description, appropriate sampling, 
storage, sample preparation, sample pre-treatment, analysis, results and the interpretation 
of results in relation to purpose (Nortcliff, 2002). This chapter presents the methods 
applied for sample preparation, PM10 extraction, microwave-assisted acid digestion and 
oral bioaccessibility, and the instrumentation for ICP-MS, X-ray diffraction and laser light 
particle size analyser equipment employed for analyses. 
2.2 Sample preparation 
Samples (< 2000 µm) used in this study had been previously sampled and their total 
elemental concentration characterized as part of the British and Commonwealth Office 
commissioned geochemical assessment of soils in Mitrovica, Kosovo (FLUVIO, 2010). 
Subsamples available from FLUVIO archive were sourced from Dr. Graham Bird, School 
of Environment, Natural Resources and Geography, Bangor University for this study. The 
description of the sampled area is provided in Section 3.2.  
Using sample volume and geographical spread, 63 surface soil and metallurgic waste 
samples were selected for this study. Of this 35 originated from designated resettlement 
sites (Roma and Bosniak Mahalla), 7 from refugee camps (Cesmin lug and Osterode), 10 
from Mitovica city centre and 11 from metallurgic waste dumps. Details of the 63 samples 
are provided in Appendix A. Each sample was air-dried and sieved through < 250 µm 
nylon mesh. The < 250 µm soil fraction preferentially sticks to hands (USEPA, 2000) and 
is the fraction recommended for bioaccessibility testing (Environment Agency, 2005; 
USEPA, 2008a). 
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2.3 Development of PM10 extraction method 
2.3.1 Introduction 
World Health Organisation (WHO), European Union and most national governments are 
using PM10 and PM2.5 as the indicators of exposure to ambient particulate matter (WHO, 
2005; European Environment Agency, 2011a). PM10 represents the fraction of ambient 
particulate matter (thoracic particles) that enters the respiratory tract (WHO, 2005; 
Kulkarni et al., 2006; Englert, 2004; Brunekreef and Forsberg, 2005) and PHEs 
accumulate within this fraction (e.g. Ajmone-Marsan et al., 2008). This fraction has also 
been classed as a health-relevant fraction for inhalation exposure because it correlates to 
toxicity, respiratory diseases and mortality (Parker et al., 2009, Adhikari et al., 2006). 
Mass contributions to ambient PM10 in several cities of the world have been traced to 
sources such as; marine/sea aerosol, secondary aerosol (NH4NO3 and (NH4)2SO4), soil, 
construction/demolition dust, cement, vehicle derived dust, farming, resuspended dust, 
industry emissions, fuel oil combustion, coal fly ash, wood burning, bush/field burning, 
traffic emissions, metal smelting and others, and soil materials have been identified as 
significant contributor (Almeida et al., 2005, 2007; Bi et al., 2007; Gupta et al., 2007; 
Kovouras et al.,  2001; Lim et al., 2010; Manoli et al., 2002; Marcazzan et al., 2003; 
Negral et al., 2008; Qin and Oduyemi, 2003; Querol et al., 2001; Behera et al., 2011; 
Salvador et al., 2004). 
2.3.2 Existing PM10 sampling methods 
Ambient Sampling of PM10: PM10 can be sampled from the atmosphere, soil and 
roadside dust. Amongst the three matrices the ambient sample represents the most 
complete spectrum of the inhalable PM10. Ambient PM10 samplers include sequential 
dichotomous impactors, cyclone inlet filters, aerosol centrifuges, impingers, and elutriators 
which collect particles in specific size ranges (Hering, 1995). Samples from the three 
methods; cyclone, impactor and the personal exposure monitor samplers are not 
statistically different (Keeler et al., 2002). These ambient inhalable particulate matter 
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sampling methods though popular in exposure studies have some limitations. The 
challenges include small sample quantity (usually insufficient for full risk assessment 
studies) and the bulk nature of samples usually masks the original mass contributors (Kao 
and Friedlander, 1995). Also with the sequential impactors, volatile and semi volatile 
chemicals can interchange with the gas phase and due to particle bouncing the sampled 
size fraction distribution may be distorted (Hering., 1995; Kao and Friedlander, 1995). 
PM10 Fractionation from Roadside Dust: Field sampling of PM10 from fugitive dust 
involves the use of leaf blowers for the mobilization of dust from surfaces (simulation of 
windy conditions) and size fractionation with cyclone separator or the Personal 
Environmental Monitor (PEM) sampler (Gelencser et al., 2011).  Laboratory-based size 
fractionation of PM10 samples from roadside dust usually involves sweeping loose material 
on surfaces into a clean dustpan with brushes (Vega et al., 2001; Kong et al., 2011; 
Garcia et al., 2004). In the laboratory the samples are fractionated to the desired particle 
size fraction with a stack of sieves to between 100-63 µm. The fractionated portions are 
re-suspended using mechanical agitators or pumps (rotating drum/flask) to simulate wind 
generated aerosol and the PM10 fraction is extracted with portable battery-powered 
cyclone or impactor units (Ho et al., 2003). On a small scale, re-suspension can be 
achieved by blowing with air/N2 and extracting with portable personal aerosol samplers (Li 
et al., 2000; Gelencser et al., 2011; Kong et al., 2011). The mechanical re-suspension of 
dust can pose health risk to personnel. 
PM10 from Re-suspended Surface Soil: For soil matrix, bulk soil is collected from the 
surface horizon (0-15 cm) to represent materials most readily resuspended into the 
atmosphere by farming, treasure search, construction operations, surface mining and 
other types of excavation (Ljung et al., 2008, 2011; Luo et al., 2011; Cesari et al., 2012). 
Most of the existing re-suspension devices are based on dry fluidization (gas dispersion), 
gravitation (fall through air) or mechanical agitation (rotating cylinder entrained into 
airflow) (Gill et al., 2006). 
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A typical prototype of the fluidization technique employs a 250 ml side-arm vacuum flask 
sealed with rubber stopper which requires air puffs into it for re-suspension of 0-100 µm 
soil that is sampled through PM10 size-selective filters (Yong et al., 2002; Ho et al., 2003; 
Zhao et al., 2006; Bi et al., 2007; Kong et al., 2011; Martuzevicius et al., 2011). A 
mechanical agitation dust generator consist of two drums (60 x 87 cm); one serving as the 
rotating chambers where re-suspension of geological materials occurs and a settling 
chambers where PM10 particulate matter is sampled with pump connected to impactor-
filter (Madden et al., 2010). The gravitational method involves dropping a specified 
amount of dust into a dust chambers and collection of a given dust fraction based on the 
time history of the particles (Hamelmann and Schmidt, 2004).  
Most of the dry fluidization techniques will require more laboratory space, experienced 
personnel to operate and are high in cost and maintenance (Ljung et al., 2008). Also 
during the induced re-suspension processes coarse particles can break apart into finer 
grain due to air pressure (Gill et al., 2006), and conversely high speed fine particles can 
collide and form larger particles. Based on these limitations research aimed at the 
development of cheap and simple laboratory-based wet extraction methods are still 
ongoing. 
Wet PM10 Sampling Methods: Existing simple and inexpensive procedures for extracting 
PM10 fraction from bulk samples usually involves the use of dispersant (Na-
hexametaphosphate) and a combination of wet sieving and sedimentation process based 
on Stokes’ law. Ljung et al., (2008) developed a method for extracting PM10 from the < 63 
µm fraction. The < 63 µm fraction was suspended in deionised water and allowed to settle 
for a calculated time (based on Stokes’ law) in specially constructed 10 cm tubes. The 
resulting suspension (estimated to be < 13 µm) was siphoned off and wet sieved through 
a 10 µm mesh size filter. The PM10 suspension was centrifuged for 2 hours, and the 
resulting pellet re-suspended and dried at 105 oC. Slightly modified versions using < 50 
and < 45 µm fractions have been reported by Luo et al., (2011) and Ljung et al., (2011), 
respectively.  
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The major concerns in application of water-based extraction protocols for PM10 from 
samples are the possibility of leaching out soluble material (Goossens, 2012) and the 
precipiatation of Pb with Na-hexametaphosphate (e.g. Gallup, 2006). An early attempt at 
conducting wet extraction of PM10 without water was conducted by Pilkington and Warren, 
(1979). They dispersed a gram of the bulk sample in acetone rather than water and the 
resulting suspension sized by repeated Stokes’ law sedimentation. The concentrations of 
Pb, Zn and Cd in the sample before and after fractionation were consistent, indicating 
negligible loss to the suspension fluid. However, other organic liquids like 
tetrabromoethane (TBE) and polyvinylpyrrolidone (PVP) were required to facilitate the 
removal the PM10 fraction. The method by Pilkington and Warren, (1979) may not be ideal 
for investigating organics in particulate matter and there are concerns about disposal 
issues for TBE and PVP. 
Given the diverse mineralogy of earth materials in particulate matter (Pina et al., 2002; 
Iordanidis et al., 2008; Shao et al., 2008; Moreno et al., 2009; Silva et al., 2010; Brown et 
al., 2011; Formenti et al., 2011; Kim et al., 2011), and the fact that the dissolution 
behaviour of particulate matter depends on the mineral phases and forms present, the 
concern about undesired removal of elements during wet extractions may have been over 
generalized. Hence the need to develop cheap and simple extraction protocols and test 
suitability on a site by site basis. In this study a simple laboratory-scale user friendly 
method for PM10 sampling from soil and other geological materials was developed.  
2.3.3 Materials and method 
Air dried surface soil samples were gently disaggregated and passed through 2 mm 
plastic mesh sieve. A known amount of the < 2 mm fraction was further sieved with 63 µm 
sieve. In a 100 mL measuring cylinder 2 g of the < 63 µm fraction of the dried soil was 
suspended in 100 ml of deionised water and dispersed with the aid of magnetic stirrer for 
10 min (step 1 of Figure 2.1). The extraction process was duplicated. The resulting
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Figure 2.1: Schematic diagram of steps employed in extracting PM10 from soils 
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suspensions were allowed to stand for 1044 seconds (17.4 minutes) and 3198 seconds 
(53.3 minutes) based on default bulk density and measured bulk density, respectively 
(Stokes’ law-equation- 2 Appendix B). The < 63 µm particle bulk density was measured 
using a water displacement technique (Blake and Hartge, 1986). Based on the displaced 
volume difference and the mass of < 63 µm fraction the bulk density was calculated as: 
ρ = m / v                             (2.1) 
Where ρ = soil bulk density 
m = mass 
v = volume 
In each of the suspensions a 50 mL pipette was placed at the 50 mL mark (step 2 of 
Figure 2.1) and 50 mL suspension was siphoned off and transferred into a 50 ml 
centrifuge tube and centrifuged for 10 min at 4000 rpm to obtain the <10 µm fraction (see 
steps 2, 3 and 5 of Figure 2.1). To the remaining suspension in the measuring cylinder 
fresh 50 ml deionised water was added and the solids re-suspended (step 4 of Figure 1), 
siphoned and centrifuged. After centrifugation the supernatant was decanted (step 6 of 
Figure 1) to obtain the particulate matter. The refilling, re-suspension, siphoning, 
centrifugation and decantation cycle was executed at room temperature and repeated 
until the resulting suspension above siphoning mark was clear.  All extracted particulate 
matter in the centrifuge tubes were transferred into desiccators for drying and subsequent 
weighing.  
Portions of the siphoned suspensions were analysed for grain size distribution with a laser 
light scattering particle size analyzer (Malvern Mastersizer 2000, Marlvern Instruments, 
Ltd UK) to determine the particle size of solids extracted. The results of the wet PM10 
extraction method are provided in Section 5.3.1. 
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2.4 Microwave-assisted acid digestion 
The USEPA has recommended several sample preparation methods to standardize the 
assessment of total PHEs in environmental matrices. They include method 3050B: hot-
plate acid (HNO3 - HCl) digestion of sediments, sludge and soils (USEPA, 1996a), method 
3051: microwave assisted acid (HNO3) digestion of sediments, sludge, soils and oils 
(USEPA, 1994), method 3051A: microwave assisted acid (HNO3 - HCl) digestion of 
sediments, sludge, soils and oil (USEPA, 2007a), and method 3052: microwave assisted 
acid (HNO3 – HCl - HF) digestion of siliceous and organically based matrices (USEPA, 
1996b).  
The USEPA method 3051A was designed to mimic extraction using HNO3 – HCl 
according to method 3050 (USEPA, 1994b). Method 3051A is applicable to microwave 
assisted acid digestion of sediment, sludges, soils and oils for the elements of interest in 
this study (e.g. As, Cd, Cu, Mn, Pb, Zn) (USEPA, 2007a). The method is a rapid multi-
element protocol and the resulting digestates are suitable for analysis by inductively 
coupled plasma spectrometry (ICP-MS) (USEPA, 2007a). Due to advances in microwave 
technology the method document suggested equipment-specific optimization of digestion 
conditions, and in line with this recommendation the microwave digestion system 
(Milestone Start D EthosEZ) used in this study has previously been optimized by Okorie et 
al. (2011).  
In this study the HNO3 – HCl (in the ratio 3:1 v/v) and 0.5 g sub-sample weight specified in 
method 3051A were used. Extractions were conducted at the conditions: at power- 750 
watts, the temperature regimes were 0 to 160 oC (15 minutes), held at 160 oC (10 
minutes) and cooling for 30 minutes (Okerie et al., 2011). The extraction tube contents 
were filtered (Whatman filter paper) into 50 ml flasks, previously acid rinsed. The tubes 
and residues were rinsed with deionized water (Milli-Q, conductivity; 18.2 MΩ cm-1 at 25 
oC) into the flasks and the resulting volumes made up to 50 ml mark with the de-ionized 
water. The filtrate obtained from the digestion was refrigerated (< 4°C) prior to analysis. 
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For each digestion, reagent blanks were also prepared to evaluate the presence of 
contaminants in the used reagents. For the evaluation of the efficiency of the aqua-regia 
extraction procedure 0.5 g of certified reference material (BCR – 143R) from the 
European Commission Joint Research Centre was also weighed and extracted in parallel. 
Quality control data for the microwave-assisted aqua regia digestion is provided in Section 
3.4.1.  
2.5 Oral bioaccessibility 
For a chemical in the environment one of the traditional soil quality indicators employed 
for human health risk assessment is its total concentration in soil. The body of knowledge 
now knows that biological effects are not related to the total concentration of a chemical in 
soil but biological receptors only respond to the fraction that is bioavailable (Harmsen, 
2002; Pospescu et al., 2012). In 2000 the International Standardization Organisation (ISO) 
Technical committee (TC) 190/Soil Quality commenced the process of standardization of 
the bioavailability body of knowledge by constituting a working group and the first draft of 
the group (ISO/DIS 17402) is summarized in a review by Harmsen (2007). The group 
recommended physiologically based methods simulating digestion of ingested chemicals 
in both stomach and intestinal phases for estimating bioavailable fraction in humans as 
protocols for future standardization. 
The BioAccessibility Research Group of Europe (BARGE) developed a robust 
methodology for estimating more scientifically realistic bioavailability factors to be applied 
in general and site-specific risk assessments (Wragg et al., 2009). The method requires a 
sample weight of approximately 0.6 g, but this was adjusted to 0.3 g due to the small 
sample mass available for this study. The procedure involves three analyses on each 
sample: 1) a simulated gastric phase, 2) a simulated gastric-intestinal phase and 3) a 
pseudo total analysis using microwave assisted acid digestion (hereto referred to as total).  
 
 
22 
 
2.5.1 Equipment and Reagents 
The equipment and reagents used for the in vitro gastrointestinal extractions are listed in 
Table 2.1 (after Wragg et al., 2009). All glassware and High-density polyethylene (HDPE) 
beakers and screw top storage vessels were washed with detergent (Decon), rinsed with 
water and soaked for 24 hours in 10% HNO3. After retrieval from the acid bath they were 
subsequently rinsed three times with deionised water before use.  
Table 2.1: List of equipment and reagents used for the UBM (after Wragg et al., 2009) 
Equipment 
 
Oven, Water bath, Incubator-rotator, Centrifuge, pH meter, Analytical balance, Volumetric  
flask, Auto pipettes, Polycarbonate centrifuge tubes with screw caps, HDPE beakers and 
HDPE screw top bottles  
Reagents 
 
Sigma, UK  
D-Glucuronic acid, Lipase (pig), α-amylase (bacillus species), Bile salt (bovine) 
Merck (Poole, England)  
Anhydrous sodium sulphate (Na2SO4), Ammonium chloride (NH4Cl), Anhydrous D + 
Glucose, D-glucosaminehydrochloride, , Bovine serum albumin (BSA), Calcium chloride 
(CaCl2.2H2O), Sodium bicarbonate (NaHCO3), Hydrochloric acid (HCl), Magnesium chloride 
(MgCl2.6H2O), Nitric acid (69%HNO3), Pancreatin (pig), Potassium chloride (KCl), Potassium 
thiocynate KSCN Pepsin (pig), Urea, and Uric 
Baker Scientific, UK 
Potassium hydrogen phosphate ( KH2PO4), Sodium hydrogen phosphate (NaH2PO4) 
Carl Roth, Germany  
Mucin (pig) 
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All synthetic fluids were prepared initially in two 500 ml portions (inorganic and organic 
phases) using 500 mL High density polyethylene (HDPE) bottles before they were 
carefully mixed with other solid constituents in a 2 L HDPE bottle and mixed thoroughly. 
The quality of the resulting fluids was assessed by comparing the pH to the range listed 
by the UBM protocol. Details of preparation steps are provided in section (2.5.2).   
2.5.2 Preparation of Extraction Fluids 
1 Litre Saliva Fluid (after Wragg et al., 2009) 
Into a 1 litre HDPE bottle about 200 ml of de-ionized water was added. Then into a 500 ml 
HDPE beaker 896 mg KCl, 888 mg NaH2PO4, 200 mg KSCN, 570 mg Na2SO4, 298 mg 
NaCl salts were dissolved with de-ionized water in the order listed and transferred into the 
HDPE bottle. This was then followed with the addition of 1.8 ml of 1.0 M NaOH and the 
content of the bottle made up to the 500 ml mark with de-ionized water. Into another 1 litre 
HDPE bottle 200 ml of de-ionized water and 200 mg urea were added and mixed to 
dissolve the organic salt. The content of the bottle was then made up to the 500 ml mark 
with de-ionized water. Into a third HDPE bottle (2 litres) 145 mg amylase, 50 mg mucin 
and 15 mg uric acid, and followed with the simultaneous addition of previously prepared 
500 ml each of the organic and inorganic phases. The pH of the resulting mixture (6.33) 
was recorded and then kept in the laboratory locker overnight (room temperature 22 ± 5 
oC). 
1 Litre Gastric Fluid (after Wragg et al., 2009) 
Into a 1 litre HDPE bottle about 200 ml of de-ionized water was added. Then into a 500 ml 
HDPE beaker 2752 mg NaCl, 266 mg NaH2PO4, 824 mg KCl, 400 mg CaCl and 306 mg 
NH4Cl salts were dissolved with de-ionized water in the order listed and transferred into 
the HDPE bottle. This was then followed with the addition of 8.3 ml (37%) HCl and the 
content of the bottle made up to the 500 ml mark with de-ionized water. Into another 1 litre 
HDPE bottle 650 mg D+glucose was dissolved with small quantity of de-ionized water and 
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in a similar manner further 20 mg glucuronic acid, 85 mg urea and 330 mg 
glucosaminehydrochloride  were solubilised and the content of the bottle made up to the 
500 ml mark with de-ionized water. Into a third HDPE bottle (2 litres) 1000 mg BSA, 3000 
mg Mucin and 1000 mg pepsin dissolved in the order listed, by the simultaneous addition 
of previously prepared 500 ml each of the organic and inorganic phases. The pH of 
resulting mixture (0.91) was recorded and then kept in the laboratory locker overnight 
(room temperature 22 ± 5 oC). 
1 Litre Duodenal Fluid (after Wragg et al., 2009) 
Into a 1 litre HDPE bottle about 200 ml of de-ionized water was added. Then into a 500 ml 
HDPE beaker  7012 mg NaCl, 5607 mg NaHCO3, 80 mg KH2PO4, 564 mg KCl and 50.0 
mg MgCl2 salts were dissolved with de-ionized water in the order listed and transferred 
into the HDPE bottle. This was then followed with the addition of 180 μl (37%) HCl and the 
content of the bottle made up to the 500 ml mark with de-ionized water. Into another 1 litre 
HDPE bottle 200 ml of de-ionized water and 100 mg urea were added and mixed to 
dissolve the organic salt. The content of the bottle was then made up to the 500 ml mark 
with de-ionized water. Into a third HDPE bottle (2 litres) 200 mg CaCl2, 1000 mg BSA, 
3000 mg pancreatin and 500 mg lipase were dissolved in the order listed, by the 
simultaneous addition of previously prepared 500 ml each of the organic and inorganic 
phases. The pH of resulting mixture (7.29) was recorded and then kept in the laboratory 
locker overnight (room temperature). 
1 Litre Bile Fluid (after Wragg et al., 2009)  
Into a 1 litre HDPE bottle about 200 ml of de-ionized water was added. Then into a 500 ml 
HDPE beaker 5259 mg NaCl, 5785 mg NaHCO3 and 376 mg KCl salts were dissolved 
with de-ionized water in the order listed and transferred into the HDPE bottle. This was 
then followed with the addition of 180 μl (37%) HCl and the content of the bottle made up 
to the 500 ml mark with de-ionized water. Into another 1 litre HDPE bottle 200 ml of de-
ionized water and 250 mg urea were added and mixed to dissolve the organic salt. The 
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content of the bottle was then made up to the 500 ml mark with de-ionized water. . Into a 
third HDPE bottle (2 litres) 222 mg CaCl2, 1800 mg BSA and 6000 mg bile were dissolved 
in the order listed, by the simultaneous addition of previously prepared 500 ml each of the 
organic and inorganic phases. The pH of resulting mixture (8.15) was recorded and then 
kept in the laboratory locker overnight (room temperature 22 ± 5 oC). 
Quality control 
Quality control for the prepared fluids was achieved by ensuring that the resulting pH for  
2.0 ml of saliva and 3.0 ml gastric fluids fell between 1.20 -1.40. Where small differences 
occurred the mixture was adjusted with either 1.0 M NaOH or 37% HCl using droppers. 
Also the pH of the resulting extraction fluid when 2.0 ml saliva, 3.0 ml gastric, 6.0 ml 
duodenal and 2.0 ml bile fluids are mixed must fall between 5.80 and 6.80 before they can 
be employed for the in vitro extractions.  
2.5.3 In vitro extraction of samples 
Before commencing the extraction with the prepared gastrointestinal fluids they were 
brought to between 35 and 37 oC. Similarly the temperature of the extraction unit was 
maintained between 35 and 37 oC. Triplicate sets of 0.3 g of the contaminated soil 
samples were weighed into labelled extraction tubes (50 ml), for the gastric and the 
gastrointestinal phases. Into the gastric phase extraction tubes 4.5 ml of saliva fluid was 
added, capped, placed on a fitted wooden rack and manually shaken. The mixture was 
allowed to stand for 15 minutes before 6.75 ml of the simulated gastric fluid was added, 
capped and placed in the extractor-incubator for 1 hr.  The pH of the resulting mixture was 
taken (range 1.20 -1.70) and the tubes centrifuged at 3000 rpm for 5 minutes. The 
schematic sketch of steps involved in the protocol is provided in Figure 2.2. The resulting 
supernatant is decanted and 1 ml transferred with pipette into ICP-MS tubes previously 
holding 9.0 ml of 0.1 M HNO3 solution. The contents of the ICP-MS tubes were 
refrigerated (< 4°C) prior to analysis. 
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Figure 2.2: Sketch of the steps involved in the of the oral bioaccessibility test 
 
G – Gastric phase and G+I – Gastrointestinal phases 
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Similarly 4.5 ml of saliva fluid was added into the extraction tubes with samples labelled 
the ‘gastrointestinal phase’, capped, placed on fitted wooden rack and manually shaken. 
The mixture was allowed to stand for 15 minutes before 6.75 ml of the simulated gastric 
fluid was added into each of the tubes, capped and placed in the extractor-incubator for 1 
hr and retrieved. After the extraction pH of resulting mixture was taken (range 1.20 -1.70), 
13.5 ml of duodenal fluid and 4.5 ml of bile fluid were added,  the tubes capped and 
shaken thoroughly. The pH of the mixture was measured and adjusted with 37% HCl or 
1M NaOH to keep within method allowable range (5.80 – 6.80), tubes capped and placed 
in the incubator for 4 hours. Retrieved and centrifuged at 3000g for 5 minutes. The 
resulting supernatant is decanted and 1 ml transferred with pipette into ICP-MS tubes 
previously holding 9.0 ml of 0.1 M HNO3 solution. The contents of the ICP-MS tubes were 
refrigerated (< 4°C) prior to analysis. 
The accuracy of the oral bioaccessibility procedures used in this study was evaluated with 
a new oral bioaccessibility reference material donated by the Medical Geology Team, 
British Geological Survey (BGS). The BGS Guidance Material 102- ironstone soil was 
prepared from naturally contaminated soil from North Lincolinshire. The CRM has certified 
values (13 ± 6 mg/kg) for Pb the stomach phase and (5.4 ± 2.4 mg/kg) for As in the 
stomach and intestinal phase. Bioaccesssibilty test were conducted in triplicate for all 
samples. For every extraction run of nine test samples, a procedural blank and an aliquot 
of CRM BGS 102 was included. Quality control data for CRM BGS 102 is provided in 
Section 3.4.1. 
2.6. Inductively Coupled Plasma Mass Spectrometry (ICP-MS) analysis of 
PHEs 
2.6.1 Introduction 
The US EPA has produced ICP-MS method 6020A which describes the multi-elemental 
determination of analytes by ICP-MS in environmental samples and the method has 
demonstrated acceptability on solid and aqueous wastes samples for a wide range of 
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elements including those of relevance in this study (USEPA, 2007b). The ICP-MS 
equipment (ICP mass spectrometer X Series 2) employed in this study complies with the 
method 6020A requirements (Thermo Scientific, 2007). ICP-MS is a highly sensitive 
technique that is complemented by a very wide dynamic range (ThermoFisher Scientific, 
2007).  
2.6.2 Instrumentation 
The instrumentation consist of five basic units: 1) generation of aerosol from sample, 2) 
ionization of sample in the ICP torch, 3) extraction of analyte ions through pumped 
vacuum interface, 4) separation of analyte ions on the basis of their mass-to-charge ratio 
by the mass spectrometer and 5) detection of ions by channeltron electron multiplier and 
calculation of concentrations (USEPA, 2007; ThermoFisher Scientific, 2007). Schematic 
sketch of the five basic components of ICP-MS is shown in Figure 2.3. 
Figure 2.3: The components of the ICP-MS equipment  
 
Adopted from ThermoFisher Scientific, 2007 
(1) Aerosol generation: A peristaltic pump passes the liquid sample to the nebulizer where 
a high velocity argon gas stream is passed at right angles to shear the liquid into very fine 
aerosols (< 10 µm) (Thomas, 2004; ThermoFisher Scientific, 2007; Perkin Elmer, 2011). 
The aerosol is filtered and homogenized in a spray chamber (impact bead spray 
chamber), with the aerosols of the right sizes transported from the spray chambers to the 
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torch by flow of gas through the nebulizer (Thomas, 2004; ThermoFisher Scientific, 2007; 
Perkin Elmer, 2011).  
 (2) Ionization of sample: The plasma torch consist of three concentric tubes and the 
passage of argon through these tubes that are wrapped by radio frequency coil which gets 
energy (typically 750 – 1500 W) supply from a radio frequency generator produces a high 
voltage spark that stripes electrons from the argon atom (Thomas, 2004; Perkin Elmer, 
2011). The mixture of argon atoms and electron is referred to as the plasma with a 
temperature range from 6000 – 10000o Kelvin and at this temperature most elements 
achieve their first ionization potential (Thomas, 2004; ThermoFisher Scientific, 2007; 
Perkin Elmer, 2011). The fine aerosols generated in the previous section on their way to 
the plasma are dried to solids and as they travel through the plasma the atoms absorb 
more energy and consequently releasing electrons to form singly charged ions that exit 
the plasma to the interface region (Figure 5) (Perkin Elmer, 2011).  
(3) Ion extraction: There is a large temperature (6000K and room temperature) and 
pressure (760 Torr and 2 Torr) difference between the ionization and interface regions 
and the later allows plasma and analyte ions to coexist (Thomas, 2004; ThermoFisher 
Scientific, 2007; Perkin Elmer, 2011). The interface consists of sampler and skimmer 
cones with very small orifices (about 1 mm) which are maintained at very low pressure 
with the aid of mechanical roughing pumps and protected from the plasma temperature by 
insertion in water cooled metallic casing (Thomas, 2004; ThermoFisher Scientific, 2007; 
Perkin Elmer, 2011). The role of the interface component is to maximize the number of 
ions reaching the mass spectrometer, whilst eliminating gas loadings associated with the 
ions (Thomas, 2004). Between the cones and the mass spectrometer is situated the ion 
lenses that allows beams extracted from the plasma to be focused (since the charge on 
the lens is same as charge on the ions) and mobilized towards the quadrupole mass 
analyser (Thomas, 2004; Perkin Elmer, 2011). 
(4) Ion separation by mass spectrometer: The quadrupole consist of 4 cylindrical or 
hyperbolic metallic rods of approximately 15 – 20 cm in length and 1 cm in diameter and 
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are operated at a frequency of 2 – 3 MHz and maintained at a pressure of 10-6 Torr 
(Thomas, 2004; Perkin Elmer, 2011). The mass analyzer works by allowing only one 
mass to pass through to the detector and the separation of the singly charged ions is 
based on the mass-to charge ratio (Perkin Elmer, 2011). The quadrupoles achieves the 
separation by rapidly selecting optimal AC/DC ratios on each pair of rod and this enables 
ions of selected mass to pass through the rods to the detector whilst the others collide 
with the rods (Thomas, 2004). 
(5) Detection of ions: The channeltron is an open glass cone coated with a 
semiconductor-type material which generates electrons as ions strikes them (Thomas, 
2004). The ions exiting the mass analyser are attracted to the high negative potential of 
the cone and consequently the ions strike the active surface of the detector and generate 
secondary electrons (Thomas, 2004; ThermoFisher Scientific, 2007; Perkin Elmer, 2011). 
The potential difference between the active surfaces induces further collisions down the 
detector and the cascading of electrons continues several times to generate millions of 
electrons for one initial ion strike (ThermoFisher Scientific, 2007). The generated electrical 
pulse is detected by a fast preamplifier which processes it to a digital discriminator and 
counting circuitry which recognizes only pulses above certain threshold values 
(ThermoFisher Scientific, 2007). The pulses are converted to readable data and 
concentrations by the software (Perkin Elmer, 2011). 
2.6.3 Quantitative analysis 
Quantitative methods available in ICP-MS include: semi quantitative (this method enables 
the confirmation of the presence or absence of elements of interest by the determination 
of concentrations of about 80 elements in unknown solutions without the use of calibration 
standards), isotope dilution (this is an absolute means of quantification for a particular 
element and involves the addition of a known concentration of one of the natural isotopes 
of the element), isotope ratio (this method measures the exact ratio of two specified 
isotopes of a given element), internal standardization (this involves the prior addition of 
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isotope(s) to the blank solution, standard solution and sample solution to correct for 
changes in analyte sensitivity due to variations in matrix and concentration range) and 
quantitative analysis (this method determines analyte concentrations in unknown 
samples) (Thomas, 2004). In the quantitative analysis mode the instrument is calibrated 
by measurement of the intensity of elements in a series of known calibration standards 
with a concentration range similar to concentrations anticipated in the unknowns and the 
instrument creates a calibration curve of intensity versus concentration for the elements 
(Thomas, 2004). The unknown samples are analysed by comparison of observed intensity 
of unknowns with calibration curves and with the aid of ICP-MS software the equivalent 
concentrations are listed (Thomas, 2004). In this study the methods adopted are the 
quantitative analysis and internal standardization. The US EPA recommended internal 
standards are 6Li, 45Sc, 74G, 89Y, 103Rh, 115In, 159Tb, and 165Ho (USEPA, 2007). 
In this study the aqua-regia digests and the UBM extracts were analysed for their PHEs 
contents with an ICP-MS instrument (X Series 2). The instrument was optimised daily 
using the built –in PlasmaLab software procedure and calibrated with internal standards 
The ICP – MS operating conditions are given in Table 2.2. ICP-MS standards solutions (0, 
20, 40, 60, 80, 100, 200, and 400 ng/ml) were prepared from ICP multi-element standard 
solutions after appropriate dilution with 1 % HNO3 solution for external calibration and the 
regression equations data are listed in (Section 3.4.1). All extracts, digests, procedural 
blanks, quality control solutions, and standard solutions were spiked with single element 
standard solutions of 45Sc, 115In and 156Tb to correct for instrument drift (non-spectral 
interferences). ICP-MS equipment detection limits for the PHEs investigated were 
calculated as the product of the standard deviation of ten blank solutions measurements 
and 3 (i.e. 3σ) (Richaud et al., 2000). Quantification limit of PHEs studied were calculated 
as the product of the standard deviation of ten procedural blank solutions measurements 
and 10 (i.e. 10σ) (Richaud et al., 2000). The calculated limits of detection and limits of 
quantification are provided in (Section 3.4.1). 
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Table 2.2: ICP-MS instrument configuration and settings  
Instrument: ICP mass spectrometer X Series II (Thermo Electron Corporation, 
Cheshire, UK  
Conditions Standard Mode CCT* Mode 
Nebulizer gas flow 
(L/min) 
0.83 0.83 
Forward Power (W) 1400 1400 
Cool gas flow 
(L/min) 
13.0 13.0 
Dwell time per 
isotope (ms) 
10 10 
Collision cell gas 
(L/min) 
NA 4.75 (7%H2/93%He) 
Quadrupole bias (V) -1.0 -14.0 
Hexapole bias (V) 0.0 -16.0 
Internal standards 45Sc, 115In and 159Tb  45Sc, 115In and 159Tb  
Isotope monitored 111Cd, 208Pb,  Mn55,  63Cu, 66Zn, 75AS ,  
NA -  not applicable 
*  - CCT (collision cell technology) mode 
2.7 X-ray Diffraction analysis 
X-ray diffraction (XRD) occurs when x-rays are scattered by atoms arranged in an orderly 
array in crystals and XRD analysis involves the control and measurement of angular 
relations between the incident and diffracted radiations (Langford and Louer, 1996; Harris 
and White, 2007). X-ray diffractometer records the intensity of the diffracted beam 
electronically at precise angles as the test sample is scanned (Harris and White, 2007). 
Basic components of an x-ray system are illustrated in Figure 2.4. The main components 
are a generator which supplies high voltage to the x-ray tube, the sealed x-ray tube 
supplies x-radiation, beam collimator functions as optical collimating and beam focusing 
tool, the focal plane of the diffractomer where test samples are mounted and the detector 
which receives the coherently scattered rays from the sample, integrates and produces 
output voltage that is proportional to the energy of the incident ray (Langford and Louer, 
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1996; Harris and White, 2007). XRD is used for the identification of mineral phases 
present in unknown samples and the process is based on the comparison of experimental 
data with d spacing and peak intensities contained in a data base, this search is facilitated 
by the use of computers (Harris and White, 2007).  
Figure 2.4: XRD basic components  
 
Adopted from Morris et al., 2008 
In this study in order to concentrate the minerals likely to host the PHEs under 
investigation heavy media were separated from the <250 µm sub-samples using lithium 
polytungstate (LST Fastfloat). A few mg of each heavy media fraction were mounted using 
a small drop of acetone onto a ‘zero background’ silicon crystal substrate. Sample mounts 
were scanned from 4.5-85°2θ at 2.76°2θ/minute using a PANalytical (Almelio The 
Netherlands) X'Pert Pro series diffractometer connected to a cobalt-target tube, 
X'Celerator detector and operated at 45kV and 40mA.  The diffraction data were then 
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analysed using PANalytical (Almelio The Netherlands) X'Pert Pro software coupled to the 
latest version (2010) of the International Centre for Diffraction Data (ICDD) database. 
Samples in this study were analysed by Dr. Simon Kemp (British Geological Survey). 
2.8 Mastersizer particle size analysis 
Particle size analysis techniques include microscopy, sieving, sedimentation, electrozone 
sensing and laser light scattering (Rawle, 2000; Horiba Scientific 2012). Sieving is a 
traditional, cheap and easy to use technique, the sedimentation method is based on 
Stokes’ law and not very suitable for emulsions and dense materials, the electrozone 
sensing (coulter counter) method involves the passage of dilute suspension through the 
orifice of a glass vessel whilst monitoring the variations in capacitance, the microscopy 
method allows one to evaluate the shape of particles of interest and the presence of 
agglomerates in suspensions, and the laser light diffraction method relies on the fact that 
diffraction angle is inversely proportional to particle size (Rawle, 2000). The laser light 
scattering technique is the preferred method in industries for quality control (Rawle, 2000) 
and is the method employed for particle size analysis in this study. Basic components of 
laser light scattering equipment are illustrated in Figure 2.5. 
The instrument consists of: helium-neon laser source, lenses for focusing beams, 
apertures for improving optics quality, the sample cell for holding the test suspension, 
photomultiplier tube to detect the radiation from the sample cell. The amplifier / 
discriminator screens incoming radiations and amplify same, whilst the autocorrelator is 
for photon counting and computer for the display of readable data (McConnell, 1981).  
In this study to validate the PM10 extraction process (as detailed in section 2.24) the sub-
samples from the resulting particulate suspensions were analysed for particle size 
distribution with a laser light scattering particle size analyzer (Malvern Mastersizer 2000, 
Marlvern Instruments, Ltd UK).   
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Figure 2.5: Basic components of laser light scattering equipment  
 
Adopted from McConnell, 1981 
2.9 Summary 
This chapter presents the methods applied for sample preparation, PM10 extraction, 
microwave-assisted acid digestion, oral bioaccessibility, and the instrumentation for ICP-
MS, X-ray diffraction and laser light particle size analyser equipment employed.  
Each sample was air-dried and sieved through < 250 µm nylon mesh. The < 250 µm soil 
fraction preferentially sticks to hands (USEPA, 2000) and is the fraction recommended for 
bioaccessibility testing (Environment Agency, 2005; USEPA, 2008a). For the PM10 
extraction portions of the < 250 µm fractions were further seized with 63 µm sieve. The < 
63 µm particle density was measured using a water displacement technique (Blake and 
Hartge, 1986). Suspensions of the < 63 µm particles were prepared in de-ionized water 
and based on Stokes’ law-equation sedimentation time for particles larger than PM10 in a 
100 mL measuring cylinder was estimated and applied for the extraction of PM10 from the 
< 63 µm particles. All extracted particulate matter were dried in desiccators and stored for 
the tracheobronchial bioaccessibility study. For quality control sub-samples from the 
36 
 
resulting particulate matter suspensions analysed for grain size distribution with a laser 
light scattering particle size analyzer (Malvern Mastersizer 2000, Marlvern Instruments, 
Ltd UK) to determine the particle size of solids extracted. 
The rapid microwave assisted multi-element extraction protocol using HNO3 – HCl 
(Method 3051A) recommended for PHEs (e.g. As, Cd, Cu, Mn, Pb, Zn) in sediment, 
sludge and soil by the USEPA (USEPA, 2007a) was applied in this study for the 
determination of both total and residual PHEs concentrations. In this study the HNO3 – 
HCl (in the ratio 3:1 v/v) and 0.5 g sub-sample weight specified in method 3051A were 
used. Extractions were conducted using microwave digestion system (Milestone Start D 
EthosEZ) at previously optimized conditions: at power- 750 watts the temperature regimes 
were 0 to 160 oC (15 minutes), held at 160 oC (10 minutes) and cooling for 30 minutes 
(Okerie et al., 2011). The resulting extracts were prepared for ICP-MS analysis. 
The BioAccessibility Research Group Europe (BARGE) developed a robust methodology 
for estimating scientifically realistic bioavailability factors to be applied in general and site-
specific risk assessments (Wragg et al., 2009) and this method was applied in this study. 
The procedure involves three analyses on each sample: 1) a simulated gastric phase, 2) a 
simulated gastrointestinal phase and 3) a pseudo total analysis using microwave assisted 
acid digestion (hereto referred to as total).  
The ICP-MS equipment (ICP mass spectrometer X Series 2) employed in this study 
complies with the method 6020A (multi-elemental determination of analytes by ICP-MS in 
environmental samples) requirements (Thermo Scientific, 2007). The ICP-MS equipment 
was used for the analysis of PHEs in the aqua-regia digests and the UBM extracts.  
For the identification of PHEs mineral phases present in samples, subsamples (< 250 µm) 
were submitted to Dr Simon Kemp (British Geological Survey) for XRD analysis. The 
process involved heavy media separations and analysis of the resulting fractions using 
PANanalytical X’Pert Pro series equipped with a cobalt-target tube with X’Celerator 
detector operated at 45 kV and 40 mA. 
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Chapter 3: Oral Bioaccessibility of Potentially Harmful Elements 
from Environmental Matrices and Implications for Human Health  
3.1 Introduction 
3.1.1 Mobility of PHEs 
The mobilisation of PHEs (As, Cd, Cu, Pb and Zn) associated with different mineral 
phases in metallliferous waste by rain water washout, fluvial and aeolain mechanisms has 
led to their enrichment in variety of environmental media (Hudson-Edwards et al., 1997; 
Fytianos et al., 2001; Eggleton et al., 2004; Hofmann and Schuwirth, 2008; Bird et al., 
2009; Dennis et al., 2009). In the environment the mobility of PHEs depends also on 
solubility, and solubility could be limited by physical processes like precipitation, 
coprecipitation or adsorption (Markiewicz-Patkowska et al., 2005). These elements can be 
released into drinking water (e.g. Kobayashi et al., 2009), edible vegetation (e.g. Zaman 
and Zereen, 1998; Komárek et al., 2007), house dust (e.g. Bosso et al.,  2008) and soils 
(e.g. Jung and Thornton, 1996; Birke and Rauch, 2000) and humans can contact them 
through ingestion (either deliberate or involuntary), inhalation and dermal absorption 
(Sedman, 1989; Abrahams, 1997; Abrahams, 1999; Abrahams, 2002; Abrahams et al., 
2006; 2012). The ingestion route has been identified as significant for PHEs uptake from 
soil and dust for children due to their characteristic hand-to-mouth habit (Hwang et al., 
1997; Schelwald, 2001), and adults practising geophagy (Abrahams, 2002; Abrahams et 
al., 2006).  
3.1.2 Human Health Risk Assessment 
Soil generic assessment criteria (GAC) have been developed as screening tools to assess 
the risks to human health from persistent exposure to contaminated soil; and exceedance 
of this concentration may trigger an unacceptable human health effects (DEFRA, 2011b; 
Nathanail et al., 2009). Generic soil screening values are used to assess risk to human 
health based on the land use scenario applicable at a given site (Nathanail, 2005; 
DEFRA, 2011; Nathanail et al., 2009). The fraction of ingested soil-bound PHEs relevant 
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for human health risk assessment is still a subject of research. The assumption in GAC is 
100% of the contaminant is released from the soil and subsequently absorbed during its 
passage through the human body. This over-simplification ignores mineral assemblage 
immobilized fractions of the PHE within the contaminated soil (Gupta et al., 1996; Davis et 
al., 1996; Schelwald, 2001). 
 A reliable risk assessment must account for the bioaccessible/bioavailable fraction of 
PHEs in their different solid phases exposed to receptors (Ruby et al., 1999). Early 
bioavailable estimates of PHEs in soil were based on in vivo studies in animals, but given 
the associated cost and constrains involved, it became clear that alternatives protocols 
are required (Ruby et al., 1999). Cheap and accurate estimation of PHEs bioavailability 
can significantly impact on risk assessment practice. The in vitro extraction tests are 
predictive of oral PHEs bioaccessibility/bioavailability from soil (Ruby et al., 1999). An 
emerging testing tool is the bioaccessibility testing protocol which aims at eliminating 
differences that exist between test animals applied in the process of obtaining Health 
Criteria Values (HCVs) and human (Nathanail and McCaffrey, 2003). 
3.1.3 Oral Bioaccessibility 
Oral bioaccessibility is defined “as the fraction of a substance that is soluble in the 
gastrointestinal environment and is available for absorption” (Ruby et al., 1999 page 
3698). There are several in vitro digestive models in use for contaminants in food and 
environmental matrices, and reviews (Ruby et al., 1999; Oomen et al., 2002; Wragg et al., 
2003; Intawongse and Dean 2006; Hur et al., 2011; and Abrahams, 2012) indicate most of 
the models have been developed to estimate oral bioaccessibility of PHEs in soil. The 
Bioaccessibility Research Group of Europe (BARGE) developed a robust multi-step 
procedure that tends to closely mimic the processes of food digestion in the different 
compartments (mouth, stomach and intestine) of the human digestive system. The unified 
BARGE method (UBM) is currently in use (e.g. Denys et al., 2009; Button et al., 2009, 
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Roussel et al 2010, Broadway et al., 2010; and Okorie et al., 2011). The same protocol 
was adopted for this study. 
3.2 Study Area 
Mitrovica is within the vicinity of the Zvecan Industrial Complex and is divided physically 
by the Ibar and Sitnica Rivers into Northern and Southern Mitrovica (Figure 3.1). The 
economy of the region has been dominated by metallurgical industries associated with the 
‘Trepca’ enterprise.  ‘Trepca’ refers to a group of metallurgical industries that have 
operated in Northern Kosovo concerned with the mining, flotation, smelting and 
processing of Pb ores.  Metal mining and smelting within the region has been occurring for 
over 200 years, however, since the Kosovan War of 1998-1999, ore production and 
smelting operations have been suspended (UNEP, 2010). The major ore deposit is 
located at Stari Trg and comprises a Miocene-age Pb-Zn-Ag skarn deposit in the form of a 
massive to submassive lens and occasional sulphide veins hosted within Palaeozoic-age 
host geology (MonTec, 2007; Borgna et al., 2009; UNEP, 2010). Stari Trg is located in the 
Trepca valley north-east of Mitrovica (Figure 1) and has accounted for 40-50% of ore 
production, with average ore grades of 8% Pb, 6% Zn and 102 g t-1 Ag (Sostaric et al., 
2011).  Metal ores were floated down-valley at Tuneli Pare and smelted at Zvecan (Figure 
3.1) along with ores from elsewhere within the region.  Tailings produced from ore flotation 
were stored in the Zharkov Potok tailings pond and Gornje Polje tailings dump (Figure 
3.1). Smelter slag from the Zvecan smelter is also stored on the Gornje Polje site, which is 
located adjacent to the River Ibar (Figure 3.1). Total quantities of metalliferous waste at 
Zarkov Potok and Gornje Polje are estimated to be 9 x 106 and 12 x 106 tonnes (UNEP, 
2010), respectively. Additionally, industrial waste generated by a former Zn electrolysis 
plant and Pb battery factory in south east Mitrovica, covers an area of approximately 35 
hectare on the banks of the Sitnica River (UNEP, 2010) (Figure 3.1).  
The conflict between Kosovo Albanians and Serb forces from 1998 to 1999 affected the 
Roma population in Roma Mahalla (Kim, 1999). Refugees resulting from the armed  
40 
 
Figure 3.1: Map of sampled locations in Mitrovica  
 
Adopted from FLUVIO, 2010 
 
conflict were initially relocated to temporary camps at Cesmin Lug and Zitkovac. The 
Cesmin Lug camp is close to the Gorne Polje tailings dump and immediately downwind of 
the Zvecan smelter (Figure 3.1) (Brown et al., 2010; FLUVIO, 2010). The proximity of the 
refugee camps to the Trepca lead-zinc beneficiation mill, mines and associated slag 
heaps indicated the possibility of exposure to PHEs. Consequently the post-conflict 
transitional administration of Kosovo coordinated by the United Nations Interim 
Administration in Kosovo (UNMIK) commissioned a report in 2000 to address the concern 
(Human Right watch, 2009). The report recommended the commencement of; 
 epidemiological studies,  
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 periodic environmental sampling, 
 medical monitoring, 
 medical treatment 
By 2004, local and international interest groups had started highlighting some lead 
poisoning related symptoms in children residing at the camps. Symptoms like- black 
gums, anxiety, learning difficulties, headaches, convulsions and high blood pressure were 
reported (Brown and Brook, 2007; Human Right Watch, 2009). Consequently UNMIK 
dismantled the camps at Kablare and Zitkovac, and relocated the displaced person to a 
former Kosovo force (KFOR) camp at Osterode (Figure 3.1). However, subsequent 
analysis of the soil at the Osterode camp also showed very high nitric acid extractible 
PHEs (FLUVIO, 2010). 
In response to the concerns raised following reports of contaminated soils at Cesmin Lug 
and Osterode camps, the British Foreign and Commonwealth Office commissioned 
FLUVIO (UK based environmental consultants) to find land areas at Roma Mahalla and 
Bosniak Mahalla with low risk to human health where permanent homes could be 
constructed for the Roma people. The samples for the bioaccessibility study were sourced 
from one of the consultants involved in the FLUVIO project at Mitrovica.  
3.3 Materials and method 
3.3.1 Sampling and preparation 
Sixty three samples (< 250 µm fraction) including soils, mine tailings and smelter wastes 
were employed for the oral bioaccessibility testing and their origin, matrix and preparation 
method are detailed in section 2.1.1.  
3.3.2 Oral Bioaccessibility testing 
The equipment and reagents used for the in vitro gastrointestinal extractions (Wragg et 
al., 2009) are listed in section 2.1.4.1. All synthetic fluids employed for the oral 
bioaccessibility testing were prepared after Wragg et al. (2009). Details of preparation 
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steps for the fluids are provided in section 2.1.4.1. The bioaccesssibilty tests were 
conducted in triplicate for all 63 samples and details of the process and quality control are 
provided in section 2.1.4.3. The quality of data obtained was assessed as listed in section 
2.4.3 and results are provided in section 3.4.1. 
3.3.3 Microwave-assisted acid digestion  
The < 250 µm size and the non-bioaccessible fractions were subjected to microwave-
assisted acid digestion (method 3051A) to obtain data required for bioaccessibility and 
mass balance calculations. Details of the method, quality control and microwave extractor 
operational conditions are provided in section 2.1.3. 
3.3.4 X-Ray Diffraction analysis 
To inform the interpretation of the bioaccessibility data representative samples (n = 15; 10 
soils, 2 tailings and 3 smelter wastes) from the list subjected to bioaccessibility testing 
were analysed for their mineralogical composition by X-Ray Diffraction (XRD) at the 
British Geological Survey. The X-ray diffraction method employed is available in section 
2.2.2. 
3.3.5 Determination of PHEs by ICP-MS 
To 1 ml of supernatant obtained from UBM test and filtrates of digestate solutions from the 
microwave-assisted acid digestion were transferred with pipette into ICP-MS tubes 
previously holding 9.0 ml of 0.1 MHNO3 solutions and spiked with internal standards for 
the ICP-MS analysis. The ICP-MS instrument optimization process, calibration solutions, 
internal standards, configuration and setting details applied for this study are listed in 
section 2.2.1.4. The quality of measurement made on the ICP-MS was evaluated based 
on data generated for the standard solutions, and for every ten samples analysed on the 
ICP-MS a blank and duplicate standards were included. 
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3.3.6 Calculation of % oral bioaccessibility 
To estimate the concentration fraction of each element that is potentially available for 
intestinal absorption, the percentage oral bioaccessibility fraction (% BAForal) was 
calculated. The % BAForal is calculated as the ratio of the bioaccessibility fraction and the 
pseudo-total fraction of PHE concentration multiplied by 100. Mathematically this can be 
expressed as: 
% BAForal = [ Cbioaccessibility / Cpseudo-total ] x100                               (3.1) 
Where; 
Cbioaccessibility is the concentration (mg/kg) of PHE released from soil in the stomach phase 
or the stomach-intestinal phase. 
Cpseudo-total is the concentration (mg/kg) of PHE extracted with aqua regia. 
3.3.7 Risk Characterisation 
3.3.7.1 Soil ingestion exposure assessment  
There are a number of approaches to estimating human health risk, and the approach 
used here is based on calculating the PHE daily intake (PHE DI) from incidental ingestion 
of topsoil, based on three different scenarios. The first assumed that 100% of PHEs 
ingested by children were bioaccessible; a conservative approach commonly used in the 
absence of bioaccessibility data. The calculated estimated is referred to as ‘total’. The 
second scenario assumes that the only fraction of PHE soluble in the gastric fluid is 
available for uptake and this approach is used when available bioaccessibility protocol is 
for the gastric phase. In this approach the total concentration is multiplied by the gastric 
BAF and the estimate intake is referred to as ‘gastric’. The third approach is based on the 
assumption that the human digestive system absorption occurs mainly in the 
gastrointestinal phase; in this approach the total concentration of a PHE is multiplied with 
the gastrointestinal BAF and estimate is referred as ‘gastrointestinal’. 
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PHE DI (µg PHE kg-1 body weight [BW] d-1) has been calculated for children (3 to < 6 
years) given their known sensitivity to metal uptake: 
PHE DI = (EC)(SIR) (ED) / (BW)                                  (3.2) 
Where, EC is the PHE concentration (as total or bioaccessible fraction in %), SIR is the 
soil ingestion rate (mg day-1), the BW, defined as 18.6 kg for a 3 to < 6 year old child 
(USEPA, 1989) and ED is the exposure duration (unitless; estimated to be 1 as exposure 
could be up to 24 hrs per day, 365 days a year, given the critical receptor is a child under 
6 and may spend the whole day in and around the home (Hemond and Solo-Gabriele, 
2004). As noted by Pouschat and Zagury (2006), SIR values have been reported in the 
literature that range from 0.009 to 8 g day-1, however the 100 mg d-1 value has been 
suggested following a detailed review by USEPA (2008).  
3.3.7.2 Toxicity assessment 
Toxicity assessment is a chemical-specific evaluation of the quantitative dose-response 
relationship in exposed population (USEPA, 2011). Dose-response evaluation entails 
establishment of the relationship between dose of a chemical contaminant potentially 
received and the adverse health effects in exposed population (USEPA, 2011). For a 
chemical two categories of health effects are usually considered; cancer and non-cancer 
health effects and numerical toxicity values are available from regulatory agencies for the 
assessments. To assess the potential carcinogenic health effects from exposure to a 
chemical two approaches are employed; the weight-of-evidence or cancer slope factor 
(the upper-bound estimate of response per unit intake of a chemical over lifetime) 
(USEPA, 1986; 2011). The slope factor for a chemical agent is selected from the most 
appropriate data base or from series of studies that support an estimate (USEPA, 2011). 
For non-cancer health effect, the quantitative risk assessment is based on the use of 
toxicity reference values (e.g. reference dose). Reference dose (RfD) is the daily oral 
intake rate of a chemical agent that is estimated to pose no appreciable risk of adverse 
health effects, even to sensitive population (USEPA, 2005). The basis of RfD can be from 
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human oral data, but in the absence of human data animal data are used (USEPA, 2011). 
In studies for setting RfD, the toxic effects are characterised by either the ‘Lowest-
observed-adverse-effect-level (LOAEL) or the ‘No-observed-adverse-effect-level (NOAEL) 
and to account for uncertainties bound in extrapolations uncertainty and modifying factors 
(MF) are usually applied (USEPA, 2011). The uncertainty factors (UFs) (multiples of 10) 
are used to adjust observed dose for variations in general population, inter-species 
differences and differences between LOAEL and NOAEL (USEPA, 2011). The modifying 
factor usually range between > 0 to 10 and reflects a qualitative assessment of additional 
uncertainties in the whole data base (USEPA, 2011). The RfD is calculated as (USEPA, 
2011): 
RfD = NOAEL or LOAEL / (UF1 x UF2 .... x MF)                  (3.3) 
One of the approaches recommended by the USEPA for the indicative estimate of non-
cancer hazard is the hazard quotient (HQ) approach (USEPA, 2005). The HQ for a given 
PHE exposed to human population is evaluated by comparing estimated xenobiotic intake 
dose (PHE DI) to the no-effect-level dose (i.e. RfD for oral exposure or RfC for inhalation 
exposure) (Tannenbaum, 2005; USEPA, 2005). The larger the HQ value, the higher 
chance of adverse effect occurring (USEPA, 2005). The HQ is a level of concern and is 
calculated as (Tannenbaum, 2005; USEPA, 2005):  
HQ = PHE DI / RfD                                                                 (3.4) 
Where;  
HQ  = hazard quotient (Unitless) 
PHE DI = average daily intake dose of a PHE (mg/kg.d) 
RfD = reference dose (mg/kg.d)  
This method of estimating non-cancer risk has been previously applied to soils and soil-
like samples from mining and smelting sites (e.g. Lee et al., 2006; Lim et al., 2008; Zheng 
et al., 2010), and same approach is applied in this study for As, Cd, Cu, Mn, Pb and Zn. 
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3.4 Results and Discussion 
3.4.1 Quality control 
The external calibration curves showed good linearity with correlation coefficients above 
0.9989 (Table 3.1a). Limits of detection and limits of quantification for PHEs are listed in 
Table 3.1a. Analytical quality control data is summarised in Table 3.1b for the microwave-
assisted acid (aqua-regia) digestion and the oral bioaccessibility test. The certified 
reference material, BCR 143R (sewage sludge amended soil certified for aqua regia 
extractable PHEs) for the extraction of the total concentrations of PHEs has certified 
values for Cd, Mn, Pb and Zn. For the Cd, Mn, Pb and Zn the range of mass recovery % 
is from 96 to 103 %. The good recoveries indicates that the micowave-assisted acid 
digestion method is efficient. Certified reference materials for oral bioaccessibility are rare,  
but the BGS guidance material 102 (ironstone soil) was available for this study. The oral 
bioaccessibility guidance material is however certified for only As in the gastrointestinal 
phase and Pb in the gastric phase. For As in the gastrointestinal phase good accurracy 
(94 %) was obtained. For Pb in the gastric phase the guidance range is 54 to 146% and 
the value (62 %) obtained in this study falls within the range. 
3.4.2 Pseudo-total concentrations 
The results for the pseudo-total of As, Cd, Cu, Mn, Pb and Zn investigated are provided in 
Appendix C, D, E, F, G and H, respectively. The total concentrations range for As, Cd, Cu, 
Mn, Pb and Zn in all the samples were 6.03 – 22600 mg/kg, 0.08 – 1440 mg/kg, 23.5 – 
7150 mg/kg, 396 – 111000 mg/kg, 54.0 – 160,000 mg/kg and 30.0 – 250,000 mg/kg, 
respectively. The order of maximum total concentration is Cd < Cu < As < Mn < Pb < Zn. 
The total concentration ranges of the PHEs investigated are diverse in the three matrices 
(smelter waste, soil and tailings) and at the different sample locations. Among the   
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Table 3.1a: ICP-MS detection limits and calibration plots of PHEs  
Element Isotope for 
quantification 
Mode  LOD (µg/L) LOQ (mg/L) in 
G fluid 
LOQ (mg/L) in 
G+I fluid  
External calibration 
regression (y = mx + c) 
Correlation coefficient 
(R2) 
As 75As CCT 0.2 0.04 0.2 196X + 32 0.9995 
Cd 111Cd Standard 0.2 0.2 0.1 3451X + 501 0.9990 
Cu 63Cu CCT 5.2 2.7 3.1 952X + 6443 0.9999 
Mn 55Mn CCT 0.5 0.1 1.6 646X + 258 0.9998 
Pb 208Pb Standard 0.8 1.0 1.6 82677X + 64784 0.9989 
Zn 66Zn CCT 5.0  1.2 1.4 2772X + 17920 0.9998 
Calibration solutions concentration range0 – 400 ppb 
CCT- collision cell technology 
LOD – limit of detection 
LOQ – limit of quantification 
G  – gastric 
G+I - gastrointestinal 
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Table 3.1b: Quality control data for microwave-assisted acid digestion and in vitro bioaccessibility methods 
PHE Microwave-assisted acid digestion  
(BCR 143R) (n = 9) 
In vitro oral bioaccessibility  
(BGS 102) (n = 9) 
 Certified 
total   
Measured 
total         
Mass recovery 
(%) 
 
G-Phase 
fraction 
Certified 
G-Phase 
fraction 
Measured 
G+I-Phase 
fraction 
Certified 
G+I-Phase 
fraction 
Measured 
Accuracy (%) 
 
As NA 8.62 ± 1.1 NA NA 4.81 ± 0.2 5.4 ± 2.4 5.1 ± 0.6 94 (GI) 
Cd 72.0 ± 1.8 69.4 ± 0.2 96 NA 0.47 ± 0.03 NA 0.2  ±0.01  
Mn 858 ± 11 829 ± 24 97 NA 500 ± 10 NA 230 ± 6  
Cu NA 127 ± 1.5 NA NA 7.7 ± 0.2 NA 16.1 ± 0.2  
Pb 174 ± 5.0 180 ± 4.5 103 13 ± 6 8 ± 0.7 NA bd 62 (G) 
Zn 1060 ± 16 1090 ± 52 102 NA 37.4 ± 4.4 NA bd  
NA - data not available.  bd – below detection.  G-Phase - gastric extractable phase.  GI-Phase – gastro-intestinal extractable phase.  
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matrices investigated smelter indicated the highest mean and maximum total 
concentration for As, Cd, Cu, Pb and Zn. 
Smelter samples 
The mean and range of concentrations for As, Cd, Cu, Mn, Pb and Zn in the 6 smelter 
waste samples are 5540 mg/kg (84.0 - 22600 mg/kg), 489 mg/kg (1.00 – 1440 mg/kg), 
2740 mg/kg (83.0 - 7150 mg/kg), 22000 mg/kg (1480 – 71,600 mg/kg), 48000 mg/kg (973 
– 160,000 mg/kg) and 104,000 mg/kg (1250 - 250000 mg/kg), respectively (Table 3.2). 
The mean concentrations of the PHEs in the smelter samples are very high and the 
mobilization of the waste by wind, rain run off water and other human activities can 
disperse the PHEs to adjoining locations. Previous isotopic studies (Prathumratana et al., 
2008; FLUVIO, 2010) have identified the smelter waste dumps as point sources of PHE 
dispersal at the study site. The exceptionaly high concentration of Pb and Zn in the 
smelter related samples observed in this study is consistent with their total contents (Pb: 
7.6% and Zn: 2.9%) in the Pb-Zn-Ag vein type mineralization predominant at Kosovo 
(Sostaric et al., 2011). 
Soil samples 
Soil matrix indicated the lowest mean total concentration of all the PHEs investigated. The 
mean and range of concentrations for As, Cd, Cu, Mn, Pb and Zn in the 52 soil samples 
studied are 57.9 mg/kg (6.03 – 270 mg/kg), 4.32 mg/kg (0.08 – 22.2 mg/kg), 89.2 mg/kg 
(23.5 – 7150 mg/kg), 842 mg/kg (396 – 1630 mg/kg), 2380 mg/kg (54.0 – 16500 mg/kg) 
and 636 mg/kg (30.0 – 3110 mg/kg), respectively (Table 3.2). Comparison of 
concentration levels observed in this study to literature (Borgna et al., 2009) background 
concentrations for As (24.0 mg/kg), Cd (0.50 mg/kg), Cu (30.0 mg/kg), Pb (84.0 mg/kg), 
and Zn (150 mg/kg) highlights significant As, Cd, Cu, Pb and Zn contamination of surface 
soils at the study area. 
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Table 3.2: Descriptive statistics of PHEs total concentrations in matrices  
PHE Matrix Mean Minimum Maximum Median 
  mg/kg 
As Smelter 5,540 84.0 22,600 2,860 
 Soil 57.9 6.03 270 26.4 
 Tailings 2,300 1,070 3,310 2,700 
Cd Smelter 489 1.00 1,440 30.0 
 Soil 4.23 0.08 22.2 2.14 
 Tailings 72.2 1.00 350 2.20 
Cu Smelter 2,740 83.0 7,150 2,120 
 Soil 89.2 23.5 235 74.9 
 Tailings 727 180 2,090 503 
Mn Smelter 22,000 1,480 71,600 8,570 
 Soil 842 396 1,630 831 
 Tailings 27,700 2,810 111,000 5,310 
Pb Smelter 48,000 973 160,000 33,700 
 Soil 2,380 54.0 16,500 929 
 Tailings 6,270 1,330 24,800 1,650 
Zn Smelter 104,000 1,250 250,000 88,800 
 Soil 636 30.0 3110 287 
 Tailings 10,100 214 47,800 527 
Smelter (n = 6), soil (n = 52) and tailings samples (n = 5) 
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Tailings 
The mean and range of concentrations for As, Cd, Cu, Mn, Pb and Zn in the 5 tailing 
samples studied are 2300 mg/kg (1070 - 3310 mg/kg), 72.2 mg/kg (1.00 - 350 mg/kg), 727 
mg/kg (180 - 2090 mg/kg), 27700 mg/kg (2810 - 111000 mg/kg), 6270 mg/kg (1330 - 
24800 mg/kg) and 10100 mg/kg (214 - 47800 mg/kg), respectively (Table 3.2). The 
elevated contents of PHEs in tailings have been highlighted in a previous report (UNEP, 
2010). Also FLUVIO (2010) have suggested tailings as one of the likely source of soil 
pollution at the study site. 
To contextualize the PHEs concentrations and the levels of contamination the samples 
were grouped to their sampling location and descriptive statistics are presented in Table 
3.3  For As samples from Gornje Polje, Zharkov Potok and Zvecan that are mostly 
metallurgic waste indicated mean concentration range from 2300 to 11300 mg/kg with 
Zvecan indicating the highest As concentration, whilst the soil samples from Bosniak 
Mahalla, Mitrovica City Centre, the IDPs and Roma Mahalla indicated mean concentration 
range from 21.5 to 140 mg/kg. For As the mean total concentration is in the order; Zvecan 
(just 2 samples) > Gornje Polje > Zharkov Potok > Bosniak Mahalla > IDPs > Mitrovica 
City Centre  > Roma Mahalla, and the mean concentration of As at Roma Mahalla (21.5 
mg/kg) is similar to the background concentration (24 mg/kg) (Borgna et al., 2009) 
estimated for Mitrovica. The concentration range of the contaminated samples from 
Bosniak Mahalla, IDPs and Mitrovica City Centre (84.8 – 140 mg/kg) is consistent with the 
mean content 105 mg/kg reported (Stafilov et al., 2010) for surface soils within Mitrovica. 
The data suggest no As contamination at Roma Mahalla and this may be due the fact that 
this site is the most distant from likely point sources at Gornje Polje, Zharkov Potok and 
Zvecan (Figure 3.1) (Frese et al., 2004). Expectedly the sites closest to metallurgic waste 
dumps; Bosniak Mahalla, Mitrovica City Centre, the IDPs indicated mean total 
concentration range (84.8 – 140 mg/kg) that is at least about 3.5 times the background 
range. 
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Table 3.3: Descriptive statistics of PHEs total concentrations (mg/kg) at sample locations 
PHE Origin Mean Minimum Maximum Median 
As BM 140 60.2 270 137 
 MCC 84.8 6.00 512 38.4 
 GP 3,350 1,910 4,340 3,810 
 IDPs 93.5 23.0 148 101 
 RM 21.5 13.1 29.4 20.7 
 ZP 2,300 1,070 3,310 2,700 
 Zv 11,300 84.0 22,600 11,300 
Cd BM 11.2 5.52 15.4 12.4 
 MCC 8.31 1.10 51.3 2.69 
 GP 957 1.00 1,440 1,430 
 IDPs 3.35 1.64 5.90 2.78 
 RM 2.11 0.08 22.2 1.22 
 ZP 72.2 1.00 350 2.20 
 Zv 4.94 1.38 8.49 4.94 
Cu BM 174 84.6 235 183 
 MCC 102 32 444 60 
 GP 3,750 323 7,150 3,790 
 IDPs 114 36.6 204 96.2 
 RM 56.7 23.5 113 66.3 
 ZP 727 180 2,090 503 
 Zv 2,370 83.0 4,660 2,370 
Mn BM 946 584 1,630 864 
 MCC 959 396 2,940 871 
 GP 18,700 2,290 39,700 14,200 
 IDPs 1000 679 1,400 927 
 RM 788 575 1,220 808 
 ZP 27,700 2,810 111,000 5,310 
 Zv 36,500 1,480 71,600 36,500 
Pb BM 7,660 2,810 16,500 7,510 
 MCC 3,120 54 20,500 1,340 
 GP 35,600 12,500 47,300 46,900 
 IDPs 2,480 571 4,400 2,600 
 RM 644 329 1,220 598 
 ZP 6,270 1,330 24,800 1,650 
 Zv 80,500 973 160,000 80,500 
Zn BM 1,310 720 2,000 1,210 
 MCC 1,320 30.0 11,700 317 
 GP 140,000 3,000 250,000 166,000 
 IDPs 1,670 272 3,110 1,390 
 RM 219 100 762 191 
 ZP 10,100 214 47,800 527 
 Zv 95,600 1,250 190,000 95,600 
Bosniak Mahalla (BM) (n = 10), Mitrovica City Centre (MCC) (n = 3), Gornje Polje (GP) (n 
= 3), IDPs (n = 7), Roma Mahalla (RM) (n = 25), Zharkov Potok (ZP) (n = 5), and Zvecan 
(Zv) (n = 2) 
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The trend for mean total Cd concentration is: Gornje Polje (957 mg/kg), Zharkov Potok 
(72.2 mg/kg), Bosniak Mahalla (11.2 mg/kg), Mitrovica City Centre (8.31 mg/kg), Zvecan 
(4.94 mg/kg), IDPs (3.35 mg/kg) and Roma Mahalla (2.11 mg/kg) ) (Table 3.3). Similar to 
the trend for As Roma Mahalla indicated the lowest mean Cd total concentration and the 
other locations (Bosniak Mahalla, Mitrovica City Centre, and IDPs) closer to Gornje Polje 
waste (Figure 3.1) indicated higher total Cd concentrations (3.35 – 11.2 mg/kg) in surface 
soils. The range of Cd concentrations at Bosniak Mahalla, IDPs, Mictrovica City Centre 
and Roma Mahalla (3.35 – 11.2 mg/kg) is consistent with those (0.4 – 11.8 mg/kg) 
reported for contaminated soils studied at the same study area by Nannomi et al. (2011). 
The mean total concentration of the metallurgic waste samples from the Zvecan and 
Zharkov Potok (Figure 3.1) is about 1 to 7 % of the mean total concentration of samples 
from the Gornje Polje waste dump, the explanation for the large difference may be due to 
the fact that during smelting processes recoveries as high as 72 – 92 % have been 
observed for Cd (Shiel et al., 2010). 
For Cu the mean total concentration trend is: Gornje Polje (3750 mg/kg), Zvecan (2370 
mg/kg), Zharkov Potok (727 mg/kg), Bosniak Mahalla (174 mg/kg), IDPs (114), Mitrovica 
City Centre (102 mg/kg), and Roma Mahalla (56.7 mg/kg) (Table 3.3). The mean 
concentrations obtained in this study from Bosniak Mahalla, IDPs, Mitrovica City Centre 
and Roma Mahalla (174, 114, 102 and 56.7 mg/kg, respectively) are expectedly 
consistent with those (18, 36, 63, 134,128,101, 43, 89, 35, 31, 50, 35, 38, 26, 27, 23, 18, 
and 69 mg/kg) obtained at the same study area for 18 samples (Nannoni et al., 2011). 
This study suggest Cu pollution in surface soils may have occurred at Bosniak Mahalla, 
IDPs and Mitrovica City Centre since the total Cu concentrations at these sites exceed the 
concentration previously published as background for the study area (30 mg/kg) (Borgna 
et al., 2009). 
The trend for mean total Mn concentration is: Zvecan (36500 mg/kg), Zharkov Potok 
(27700 mg/kg), Gornje Polje (18700 mg/kg) IDPs (1000 mg/kg), Mitrovica City Centre 
(959 mg/kg), Bosniak Mahalla (946 mg/kg) and Roma Mahalla (788 mg/kg) (Table 3.3). 
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The highest mean total Mn concentration was found at the Zvecan smelter which 
produced raw and refined Pb from geological material while operational. Some Pb-bearing 
minerals are rich in Mn (e.g. coronadite- Pb (Mn4+, Mn2+)8 O16 (Kogarko et al., 2007)), thus 
the very high Mn concentration at this site can be expected. At the study area unlike other 
PHEs studied the Mn concentration at Roma Mahalla is as high as those in samples close 
to the metallurgic waste sites and this may be an indication that other sources may also 
have contributed to the distribution of Mn.  
The order of mean total concentration of Pb in samples at the different locations is as 
follows; Zvecan (80,500 mg/kg) > Gornje Polje (35600 mg/kg) > Bosniak Mahalla (7660 
mg/kg) > Zharkov Potok (6270 mg/kg) > Mitrovica City Centre (3120 mg/kg) > IDPs (2480 
mg/kg) > RM (644 mg/kg) (Table 3.3). Products from the Zvecan smelter are raw and 
refined Pb and the premises are littered with them (Frese et al., 2004), therefore that 
waste from this site indicated the highest Pb mean total concentration is not unexpected. 
The level of Pb concentrations at the different locations suggest Pb pollution in surface 
soil, since even the lowest mean concentration obtained at Roma Mahalla is about seven 
times more than the background Pb concentration (84.0 mg/kg) for the area (Borgna et 
al., 2009). The significantly elevated Pb levels found at the sites in this study has 
previously been highlighted (Prathumratana et al., 2008; Borgna et al., 2009; Fluvio, 2010; 
Nannoni et al., 2011) and is consistent with adverse health effects observed at the study 
area (Factor-Litvak et al., 1999; Brown et al., 2010; Wasserman et al., 1997; 2003). 
The mean total Zn concentrations for Gornje Polje, Zvecan, Zharkov Potok, IDPs, 
Mitrovica City Centre, Bosniak Mahalla, and Roma Mahalla are 139668 mg/kg, 95625 
mg/kg, 10100 mg/kg, 1670 mg/kg, 1320 mg/kg, 1310 mg/kg, and 219 mg/kg, respectively 
(Table 3.3). The mean concentration range observed at Bosniak Mahalla, IDPs, Mitrovica 
City Centre and Roma Mahalla (219 – 1670 mg/kg) is consistent with the range (89 – 
1553 mg/kg) previously published for the area by Nannoni et al. (2011). The data from this 
study suggest Zn pollution at all sites except Roma Mahalla which indicated mean total 
concentration of 219 mg/kg that is not significantly different from the soil background 
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concentration (150 mg/kg) for the area (Borgna et al., 2009). The IDPs (Cesmin Lug and 
Osterode) which are closer to the metallurgic wastes dumps (Figure 3.1) expectedly 
indicated the highest mean Zn total concentration for surface soils. 
3.4.3 Bioaccessible PHEs concentration 
Results for bioaccessible PHEs concentrations are given in Appendix C – H and the 
descriptive statistics is provided in Table 3.4. To evaluate the implications of the 
bioaccessible PHE concentrations soil regulatory values from the study area are required. 
However, the Kosovo Environmental Protection Agency (KEPA) is still at its infancy, only 
established in 2003 by UNMIK Regulation No. 2003/9 (UNMIK, 2003). The environmental 
protection framework law basically state that the EU environmental standards shall be 
introduced into the subsidiary and normative law (UNMIK, 2003; Frese et al., 2004). In the 
light of the lack of any specific Kosovan human health risk assessment guidelines, risk 
assessment guidelines of a number of other EU countries (e.g. UK, Dutch and Italy) will 
be taken into consideration. 
For As the smelter wastes and tailings indicated higher bioaccessible concentrations in 
the gastric phase, whilst the soils samples indicated higher bioaccessible concentrations 
in the gastrointestinal phase (Figure 3.2). The mean and range of gastric bioaccessible 
concentrations for the smelter, soil and tailing samples are 331 mg/kg (29.0 – 1,270 
mg/kg), 11.8 mg/kg (1.43 – 46.7 mg/kg) and 137 mg/kg (35.2 – 285 mg/kg), respectively. 
For the gastrointestinal phase the mean and range of bioaccessible concentrations are 97 
mg/kg (19.2 – 305 mg/kg), 14.5 mg/kg (1.44 – 65.6 mg/kg) and 105 mg/kg (44.2 – 119 
mg/kg) for smelter, soil and tailings samples, respectively. The bioaccessible 
concentrations appear to follow the order found in total concentrations where the 
metallurgic waste materials samples indicated elevated As concentrations (Table 3.2). 
Mean bioaccessible concentrations for soil samples in both phases are below the UK soil 
guideline value (32.0 mg/kg dry weight) (Environment Agency, 2009b) for residential land 
use scenario and the Dutch intervention value for remediation (55 mg/kg) (Carlon, 2007)  
56 
 
Table 3.4: Descriptive statistics of the bioaccessible concentrations of PHEs in matrices 
PHE n Phase Matrix Mean Minimum Maximum Median 
    mg/kg 
As 6 Gastric Smelter 322 29.0 1270 175 
 52  Soil 11.8 1.43 46.7 6.05 
 5  Tailings 137 35.2 285 90.0 
 6 Gastrointestinal Smelter 97.4 19.2 305 56.7 
 52  Soil 14.5 1.44 65.6 6.62 
 5  Tailings 105 44.2 162 119 
Cd 6 Gastric Smelter 216 0.12 650 13.0 
 50  Soil 2.38 0.04 14.90 1.22 
 3  Tailings 15.7 0.40 45.8 0.80 
 4 Gastrointestinal Smelter 143 0.34 527 23.0 
 19  Soil 1.26 0.19 4.04 0.86 
 1  Tailings 7.62 7.62 7.62 7.62 
Cu 6 Gastric Smelter 1170 10.0 5200 56.0 
 46  Soil 20.6 4.60 70.8 18.3 
 4  Tailings 132 13.0 473 21.0 
 6 Gastrointestinal Smelter 585 10.0 2120 69.0 
 44  Soil 27.2 5.07 80.6 24.5 
 4  Tailings 203 21.0 664 64.0 
Mn 6 Gastric Smelter 905 43.0 2440 698 
 52  Soil 440 272 679 437 
 5  Tailings 2350 26.0 8550 497 
 6 Gastrointestinal Smelter 595 4.00 1360 460 
 52  Soil 210 138 377 192 
 5  Tailings 667 2.00 2590 226 
Pb 6 Gastric Smelter 11100 154 53300 1680 
 52  Soil 1280 27.0 8370 591 
 3  Tailings 1300 70.0 3750 88.0 
 5 Gastrointestinal Smelter 7380 66.0 25700 1100 
 44  Soil 565 10.0 3250 63.0 
 2  Tailings 870 20.0 1720 870 
Zn 6 Gastric Smelter 25500 151 58500 24300 
 50  Soil 332 3.40 2670 115 
 1  Tailings 11800 11800 11800 11800 
 5 Gastrointestinal Smelter 13200 89.0 23200 19500 
 27  Soil 141 4.80 480 72.8 
 1  Tailings 3170 3170 3170 3170 
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Figure 3.2, but some samples from Bosniak Mahalla indicated bioaccessible 
concentrations above the two regulatory values (indicated as outliers in Figure 3.2). The 
elevated bioaccessible As concentrations observed in this work is consistent with the 
enhanced As concentrations determined from human hair at Mitrovica by Runow (2005). 
Though the smelter and tailing samples indicated higher bioaccessible As concentrations 
than the soil samples, the locations of most the metallurgic waste samples are presently 
classed as abandoned thus their comparison with soil screening values were not 
conducted (Figure 3.2).  
For Cd the smelter, soil and tailing samples indicated higher mean bioaccessible 
concentrations in the gastric phase than the gastrointestinal phase (Figure 3.3). The mean 
and range of gastric bioaccessible concentrations for the smelter, soil and tailing samples  
Figure 3.2: Boxplot of bioaccessible As concentrations for matrices 
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are 216 mg/kg (0.12 – 650 mg/kg), 2.38 mg/kg (0.04 -14.9 mg/kg) and 15.7 mg/kg (0.40 – 
45.8 mg/kg), respectively. In the gastrointestinal phase the mean and range of 
bioaccessible concentrations are 143 mg/kg (0.34 – 527 mg/kg), 1.26 mg/kg (0.19 – 4.04 
mg/kg) and 7.62 mg/kg for the smelter, soil and tailing, respectively. In the gastrointestinal 
phase the outlier points are for samples collected at Osterode and Cesmin lug (IDPs) 
(Figure 3.1). The mean bioaccessible concentration of soil samples in the gastric (2.38 
mg/kg) and gastrointestinal (1.26 mg/kg) phases are below UK soil guideline value (10 
mg/kg dry weight) and the Dutch soil intervention value for remediation (12.0 mg/kg dry 
weight) (Carlon, 2007) for residential exposure (Figure 3.3), but in the gastric phase one 
sample indicated a value above both regulatory values. The high bioaccessible Cd 
concentrations observed for the IDPs is consistent with elevated Cd concentration 
previously determined in human hair at the IDPs by Runow (2005).   
Figure 3.3: Boxplot of bioaccessible Cd concentrations for matrices 
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Mean (  ), outlier (*) Median (-), Upper and lower 75 % distribution of data (I)  
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For Cu, soil and tailings indicated higher mean bioaccessible concentrations in the 
gastrointestinal phase, whilst the smelter wastes indicated higher mean concentration in 
the gastric phase (Figure 3.4). The trend observed for the soil samples in this study is 
consistent with that published by Sialelli et al. (2010) for urban soils from the city of 
Glasglow, UK. The mean and range of gastric bioaccessible concentrations for the 
smelter, soil and tailing samples are 1170 mg/kg (10.0 – 5,200 mg/kg), 20.6 (4.60 – 70.8 
mg/kg) and 132 mg/kg (13.0 – 473 mg/kg), respectively. The gastrointestinal phase mean 
and range of bioaccessible concentrations are 585 mg/kg (10.0 – 2,120 mg/kg), 27.2 
mg/kg (5.07 – 80.6 mg/kg) and 203 mg/kg (21.0 – 664 mg/kg) for the smelter, soil and 
tailing samples, respectively. Some soil samples from the IDP camps and Bosniak  
Figure 3.4: Boxplot of bioaccessible Cu concentrations for matrices 
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Mahalla indicated bioaccessible concentrations far above the mean values in both phases 
(see outliners in Figure 3.4). The mean bioaccessible concentrations in both phases for 
soils are below the Dutch and Italian intervention values (190 and 120 mg/kg dry weight) 
(Carlon, 2007) for residential land use and is consistent with a UNEP report (UNEP, 2010) 
on metal contamination at Mitrovica which excluded Cu from the list of metals of concern 
from soil. The smelter and tailings samples in both gastric and gastrointestinal phases 
indicated higher bioaccessible Cu concentrations than the soil samples but most of the 
metallurgic waste dump sites are not residential. 
The mean bioaccessible Mn concentrations are higher in the gastric phase for all three 
matrices (Figure 3.5). The mean and range of gastric bioaccessible concentrations for the  
Figure 3.5: Boxplot of bioaccessible Mn concentrations for matrices  
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smelter, soil and tailing samples are 905 mg/kg (43.0 – 2,440 mg/kg), 440 mg/kg (272 – 
679 mg/kg) and 2,350 mg/kg (26.0 – 8,550 mg/kg), respectively. The mean and range of 
gastrointestinal bioaccessible concentrations are 595 mg/kg (4.00 – 1,360 mg/kg), 210 
mg/kg (138 – 377 mg/kg) and 667 mg/kg (2.00 – 2,590 mg/kg) for the smelter, soil and 
tailing samples, respectively. For the soil matrix in the gastrointestinal phase two samples 
(one each from Roma Mahalla and Bosniak Mahalla) indicated bioaccessible Mn 
concentrations significantly above the mean value (see outliers in Figure 3.5). The 
elevated bioaccessible Mn concentrations observed for all matrices investigated in this 
work might help explain the high Mn concentrations determined in human teeth studied at 
Mitrovica (Kamberi et al., 2009; Kamberi et al., 2011).  
Pb in all three matrices was more bioaccessible in the gastric phase (Figure 3.6). The 
mean and range of gastric bioaccessible concentrations for the smelter, soil and tailing 
samples were 11,100 mg/kg (154 – 53,300 mg/kg), 1,280 mg/kg (27.0 – 8,370 mg/kg) and 
1,300 mg/kg (70.0 – 3,750 mg/kg), respectively. The mean and range of Pb 
gastrointestinal phase concentrations are 7,380 mg/kg (66 – 25,700 mg/kg), 565 mg/kg 
(10.0 – 3,250 mg/kg) and 870 mg/kg (20.0 – 1,720 mg/kg) for the smelter, soil and tailing 
samples, respectively. The bioaccessible concentrations of a smelter sample (53,300 
mg/kg) and two soil samples (4680 and 8370 mg/kg) in the gastric phase and four soil 
samples (2,070, 2,370, 3,220 and 3,250 mg/kg) in the gastrointestinal phase, were 
exceptionally higher than their associated means (see outliers in Figure 3.6). For the soil 
samples mean bioaccessible concentrations of Pb in the gastric (1,280 mg/kg) and 
gastrointestinal (565 mg/kg) phases are above the former UK CLEA soil guideline value 
(450 mg/kg) (Environment Agency, 2002) and the Dutch intervention value (530 mg/kg) 
(Carlon, 2007) for residential land use scenarios. The observation in this study that most 
samples indicated bioaccessible Pb concentrations above regulatory levels is consistent 
with elevated blood and teeth Pb concentrations recently reported in children and adults at 
the study site (WHO, 2004; Wasserman et al., 2003; Kamberi et al., 2011). 
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Figure 3.6: Boxplot of bioaccessible Pb concentrations for matrices  
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Smelter waste: Pb_G (n = 6), Pb_G-I (n = 5), soil: Pb_G (n = 52), Pb_G-I (n = 44) and 
tailings: Pb_G (n = 5), Pb_G-I (n = 5) 
Mean (  ), outlier (*) Median (-), Upper and lower 75 % distribution of data (I)  
Representing middle 50 % of data (   )   
Pb_G: Gastric Phase, Pb_G-I: Gastrointestinal phase 
Zinc in all three matrices was more bioaccessible in the gastric phase (Figure 3.7). The 
mean and range of gastric bioaccessible concentrations for the smelter, soil and tailing 
samples were 25,500 mg/kg (151 – 58,500 mg/kg), 332 (3.40 – 2,670 mg/kg) and 11,800 
mg/kg (n = 1), respectively. In the gastrointestinal phase the mean and range of 
concentrations are 13,200 mg/kg (89.0 – 23,200 mg/kg), 141 mg/kg (4.80 – 480 mg/kg) 
and 3,170 mg/kg (n = 1) for the smelter, soil and tailing samples, respectively. For soil 
samples the mean bioaccessible concentrations of Zn in the gastric (332 mg/kg) and 
gastrointestinal (141 mg/kg) are below the Dutch intervention value (720 mg/kg) (Carlon, 
2007) for residential land use scenarios but the gastric phase bioaccessible concentration 
is above the Italian soil intervention value (150 mg/kg) (Carlon, 2007) for residential land 
use scenario.  
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Figure 3.7 Boxplot of bioaccessible Zn concentrations for matrices  
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3.4.4 Correlations between bioaccessible and pseudo-total concentrations 
In this study bioaccessible concentration of soil-bound As, Cd, Cu, Pb and Zn in the 
gastric phase indicated strong positive correlations with the pseudo-total concentrations 
(Table 3.5). For soil in the gastrointestinal phase strong positive correlations were also 
observed between the bioaccessible and total concentrations for As, Cu, Pb and Zn. 
Similar positive correlations have been previously reported for soil-bound As, Cd, Cu, Pb 
and Zn by Sarker et al. (2007), Poggio et al. (2009) Sialleli et al. (2010) Farmer et al. 
(2011) Gbefa et al. (2011) Pelftrene et al. (2011) and Sialelli et al. (2011) (Table 3.5). For 
the soil samples in the gastric phase the As, Cd, Cu, Pb and Zn correlation coefficients 
were 0.89, 0.99, 0.88, 0.95 and 0.95 respectively (Table 3.5). The values for Pb (0.95) 
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and Zn (0.95) are consistent with those published by Gbefa et al. (2011) (Pb: 0.93, Zn: 
0.95) for historic lead works site and Sialelli et al. (2011) (Pb: 0.98, Zn: 0.91) for 
contaminated urban soils (Table 3.5). In the gastrointestinal phase Cu, Pb and Zn 
correlation coefficients were 0.89, 0.83 and 0.60 respectively and the values are similar to 
those reported for Cu (0.87), Pb (0.85) and Zn (0.82) by Poggio et al. (2009) (Table 3.5). 
Table 3.5: Correlation coefficients between bioaccessible and total concentrations  
Variables As Cd Cu Mn Pb Zn Reference 
 Correlation Coefficients  
Bioaccessible 
concentration in 
gastric phase 
 vs  
Pseudo-total 
concentration 
 0.16 0.96  0.93 0.95 Gbefa et al., (2011) 
  0.65  0.65 0.53 Poggio et al., (2009) 
    0.92  Farmer et al., (2011) 
    0.90  Sialelli et al., (2010) 
    0.98 0.91 Sialelli et al., (2011) 
 0.82    0.83 Pelftrene et al., (2011) 
0.70      Sarker et al., (2007) 
0.89 0.99 0.88 0.32 0.95 0.95 This study (soil) 
0.10 0.99 0.83 0.90 0.94 0.99 This study (metallurgic waste) 
Bioaccessible 
concentration in 
gastrointestinal 
phase  
vs  
Pseudo-total 
concentration 
 0.08 0.98  0.93 0.96 Gbefa et al., (2011) 
  0.89  0.84 0.82 Poggio et al., (2009)  
    0.85  Farmer et al., (2011)  
  0.87    Sialelli et al., (2011)  
 0.82    0.37 Pelftrene et al., (2011)  
0.76      Sarker et al., (2007)  
0.99 0.95 0.96  0.89 0.95 Okorie et al., 2011 
0.88 0.28 0.89 0.48 0.83 0.60 This study (soil)  
0.11 0.65 0.84 0.27 0.88 0.98 This study (metallurgic waste)  
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For the metallurgic wastes in the gastric phase strong positive correlations were indicated 
between the bioaccessible and total concentrations of Cd, Cu, Mn, Pb, and Zn, whilst in 
the gastrointestinal phase strong positive correlations were only indicated for Cd, Cu, Pb 
and Zn (Table 3.5). Comparison of the correlation data obtained in this study for the 
metallurgic samples with data from other studies was difficult due to scarcity of published 
bioaccessibility data. For the metallurgic samples in the gastric phase the Cd, Cu, Mn, Pb 
and Zn correlation coefficients were 0.99, 0.83, 0.90, 0.88, 0.94 and 0.99, respectively 
(Table 3.5). For the metallurgic samples in the gastrointestinal phase the Cd, Cu, Pb and 
Zn correlation coefficients were 0.65, 0.84, 0.88 and 0.98, respectively (Table 3.5).  
The strong positive correlations observed between bioaccessible and total concentrations 
for most of the PHEs of interest in this study implies potentially high in vivo concentrations 
in humans exposed at locations with elevated total PHEs concentrations, and this is 
consistent with reports by WHO (2004), Brown et al. (2010) and Kamberi et al. (2011). 
3.4.5 Oral bioaccessibility  
The order of mean % bioaccessibility in the gastric phase is Pb > Cd > Mn > Zn > Cu > As 
and the gastrointestinal phase is Cu > As > Mn > Cd > Pb > Zn. From this study the mean 
and range of gastric % bioaccessibility for As, Cd, Cu, Mn, Pb and Zn are 20.3 % (1.01 - 
39.5 %), 51.0 % (12.0 – 74.7 %), 22.1 % (1.00 – 72.7 %), 47.2 % (0.40 – 95.4 %), 56.8 % 
(1.20 – 92.2 %) and 40.9 % (3.43 – 86.1 %), respectively. In the gastrointestinal phase the 
mean and range of bioaccessibility for As, Cd, Cu, Mn, Pb and Zn are 21.5 % (0.44 – 48.9 
%), 17.7 % (2.18 – 75.5 %), 26.2 % (1.61 – 46.1 %), 22.5 % (0.10 – 52.0 %), 15.5 % (0.99 
– 55.9 %) and 13.7 % (2.83 – 45.7 %), respectively. The % oral bioaccessibility patterns 
for PHEs in samples are far from simple with some PHEs indicating bioaccessibility from 
circa 0 to 100 % (Figure 3.8) (Appendix C - H), thus bioaccessibility indicated for each of 
the PHEs might not compare well with literature data. Previous inter-laboratory trial of the 
UBM bioaccessibility method for As, Cd and Pb in slag material, soils, river sediment and 
house dust in the gastric phase indicated similar broad ranges; 1.20 – 27.3 %, 24.2 – 86.4 
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% and 0.60 – 113 % for As, Cd and Pb, respectively (Wragg et al., 2011). In the 
gastrointestinal phase Wragg et al. (2011) also reported broad bioaccessibility ranges of 
1.80 – 8.30 %, 17.1 – 107 % and 0.10 – 89.5 % for As, Cd and Pb, respectively. For the 
gastrointestinal phase Okorie et al. (2011) published narrower bioaccessibility ranges of 
42 – 64 %, 60 – 96 %, 62 – 78 %, 25 – 58 % and 37 – 62 % for As, Cd, Cu, Pb and Zn, 
respectively. The narrower range reported by Okorie et al. (2011) could be due the fact 
that their samples were more homogeneous in terms of matrix and mineralogy. The wide 
range of bioaccessibility observed for the Cd and Pb in both phases in this study and by 
Wragg et al. (2011) is suggestive of the possible strong influence sample matrix has on 
PHE bioaccessibility.  
Figure 3.8: Boxplot of % oral bioaccessibility for PHEs  
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When the bioaccessibility data are grouped based on matrices distinct patterns emerged 
for the different matrices and the summary of the data is provided in Table 3.6. The 
grouping of samples based on matrix appear to have yielded narrower range of 
bioaccessibility for the tailings but the smelter and soil samples still exhibit a large range 
for most of the PHEs investigated. The analysis has indicated the tailing samples with the 
lowest (both in terms of maximum and range) bioaccessibility in both phases for most of 
the PHEs investigated (Figure 3.9 a - c). For As, Cd, Mn and Pb the mean % 
bioaccessibility in both gastric and gastrointestinal phases is in the order: soil > smelter > 
tailings (Figure 3.9 a - c). For Cu the % bioaccessibility in gastric phase is in the order: 
smelter > soil > tailings and the gastrointestinal phase is in the order: soil > smelter > 
tailings (Figure 3.9 a - c). For Zn the % bioaccessibility in gastric phase is in the order: soil 
> smelter > tailings and the gastrointestinal phase is in the order: smelter > soil > tailings.  
Meunier et al. (2010) and Cave et al. (2003) have published similar gastric % 
bioaccessibility ranges of 0.1 – 47 % and 0.5 – 45%, respectively for As in diverse 
matrices. Meunier et al. (2010) work was on tailings and soils, whilst Cave et al., (2003) 
work was on natural and contaminated soils from Wales and England. The assessment of 
8 mine site soil samples for As gastric bioaccessibility by Juhasz et al. (2007) using in 
vitro methods on < 250 µm size fraction indicated a range (5 – 36 %) that is consistent 
with the range (5 – 39 %) (Figure 3.9b) recorded for the soil samples in this study. The 
different patterns observed for As in soil and metallurgic samples (3.9 a - c) may be 
explained by the fact that not all As forms are acid extractable. Unlike the soil, smelter and 
tailings indicated lower bioaccessibility for the gastrointestinal leaching which was 
conducted at higher pH range (5.8 - 6.3). Al-Abed et al. (2007) has previously observed 
that As from mineral processing wastes is more extractable in acidic medium and that at 
higher pH As can precipitate out with Fe-oxyhydroxides and oxide. The suggestion by Al-
Abed et al. (2007) may help explain why the smelter and tailing samples indicated lower 
% bioaccessibility in the gastrointestinal phase. For As in soil higher maximum % 
bioaccessibility was observed in the gastrointestinal phase and this could be due the fact  
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Table 3.6: Range and mean bioaccessibility of PHEs in matrices 
PHE Gastric Bioaccessibility (%) Gastrointestinal Bioaccessibility (%) 
 Smelter Soil Tailings Smelter Soil Tailings 
As 17.3 (1.01 – 35.1) 
(n = 6) 
21.9 (5.26 – 39.5) 
(n = 52) 
6.52 (2.70 – 16.5) 
(n = 5) 
7.64 (0.44 – 22.9) 
(n = 6) 
24.8 (10.5 – 48.9) 
(n = 52) 
4.90 (1.88 – 9.36) 
(n = 5) 
Cd 39.7 (12.0 – 53.1) 
(n = 6) 
54.7 (39.5 – 74.7) 
(n = 49) 
14.4 (12.5 – 17.7) 
(n = 3) 
13.4 (2.90 – 36.8) 
(n = 4) 
19.5 (3.09 – 75.5) 
(n = 19) 
2.18a 
Cu 27.8 (1.00 – 72.7) 
(n = 6) 
22.5 (10.9 – 34.7) 
(n = 46) 
9.30 (3.5 – 22.6) 
(n = 4) 
19.8 (1.61 – 38.4) 
(n = 6) 
27.9 (13.6 – 46.1) 
(n = 44) 
16.3 (9.22 – 31.8) 
(n = 4) 
Mn 13.6 (0.80 – 49.2) 
(n = 6) 
54.8 (32.0 – 95.4) 
(n = 52) 
8.53 (0.40 – 15.8) 
(n = 5) 
8.53 (0.10 – 29.4) 
(n = 6) 
25.8 (14.9 – 52.0) 
(n= 52) 
4.74 (0.10 – 16.1) 
(n = 5) 
Pb 26.4 (1.20 – 71.3) 
(n = 6) 
63.1 (13.3 – 92.2) 
(n = 52) 
8.73 (5.26 – 15.1) 
(n = 3) 
14.6 (0.99 – 46.7) 
(n = 5) 
16.2 (1.08 – 54.8) 
(n = 43) 
4.21 (1.48 – 6.93) 
(n = 2) 
Zn 30.5 (5.02 – 66.9) 
(n = 6) 
42.5 (3.43 – 86.1) 
(n = 50) 
24.7a 16.9 (7.13 – 45.7) 
(n = 5) 
13.4 (2.83 – 42.1) 
(n = 27) 
6.60a 
The numbers in parenthesis represent the bioaccessibility range, a – single data 
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 Figure 3.9a:  Boxplot of oral % bioaccessibility for smelter wastes 
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Figure 3.9b:  Boxplot of oral % bioaccessibility for soils  
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Figure 3.9c:  Boxplot of oral % bioaccessibility for tailings  
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that some of the As in the soil are not acid extractable and in such situation other 
variables (e.g. liquid-solid-ratio) may have enhanced bioaccessibility of As in the 
gastrointestinal phase. 
All three matrices indicated higher mean Cd % bioaccessibility in the gastric phase (Figure 
3.9 a - c) and the pattern is consistent with the trend observed for Cd (most samples) in a 
publication by Wragg et al. (2011) for an inter-laboratory trial of the UBM bioaccessibility 
method. Roussel et al. (2010) using the UBM protocol employed in this study for soils 
impacted by two Pb-Zn smelter plants reported gastric and gastrointestinal phase 
bioaccessibility ranges of 58 – 81 % and 16 - 59 %, respectively, that are similar to those 
(gastric: 39 – 75 %, gastrointestinal: 3.9 – 75 %) observed in this study. The fact that all 
three matrices indicated elevated bioaccessibility in the more acidic gastric medium is not 
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unexpected since it is known that pH is one of the most important variables that affects 
soluble Cd concentration, sorption and desorption from geogenic and contaminated soils 
(Gray et al., 1999).  
For Cu the mean % bioaccessibility indicated by all matrices in the gastric and 
gastrointestinal phases are 22.2 % (range: 1.00 – 72.7 %) and 26.2 % (range: 1.61 – 46.1 
%), respectively (Figure 3.8). The mean gastric bioaccessibility value indicated for the 
samples in this study is consistent with 23.2 % reported for urban street dust by Okorie et 
al. (2012). Hu et al. (2011) also published a mean gastric bioaccessibility of 29.8 ± 6.42 % 
for street dust samples from Nanjing, China. Soil and tailing samples indicated higher 
bioaccessibility in the gastrointestinal phase but the smelter sample indicated higher 
bioaccessibility in the more acidic gastric phase (Figure 3.9 a - c) as expected for heavy 
metal leaching. Even within the same matrix (e.g. soil) different % bioaccessibility have 
been previously reported by Poggio et al. (2009). Amongst the matrices investigated the 
tailing samples indicated the lowest bioaccessibility and the reduced leachability may be 
due to the presence of immobilized Cu forms. Southmam and Berveridge (1992) have 
reported possible in situ formation of secondary Cu minerals from tailings. The range of 
gastric % bioaccessibility obtained for soil in this work (11 – 35 %) (Figure 3.9 b) is similar 
to the range (27 -35 %) Sialelli et al. 2011 published for ten urban soils from Torino, Italy 
though the minimum bioaccessibility obtained from this study is relatively lower. The lower 
bioaccessibility observed in this study may be due contamination from particulate tailings 
that indicated lowest bioaccessibility in this study.  Amongst the three matrices 
investigated smelter wastes indicated the highest mean and maximum gastric % 
bioaccessibility, and this could be due the fact that some of the Cu are associated with 
mineral forms (e.g. chalcopyrite) which leaches effectively at a pH value (1.5 – 2.0) 
(Antonijevic and Bogdanovic, 2004) that is within the pH range recommended for gastric 
bioaccessibility. 
A relatively small amount of published data is available for the bioaccessibility of Mn in 
contaminated soils, rather more data is available for the application of Mn as oxides in 
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remediation studies. Mn oxyhydr (oxides) have been applied for the remediation of lead in 
contamination soil and wastewater (Hettiarachchi et al., 2000; Hettiarachchi and 
Pierzynski, 2002; Khraisheh et al., 2004; Sonmez and Pierzynski, 2005) on the premise 
that it adsorbs to Pb better than any other metal (hydr) oxides (Hettiarachchi et al., 2000) 
but Mn oxides can be reduced and the resulting Mn2+ released to aqueous phase 
(Busschmann et al., 2007). Over exposure to elevated Mn concentrations in the 
environment are hazardous for human beings (Busschmann et al., 2007; Menezes-Filho 
et al., 2009). Lucchini et al. (2009) in their review paper on Mn exposure evolution 
suggested that future research should be focused on understanding the impact of Mn 
exposure in both occupational and community settings. In this study mean % 
bioaccessibility observed for the all samples in the gastric and gastrointestinal phases are 
47.2 % (range: 0.40 – 95.4 %) and 22.5 % (range: 0.10 – 52.0 %), respectively (Figure 
3.8). The ranges observed in the gastric (32.0 – 95.4 %) and gastrointestinal (14.9 – 52.0 
%) (Table 3.6) phases in this study for the soil samples are similar to 33.6 – 75.5 % and 
3.3 – 65.9 % published for gastric and gastrointestinal phases respectively by Karadas 
and Kare (2011) for soil contaminated by Mn-Pb-Zn mines. All three matrices indicated 
higher bioaccessibility in the gastric phase and the order of bioaccessibility was soil > 
smelter > tailings (Figure 3.9 a - c). The relatively lower mean % bioaccessibility observed 
for Mn in the gastrointestinal phase may be due the fact that Mn adsorption onto clay 
increases with increasing pH (Bradl, 2004), and since the extraction in the gastrointestinal 
phase was conducted at higher pH value the lower bioaccessibility observed for the 
gastrointestinal is expected.  
When Pb % bioaccessibility were grouped according to matrix the gastric phase indicated 
a mean % bioaccessibility of 26.4 % (range: 1.20 – 71.3%), 63.1 % (range: 13.3 – 92.2 %) 
and 8.7 % (range: 5.26 – 15.1) for smelter, soil and tailings, respectively (Figure 3.9 a – 
c). The gastric phase Pb bioaccessibility range of 5 – 15 % obtained for mine tailings in 
this study is consistent with the ranges (3 – 15 %) and (8 and 16%)  published by Ruby et 
al. (1993) and Ruby et al. (1996), respectively  for mine tailing samples after leaching with 
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a synthetic gastric fluid. The gastrointestinal phase mean % bioaccessibility were 14.6 % 
(range: 0.99 – 46.7 %), 16.2 % (range: 1.08 – 54.8 %) and 4.21 % (range: 1.48 – 6.9 %) 
for smelter, soil and tailings, respectively (Figure 3.9 a – c). Pb in all three matrices 
indicated more bioaccessibility in the gastric phase (Figure 3.9 a - c). It has been 
suggested that Pb in soil is affected by factors such as adsorption to solid phase, 
precipitation and formation of stable complexes (e.g. Pb hydroxides and phosphates), and 
the factors are influenced by pH (Zhang et al., 1998; Bradl, 2004). A previous study by 
Zhang et al. (1998) has reported the dissolution of Pb and Pb minerals at low pH values 
and the precipitation of soluble Pb at higher pH values and this Pb property may be the 
reason why Pb in all matrices indicating greater bioaccessibility in the gastric phase 
extraction which is conducted at lower pH (< 2.0). The mean gastric % bioaccessibility for 
Pb in this study was more for soil samples (Figure 3.9 b) The metallurgic waste samples 
may have indicated lower mean gastric bioaccessibility in this study because of the higher 
Mn mean concentrations associated with them (soil: 842, tailings: 6274, smelter: 288029 
mg/kg (Table 3.2). Mn in the form of oxides is known to adsorb Pb more strongly than any 
other metal (hydr) oxides (Hettiarachchi, 2000; Hettiarachchi and Pierzynski, 2002; 
Matocha et al., 2001) and this may explain the reason why soils with the lowest Mn 
concentrations indicated the highest Pb bioaccessibility in this study. The % gastric 
bioaccessibility of soil-Pb in this study range from 13 to 92 % and is consistent with the 
range (17 – 100 %) published for soil Pb at a Pb-Zn smelter site using the Simplified 
Bioaccessibility extraction Test (SBET) (Lamb et al., 2009). The soil gastric phase mean 
Pb bioaccessibility of 63% obtained in this study (Figure 3.9 b) is comparable to 64% 
reported by Bosso et al. (2008) for soils contaminated by metallurgic wastes. Also 
Roussel et al. (2010) published similar mean gastric bioaccessibility of 62 % for urban 
surface soil contaminated by Pb-Zn smelters. Smelter samples in this study in the gastric 
phase fluid indicated a range of 1.2 – 71 % (Figure 3.9 a) and similar ranges (14 – 80 %, 
n= 4) and (29 – 63 %, n = 9) have been published by Bosso et al. (2008), and Morrison 
and Gulson (2007), respectively for the same matrix. The very low % bioaccessiblity 
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indicated by Pb in some smelter samples may be due the presence of stable Pb mineral 
phases.  
For Zn the bioaccessibility order in the gastric phase is soil > smelter > tailings, whilst in 
the gastrointestinal the order is smelter > soil > tailings (Figure 3.9 a - c). For the smelter 
matrix the mean % bioaccessibility for the gastric and gastrointestinal phases were 30.5 % 
(range: 5.02 – 66.9 %) and 16.9 % (range: 7.13 – 45.7 %), respectively (Figure 3.9 a). For 
the soil matrix the mean % bioaccessibility for the gastric and gastrointestinal phases 
were 42.5 % (range: 3.43 – 86.1 %) and 13.4 % (range: 2.83 – 42.1 %), respectively 
(Figure 3.9 b). Roussel et al. (2010) have reported similar mean and range of gastric and 
gastrointestinal bioaccessibility of 47 % (range: 17 – 85 %) and 23 % (range: 8 – 47 %), 
respectively for 27 surface soil samples collected within 2 Km of two Pb-Zn smelters using 
the BARGE protocol. For the tailing matrix only one sample indicated detectable 
concentrations in both phases and the % bioaccessibility for the gastric and 
gastrointestinal phases were 24.7 % and 6.60 % (Figure 3.9 c) respectively.  All three 
matrices indicated higher bioaccessibility in the gastric phase than the gastrointestinal 
phase. The explanation for lower bioaccessibility in the gastrointestinal phase could be the 
higher pH (6.3 ± 0.5) at which extractions were conducted in the gastrointestinal phase 
because Kaya and Oren (2005) have suggested that between pH values 4 and 7, Zn2+ in 
aqueous solutions containing clay minerals replaces alkaline and alkaline earth metals 
from exchangeable site, thus reducing Zn2+ concentration in solution. 
 3.4.6 Mineralogy 
Heavy mineral yields from the XRD analysis for mine tailings, smelter and soil samples 
were 54.4% (range: 47.7 – 61.2), 46.5 % (range: 30.4 – 55.9) and 1.81% (range: 0.40 – 
3.40 %) respectively (Figure 3.10). As expected PHEs concentrations for the different 
matrices (Table 3.2) have also indicated elevated levels for the metallurgic samples. 
The results of the mineralogy analysis of the selected sub-samples are listed in Table 3.7. 
Arsenianpyrite and beudantite were the As bearing minerals identified in 3 metalliferous 
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waste samples. The others samples had no As bearing mineral phases. In the case of Mn, 
ankerite, franklinite, coronadite and manganite were identified as Mn minerals in 4 soil and 
4 metalliferous waste samples. The other seven samples had no XRD visible Mn 
minerals. For Pb galena, angelsite, beudantile, coronadite, cerussite and lanarkite were 
identified as minerals in 2 soil samples collected from IDPs sites and 7 metalliferous 
waste samples. All 4 soil samples from Roma Mahalla, indicating no visible XRD minerals. 
The presence of Pb-bearing phases in samples collected within former mining/smelter site 
has been previously reported by Kamberi et al., (2011). For Zn, frankinite, willemite, 
sphalerite, and zincochromite minerals were identified in 13 samples. The only 1 smelter 
sample indicated Cu bearing mineral, chalcopyrite.  
Figure 3.10: Boxplot of % heavy mineral separated from matrices 
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Table 3.7: PHE-bearing mineral assemblages in Mitrovica samples 
Matrix  Location % Range 
HM 
separated1 
n As  Mn Pb  Zn  Others2  
    Mineral phases 
Smelter 
waste3 
Gornje 
Polje  
30.4-55.9 3 Beudantite  Franklinite 
Coronadite 
Beudantite 
Anglesite 
Cerussite 
Sphalerite 
Franklinite 
Williemite 
Hematite Goethite 
Chalcopyrite  
Tailings4  Zarkov 
Potok 
47.7-61.2 2 Arsenian 
pyrite 
Manganite 
- 
Beudantite 
Lanarkite 
Williemite 
Zincochromite  
Goethite Chlorite  
Soil Cesmin lug 2.30-3.40 4 - Ankerite 
Coronadite 
Coronadite 
galena 
Zincochromite  Hematite Mica 
Chlorite   
Soil Roma 
Mahalla  
0.40-1.40 4 - 
- 
- - Hematite Goethite  
Pyrite Mica Chlorite 
Soil Osterode 1.00-2.60 2 - 
Coronadite 
Coronadite 
- 
Zincochromite  Hematite Goethite 
Mica chlorite 
1Percentage range of heavy mineral separated from matrix. 
2Other possible As and metal-bearing minerals in samples (Drahota and Filippi, 2009; Meunier et al., 2010). 
3Smelter wastes are flue dust and slag generated during the roasting of concentrates obtained from the milling and floatation processes 
(Moore and Luoma, 1990). 
4Tailings are waste rocks (90% of the ore body) separated from ore by milling and floatation (Moore and Luoma, 1990).  
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The PHEs in metalliferous waste samples expectedly are associated with mineral 
assemblages, whilst the PHEs in samples from Roma Mahalla (the most distant location 
from the metallurgic deposits) are free from mineral encapsulation. The surface soil 
mineralogy appears to be dominated by Fe/Fe oxide minerals (hematite and goethite) and 
consequently sorption to these minerals is likely to be an additional source for metals and 
As. The significant absence of PHE-bearing mineral phases in surface soils within 
Mitrovica have been highlighted previously (Kamberi et al., 2011).  
3.4.7 Indicative role of mineralogy 
Since the mineral assemblages in samples are somewhat different (Table 3.7), the 
bioaccessibility data for the actual subsamples submitted for XRD analyses were plotted 
based on mineral phases for As, Mn, Pb and Zn and narrower ranges of % bioaccessibility 
spread were obtained (Figures 3.11 – 3.14).  
 Arsenic: The mean % bioaccessibility for As was very low in samples with As-bearing 
minerals (Figure 3.11) and where a high % heavy mineral fraction (HM > 40 %) was 
observed. Two tailing samples and one smelter sample associated with As bearing 
arsenianpyrite and beudantite minerals indicated < 8 % mean and maximum 
bioaccessibility in both the gastric and gastric-intestinal phases (Figure 3.11). A similar 
range < 10 % was observed for samples with naturally elevated As concentrations by 
Juhasz et al. (2007). Also the low range observed in this work for arsenianpyrite and 
beudantitle dominated samples is consistent with the bioaccessibility predicted/observed 
for such minerals (Ruby et al., 1999; Roussel et al., 2000; Meunier et al., 2010; 
Kocourkova et al., 2011). The twelve samples with no XRD visible As mineral phase 
indicated mean gastric and gastrointestinal bioaccessibilities of 20.1 % and 17.0 %, 
respectively and the mean % bioaccessibility obtained in this study for the gastric phase is 
consistent with the mean (23.5 %) obtained for eight contaminated soil samples (with 
mineralogy dominated by hematite and quartz) from a former smelting and tailings sites at 
Victoria, Australia by Juhasz et al. (2007). 
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Figure 3.11: Boxplot of As % bioaccessibility and mineral assemblages  
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Manganese: Stermer et al. (1996) have suggested a form of Mn oxide in soil as the 
source of Mn in enamel and teeth of humans. Kamberi et al. (2009) have attributed the 
high level of Mn in the teeth of inhabitants at Mitrovica (northern Kosovo) and Klina 
(western Kosovo) to the operations of the bauxite mine around Klina neighbourhood. XRD 
data obtained in this work have indicated coronadite, ankerite, franklinite and manganite 
as the mineral forms of Mn. The mean gastric bioaccessibility of samples containing 
ankerite/coronadite and franklinite/manganite are 53.9 % and 3.50 %, respectively. The 
gastrointestinal bioaccessibility of samples containing ankerite/coronadite and franklinite/ 
manganite are 18.3 % and 0.97 %, respectively (figure 3.12). Ankerite dissolves readily in 
acid water yielding Mn2+ which interacts with Fe in solution, and since the Fe/Mn 
interaction is mainly based on sorption at neutral pH sorption is significant (Olias et al., 
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2004), thus the relatively high bioaccessibility (53.9 %) observed in the gastric phase pH 
(< 2.0) and the low bioaccessibility (18.3 %) indicated at the gastrointestinal pH (6.3 ± 0.5) 
are expected. Coronadite (PbMn8O16; a Mn dominated mineral) is also a highly 
bioavailable mineral (Ruby et al., 1999; USEPA, 2007e) and is also expected to release 
Mn easily so the relatively high bioaccessibility observed for samples bearing coronadite 
is expected. 
Figure 3.12: Boxplot of Mn % bioaccessibility and mineral assemblages  
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Metalliferous samples were also associated with stable Mn dioxide minerals, manganite 
( -MnOOH) (Fritsch et al., 1997; Post, 1999) and the primary franklinite mineral, hence the 
very low % bioaccessible indicated for this group in both phases are expected. Four Roma 
Mahalla and two IDP samples with no XRD visible Mn-mineral phases indicated the 
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highest mean gastric (59.3 %) and gastrointestinal (18.4 %) bioaccessibility. Mn can form 
labile mineral entities with chlorite and mica (Jurjovec et al., 2002) from which Mn can 
easily desorb and this may be one the reasons why samples without Mn-bearing minerals 
but containing chlorite and mica minerals (Table 3.7) indicated the highest mean 
bioaccessibility value in this study. The indication of an exceptionally low gastric 
bioaccessibility for a sample with no Mn-mineral phases (Figure 3.12 outlier) may be due 
difficulty in the XRD identification process. Nimfopoulos and Pattrick (1991) and Lee et al. 
(2002) have reported difficulties associated with identifying Mn-mineral because of poor 
crystals and multiple valance state exhibited in Mn mineralization.   
Lead: The very wide Pb bioaccessibility range recorded in this work for the gastric and 
gastriointestinal phases (Figure 3.8) may be due in part, to the diverse mineralogy of the 
samples and Davies et al. (1996) have previously highlighted the dependence of Pb 
bioaccessibility on the mineral and chemical forms of Pb in the soil. Five tailing and 
smelter samples associated with anglesite, beudantile, cerussite, coronadite, and lanarkite 
indicated the lowest mean gastric and gastrointestinal bioaccessibility of 2.8 % and 1.6 %, 
respectively (Figure 3.13). Anglesite and beudantite have previously been classified by 
Ruby et al. (1999) and USEPA (2007e) as having low relative bioavailability. Three IDP 
camp samples associated with coronadite (a PbMn oxide mineral) indicated high mean 
gastric bioaccessibility of 59.1 % which is consistent with the ranking of the mineral as 
highly bioavailable (Ruby et al., 1999; USEPA, 2007e). The sample associated both 
coronadite and galena indicated lower mean gastric bioaccessibility of 40.0 % which is 
lower than expected for coronadite mineral alone, and the lower value observed for the 
two minerals may be due to the presence of the less soluble galena (Ruby et al., 1999). 
Four Roma Mahalla and two IDP soils with no XRD visible Pb-bearing minerals indicated 
the highest mean gastric bioaccessibility; (72.2 %). The relatively high bioaccessibility 
(59.1 and 72.2 %) and elevated Pb total concentrations (mean: 2480 mg/kg) observed for 
the IDP samples may explain the high blood lead levels recorded for children at the IDP 
camps (Brown et al., 2010).  
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Figure 3.13: Boxplot of Pb % bioaccessibility and mineral assemblages 
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Zinc: The metalliferous samples indicated the presence sphalerite (ZnS), willemite [Zn2 
(SiO4)] - a secondary mineral resulting from incorporation of Zn into secondary silicate 
clay, zincochromite (ZnCr2O4) and franklinite (Zn0.65Mn0.35)Fe2O4 (Doriguetto and 
Fernandes, 1999) as Zn mineral phases. The mean gastric and gastrointestinal 
bioaccessibility observed for samples bearing sphalerite, willemite and franklinite minerals 
are 25.3 % and 10.5 %, respectively (Figure 3.14). Zincochromite usually found in ferrous 
metallurgic Zn tailings as a remnant from the parent rock (Isaure et al., 2005) was 
identified in samples collected from Osterode and Cesmin Lug sites close to tailings waste 
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(Figure 3.1). The soil samples bearing zincochromite indicated moderate mean gastric 
bioaccessibility (51.1 %) and low gastrointestinal bioaccessibility (5.48 %) (Figure 3.14) 
and Terzano et al. (2007) have previously highlighted the easy mobilization of Zn from 
soils dominated by zincochromite minerals. The mean % gastric bioaccessibility for the 
soil samples without Zn mineral phases (38.3 %) obtained in this study is consistent with 
the mean  gastric bioaccessibility, 40 % reported for Zn by Schaider et al. (2007) using 
SBET method for contaminated soils sampled at the Tar Creek Superfund site, USA. 
Similar to the mineralogy data from this study, most of the Zn in the samples studied by 
Schaider et al. (2007) did not indicate Zn mineral phases. 
Figure 3.14: Boxplot of Zn % bioaccessibility and mineral assemblages  
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3.4.8 Human Health Risk Assessment 
3.4.8.1 Soil ingestion exposure assessment in Mitrovica 
Risk assessment of PHEs is based on their estimated oral toxicity and such estimates are 
typically obtained following ingestion of PHEs salts dissolved in water or mixed with food 
consumed by an animal or human (Ruby et al., 1999). Those processes do not consider 
the site specific soil bioaccessibility of the PHEs. With the application of total, gastric 
phase or gastric-intestinal phase concentrations it is possible to better quantify and 
compare the potential human exposure risk associated with the ingestion of soil-
associated PHEs for a child (3 to < 6 years). The calculated daily intake (Equation 3.2) 
and the amount soil that need to be consumed by a child to exceed concentrations of As, 
Cd, Cu, Mn, Pb and Zn considered safe (TDIoral) for people living in residential areas were 
based on criteria listed in Table 3.8.  
Table 3.8: Criteria used to calculate PHE DI and concentrations required to exceed TDI  
Soil 
ingestion 
ratea 
 (mg d-1) 
Body 
weight 
(kg) 
Asc 
TDI 
Cdd 
TDI 
Cue 
TDI 
Mnf 
TDI 
Pbg 
TDI 
Zne 
TDI 
AEF 
d 
  (µg kg-1BW d
-1)  
100 18.6 0.30 0.36 160 140 3.60 600 365 
a- USEPA 2002 
b –USEPA 2011 
c-Environment Agency (2009d)  
d -Environment Agency (2010) 
e -Nathanail et al. (2009) 
f- USEPA, (2007) 
g- FAO/WHO JECFA (1987)  
AEF – Annual exposure frequency, TDI - Tolerable daily intake 
PHE DI – PHE daily intake 
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Reports suggest that the IDP camps (Cesmin lug and Osterode) are located in the vicinity 
of the uncontained metallurgic waste (Human Right Watch, 2009, CNN, 2012) and camp 
residents were exposed to materials from the waste dumps (UNEP, 2010). Based on 
these reports, exposure to metallurgic waste samples a worst case scenario (24 hour 
exposure, 365 day) was considered. Wcislo et al. (2002) have previously conducted 
human health risk assessment for PHEs in surface metallurgic waste materials. The PHE 
daily intake (PHE DI) from incidental ingestion of topsoil and metallurgic waste were 
estimated based on equation 3.2 based on the three scenarios (i.e. total, gastric and 
gastrointestinal) listed in Section 3.3.8.1. The amount of soil that could be consumed to 
exceed TDIoral was calculated as: 
Required ingestion (mg.d-1) = (TDIoral x SIR) / PHE DI        (3.5) 
Where: 
TDIoral is the tolerable daily intake through ingestion, (µg kg
-1
BW d
-1)  
SIR is the Soil ingestion rate, (mg.d-1) 
PHE DI is the estimated daily intake of a PHE, (µg kg-1BW d
-1)  
The results are listed in Appendix I – N and the summary is provided in Tables 3.9a and 
3.9b. Soil samples indicated daily chronic intake concentrations above TDIoral for As and 
Pb (Table 3.9a). The metallurgic waste samples indicated daily chronic intake above 
TDIoral for all PHEs investigated except Cu (Table 3.9b). The metallurgic waste samples 
indicated greater daily chronic intake levels than the soil samples for all the PHEs studied 
(Table 3.9a and 3.9b). For As in soil samples the estimated daily intake dose mean and 
range are 0.38 µg kg-1BW d
-1 (0.03 – 1.45 µg kg-1BW d
-1), 0.06 µg kg-1BW d
-1 (0.01 – 0.25 µg 
kg-1BW d
-1) and 0.08 µg kg-1BW d
-1 (0.01 – 0.35 µg kg-1BW d
-1) for the aqua regia, gastric and 
gastrointestinal fluids concentrations, respectively (Table 3.9a). A similar range of DI have 
been reported for aqua regia (0.45 – 4.50 µg kg-1BW d
-1) and bioaccessible (0.20 – 3.45 µg 
kg-1BW d
-1) in soils spiked with sodium arsenite with total concentration between 45 and  
85 
 
Table 3.9a: Mean PHE DI and the minimum required ingestion to exceed the TDIoral from soil ingestion 
 PHE DI (µg kg-1BW d
-1) 
Based on 100 mg.d-1 ingestion 
TDI oral  
(µg kg-1BW d
-1) 
Minimum required ingestion (mg.d-1) to 
exceed TDI oral 
 Aqua Regia Gastric Gastrointestinal  Aqua Regia Gastric Gastrointestinal 
As 0.38 (0.03 – 1.45) 0.06 (0.01 – 0.25) 0.08 (0.01 – 0.35) 0.30 21.7 119 85.7 
Cd 0.02 (bd – 0.12) 0.01 (bd – 0.08) 0.01 (bd – 0.02) 0.36 302 449 1660 
Cu 0.48 (0.13 – 1.26) 0.11 (0.02 – 0.38) 0.15 (0.03 – 0.43) 160 12700 42000 36900 
Mn 4.52 (2.13 – 8.76) 2.37 (1.46 – 3.65) 1.13 (0.74 – 2.03) 140 1600 3800 6900 
Pb 12.8 (0.29 – 88.7) 6.88 (0.15 – 45.0) 3.04 (0.05 – 17.5) 3.60 4.06 8.00 20.6 
Zn 3.40 (0.08 – 16.7) 1.78 (0.02 – 14.3) 0.76 (0.03 – 2.58) 600 1450 4180 23200 
Data in in parentheses represents range 
Numbers in bold italics indicate a PHE intake greater than the TDI  
TDIoral - tolerable daily intake (or index dose for arsenic) 
Minimum required ingestion to exceed the TDIoral are calculated based on the sample with the maximum concentration 
Aqua regia – calculations based on aqua regia soluble PHE concentration 
Gastric – calculations based PHEs bioaccessible concentrations in the gastric phase 
Gastrointestinal – calculations based on PHEs bioaccessible in the gastrointestinal phase 
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Table 3.9b: Mean PHE DI and the minimum required ingestion to exceed the TDIoral from Metallurgic waste ingestion 
 PHE DI (µg kg-1BW d
-1) 
Based on 100 mg.d-1 ingestion 
TDI oral  
(µg kg-1BW d
-1) 
Minimum required ingestion (mg.d-1) to 
exceed TDI oral 
 Aqua Regia Gastric Gastrointestinal  Aqua Regia Gastric Gastrointestinal 
As 21.8 (0.45 - 121) 1.30 (0.16 – 6.83) 0.54 (0.10 – 1.64) 0.30 0.25 4.39 17.8 
Cd 1.61 (0.01 – 7.74) 0.80 (bd – 3.49) 0.62 (bd – 2.83) 0.36 4.65 10.3 12.7 
Cu 9.81 (0.44 – 38.4) 4.05 (0.05 – 28.0) 2.32 (0.06 – 11.4) 160 420 570 1400 
Mn 145 (7.96 - 597) 8.66 (0.14 – 46.0) 3.27 (0.01 – 13.9) 140 23.4 305 1000 
Pb 860 (5.23 - 8600) 42.2 (0.38 - 287) 29.6 (0.11 - 138) 3.60 0.04 1.25 2.61 
Zn 328 (1.15 - 1340) 126 (0.18 - 314) 62.1 (0.48 - 125) 600 40.8 190 480 
Data in in parentheses represents range 
Numbers in bold italics indicate a PHE intake greater than the TDI  
TDIoral - tolerable daily intake (or index dose for arsenic) 
Minimum required ingestion to exceed the TDIoral are calculated based on the sample with the maximum concentration 
Aqua regia – calculations based on aqua regia soluble PHE concentration 
Gastric – calculations based PHEs bioaccessible concentrations in the gastric phase 
Gastrointestinal – calculations based on PHEs bioaccessible in the gastrointestinal phase 
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450 mg/kg (Datta and Sarker, 2005). Also Guney et al. (2010) have reported a DI of 0.01 
µg kg-1BW d
-1for children exposed to playground, parks and picnic soil but with a lower As 
maximum concentration of 42.8 mg/kg compared to the 270 mg/kg recorded in this work. 
The estimated As daily intake mean and range from metallurgic waste samples are 21.8 
µg kg-1BW d
-1 (0.45 – 121 µg kg-1BW d
-1), 1.30 µg kg-1BW d
-1 (0.16 – 6.83 µg kg-1BW d
-1) and 
0.45 µg kg-1BW d
-1 (0.10 – 1.64 µg kg-1BW d
-1) for the aqua regia, gastric and gastrointestinal 
fluids concentrations, respectively (Table 3.9b). At Mitrovica based on bioaccessible As 
concentrations obtained in this study at soil ingestion rate of 119 mg d-1 and metallurgic 
waste ingestion rate of 17.8 mg d-1 children may indicate adverse health effects. Health 
effects resulting from exposure to As at Mitrovica may have been been underestimated 
since As induces similar noncancer diseases like developmental abnormality and 
neurologic disorder (Tchounwou et al., 2004) that are also associated to Pb exposure. 
The estimated Cd daily intake mean and range from soil for the aqua regia, gastric phase 
and gastrointestinal phase concentrations are 0.02 µg kg-1BW d
-1 (bd – 0.12 µg kg-1BW d
-1), 
0.01 µg kg-1BW d
-1 (bd – 0.08 µg kg-1BW d
-1) and 0.01 µg kg-1BW d
-1 (bd – 0.02 µg kg-1BW d
-1), 
respectively (Table 3.9a). Pelfrene et al. (2012) have reported similar ranges, 0.02 – 0.19 
µg kg-1BW d
-1 and 0.02 – 0.14 µg kg-1BW d
-1for aqua regia and gastric fluids soluble 
concentrations, respectively for 34 soil samples from a former Pb smelter. The estimated 
Cd daily intake mean and range from metallurgic waste samples are 1.61 µg kg-1BW d
-1 
(0.01 – 7.74 µg kg-1BW d
-1), 0.80 µg kg-1BW d
-1 (0 – 3.49 µg kg-1BW d
-1) and 0.62 µg kg-1BW d
-1 
(0 – 2.83 µg kg-1BW d
-1) for the aqua regia, gastric and gastrointestinal fluids 
concentrations, respectively (Table 3.9b). The mean value (1.61 µg kg-1BW d
-1) obtained 
from metallurgic waste samples in this study (Table 3.9b) using aqua regia (total) 
concentrations is similar to 2.0 µg kg-1BW d
-1 reported for a mean total concentration of 
2150 mg/kg by Wcislo et al. (2002) for a children (< 6 year old) from surface metallurgic 
waste material obtained from the abandoned Pb-Zn smelter at Warynski, Poland although 
they used slightly different exposure scenarios. For the body weight of a child, exposure 
duration and the AEF Wcislo et al. (2002) used 16.7 kg, 2 hrs d-1 and 214 days 
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respectively. Children at this site may indicate adverse health effects if they ingest soil and 
metallurgic waste at the rate of 449 mg d-1 and 10.3 mg d-1 respectively. 
For Cu in soil samples the estimated daily intake mean and range are 0.48 µg kg-1BW d
-1 
(0.13 – 1.26 µg kg-1BW d
-1), 0.11 µg kg-1BW d
-1 (0 .02 – 0.38 µg kg-1BW d
-1) and 0.15 µg kg-
1
BW d
-1 (0.03 – 0.43 µg kg-1BW d
-1) for the aqua regia, gastric and gastrointestinal fluids 
soluble concentrations, respectively (Table 3.9a). The estimated daily intake mean and 
range from metallurgic waste for aqua regia, gastric phase and gastrointestinal phase 
concentrations are 9.81 µg kg-1BW d
-1 (0.44 – 38.4 µg kg-1BW d
-1), 4.05 µg kg-1BW d
-1 (0.05 – 
28.0 µg kg-1BW d
-1) and 2.32 µg kg-1BW d
-1 (0.06 – 11.4 µg kg-1BW d
-1), respectively. 
Expectedly for a lower Cu mean total concentration of 1,730 mg/kg, lower exposure 
duration of 2 hrs d-1 and lower AEF of 214 d/year, compared with this study Wcislo et al. 
(2002) have reported a lower mean daily intake of 1.6 µg kg-1BW d
-1  for surface metallurgic 
waste materials. In this study based on the maximum bioaccessible concentration the 
estimated minimum amount of soil that a child will require to ingest to reach TDIoral value is 
37 g d-1 and this value is well above the estimate of 100 mg d-1 intake assumed for a 
children. A higher minimum of 47 g d-1 was published by Sialelli et al. (2010) for urban 
soils from Glasgow, UK. The lower minimum indicated for Mitrovica may be due to the 
differences in the total Cu concentrations and TDIoral values applied in the studies. Sialelli 
et al. (2010) used a TDIoral of 3,000 µg and a maximum total concentration of 194 mg/kg. 
The estimated Mn daily intake mean and range from soil for aqua regia, gastric phase and 
gastrointestinal phase concentrations are 4.52 µg kg-1BW d
-1 (2.13 – 8.76 µg kg-1BW d
-1), 
2.37 µg kg-1BW d
-1 (1.46 – 3.65 µg kg-1BW d
-1) and 1.13 µg kg-1BW d
-1 (0.74 – 2.03 µg kg-1BW 
d-1), respectively (Table 3.9a). Estimated Mn daily intake dose from metallurgic waste for 
aqua regia, gastric phase and gastrointestinal phase concentrations are 145 µg kg-1BW d
-1 
(7.96 – 597 µg kg-1BW d
-1), 8.66 µg kg-1BW d
-1 (0.14 – 46.0 µg kg-1BW d
-1) and 3.27 µg kg-1BW 
d-1 (0.01 – 13.9 µg kg-1BW d
-1), respectively. Expectedly with a lower Mn mean total 
concentration of 2300 mg/kg, 2 hours of exposure per day and lower AEF of 214 d/year, 
compared with this study Wcislo et al., (2002) have reported a lower mean daily intake 
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dose of 1.9 µg kg-1BW d
-1  for surface metallurgic waste materials. For a child to be at risk 
from Mn at Mitrovica using maximum bioaccessible Mn concentration, a minimum of 3.8 g 
d-1 of soil need to be ingested and this well above the estimate of 100 mg intake. Sialelli et 
al., (2010) estimated minimum soil ingestion rate of 6.2 g d-1 for urban soils from 
Glasglow, UK required by a child to exceed TDIoral. The different minimum soil ingestion 
rates estimated from both studies may be due to the different maximum total Mn 
concentrations in the different soils and differences in applied TDIoral. The maximum Mn 
total concentrations observed for Mitrovica and Glasgow surface soil samples were 1,630 
mg/kg and 618 mg/kg respectively. The TDIoral applied in this study and Sialelli et al., 
(2010) are 140 µg kg-1BW d
-1 and 60 µg kg-1BW d
-1 , respectively. 
For Pb in soil samples the estimated daily intake mean and range are 12.8 µg kg-1BW d
-1 
(0.29 – 88.7 µg kg-1BW d
-1), 6.88 µg kg-1BW d
-1 (0.15 – 45.0 µg kg-1BW d
-1) and 3.04 µg kg-1BW 
d-1 (0.05 – 17.5 µg kg-1BW d
-1) for the aqua regia, gastric and gastrointestinal fluids 
concentrations, respectively (Table 3.9a).  Also assuming soil ingestion rate of 100 mg.d-1 
Ettler et al. (2012) have reported a similar range of 0.4 – 34.2 µg kg-1BW d
-1 for smelter 
contaminated soil samples using gastric phase concentrations. Also the range obtained in 
this work for aqua regia and gastric Pb (Table 3.9a) is consistent with the aqua regia, 1.70 
– 12.78 µg kg-1BW d
-1 and gastric, 1.11 – 6.61 µg kg-1BW d
-1 ranges reported by Pelfrene et 
al. (2012) for soil samples from a former Pb smelter. The lower maximum daily intake 
dose values reported by Pelfrene et al. (2012) compared to data from this work might be 
due to the lower Pb concentration range (214 – 1,425 mg/kg) in the samples they studied. 
The estimated Pb daily intake mean and range from metallurgic waste for aqua regia, 
gastric phase and gastrointestinal phase concentrations are 860 µg kg-1BW d
-1 (5.23 – 
8,600 µg kg-1BW d
-1), 42.2 µg kg-1BW d
-1 (0.38 – 287 µg kg-1BW d
-1) and 29.6 µg kg-1BW d
-1 
(0.11 – 138 µg kg-1BW d
-1), respectively (Table 3.9b). For similar metallurgic waste samples 
Wcislo et al. (2002) have estimated a lower mean daily intake dose of 89 µg kg-1BW d
-1 
based on a mean total concentration of 106,000 mg/kg. The lower mean daily intake 
estimated by Wcislo et al. (2002) compared with data from this study (Table 3.9b) is due 
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the lower AEF and lower exposure duration variables employed by Wcislo et al. 2002 for 
their risk estimation. For Pb based on both aqua regia and bioaccessible concentrations, 
soil ingestion rate of 20.6 mg d-1 (below the recommended 100 mg d-1 soil ingestion rate 
for a child) may be sufficient to trigger adverse health effects. Hence, the Pb related 
health problems observed at Mitrovica (Brown et al., 2010, UNEP, 2010) are consistent 
with the findings in this study. 
The estimated Zn daily intake mean and range from soil for the aqua regia, gastric phase 
and gastrointestinal phase concentrations are 3.40 µg kg-1BW d
-1 (0.08 – 16.7 µg kg-1BW d
-
1), 1.78 µg kg-1BW d
-1 (0.02 – 14.3 µg kg-1BW d
-1) and 0.76 µg kg-1BW d
-1 (0.03 – 2.58 µg kg-
1
BW d
-1), respectively (Table 3.9a). Using gastric phase Zn concentration Ettler et al. (2012) 
obtained a range of 0.4 – 22.5 µg kg-1BW d
-1 for a total Zn concentration range of 17 – 450 
mg/kg from smelter contaminated soils. Although similar gastric bioaccessibility were 
observed in both studies and lower total concentration ranges were employed by Ettler et 
al. (2012). The greater daily intake dose range recorded by Ettler et al., (2012) compared 
to this study is due to the fact that a 10 kg body weight was used for children in their 
calculations compared to 18.6 kg used in this work, and the lower body weight employed 
by  Ettler et al. (2012) can elevate the estimated intake dose. The estimated Zn daily 
intake mean and range from metallurgic waste for aqua regia, gastric phase and 
gastrointestinal phase concentrations are 328 µg kg-1BW d
-1 (1.15 – 1340 µg kg-1BW d
-1), 
126 µg kg-1BW d
-1 (0.81 – 314 µg kg-1BW d
-1) and 62.1 µg kg-1BW d
-1 (0.48 – 125 µg kg-1BW d
-
1), respectively (Table 3.9b). Based on the total Zn concentrations, Wcislo et al. (2002) 
reported a lower mean daily intake of 51 µg kg-1BW d
-1 for similar metallurgic samples. The 
lower mean daily intake estimated by Wcislo et al. (2002) is due to lower Zn 
concentration, lower hours of exposure and lower AEF employed in their calculations. At 
this site based on bioaccessible Zn concentrations a high soil ingestion rate of 4.2 g d-1 is 
required for intake dose to exceed TDIoral  for Zn compared with the assumed soil 
ingestion rate of 0.1 g d-1 for a normal child, thus adverse health effects due to exposure 
to Zn are potentially less likely. 
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3.4.8.2 Toxicity assessment 
Non-carcinogenic toxicity of PHEs in an individual is assessed by comparing PHE DI over 
a specific period of time with the tolerable daily intake dose (RfDoral) (Section 3.3.8.1). The 
ratio is referred to as the hazard quotient (HQ) and when the PHE DI exceeds the 
threshold (i.e HQ > 1) there may be concern for potential non-cancer risk (USEPA, 1989). 
The calculated hazard quotient values based on three different scenarios (PHE fractions 
soluble in aqua regia, in vitro gastric and gastrointestinal fluids) are listed in Appendix I – 
N, and summaries for soils and metallurgic waste samples are provided in Table 3.10a 
and 3.10b respectively. Individually Cd, Cu, Mn and Zn in soil samples indicated hazard 
quotients below 1 for the aqua regia (total) and bioaccessible concentrations, implying 
less likelihood for non-cancer health effects resulting from exposure to Cd, Cu, Mn, and 
Zn in soil matrix at the study site. For Cu in metallurgic wastes all samples indicated HQ 
below 1 for both aqua regia and bioaccessible concentrations. 
For As in soil, based on aqua regia concentration the mean (1.07) and maximum (4.80) 
HQs are above 1(Table 3.10a), and the bioaccessible concentration in the 
gastrointestional phase also indicated a value (1.20) above 1 for the maximum (Table 
3.10a). Therefore at Mitrovica based on total and bioaccessible concentrations As-related 
non-cancer health effects are expected from soil ingestion. The mean HQ values 
estimated for metallurgic wastes are 77.7, 4.37 and 1.81 for aqua regia, gastric phase and 
gastrointestinal phase concentrations, respectively (Table 3.10b). Based on the aqua 
regia concentrations all metallurgic waste samples investigated indicated HQ values 
above 1 (Table 3.10b). Hence the ingestion of metallurgic waste at Mitrovica may induce 
As-related adverse health effects in children. 
For Cd in metallurgic wastes the aqua regia, gastric phase and gastrointestinal 
concentrations indicated mean HQ values of 4.31, 3.99 and 2.17, respectively (Table 
3.10b), thus the ingestion of metallurgic waste by children at Mitrovica may cause adverse 
health effects associated with Cd. For similar daily intake dose level [this study: 1.61 µg 
kg-1BW d
-1 and Wcislo et al. (2002): 2.00 µg kg-1BW d
-1] Wcislo et al. (2002) reported a lower 
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Table 3.10a: PHEs Mean Hazard Quotient values for soils ingestion  
 TDIoral  
(µg kg-1BW d
-1) 
Hazard Quotient 
(unitless) 
  Aqua Regia Gastric Gastrointestinal 
As 0.3 1.07 
(0.10 – 4.80) 
0.21 
(0.03 – 0.83) 
0.27 
(0.07 – 1.20) 
Cd 0.36 0.07 
(0.03 – 0.33) 
0.06 
(0.03 – 0.22) 
0.06 
(0.03 – 0.06) 
Cu 160 0.003 
(0.001 – 0.008) 
0.001 
(0.0001 – 0.002) 
0.001 
(0.0002 – 0.003) 
Mn 140 0.03 
(0.02 – 0.06) 
0.02 
(0.01 – 0.03) 
0.01 
(0.01 – 0.01) 
Pb 3.6 3.40 
(0.08 – 24.0) 
1.90 
(0.04 – 12.0) 
0.88 
(0.01 – 4.90) 
Zn 600 0.006 
(0.0001 – 0.028) 
0.003 
(0.00003 – 0.024) 
0.001 
(0.00005 – 0.0043) 
Data in in parentheses represents range 
Numbers in bold italics indicate hazard quotient values > 1 
Aqua regia – calculations based on aqua regia soluble PHE concentration 
Gastric – calculations based PHEs bioaccessible concentrations in the gastric phase 
Gastrointestinal – calculations based on PHEs bioaccessible in the gastrointestinal phase 
 
Table 3.10b: PHEs Mean Hazard Quotient values for metallurgic waste ingestion  
 TDIoral  
(µg kg-1 
BW d-1) 
Hazard Quotient 
(unitless) 
  Aqua Regia Gastric Gastrointestinal 
As 0.3 77.7 
(1.50 – 400) 
4.37  
(0.53 – 23.0) 
1.81  
(0.33 – 5.50) 
Cd 0.36 4.31  
(0.03 – 21.0) 
3.99  
(0.06 – 9.70) 
2.17  
(0.06 – 7.90) 
Cu 160 0.062 
(0.003 – 0.24) 
0.025 
(0.0003 – 0.17) 
0.045 
(0.0004 – 0.071) 
Mn 140 0.01 
(0.003 – 4.30) 
0.06 
(0.001 – 0.33) 
0.02 
(0.0001 – 0.10) 
Pb 3.6 230 
(1.40 – 2300) 
11.9 
(0.11 – 80.0) 
8.15  
(0.03 – 38.0) 
Zn 600 0.39 
(0.17 – 2.20) 
0.21 
(0.001 – 0.52) 
0.09 
(0.001 – 0.21) 
Data in in parentheses represents range 
Numbers in bold italics indicate hazard quotient values > 1 
Aqua regia – calculations based on aqua regia soluble PHE concentration 
Gastric – calculations based PHEs bioaccessible concentrations in the gastric phase 
Gastrointestinal – calculations based on PHEs bioaccessible in the gastrointestinal phase 
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HQ value of 1.20 for the mean total Cd concentration. The lower HQ value obtained by 
Wcislo et al. (2002) is due to the higher RFDoral (1.0 µg kg
-1
BW d
-1) value utilised by them.   
The mean and range of Pb HQ values from soil samples for the aqua regia, gastric phase 
and gastrointestinal phase concentrations are 3.40 (0.08 – 24.0), 1.90 (0.04 – 12.0) and 
0.88 (0.01 – 4.90), respectively (Table 3.10a). Based on total Pb concentrations in soil 
Pelferene et al. (2012) calculated HQ range of 3.70 – 30.6 for soil samples from a former 
Pb smelter, that are higher, though consistent with the range (0.08 – 24.0) obtained in this 
work. The higher HQ values obtained by Pelfrene et al. (2012) could well be due the fact 
that they used a lower body weight (11.15 kg) for children in their exposure calculation 
and lower body weight input into the model elevates the daily intake dose of an ingested 
contaminant. The mean and range of Pb HQ values from metallurgic waste for the aqua 
regia, gastric phase and gastrointestinal phase concentrations are 230 (1.40 – 2300), 11.9 
(0.11 – 80.0) and 8.15 (0.03 – 38.0), respectively (Table 3.10b). For Pb, excluding 
samples from Roma Mahalla the hazard quotients significantly exceeded 1 (Appendix M) 
for both soil and metallurgic matrices, based on total and gastric phase concentrations. 
That most sample locations indicated HQs above the threshold of 1 for Pb suggest a 
strong likelihood of Pb-related non-cancer health in children at Mitrovica. Results of 
epidemiological studies conducted by Brown et al. (2009), Factor-Litvak et al. (1999) and 
Kamberi et al. (2011) for children at Mitrovica have highlighted Pb-related non-cancer 
health effects such as high blood lead levels, elevated lead concentrations in teeth, 
decrement in intelligence, small increase in blood pressure, increase in behaviour 
problems, risk of proteinuria and perturbed hematopoiesis.   
For Mn and Zn in metallurgic samples only maximum HQs derived using aqua regia 
soluble concentrations are above 1 (Table 3.10b) and if toxicity of Mn and Zn depend on 
bioaccessible dose, no negative non-cancer health effects are expected for children at 
Mitrovica from Mn and Zn individually.  
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3.5 Summary 
The mass recovery test for the validation of microwave-assisted acid extractions for Cd, 
Mn, Pb and Zn from samples using the certified reference material (BCR 143R) was good 
(96 to 103 %). For the oral bioaccessibility accuracies obtained for As and Pb from BGS 
102 were within the range specified. 
The total concentrations range for As, Cd, Cu, Mn, Pb and Zn in all the samples were 6 – 
22600 mg/kg, 1 – 1,440 mg/kg, 23 – 7,150 mg/kg, 396 – 11,1000 mg/kg, 54 – 160,000 
mg/kg and 30 – 250,000 mg/kg, respectively. The order of maximum total concentration is 
Cd < Cu < As < Mn < Pb < Zn. 
Strong positive correlations (0.83 – 0.95) have been observed between soils total and 
bioaccessible concentrations of As, Cu and Pb. Also similar positive correlations (0.88 – 
0.94) were observed between total and bioaccessible concentrations for Cu, Pb and Zn in 
metallurgic waste samples. Such strong positive correlations coupled with the elevated 
total concentrations observed at the study area suggest the possible occurrence of PHEs 
related health effects.  
Generic risk assessment based on bioaccessible concentrations of As, Cd, Pb and Zn in 
soil with the UK CLEA soil guideline values, Dutch and Italian soil intervention values 
(Carlon, 2007) indicated exceedance for residential exposure scenario. 
The mean and range of bioaccessibility indicated in the gastric phase for all three matrices 
are 20.3 % (1.01 - 39.5 %), 51.0 % (12.0 – 74.7 %), 22.1 % (1.00 – 72.7 %), 47.2 % (0.4 – 
95.4 %), 56.8 % (1.2 – 92.2 %) and 40.9 % (3.43 – 86.1 %) for As, Cd, Cu, Mn, Pb and 
Zn, respectively. The mean and range of bioaccessibility indicated in the gastrointestinal 
phase for all three matrices are 21.5 % (0.44 – 48.9 %), 17.7 % (2.18 – 75.5 %), 26.2 % 
(1.61 – 46.1 %), 22.5 % (0.10 – 52.0 %), 15.5 % (0.99 – 55.9 %) and 13.7 % (2.83 – 45.7 
%), respectively. The bioaccessibility range for Cd, Cu, Mn, Pb and Zn are very wide, so 
comparison with literature may be challenging. Grouping of the PHE bioaccessibility 
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according to their matrix have narrowed the bioaccessibility range for As, Cd, Cu, Mn and 
Pb for the tailing and smelter samples. For soil narrower range were obtained for Cd and 
Cu. 
Heavy mineral yields from the XRD analysis for mine tailings, smelter and soil samples 
were 54.4% (range: 47.7 – 61.2), 46.5 % (range: 30.4 – 55.9) and 1.81% (range: 0.40 – 
3.40) respectively. The metallurgic samples as expected also indicated significantly higher 
PHE total concentrations than the soil samples.  
Data from this study suggest that PHE mineralization has a large influence on the 
bioaccessibility. PHEs in readily bioaccessible forms as indicated in the surface soils with 
no XRD identifiable PHE mineral phases indicated the highest bioaccessibility for most of 
the PHEs studied, and is consistent with the interpretation of the preferential binding of 
‘unencapsulated’ PHEs to more labile physico-chemical phases (e.g. hematite and 
goethite) (Xu et al., 2009). Most of the geogenically-derived PHEs (e.g. tailing samples) 
indicated lower bioaccessibility, and are generally, though not exclusively, present in more 
strongly bound, less bioaccessible forms (e.g. arsenianpyrite and galena), typically 
incorporated into the mineral structure (Corriveau et al., 2011; Kocourkova et al., 2011). 
Mineralogy amid other numerous physico-chemical factors may have significant influence 
on the fraction of ingested soil-bound PHEs available for absorption in the digestive 
system. 
Calculated daily intake dose for As, Cd, Cu, Mn, Pb and Zn from ingested soil for children 
at the study site (Mitrovica, Kosovo) have only indicated exceedance for As and Pb, and 
these observations are consistent with recent elevated in vivo levels of As and Pb 
determined and highlighted for children at the site (Runow, 2005; Brown et al., 2010). 
Most soil and metallurgic waste sample indicated HQs greater than 1 for Pb in this study 
as expected since several workers (Wasserman et al., 1997; Factor-Litvak et al., 1999; 
Brown et al., 2010; UNEP, 2010) have previously highlighted Pb noncancer health effects.  
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Risk assessments PHEs at other areas should not be based on the conclusions listed 
above but the results can be used as part of a line of evidence approach at other sites. 
Studies at other site will still require site-specific bioaccessibility test due to local 
conditions. It is hoped that this data alongside other results from other studies will facilitate 
a site-specific risk appraisal for Mitrovica. 
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Chapter 4: Epithelial fluid Formulation and Method Development 
for In vitro Bioaccessibility Testing for Pb in Inhalable 
Particulates  
4.1 Introduction 
The rationale behind estimating the bioaccessible fraction of particulate matter associated 
contaminants in the respiratory environment is the understanding that soluble fractions in 
the fluids that line the respiratory tract will be available for uptake and consequent health 
effects (Muhle and Mangelsdorf, 2003; Gray et al., 2008; BeruBe et al., 2009). Based on 
limited understanding of respiratory fluids, cost and simplicity several substitute 
dissolution agents, such as de-ionised water, dilute acids, polydentate chelant (ethylene 
diaminetetraacetic acid -EDTA), acetate buffer, phosphate buffers and physiological 
sodium chloride solution that do not properly represent the lung fluid in composition have 
been used to estimate biodissolution (e.g. Artelt et al., 1998; Birlimi et al., 2006;  Canepari 
et al., 2006; Santos et al., 2009; Canepari et al., 2010; Harrington et al., 2012;). The 
pioneer synthetic human airway fluid commonly referred to as Gamble’s solution (Holliday, 
2000) was designed after the interstitial fluid within the lung and is commonly used for the 
exposure assessment of human to inhalable pollutants (Marques et al., 2011). Recently 
this original recipe has been modified (Wragg and Klinck, 2007; Julien et al., 2011) but the 
caption ‘Gamble solution’ is still retained. Others have employed captions like; ‘Modified 
Gamble’s solution’ (Gray et al., 2010), Gamble serum simulant’ (Ansoborlo et al., 1990), 
‘Simulated lung fluid’ (Taunton et al., 2010), ‘Synthetic serum’ (Kanapilly et al., 1973), 
‘Artificial interstitial fluid’ (Stopford et al., 2003; Stenbounova et al., 2011), and ‘Pseudo 
alveolar fluid’ (Takaya et al., 2006). The original “Gamble’s solution” and subsequent 
modifications by authors are listed in Table 4.1 and indicate both similarities and 
differences in the compounds that makeup the recipes.  
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Table 4.1: A list of authors and pH of solutions, chemicals and concentrations used to prepare existing in vitro inhalation bioaccessibility 
fluids  
AUTHORS Moss 1979  Takaya et 
al., 2006,  
Taunton et 
al., 2010  
Stopford 
et al., 
2003 
Wragg and 
klinck, 
2007  
Gray et al., 
2010;  
Kanapilly et 
al., 1973  
Julien  et 
al., 2011 
CAPTION Original  
Gamble 
Solution*  
Pseudo 
Alveolar 
Fluid 
Simulated 
Lung 
Fluid  
Artificial 
Interstitial 
Fluid  
Gamble 
Solution  
Modified 
Gamble 
solution  
Synthetic 
Serum  
Gamble 
Solution 
MgCl2.6H2O (mg/L) 203 212 212 203     
NH4Cl (mg/L)     535 5300 535 118 
NaCl (mg/L) 6019 6415 6400 6193 6786 6800 6786 6400 
CaCl2 (mg/L)     22  22  
CaCl2.2H2O (mg/L) 368 255 255 368  290  225 
Na2SO4 (mg/L) 71 79  71     
H2SO4 (mg/L)     45 510 45  
Na2SO4 .10H2O (mg/L)   179       
Na2HPO4 (mg/L)  148 148 142    150 
NaH2PO4 (mg/L) 142    144  144  
NaH2PO4 .H2O (mg/L)      1700   
H3PO4  (mg/L)      1200   
NaHCO3 (mg/L) 2604 2703 2700 2604 2268 2300 2268 2700 
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Na2CO3 (mg/L)      630   
NaHC4H4O6.2H2O (Sodium 
Hydrogen Tartrate Dihydrate) 
(mg/L) 
 180 180      
H2C6H5O7Na.2H2O (Sodium 
dihydrogen Citrate Dihydrate) 
(mg/L) 
97 153 153      
CH3CHOHCOONa (Sodium 
Citrate) (mg/L) 
 175   52  52 160 
Citric acid. H2O (mg/L)      420    
NaOCOCOCH3 (Sodium 
Pyruvate) (mg/L) 
 0.72 172      
NH2CH2COOH (Glycine) 
(Gly) (mg/L) 
 118 118  375 450 450 190 
L-Cysteine (C3H7NO2S)  
(mg/L) 
    121    
DPPC (Dipalmitoyl 
Phosphatidyl Choline 
(C40H80NO8P) (mg/L) 
       200 
CH3COONa.3H2O (Sodium 
Acetate Trihydrate) (mg/L) 
953   952     
Sodium Acetate 
(CH3COONa) (mg/L)  
     580   
HOC 
(COONa)(CH2COONa)2.2H2O 
(Sodium Citrate Dihydrate) 
(mg/L) 
 -  97  590   
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C3H5NaO3 (Sodium Lactate) 
(mg/L) 
  290      
KCl (mg/L) 298 -  298     
Potassium hydrogen 
phthalate (C8H5KO4) (mg/L)  
     200   
C14H23N3O10 (DTPA)
 (Pentetic 
acid) (mg/L)  
    79    
C21H38NCl (ABDAC)
 (mg/L) 
(Benzalkonium Chloride)  
    50    
pH (adjustment with HCl)   7.6  7.4 7.3 7.4 7.3  
  
*- The original Gamble’s solution was based on extrapolation of molar equivalent ion (e.g. Na+, Ca2+, Mg2+, K+, Cl-, HCO3
-, HPO4
2-, and SO4
2-) 
concentrations from a bar graph (Moss, 1979; Holiday, 2000). 
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4.1.1 In vivo chemical components of the airway lining fluid 
For any solution to model the airway fluid for in vitro assaying, it should be as similar as 
possible, within the limits of experimental capability to the native solution (Moss, 1979). In 
vivo determination of the composition of the human body fluids at the atomic level 
indicates 11 main elements (oxygen, carbon, hydrogen, nitrogen, calcium, phosphorus, 
sulphur, potassium, sodium, chlorine and magnesium) (Wang et al., 1992). Consequently 
in the recipes of published existing synthetic airway fluids these 11 elements are 
represented. However, at the molecular level the native lung fluid consists of minerals 
(inorganic salts), lipids, protein and water (Wang et al., 1992; Widdecombe and 
Widdecombe, 1995; Ellis, 2000; Lillehoj and Kim, 2002). There is an indication of 
consensus for inorganic salts and their concentrations in the native airway lining fluid   
(Joris et al., 1993; Knowles et al., 1997; Hull et al., 1998; Baconnais et al., 1998; Cadwell 
et al., 2002; Vanthanouvong and Roomans, 2004; Effros et al., 2005), but great variability 
exists with respect to the other constituents.  
Respiratory tract lining fluids (RTLF) like other body fluids also contain surfactant lipids 
(lipoproteins), lubricating glycoproteins and antioxidant proteins (Table 4.2). 
Dipalmitoylphosphatidycholine (DPPC) has been identified as the predominant surfactant 
lipid responsible for the surface-active property of the fluid in the airways (Lohninger et al., 
1983; Hamm et al., 1996; Kendall, 2007). Mucin, a metal-binding glycoprotein synthesized 
by epithelial cells is also present in the respiratory tract lining fluid (Cooper et al., 1985; 
Schenkels et al., 1995; Jeffery and Li, 1997; Puchelle et al., 2002; Holmen et al., 2004; 
Gray et al., 2004; Rose and Voynow, 2006). Amino acids such as glycine, a strong 
antioxidant and cysteine a precursor of glutathione (Schenkels et al., 1995) have also 
been identified as constituents of human airway secretion (Rose et al., 1979; Woodward 
et al., 1982; Reddy, 1992; Holmen et al., 2004).  
The RTLF also contain glutathione, an antioxidant that protects epithelial cells against the 
burden of toxic oxidant (Cantin et al., 1987; Neurohr et al., 2003; Kelly, 1999). Other 
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antioxidant proteins present in human respiratory tract lining fluids are ascorbic 
(ascorbate) and uric acid (urate) (Vliet et al., 1999; Peden et al., 1990; Kelly and Tetley, 
1997;; Behndig et al., 2006). Albumin has also been found in the respiratory tract lining 
fluids of healthy human subjects (Schenkels et al., 1995; Mudway et al., 1999; Bredow et 
al., 2001).   
4.1.2 Critique of published synthetic epithelial lung fluids 
Most existing in vitro models are based on blood plasma constituents alone whilst the 
actual airways constituents also include surfactants and proteins (Ehrhardt et al., 2008a). 
Possible limitations of existing RTLF are highlighted when their recipes at the molecular 
level are compared with the BARGE UBM recipe for oral bioaccessibility studies. At the 
molecular level the BARGE UBM recipe contains minerals (salts), water, proteins (e.g. 
albumin, mucin), organic acids (e.g. uric acid) and lipid (e.g bile salt), thus all four 
molecular components of human body fluids are represented. Typical recipes (Table 4.1) 
for respiratory airway fluids indicate sufficient salt contents but appear to be inadequate in 
approximating the content of organic molecules in the native respiratory tract environment 
(Marques et al., 2011). Though some authors have substituted proteins with citrates/citric 
acid and organic acids with acetates (Stopford et al., 2003; Takaya et al., 2006; Wragg 
and Klinck, 2007; Gray et al., 2010), it may be difficult to justify these substitutions 
especially when the same organic molecules have been used in other aqueous in vitro 
protocols (e.g. BARGE UBM) and are readily available on the market. Lipids, known to be 
present in RTLF (Lohninger et al., 1983; Hamm et al., 1996; Kendall, 2007) have also 
been excluded in many lung bioaccessibility models with minimal to no justification. There 
is a need for research aimed at investigating the applicability of a synthetic fluid that 
includes some of these excluded native constituents in RTLF as a leaching medium for 
metal such as Pb from PM.  
Leaching of solids depends on wetting, dissolution and outward diffusion processes (Gray 
et al., 2008; Benedik et al., 1999). Surfactants are capable of enhancing the dissolution of 
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compounds with low solubility in different solvents (Miller, 1995; Polat and Erdogan, 2007; 
Davies and Feddah 2003). Kendall (2007) has provided evidence that surfactant 
(dipalmitoylphosphatidycholine -DPPC), proteins and amino acids respiratory in tract lining  
Table 4.2 Typical proteins identified in human saliva, plasma, tears and RTLF 
Body Fluids Typical Proteins References 
Saliva serum albumin, mucin, cysteine, 
glutathione, amylase, uric acid 
Kaufman and Lamster, 2002 
Nagler et al., 2002 
Vitorino et al., 2004 
Oppenhein et al., 2007 
Plasma serum albumin, mucin, transferin, 
cysteine, glycine, glutathione, amylase, 
lipoprotein  
Winzler et al., 1948 
Lee and Alaupovic, 1970 
Chapman et al., 1981 
Anderson and Hunter, 2006 
Tears serum albumin, mucin, transferin, 
lipoprotein, cysteine, glycine, 
glutathione, ascorbate, urate 
Jumblatt et al., 1999 
Ng et al., 2000 
Ng et al., 2001 
Li et al., 2005 
RTLF Serum albumin, mucin, cysteine, 
glycine, glutathione, ascorbic acid, uric 
acid, DPPC 
Cantin et al., 1987 
Cross et al., 1994 
Samet and cheng, 1994 
Khanvilka et al., 2001 
 Rose and Voynow, 2006 
 Behndig et al., 2006  
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fluid can adsorb to PM surfaces. Such adsorption prevents the agglomeration of fine 
particulates by dispersion enhancement (Jiang et al., 2009) and can influence dissolution 
kinetics of contaminants associated with PM. It is also suggested that single and multiple 
antioxidant solutions of uric acid, ascorbic acid and glutathione can change the surface 
chemistry of PM (Zielinski et al., 1999). PM containing metals undergoes oxidative 
interactions with RTLF and the kinetics are significantly influenced by concentrations of 
ascorbic acid, lipid and glutathione (Sun et al., 2001) Therefore, the use of in vitro 
respiratory models that are inadequate representatives of the native RTLF may have 
important implications when the bioaccessibility data obtained from their application are 
employed for human risk assessment studies. In 2008 the Inhalation Ad Hoc Advisory 
Panel for the US Pharmacopeia (USP) Performance Tests of Inhalation Dosage Forms 
acknowledged the lack of standards for dissolution of inhalation dosage (Gray et al., 
2008). Gray et al., (2008) also suggested that a careful and thorough selection of 
apparatus, dissolution media, and sample preparation must be made before reasonable in 
vitro and in vivo correlations can be attained. 
4.1.3 Inhalation pathways for particulate lead 
Particulate matter (PM) can enter the human circulatory system by three routes: ingestion, 
inhalation and dermal absorption (Needham et al., 2005; Charlet et al., 2012). Inhalation 
exposure is considered the most important for assessing the toxicology of airborne 
particulate matter and pulmonary absorption of Pb is efficient when airborne particulates 
are inhalable (Patocka and Cerny, 2003; Russell and Brunekreef, 2009).  Aerodynamic-
size property of suspended particulate matter governs the deposition pattern of inhalable 
particulate matter in the respiratory tract (Lippmann et al., 1980). The Task Group on Lung 
Dynamics describes dust deposition in terms of three anatomical compartments (the 
nasopharynx, the trachea-bronchial tree and the pulmonary compartment) (Task Group on 
Lung Dynamics, 1966). The epithelial region is represented by both the nasopharynx and 
the trachea-bronchial compartments (Reznik, 1990; Ehrhardt et al., 2008b).  
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Inhaled particulate matter can dissolve in respiratory tract fluids (Davies and Feddah, 
2003). Recently Censi et al., (2011) have reported Pb dissolution in human bronchial 
fluids and suggested the use of trace element distribution in bronchoalveolar lavage (BAL) 
as a tracer of the diverse human exposure sources of inhaled airborne particulates. 
However, due to difficulties associated with the use of human subjects, in vitro testing is 
an attractive assessment option. 
4.1.4 Inhaled particulate lead exposure and health 
The toxicity of inhaled particulate matter is influenced by trace metal content, acid content, 
sulphate content and bulk chemical composition (Harrison and Yin, 2000). Both low and 
high levels of lead exposure in the form of particulate matter have been associated with 
several adverse health effects (Chen and Lippmann, 2009). Advanced analytical methods 
coupled with refined epidemiological techniques have lowered the least observable effect 
level for lead to almost zero (Landrigan, 1989: Needleman et al., 1990 Goyer, 1993; 
Landrigan and Todd, 1994; Canfield et al., 2003; Telisman et al., 2007). Recently, at a 
workshop organised by the Society of Brownfield Risk Assessment on “Human health risk 
assessment of lead in soil” it was recommended that index dose (ID) approach be 
adopted in estimating HCV (SOBRA, 2012). Health endpoints associated with 
asymptomatic lead toxicity are neurological deficits (White et al., 1993; Factor-Litvak et al., 
1999; Canfield et al., 2003; Sanders et al., 2009), high blood pressure (Factor-Litvak et 
al., 1999; Vupputuri et al., 2003) and developmental problems (Wasserman et al., 1997; 
Factor-Litvak et al., 1999; Schnaas et al., 2000), whilst elevated levels are associated with 
cardiovascular problems (Schwartz, 1991; Fewtrell et al., 2004; Vaziri, 2008; Park et al., 
2008), lung function decline (Bagci et al., 2004; Pak et al., 2012), fetal neurologic damage 
(Granjean and Landrigan, 2006; Julvez and Grandjean, 2009), reduced birth weight and 
stature (Lamb et al., 2008; Afeiche et al., 2011). However, human subjects are not equally 
susceptible to lead toxicity although the reasons for this are still not well known. Major risk 
factors for lead toxicity are age, nutrition (food intake) and socioeconomic status (Goyer, 
1993). To understand the toxicological variability in human more data is needed in the 
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areas of potential exposure sources, pathways and fate of intake dose. However, there is 
now agreement that an absorbed dose is more relevant than intake dose (SOBRA, 2012) 
and this study is aimed at formulating in vitro epithelial fluid for the estimating 
bioaccessible dose that will be available for absorption. 
4.1.5 Previous Pb inhalation bioaccessibility studies 
In order to have a more reliable estimate of exposure concentrations a number of 
dissolution experiments have been conducted for particulate Pb from different sources 
(e.g coal derived fly ash, mine tailings, urban particulate matter, soil-derived dust) in 
synthetic airway fluids and the summary is provided in Table 4.3. However, amongst the 
published studies, none investigated particulate matter derived from soil; a matrix 
contributing significant mass fraction of airborne Pb. The reviewed studies (Table 4.3) 
employed Gamble’s solution, Hatch’s solution, artificial lysosomal fluid, lung fluid simulant 
or serum simulant. The lung consists of two functional parts (the airways and the alveoli) 
with the airways including the trachea, bronchi and the bronchiole (Ehrhardt et al., 2008; 
Yang et al., 2008). It is important to determine the regions that the existing studies are 
simulating but this is far from clear.  The airways are relevant in health risk assessment 
because absorption also occurs within the tracheobronchial tract (Efthimou et al., 1982; 
Greiff et al., 1990; Bryon and Patton, 1994; Marsh and Birchall, 1999; Sakagami et al., 
2002; Tian and longest, 2010). Beeston et al., (2010) and Shaider et al., (2007), based on 
the pH of the leaching medium appear to be simulating dissolution in the lung alveoli 
however particles too large to reach this region were being tested in their study. Synthetic 
gastric juice was used for inhalable particles by Falta et al., (2008) to simulate inhalable 
particulates cleared by mucociliary clearance into the digestive tract. The other studies 
listed with fluid pH of 7.2 -7.4 were investigating bioaccessibility within the airways, but in 
nearly all the studies the actual compartment within the airway being simulated was not 
explicitly considered.  
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Table 4.3: Examples of Pulished Pb inhalation bioaccessibility studies 
Particle size 
(µm) 
Test Fluid and pH Matrix  Sampling 
method  
Geographical 
location 
Reference 
7.2 Serum simulant 
7.4 
Airborne particulate 
matter 
Air sampler Northern Greece Vousta and Samara, 
2002 
10 Lung fluid simulant 
7.2 
Coal derived fly 
ash 
Electrostatic 
precipitator 
Indiana, United 
States 
Twining et al., 2005 
10 and 76 Serum simulant 
7.3-7.4 
Aerosol and settled 
dust from 
phosphate plants 
Sieving and Air 
sampling 
Florida, United 
States 
Kim et al., 2007 
0.16-1, 1-2.5, 
2.5-10, 10-34 
Artificial lysosomal 
fluid 
4.5-5.0 
Chat piles Air aspirator and 
cascade impactor 
Oklahoma, United 
States 
Schaider et al., 2007 
10 Gamble’s solution 
7.4 
Mine tailings Nylon sieving Rheidol, Wales Wragg and Klinck, 2007 
5 Gamble’s and Hatch’s 
solutions 
7.4 
Welding fumes Air sampler Sweden Berlinger et al., 2008 
2.5, 10 Synthetic gastric fluid Urban particulate 
matter 
Air sampler Vienna, Austria Falta et al., 2008 
3 Artificial lysosomal 
fluid 
4.2  
PbS and PbSO4 
aerosol  
Air aspirator and 
cascade impactor  
Slovenia Beeston et al., 2010 
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4.2 Materials and Method 
4.2.1 Chemicals 
All chemicals were analytical grade and the epithelial lung fluid was prepared using MilliQ 
water (18.2 MΩ cm). Anhydrous sodium sulphate (Na2SO4), bovine serum albumin (BSA), 
calcium chloride (CaCl2.2H2O), sodium bicarbonate (NaHCO3), hydrochloric acid (HCl), 
magnesium chloride (MgCl2.6H2O), sodium Chloride (NaCl), nitric acid (69% HNO3) and 
potassium chloride (KCl) were purchased from Merck (Poole, England). Sodium hydrogen 
phosphate (NaH2PO4) was sourced from Baker Scientific, UK. Mucin was sourced from 
Carl Roth, Germany. Ascorbic acid, Uric Acid, Glutathione, dipalmitoylphophatidylcholine 
(DPPC), Glycine and Cysteine sourced from Sigma-Aldrich, UK. Five certified reference 
materials that are commonly used by the environmental community in quality control 
assessments of metal contamination analysis (Table 4.4) were considered in this study. 
BCR 038, BCR 143R, BCR 176R and BCR 732 were sourced from Sigma-Aldrich, UK. 
BGS 102 was provided by Joanna Wragg of the British Geological Survey (BGS), 
Nottingham. 
Table 4.4: Details of Certified Reference Materials used in this study 
CRM name Origin Supplied Particle size 
(µm) 
BCR 143R Sewage sludge amended soil <90 
BCR 723 Road dust <90 
BCR 176R Fly ash <105 
BCR 038 Fly ash from pulverised coal <10 
BGS 102 Naturally contaminated soil from 
North Lincolnshire 
<40 
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4.2.2 Bioaccessibilty apparatus 
An extractor-incubator unit was employed to conduct the bioaccessibility study for the Pb-
contaminated soils.  
4.2.3 Simulated epithelial lung fluid- Recipe justification 
All the constituents of the respiratory tract lining fluid need not be included, but to better 
approximate the native contents all molecular groups were represented. Inorganic salts, 
surfactant lipid, large-molecular-mass proteins, low molecular-mass antioxidant proteins 
and organic acids (Table 4.5) are native to the epithelial lung fluids of healthy non-
smoking humans (Lohninger et al., 1983; Cantin et al., 1990; Kelly et al., 1995; Hamm et 
al., 1996; Vliet et al., 1999; Vanbever et al., 1999; Kirkham and Rahman, 2006; Kendell, 
2007) so in this formulation their dominant representatives are included. Albumin, 
ascorbic, glutathione, uric acid and mucin have been identified as components of the 
RTLF that can provide initial protection of the airways against inhaled environmental 
toxins (Cross et al., 1994; Khanvilka et al., 2001). 
4.2.3.1 Inorganic salts 
Inorganic salts (sodium chloride, calcium chloride, sodium dihydrogen phosphate, sodium 
bicarbonate, potassium chloride, magnesium chloride hexahydrate, sodium sulphate) and 
their concentrations in existing models (Table 4.1) closely approximate published in vivo 
data for healthy humans (Joris et al., 1993; Knowles et al., 1997; Hull et al., 1998; Kerem 
et al., 1999; Zhang and Engelhardt, 1999; Jararaman et al., 2001; Cadwell et al., 2002; 
Vanthanovong and Roomans, 2004). Thus in this formulation (Table 4.5) the same salts 
and similar concentrations were maintained.  
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Table 4.5: Recipe for synthetic tracheobronchial fluid  
Reagent Concentration (mg/ L) 
Inorganic salts 
NaCl 6020 
CaCl2.2H2O 256 
Na2HPO4 150 
NaHCO3 2700 
KCl 298 
MgCl2 200 
Na2SO4 72 
Surfactant lipid 
DPPC 100 
Large-molecular-mass proteins 
Albumin 260 
Mucin 500 
Low-molecular-mass antioxidants 
Ascorbic acid 18 
Uric acid 16 
Glutathione 30 
Organic acids 
Glycine 376 
Cysteine 122 
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4.2.3.2 Surfactant lipid 
DPPC is the major lipid in human RTLF (Pison et al., 1986; Johansson et al., 1994; 
Gregory et al., 1991; Griese, 1999). The lipid is capable of forming a gel at human basal 
temperature (Possmayer et al., 2001), and enhances dispersion of nanoparticles (Gehr et 
al., 1994). The surfactant which has been used (Davies and Feddah, 2003; Sun and 
Tilton, 2001; Son and McConville, 2009 Julien et al., 2011) for in vitro inhalation 
bioaccessibility models was selected for this formulation. Varying concentrations have 
been applied in a number of in vitro models, ranging between 200-10000 mg/L. However, 
based on in vivo DPPC concentrations data; 73 mg/L (Hallman et al., 1982) and 114 mg/L 
(Bunger and Pison, 1995), 100 mg/L of DPPC was adopted for the formulation (Table 
4.5). Griese, (1999) while reviewing surfactant concentrations from healthy human 
subjects reported a range (10 -130 mg/L phospholipid concentration from 22 studies) and 
is consistent with the 100 mg/L applied here. Davies and Feddah (2003) have shown that 
at the adopted concentration the surfactant can still influence the solubility of chemical 
agents.  
4.2.3.3 Large-molecular-mass proteins 
Albumin and mucin are the major secretory products of human serous and mucous gland 
cells (Finkbeiner, 1999; Kesimer et al., 2009) and so were selected as representative of 
high molecular weight proteins in this formulation. Analyses of exhaled endogenous solids 
from healthy individuals have indicated the presence of albumin (e.g. Breberg et al., 
2012). The in vivo concentration range of albumin (50 - 5500 mg/L) (Fick et al., 1984; 
Lemer et al., 1993; Cross et al., 1994) in the RTLF is high. In the presence of CaCl2 and 
MgCl2 albumin solubility in water can be influenced (Arakawa and Timasheff, 1982).  Also 
at high concentrations of NaCl albumin precipitates from solutions (Arakawa and 
Timasheff, 1982). Albumin binds to polystyrene and glass surfaces (silica-water interface) 
(Bakker, 1988; Su et al., 1998) at concentrations above 260 mg/L (Bakker, 1988) hence 
this peak concentration was adopted for the formulation (Table 4.5), although Twining et 
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al., (2005) had previously applied a lower concentration (200 mg/L) in a lung 
bioaccessibility in model.  
The airway mucus gel protects the respiratory tract against environmental challenges 
(Cooper et al., 1985; Khanvilka et al., 2001; Thornton et al., 2008). It has been suggested 
that glycoproteins bind with metals in solution (Cross et al., 2001; Duranti et al., 2001). 
Mucin has been shown to interact with Pb2+ at neutral pH values influencing the solubility 
of Pb (Duranti et al., 2001).  At physiologic concentrations (20,000 – 50,000 mg/L) (Bansil 
et al., 1995; Lee et al., 2005), mucin exhibits extensive aggregations and forms gel-like 
solids (Cao et al., 1999; Bromberg and Barr, 2000; Lee et al., 2005; Bansil and Turner, 
2006).  At dilute concentrations (< 1500 mg/L), undesirable aggregations are avoided, but 
the characteristic lubricating properties are retained (Lee et al., 2005). Considering the 
fact that mucin concentration in both bronchial and nasal secretions is more than that of 
albumin (Schenkel et al., 1995), a concentration of 500 mg/L was chosen for this 
formulation. As far as known this is the first time mucin has been included in lung 
bioaccessibility fluid formulations. Significant differences exist in the adsorption properties 
of albumin and mucin (Feiler et al., 2007) and in solution albumin aids the viscosity of 
mucin (List et al., 1978). 
4.2.3.4 Low-molecular-mass antioxidant proteins 
Antioxidant solutions at pH of 7.4 consisting of saline, ascorbic acid, uric acid and 
glutathione have been used to represent normal human airway secretions (Zelinski et al., 
1999). In vivo concentrations of ascorbic acid, uric acid and glutathione in the 
bronchoalveolar lining fluids of healthy human subjects have been documented as 17.6 
mg/L, 15.1 mg/L, 30.7 mg/L respectively (Cross et al., 1994), and approximately the same 
concentrations (Table 4.5) were chosen for this formulation.  
 
 
113 
 
4.2.3.5 Organic acids 
Organic acid components of the human RTLF have been represented by glycine 
(Kanapilly et al., 1973; Ansoborlo et al., 1990; Jurinski and Rimstidt, 2001; Takaya et al., 
2006; Wragg and Klinck, 2007; Gray et al., 2010; Julien et al., 2011; Drysdale et al., 2012) 
and cysteine (Harris and Silberman, 1983; Ansoborlo et al., 1990; Vousta and Samara, 
2002; Wragg and Klinck, 2007). Both acids help maintain glutathione balance (Kelly, 
1999) and exhibit anti-inflammatory effects during endothelial inflammation (Ichiyama et 
al., 2012). In this formulation the concentrations of glycine and cysteine were set at 376 
mg/L and 122 mg/L respectively (Table 4.5) according the formulation by Wragg and 
Klinck, (2007). 
4.2.4 Experimental Parameters  
4.2.4.1 Calculation of exposure dose and sample size 
To estimate the PM10 inhaled dose for chronic exposure by a healthy adult, PM10 
concentration not to be exceeded in a calendar year (European Environment Agency, 
2011b), the average respiratory volume of an adult per day (USEPA, 1991) and the 
exposure frequency for residential land use (USEPA, 1991) were multiplied (Equation. 
4.1)   
mPM10 = PMlimit . Vresp . EF                                                                     (4.1) 
In equation 4.1, mPM10 (µg) represents the PM10 dose for chronic exposure, the PMlimit (40 
µg/m3) represents PM10 concentration not to be exceeded for an averaging period of a 
calendar year, Vresp (m
3/day) represents the average adult respiration volume (20 m3/day) 
and EF (days/year) represent the exposure frequency for a calendar year (365 days/year). 
The default inhalation rate of 20 m3 / day (USEPA, 1991) was applied to represent a 
reasonable upper-bound value for adults.  
The calculated PM10 dose for chronic exposure was 292000 µg (292 mg) the value was 
rounded up to 300 mg and used as the sample size for this study. Similar values of 250 
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mg (Drysdale et al., 2012) and 450-550 mg (Wragg and Klinck, 2007) have been 
previously used though the methods of estimation were not published. 
4.2.4.2 Volume of Respiratory tract lining fluid 
A volume of 0.3 ml/Kg body mass has been recorded for healthy non-smoking human 
subjects by both Miserocchi, (1997) and Noppen et al., (2000). For a 70 Kg man this 
would correspond to 21 mL. For this study the value was rounded down to 20mL and set 
as the experimental volume of the epithelial lung fluid. The same volume has also been 
used in previous related studies (Wragg and Klinck, 2007; Twining et al., 2005; Gray et 
al., 2010; Twining et al., 2005). 
4.2.4.3 Extraction temperature 
The nasopharynx and main bronchi regions of the respiratory tract have indicated 
temperatures between 33.9 to 36.7 oC (Elad et al., 2008) and 37 oC (Wolf et al., 2004) 
respectively and the values approximate the basal human body temperature (37oC) 
chosen for the experimental protocol for this study. 
4.2.4.4 Extraction pH 
Fischer and Widdecombe, (2006) in a review of acid-base secretions in the human 
epithelium looked at published data on nasal and tracheal-bronchial mucosal airway pH 
from normal human subjects. For the nasal (7 authors) and tracheal-bronchial (9 authors) 
airway regions pH ranges of 5.5 to 7.9 and 5.7 to 7.5 were respectively reported. 
However, it has been suggested the pH probe in situ triggers the release of alkaline 
mucus onto the airway surface which may enhance the nasal pH (McShane et al., 2003). 
To minimize the undesired mucus release, measurements were taken under anaesthetics, 
areas covered by mucus were excluded and the pH obtained beyond the nasal region 
(tracheal-bronchial) was 7.1 ± 0.1 (McShane et al., 2003). Based on the McShane et al., 
(2003) data (pH 7.1 ± 0.1) and the maximum pH value 7.5 reported in Fischer and 
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Widdecombe, (2006) in their review, the pH for this bioaccessibility study was set at 7.4 ± 
0.2. 
4.2.4.5 Extraction time 
For oral bioaccessibility nutritional studies have indicated emptying times for different 
phases and in vitro models reflect these time frames (Ng et al., 2010) but for inhalation 
bioaccessibility such agreed time frames are presently not available. Hence times in the 
range of 5 mins to 26 days have been previously applied (Julien et al., 2011), with most 
workers restricting extraction times to ≤ 24hrs. However, it has been suggested that about 
10 to 15% of particles deposited in the human bronchial tree were still retained beyond 24 
hrs (Hofmann and Asgharian, 2003). For this study different extraction times (30 min to 
170 hours) were evaluated to determine optimum time required for the bioaccessibility 
testing of Pb PM10. Wragg and Klinck, (2007) have previously suggested that a minimum 
dissolution testing time of 100 hours is required for conservative estimate of Pb 
bioaccessibility of the lungs. 
4.2.4.6 Fluid preparation 
The simulated tracheobronchial fluid preparation involved prior dissolution of the inorganic 
and organic constituents and subsequent mixing of both phases with the lipid and 
proteins. Full description of the procedure is provided in Appendix O. 
4.2.5 Soil sample preparation and extraction with lung fluid  
A soil sample (< 250 µm) obtained from an historic white lead works site was 
homogenized by ball milling. The resulting soil powder was subjected to the 
bioaccessibility testing procedure using the formulated epithelial lung fluid (see Appendix 
P for the full description of steps). The bioaccessible Pb in soil was determined by placing 
0.3 g of the ball-milled sample in 50 mL centrifuge tube holding 20 mL of lung fluid. The 
centrifuge tubes were screw-capped and fitted to an orbital rotator. The tubes were then 
rotated at 25 cycle/min (same rotation speed had previously been used to simulate 
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inhalation scenario by Midlander et al., 2005) in a incubator set at 37 oC for 0.5 hr 1hr, 2 
hrs, 3 hrs, 4hrs, 5 hrs, 6 hrs, 10 hrs, 12 hrs, 24hrs, 48 hrs, 60 hrs, 70 hrs, 80 hrs, 96 hr 
and 170 hrs. At the end of these listed times the leaching process is stopped, suspension 
centrifuged for 10 min at 3000 rpm and 1 mL of the resulting clear liquid siphoned off. The 
siphoned leachates were acidified with 9 mL 1 vol, % concentrated analytical grade HNO3 
to retain the elemental constituents in solution and stored in the fridge before analysis.  
4.2.6 Microwave extraction of PHEs from test samples 
The initial soil and the resulting residual solids were subjected to aqua regia extraction. 
0.5 g of the ball-milled experimental soil was weighed into Teflon polytetrafluoroacetate 
(PFA) vessels (65 ml) and 13 ml of aqua regia (HCl : HNO3 in the ratio 3:1 v/v) was 
added. The PFA vessels were screw sealed with their caps and placed in stands provided 
on the rotor of the microwave digestion unit before submission to microwave extraction. 
The digestion was done using recommended conditions (Okorie el at., 2011). Microwave 
assisted aqua regia digestion conditions and digestate preparation for ICP-MS analysis 
have been described in Section 2.3.  
4.2.7 Determination of Pb by ICP-MS 
10 mL of the acidified leachates from the aqua-regia microwave extraction and the 
inhalation bioaccessibility were spiked with internal standard before analysis for Pb 
concentration with the ICP-MS instrument. The ICP-MS operating conditions applied for 
this study have been previously described in full in Chapter 2, the mode of analysis, 
internal standard and Pb isotope analysed are listed in Table 4.6.  
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Table 4.6: ICP-MS Pb analysis setting and internal standard 
Instrument: ICP mass spectrometer X Series II (Thermo Electron 
Corporation, Cheshire, UK) 
Condition Standard Mode 
Internal standard 159Tb  
Isotopes monitored 208Pb,  
 
4.2.8 Analytical Quality Control for lung bioaccessibility and aqua regia 
extraction  
Procedural blanks were included within the inhalation bioaccessibility extraction to check 
the potential contamination from reaction tubes and the reagents and also for data 
required for the determination of the limit of detection for Pb. To test method 
reproducibility samples were extracted for a minimum of 3 times. Each extraction run 
consisted of a test soil (historic Pb works), one extraction blank and five certified reference 
materials; [BCR 030 (fly ash), BCR 176R (fly ash), BCR 723 (road dust), BCR 143 R 
(sewage sludge amended soil) and BGS 102 (Naturally contaminated ironstone soil)].  
For the microwave assisted acid digestion 0.5 g of certified reference material (BCR – 
143R) from the European Commission Joint Research Centre was also weighed and 
extracted in parallel to assess the efficiency of the digestion procedure.  
For the ICP-MS analysis quality control; procedural blanks and two quality control 
standards (low and high) were analysed after no more than 10 unknown samples. All 
reported data are based on the average of the three replicate analyses. External 
calibration of the ICP-MS equipment was conducted by analysing standard solutions (0, 
20, 40, 60, 80, 100, 200, and 400 ng /mL). 
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4.3 Results and discussion 
4.3.1 Quality control data for aqua regia digestion  
The aqua regia procedure for pseudo total Pb concentration was validated by analysing a 
certified material (BCR 143 R) in parallel and the recovery rate (103%) (Table 4.7) was 
good. The concentration (2950 ± 97 mg/kg) (Table 4.8) obtained for the historic Pb works 
sample is within the range (174 – 33306 mg/kg) reported (Okorie, 2010) for 19 samples 
previously investigated from the site. The total Pb concentrations obtained for the 
reference materials in this work closely agrees with the certificate values (Table 4.8). 
Mass balance analysis was conducted to ascertain if Pb was lost during sample 
preparation and solution transfers. The sum of residual Pb values and the extracted Pb 
values were compared with the aqua-regia totals to calculate the mass balance recovery 
of the in vitro extraction model methodology. Mass balance recoveries ranged between 
99.9 and 102.9 % while the mean for the six materials is 101%.  
Table 4.7: Quality control / Accuracy data for microwave-assisted acid digestion  
Certified value  
(mean± SD)(mg/kg) 
Measured value 
 (mean ± SD, n = 9) (mg/kg) 
Recovery rate 
(%) 
BCR 143R 
174 ± 5 180 ± 4 103 
 
4.3.2 Quality control data for tracheobronchial bioaccessibility 
For the in vitro extraction model methodology the precision, expressed as relative 
standard deviation (%), is presented in Table 4.8. The in vitro extraction exhibited 
precision values generally lower than 16.3%, though Wragg et al., 2011 have proposed 
that within laboratory repeatability should be less than 10 % RSD. The precision obtained 
for BCR 038 in this work and that conducted by Julien et al., (2011) are 7.5% and 12.5% 
respectively. The reproducibility obtained in this work for BCR 038 suggest that inclusion   
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Table 4.8: Aqua regia, bioaccessible, residual concentrations, bioaccessibility and mass balance for inhaled Pb  
Sample Type Certified 
(mg/kg) 
Aqua 
Regia 
(mg/kg) 
Inhalation 
Bioaccessible  
Fraction 
(mg/kg) 
RSD1 
(%) 
Residual 
(mg/kg) 
Bioaccessibility2 
(%) 
Mass balance3 
(%) 
BCR 038 Fly ash 262 ± 11 252 ± 3.0 0.80 ± 0.06 7.50 252 ± 20 0.30 100 
BCR 143R Sewage 
sludge 
174 ± 5 172 ± 3.0 14.4 ± 2.2 15.3 160 ± 2 8.40 101 
BCR 176R Fly ash 5000 ± 500 5020 ± 51 190 ± 31 16.3 4880 ± 
311 
3.80 101 
BCR 723 Road dust 866 ± 16 851 ± 21 33.8 ± 3.0 8.90 832 ± 18 4.00 102 
BGS 102 Fly ash from 
coal 
79.4 ± 1.4 70.2 ± 3.4 3.50 ± 0.2 5.70 68.8 ± 0.6 5.00 103 
St Anthony 
soil 
Ironstone soil - 2950 ± 97 31.4 ± 3.6 11.5 2920 ± 86 1.10 99.9 
1Relative standard deviation (RSD) = (Standard deviation / mean) x 100 
2% Bioaccessibility = (Inhalation bioaccessible fraction / Aqua regia) x 100 
2 % Mass balance = [(Residual Pb + Bioaccessible Pb) / (total Pb)] x 100 
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of albumin, mucin and antioxidants in the formulation of synthetic lung fluid, with the aim 
of obtaining fluids that more closely approximate the in vivo fluid does not reduce method 
precision.   
4.3.3 Influence of extraction-time on inhalation bioaccessibility 
Figure 4.1 shows the kinetics of Pb dissolution in the formulated lung fluid and the results 
indicate that extractable Pb is time-dependent (Appendix Q) for the historic Pb works soil 
investigated. The profile of the chart (Fig. 4.1) shows rapid dissolution of Pb in the first 0.5  
Figure 4.1: Plot of time-dependent bioaccessible Pb in tracheobronchial fluid   
 
Experiments  (n = 9) 
 
to 96 hours of the assay and asymptotic response between 96 and 170 hours. To validate 
the time, 9 experimental runs were conducted and variance in extraction at each time 
interval is indicated as the error bar (Figure 4.1). The maximum extractable Pb was 
measured after 96 hours of extraction and this value is consistent with the 100 hours 
reported by Wragg and Klinck, (2007) for optimal duration of extraction time for 
bioaccessible Pb in their in vitro extraction study with a Gamble solution. 
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4.3.4 Pb Bioaccessibility-96 hour extraction test 
The analytical data is summarised in Table 4.8 for bioaccessible Pb extracted after 96-
hours. The bioaccessible Pb content for the St Anthony soil and the five reference 
materials ranged between 0.80 – 190 mg/kg. % bioaccessibility was calculated as:  
% Bioaccessibility = (Extracted Pb after 96 hours/Total Pb) x 100 %                    (4.2) 
The range of bioaccessibility (0.30 -8.40 %) obtained in this study is below the range (14.4 
– 61.3 %) reported by Wragg and Klinck, (2007). The wide variance in bioaccessibility 
between two studies could be due to the differences in leaching fluids composition and Pb 
mineral phases in the samples tested. The presence of proteins in the tracheobronchial 
fluid may be responsible for the lower bioaccessibility indicated in this study, since Pb2+ is 
known to bind unto surfaces of proteins (Garza et al., 2006).  The bioaccessibility for the 
historic Pb works soil sample (1.1 %) is indicative of stable Pb phase. Pb from lead works 
are primarily in the form of antimonial lead clusters (SbnPbm) (Eckel et al., 2002) and 
because of their enhanced stabilities (Schild et al., 1987) the low bioaccessibility of the 
former lead work sample is expected.  
The certified reference materials sourced from fly ash (BCR 038 and BCR 176R) also 
indicated very low bioaccessibility. Under high temperature (such as during incineration) 
conditions Pb forms stable products with decreased leaching rate (Wei et al., 1997; Park 
and Heo, 2002). The low levels of bioaccessibility obtained for fly ash based reference 
material is consistent with the observations by Wei et al., (1997) and Park and Heo, 
(2002). Also at the operating pH (7.4 ± 0.2) applied in this work fly ash significantly 
adsorbs Pb2+ from solutions (Cho et al., 2005; Alinnor, 2007). The bioaccessibility for BCR 
038 in this work (0.3 %) is consistent with the 0.8% obtained for Pb leached from a coal-
derived fly ash using a normal canine serum (Harris and Silberman, 1988). This serum 
attempts to approximate the respiratory tract lining fluid as we set out to formulate. The 
value 0.3% is however below the 3.3% reported by Julien et al., (2011) for the same 
reference material determined using a Gamble solution. The variance may be due to the 
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absence of metal binding mucin and antioxidant proteins in the Gamble solution. The 
mucin may have adsorbed the soluble Pb, a possibility noted earlier in Section 4.2.3.3. 
Lead bioaccessibility in BCR 038 reduced by about 90 % in the tracheobronchial fluid. 
For the other reference materials, because of limited work in respiratory bioaccessibility 
(Plumlee and Ziegler, 2005) it is difficult to find literature data with which to compare. 
However, Pb in sludge-amended solids are more leachable than in natural soils even at 
neutral pHs (pH 7.1) (Sukreeyapongse et al., 2002) and this observation is in agreement 
with the bioaccessibility trend in this work where the highest observed % bioaccessibility , 
8.4 % is for the sludge-amended -BCR 143R.  
4.4 Summary 
Table 4.5 reports the formulation for the synthetic tracheobronchial fluid. In addition to the 
inorganic salts that presently dominate the recipes of typical artificial airway interstitial 
fluids in published literature this fluid also includes a surfactant, lubricating glycoproteins 
and other antioxidant proteins that are native to airways of healthy humans, and are 
capable of modifying the dissolution kinetics of inhalable environmental particulates. 
Based on scientific data an extraction protocol was developed and applied to a historic Pb 
works soil sample (< 100 µm size fraction). Results indicated an optimal extraction time of 
96 hr that is consistent with test duration of 100 hours recommended for the estimation of 
bioaccessible Pb by Wragg and KlincK, (2007). The protocol was applied for the 
bioaccessibility testing of BCR 143R, BCR 723, BCR 176R, BCR 038 and BGS 102 and 
the % bioaccessibility are 8.40 %, 4.00 %, 3.80 %, 0.30 % and 5.00 % respectively. One 
of the reference materials (BCR 038) indicated lower Pb bioaccessibility (about 90 %) in 
the tracheobronchial fluid than in Gamble solution (Julien et al., 2011) The low Pb 
bioaccessibility indicated for the reference material implies that inhalable Pb is unlikely to 
be in soluble form in the tracheobronchial environment. The presence of proteins in the 
tracheobronchial fluid may be responsible for the lower bioaccessibility indicated in this 
study, since Pb2+ is known to bind unto surfaces of proteins (Garza et al., 2006). The 
lower bioaccessibility is also consistent with suggestions that chemical components of the 
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RTLF serve as first line of defense against inhalable environmental toxins (Cross et al., 
1994; Todoroff and Vanbever, 2011). 
Further studies are required to investigate the chemical composition of the different fluids 
in respiratory tract. There is need for the formulation of artificial fluids for the other 
compartments of the respiratory tract based on recent scientific evidence as this could 
provide more realistic basis for the assessment of risk from inhalable environmental 
contaminants. 
There is need for certified reference materials developed specifically for inhalation 
bioaccessibility method validation. 
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Chapter 5: Application of inhalation bioaccessibility: a case study 
of Pb from Mitrovica, Kosovo 
5.1 Introduction 
Analyses of ambient urban and industrial particulates globally have highlighted Pb as a 
very dominant PHE in terms of concentration (USEPA, 1979; Countess et al., 1980; 
Harrison and Jones, 1995; Pakkanen et al., 2001; Williamson et al., 2004; Arditsoglou and 
Samara, 2005). With the aid of isotopic signatures it is possible to trace the source of Pb 
pollution and dispersal on a global scale (Bollhofer and Rosman, 2000; Simonetti et al., 
2003; Cloquet et al., 2006; Fluvio, 2010). As atmospheric pollutants are usually dispersed 
beyond nations and continents Pb is even present in the atmosphere of remote 
ecosystems (Hopper, 1991; Wang et al., 1995; Hernandez et al., 2003). Atmospheric Pb 
is mainly of industrial origin with contributions generally greater than 50% (Widory et al., 
2004). Smelting areas have been identified as representing point-source to public health 
problems (USEPA, 1971). Assessment of peat cores for Pb has indicated atmospheric Pb 
deposits on land surfaces (Weiss et al., 1999; Hernandez et al., 2003) and in some acid 
soils Pb accumulates in the surfaces soil horizon (Hernandez et al., 2003) where 
exposure to humans is more likely. 
Re-suspension of previously deposited lead from surface soil or waste/spoil heaps is a 
dominant source of atmospheric lead for any local population (Young et al., 2002; Laidlaw 
et al., 2008; Laidlaw et al., 2012; Del Rio-Salas et al., 2012), and the assessment of the 
contribution of contaminated soil to aerosol Pb is still a subject of current research (e.g. 
Del Rio-Salas et al., 2012). Although surface soils act as repository of deposited 
particulate Pb from several sources, little attention has been paid to contributions from this 
source in studies directed at assessing health risk of Pb associated with inhalable or 
respirable particulate matter. Resuspended dust from waste dumps and emissions from 
active industrial sites have been highlighted as major sources of airborne particles around 
metallurgic towns (Udachin et al., 2003; Williamson et al., 2004). Subsequent 
resuspension of historic Pb in surface soils was one of the rationales for the review of 
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ambient air quality standard for Pb by the USEPA (USEPA, 2008b). An urban airborne Pb 
source study by Pingitore et al., (2009) in El Paso, TX, USA demonstrated that the source 
of ambient air Pb was not current anthropogenic output but rather local contaminated soil; 
a legacy of earlier Pb releases. The size fraction of ambient PM that is strongly associated 
with resuspended surface soils and dust is the PM10 (Tiitanen et al., 1999; Yokovleva and 
Hopke, 1999; Lenschow et al., 2001; Marcazzan et al., 2003; Khodeir et al., 2012). In this 
study, fugitive dust was obtained from Pb-contaminated surface soils and exposed 
metallurgic wastes on the basis that these are the dominant source of inhalable Pb at the 
study area (for map of study area see Section 3.2). 
5.1.1 Exposure assessment 
Exposure assessment requires estimates that are representative of the range of exposure 
levels in the population under study. Exposure to air pollution is traditionally determined by 
the measurement of ambient concentration of air pollutants (e.g. PM10) in the environment 
where human populations spend time and the methods include fixed site measurement of 
air pollutant, modelled estimates of pollutant concentrations and personal measurement of 
exposure (WHO, 2006). The fixed site measurement of air pollutants is not a reliable 
environmental health risk indicator since environment-related health effects are triggered 
through exposure (WHO, 2006). Particulate Pb, when inhaled, is deposited and absorbed 
in the upper and lower respiratory tract compartments, or indirectly in the gastrointestinal 
tract (DTSC, 2004; USEPA, 2008b). Inhalation is the dominant pathway for Pb exposure 
for workers in industries producing and refining Pb and Pb products (IPCS, 1995). Blood 
Pb concentrations are used globally as index or biomarkers of Pb exposure (USEPA, 
2008). The ambient air Pb concentration and the blood Pb concentration relationship is 
limited because significant variability has been observed for different populations and age 
groups exposed to particulate Pb and attempts have been made to explain the variance 
(USEPA, 2008b). The variability may be due to the fact that blood Pb levels are related to 
environmental concentration instead of bioavailable concentrations. Chen and Lippmann 
(2009) in their review of literature providing insights on health effect caused by inhalation 
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of PM containing metals, have highlighted the need for studies focused on defining the 
relationship between human exposure and ambient concentrations for metal species (e.g. 
Pb) in PM.  
Reliable concentration-response data for specific health endpoints are more likely if one 
considers the internal dose (Lioy, 1990). The external exposure dose is the amount of 
xenobiotic material available to an organism, whereas the internal dose is the quantity of 
the material that is absorbed into the body (Committee on Biological Markers of the 
National Research Council, 1987). After particles have been inhaled and deposited in the 
respiratory tract, within the tracheobronchial region they interact with the lining fluid 
(Figure 5.1) before absorption through the airways (Edsbacker and Johansson, 2006; 
Pires et al., 2009). Hence varied dissolutions of inhaled particles will influence the dose 
available for absorption in the respiratory tract. The field of respiratory tract dissolution 
kinetics for radioactive air pollutants (e.g. Uranium) is well developed, but the same 
cannot be said for particulate Pb. Upon deposition, particles interact with the complex 
respiratory tract lining fluid which serves as fluid sink for dissolution (Widdicombe, 1997). 
Dissolutions are monitored in bronchoalveolar lavage or simulated respiratory tract fluids 
(as discussed in Section 2.5) and it is one of the important steps in determining the fate of 
environmental contaminants within the body (Borm et al., 2006).  
Recently Hayes et al., (2012) suggested poor correlation of measured total Pb in 
geomedia with blood Pb levels. In addition, outputs from the US EPA Integrated Exposure 
Uptake Biokinetic Model (IEUBK) for Pb have been challenged by poor correlations with in 
vivo Pb measurements (Hilts, 2003). The problem may lie with some of the defaults built 
into this model which assumes that 100% of Pb particulates reaching the lung are 
absorbed into the blood system (Shoaf, 1991). Contrary to such over generalised 
assumptions it is suggested that the physiochemical nature of a xenobiotic and the matrix 
in which it is encapsulated influences the accuracy of exposure monitoring (Committe on 
Biological Markers of the National Research Council, 1987).  
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Figure 5.1: Deposition and dissolution of xenobiotics in the tracheobronchial region  
 
After James et al., 1977; Patton and Byron, 2007 
Hilt et al., (2003) have suggested in their baseline risk assessment for childhood Pb 
exposure that the amount of Pb absorbed into the blood through the respiratory tract 
depended on the amount inhaled, the bioavailability (bioaccessibility) of the lead and 
dietary factors. Analyses of bronchial fluids of human receptors exposed to anthropogenic 
particulates show Pb in dissolved form (Cenci et al., 2011). Misjudgements of uptake 
(bioaccessible) dose of Pb could translate into possible misattributions of risk to various 
forms of Pb. In this study inhalable particles (PM10) from surface soils contaminated by 
metallurgic wastes and exposed metallurgic wastes were extracted with synthetic 
tracheobronchial fluid as a mean of estimating soluble Pb concentrations available for 
absorption through the absorptive epithelial wall in the tracheobronchial compartment of 
human respiratory tract. 
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5.2 Study area and samples 
The study site (Mitrovica, Kosovo, section 3.2) has been described as one of the capitals 
of Europe in terms of the worst air pollution (Syla et al., 2009). A study investigating the 
level of total suspended PM and the major trace elements in ambient PM at four sites in 
Kosovo, including Mitrovica (Arditsoglou and Samara 2005) has indicated ambient 
concentrations above European limits. Pb exhibited maximum concentrations at Mitrovica 
in suspended particulate matter and Arditsoglou and Samara, (2005) multivariate 
statistical receptor model indicated resuspension of soil dust as one of the significant 
sources of particulate Pb at the study sites.   
Sample locality information and matrix for the 33 samples that were assessed in this study 
for in vitro tracheobronchial airways bioaccessibility are summarised in Table 5.1. The 
subsamples were selected largely on the basis of sample size and Pb concentration from 
the 63 samples (Appendix A) provided for the UBM study (Chapter 3). The samples 
include 4 smelter samples, 24 soil samples and 5 tailing samples from Roma Mahalla, 
Zharkov Potok, Osterode, Cesmin Lug, Gornje Polje, Bosniak Mahalla, Mitrovica City 
Centre and Ibar River (Table 5.1).  
5.3 Materials and method 
5.3.1 Sample preparation 
Fugitive dusts (< 10 µm) were extracted from the samples using a wet method optimized 
in this study (Section 2.2.3). For quality control, portions of extracted liquid suspensions of 
the fugitive dust were stored for the determination of Pb concentration lost during 
extraction to water. For the validation of size fraction extracted, portions were also 
analysed with Malvern Mastersizer equipment. 
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Table 5.1: Summary of sample details 
SAMPLE ID ORIGIN Matrix 
RM6 Roma Mahalla Soil 
RM19 Roma Mahalla Soil 
RM27 Roma Mahalla Soil 
RM28 Roma Mahalla Soil 
RM42 Roma Mahalla Soil 
RM45 Roma Mahalla Soil 
RM49 Roma Mahalla Soil 
RM54 Roma Mahalla  Soil 
RM66T1 Zharkov Potok Tailings 
RM66T2 Zharkov Potok Tailings 
RM66T3 Zharkov Potok  Tailings 
RM67 Osterode Soil 
RM69 Osterode Soil 
RM70 Cesmin lug Soil 
RM71 Cesmin lug Soil 
RM72 Cesmin lug Soil 
RM74 Cesmin lug Soil 
RM76 Gornje Polje Smelter Waste 
RM77(S/T) Gornje Polje Smelter Waste 
RM77(W) Gornje Polje Smelter Waste 
BM3 Bosniak Mahalla Soil 
BM5 Bosniak Mahalla Soil 
BM9 Bosniak Mahalla Soil 
BM11 Bosniak Mahalla Soil 
BM21 Ibar River Bank Soil 
BM32 Zharkov Potok Tailings 
BM36 Zharkov Potok Tailings 
BM41 Mitrovica City Park Soil 
BM45 Mitrovica City Road side Soil 
BM46 Mitrovica City Park Soil 
BM47 Ibar River Bank  Soil 
BM49 Mitrovica City Center Smelter-public Waste 
BM50 Mitrovica City Park Soil 
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5.3.2 Tracheobronchial airways bioaccessibility of Pb 
The extracted PM10 samples were subjected to the bioaccessibility testing procedure 
using the tracheobronchial airways fluid formulated in this study (Section 4.2.3). Details of 
the extraction protocol employed for the tracheobronchial bioaccessibility and quality 
control are provided in Sections 4.2.5 and 4.2.8, respectively. 
5.3.3 ICP-MS analysis of Pb 
Full description of preparation of test solutions, quality control method and operating 
conditions for the ICP-MS analysis is provided in Section 4.7.2. 
5.3.4 Risk Assessment 
Exposure of Pb in the resuspended inhalable particulate from surface soils and 
metallurgic waste dumps for a child and adult receptors at the study area was estimated 
as described by Chen et al., (2011). Inhalable dose (DI) (µg.kg-1bw.dy-1) was calculated 
as: 
DI = (Cs x TR x SP x AIR) / BW                                          (5.1) 
Where; 
Cs is the concentration of Pb in PM10 (kg /kg) 
TR is the tracheobronchial retention fraction (unitless) 
SP is the concentration of total suspended particulate (µg m-3) 
AIR is the inhalation rate (m3 d-1) 
BW is the body weight (kg) 
Risk assessments from exposure to atmospheric pollutants in addition to exposure 
assessment also require dose-response assessment (Shoaf et al., 1991). One of the 
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methods for conducting the dose-response assessment from atmospheric pollutants 
involves the use of the inhalation reference concentration (RfC) (µg.kg-1bw.day-1); an 
estimate of the daily exposure that is unlikely to induce appreciable deleterious effects 
during lifetime to human population (Shoaf et al., 1991). The RfC is determined as 
described by equation 3.3 (Section 3.3.8.2), but presently due to the absence of an 
acceptable no-observed-adverse-effect level for inhaled Pb, hence presently there are no 
published RfC data for the inhalation of Pb by national agencies (e.g. USEPA and UK’s 
Environment Agency). However, as part of a human health risk assessment project Viridor 
Waste Ltd (Viridor, 2009) has proposed a tolerable daily intake value (0.07 µg kg-1BW d
-1) 
for the inhalation of Pb based a new stringent Air Quality Objective (AQO) 0.25 µg m-3. In 
this study the TDIinh proposed by Viridor, (2009) was adopted as the RfD and used to 
estimate potential noncarcinogenic risk. Non-carcinogenic risk was evaluated by hazard 
quotient (HQ) and description of the method is provided in Section 3.3.8.2. 
5.4 Results and discussion 
5.4.1 Development of PM10 extraction method  
To extract PM10 fraction from the soil and metallurgic waste samples for the 
tracheobronchial bioaccessibility investigation, an existing method (Luo et al., 2011; Ljung 
et al., 2011) was optimized and adjusted to laboratory scale in this study (Section 2.2). 
The results are presented herein.  
The particle density determined for the 63 µm fraction of the test soil was 1.54 g.cm-3. 
Sedimentation times were calculated based on the default (2.56 g.cm-3) and measured 
(1.54 g.cm-3) densities using the Stokes’ equation (Appendix B) as 1044 seconds (17.4 
minutes) and 3198 seconds (53.3 minutes), respectively. Particle size analysis of the 
siphoned suspensions indicated PM10 volumes of 18.0 %, 55.7 % and 89.5 % for the 
times 1.0, 17.4 and 53.3 minutes, respectively (Table 5.2). The volume of PM10 obtained 
following the optimization is less than 90 %. The particle diameter of the extracted 
fractions were 59.0 µm, 20.7 µm and 10.2 µm for fractions siphoned after 1.0, 17.4 and 
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53.3 minutes, respectively (Table 5.2). The method separates finer particles from the bulk 
samples and the optimization has yielded greater amount of the desired particle size 
fraction. Previous water-based PM10 extraction studies from soil and dust did not report 
particle size distribution data, but Moreno et al., (2007), Amato et al., (2009), Buhre et al., 
(2006) and Li et al., (2008) while developing dry protocols for PM10 extraction were also 
able to adjust their methods to optimise PM10 yield with the aid light scattering particle size 
analyzer. 
Table 5.2: Sedimentation time, basis, volume of PM10 in extracted fraction and particle 
diameter 
Basis Sedimentation time 
(minutes) 
% Volume of PM10 in 
extracted fraction  
 
(n = 3) 
Particle 
diameter (μm) 
 
 (n = 3) 
Default particle 
density of 
2.56 g.cm-3 
17.4 55.7 ± 5.5 20.7 ± 1.73 
Estimated particle 
density of 
1.54 g.cm-3 
53.3 89.5 ± 0.1 10.2 ± 0.1 
Control  1.00 18.0 ± 0.2 59.0 ± 3.0 
 
5.4.2 Quality control for PM10 extraction 
The concern about undesired removal of Pb during water based extraction of PM10 was 
investigated in this study by submitting portions of siphoned suspension for ICP-MS 
analysis for Pb. The results for Pb lost during PM10 extraction are listed in Appendix Q and 
a summary in Table 5.3. The % Pb lost during the PM10 extraction process (i.e. the % 
water extractable fraction, % WEF) was low; 0.03 to 0.35% for smelter samples, 0.07 to 
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0.30% for soil samples and 0.01 to 0.94% for tailings (Figure 5.2). The method is therefore 
considered suitable for extraction of PM10 in this study.  
Table 5.3: Descriptive statistics Pb Total and bioaccessible concentrations, and % 
inhalation bioaccessibility  
Matrix Mean Minimum Maximum Median 
 Total concentration (mg/kg) 
Smelter 43000 20900 72800 39200 
Soil 3240 274 13700 2280 
Tailiings 8450 2990 25300 4720 
 Bioaccessible concentration (mg/kg) 
Smelter 272 7.00 965 58.0 
Soil 202 9.80 1060 57.4 
Tailings 15.0 0.70 49.2 10.2 
 Bioaccessibility (%) 
Smelter 1.20 0.03 4.60 0.08 
Soil 5.34 0.50 11.00 5.70 
Tailings 0.29 0.02 1.20 0.05 
 Total mass recovery (%) 
Smelter 101 99.3 104 100 
Soil 99.9 96.2 104 99.5 
Tailings 101 98.3 102 101 
 % WEF 
Smelter 0.16 0.03 0.35 0.13 
Soil 0.17 0.07 0.37 0.16 
Tailiings 0.22 0.01 0.94 0.04 
WEF - water extractable fraction 
Smelter (n = 4), soil (n = 24) and tailings (n - 5) samples   
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Figure 5.2: Boxplot of % Pb lost to water during PM10 extraction for matrices 
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Smelter (n = 4), soil (n = 24) and tailing (n = 5)  
Mean (  ), outlier (*) Median (-), Upper and lower 75 % distribution of data (I)  
Representing middle 50 % of data (   )     
To verify if the correct particle size was extracted from test samples representative 
siphoned suspensions were submitted for particle size analyses and the results are 
presented in Table 5.3.  For a metallurgic waste sample (RM 77W) 99.9 % of the 
extracted particles can be classified as PM10. However for the 3 soil samples analysed 
between 84.7 and 87.3 % of the extracted particles were < 10 µm. The range obtained for 
the soil samples is consisted with the volume (89.5 %) obtained for test soil sample 
employed for the optimization of PM10 extraction method. The lower yield of PM10 particles 
obtained for the soil samples compared to the metallurgic waste sample may be due to 
agglomeration of fine particles in situ to larger units during centrifugation of dilute 
suspensions; a step needed to achieve sufficient obscuration for the mastersizer 
equipment.  Water-based fine particulate suspensions are usually plagued with 
agglomeration problems (Takenaka et al., 2001: Zhang et al., 2004). The particle size 
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data also indicates that between 17.88 to 95.51 % of the extracted particles are < 2.5 µm. 
The variance in the % volume of respirable fractions may be due to matrix differences 
(e.g. smelter waste: RM77 and soil: RM 19) and Ohmsen, (2001) has suggested that 
emissions from smelters are usually of a finer particle size.   
Table 5.4: % Volume of < 1.00, < 2.50, < 5.00, < 7.50, and < 10.0 µm particles extracted 
from PM10 suspension 
Sample ID Matrix < 1.00 < 2.50 < 5.00 < 7.50 < 10.0 
 µm 
RM69 soil 9.54 18.6 46.6 70.4 84.7 
RM19 soil 9.05 17.9 47.7 72.0 86.1 
RM71 soil 12.0 24.2 53.5 75.8 87.3 
RM77W Smelter 
waste 
95.5 95.5 98.8 99.8 99.9 
 
5.4.3 Quality control for tracheobronchial bioaccessibility 
For bioaccessibility assay the sum of residual Pb values and the extracted Pb values were 
compared with the aqua-regia totals to calculate the mass balance recovery of the in vitro 
extraction model methodology. Mass balance recoveries ranged between 96.2 and 104 % 
(Appendix Q) while the mean for all samples is 100 %. The aqua regia procedure for 
pseudo total Pb concentration was validated by analysing a certified material (BCR 143 R) 
in parallel and the recovery rate (103 %) (Section 4.3.1) was good.  
5.4.4 Total Pb concentration in the extracted PM10 fraction 
The concentrations of Pb in the < 10 µm fraction (Appendix Q) are higher than in < 250 
µm (Appendix G) for most of the samples investigated. The observed trend is consistent 
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with previous observations by Roussel et al. (2000), Young et al. (2001) and Ajmone-
Marsan et al. (2008), and implies preferential concentration of Pb in the finer particles. 
The trends observed for BM 36 and BM 49 where there were no obvious size 
dependencies on Pb concentrations is consistent with samples where Pb bearing mineral 
phases constitute significant fraction of the matrix (Kim et al., 2011). For the soil samples 
(n = 24) (Figure 5.3) the concentrations of Pb in the extracted PM10 fractions, compared to 
the < 250 µm fractions, indicated enhancement factors between 1 - 82 %. Similar 
enhancements (69 and 79%) were reported (Kim et al., 2011) for two surfaces soil sample 
collected from a mining town. The higher enhancement observed in this study may be due 
to the finer fractions generated in this study; Kim et al., (2011) compared < 250 µm with < 
20 µm, whilst in this study the comparison was between < 250 µm with < 10 µm. The 
smelter samples [RM 76, RM 77 (ST), RM77 (W) and BM 49] (Figure 5.3), excluding BM 
49 (old smelter waste ground now a public waste dump), indicated enhancement factors 
range of 21 to 72 %. For the tailing samples (RM66T1, RM66T2, RM66T3 and BM 36) 
excluding BM 36, the enhancement was even greater (127 – 227%) (Figure 5.3). Kim et 
al., (2011) reported lower enhancements (between < 250 µm with < 20 µm size fractions), 
70 and 90% for waste rock and mine tailing samples respectively. Whilst the 
enhancement for the waste rock is consistent with the value observed for smelter waste 
samples in this study the enhancement recorded for the mine tailing sample is significantly 
lower than values observed for tailing samples in this study. The higher values observed 
for tailings in this study could be due the fact that a finer size fraction Pb concentration (< 
10 µm) was compared with < 250 µm against the < 20 µm employed by Kim et al., (2011). 
The median concentrations of Pb in the < 10 µm fraction from the different locations 
studied are as follows Zharkov Potok and Gornje Polje (13,414 mg/kg), Bosniak Mahalla 
(10,168 mg/kg), IDPs (3587 mg/kg), Mitrovica City Centre (2,452 mg/kg) and Roma 
Mahalla (768 mg/kg) (Figure 5.4). These total concentrations have environmental 
implications considering that a previous study by Regaini et al. (1977) have reported 
137 
 
Figure 5.3: Plot of Pb total concentrations in < 250 µm and < 10 µm fractions 
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ambient aerosol enrichment from suspended soils as high as 110 % for Pb at a smelting 
town. The concentration of Pb in the < 10 µm fraction was lowest at Roma Mahalla and 
this could be due the fact that this location is the most distant from the exposed 
metallurgic waste dump at Gornje Polje (Figure 3.1). The IDPs, Mitrovica City Centre and 
Bosniak Mahalla sites are closer to Gornje Polje (Figure 3.1). A similar range of Pb 
concentrations (3878 – 12026 mg/kg) have been reported by Niu et al. (2010) for ambient 
particulate matter collected from Ottawa, Canada. The median concentration of Pb in the 
< 10 µm fraction at Bosniak Mahalla is more than 13 times the concentration indicated at 
Roma Mahalla. The median concentration of Pb in the < 10 µm fraction from the IDPs is 
more than 4 times the concentration indicated at Roma Mahalla. The preferential 
enhancement of Pb in the < 10 µm fraction compared to the < 250 µm at Zharkov Potok 
and Gornje Polje (84 %), Bosniak Mahalla (37 %), IDPs (51 %), Mitrovica City Centre (71 
%) and Roma Mahalla (34 %) is not consistent with the order of PM10 Pb concentrations 
observed. Mitrovica City Centre indicated the highest enhancement (71 %) amongst the 
residential areas studied even when it was not the closest site to the metallurgic waste 
dumps (Figure 3.1). At Mitrovica City Centre vehicle exhaust Pb may have contributed fine 
Pb particles to surface soils.  
5.4.5 Tracheobronchial bioaccessibility 
The percentage bioaccessible fraction (%BAF) was calculated for the tracheobronchial 
compartment as follows: 
               (5.2) 
Where: Cbio. Is the bioaccessible concentration of Pb and Ctotal is the total concentration of 
Pb. 
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Figure 5.4: Boxplot of Pb total concentration in < 10 µm and < 250 µm size fractions from sample locations 
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8) 
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The bioaccessibility of Pb in tracheobronchial airways fluid was very low for all the 33 
samples tested in this study (Appendix Q). The observed range 0.02 to 11.0 % 
bioaccessibility (Figure 5.5) closely approximates the range 0.17 to 10.7 % previously 
reported by Harris and Silberman (1988) for Pb in inhalable particulates (< 22 µm) 
extracted with canine serum (a biological fluid selected to mimic human airways lining 
liquid). The extraction of Pb dust (sourced from primary smelting) using a two step 
sequential extraction, with an exchangeable (1.0 M MgCl2, pH 7.0) and a mildly acidic (1.0 
NaOAc, pH 5.0) phase, with the aim of simulating inhalable and respirable exposure, 
indicated solubility of Pb at less than 10% (Spear et al., 1998). Also simulating the neutral 
lung environment, this time with ammonium acetate at pH of 7, for two 1 µm size fraction 
samples Niu et al. (2010) reported < 16 % bioaccessibility for particulate Pb. The mean Pb 
bioaccessibility (0.30%, range: 0.02 – 1.26 %) obtained for the 5 mine tailing samples 
from Mitrovica (Figure 5.5) with the tracheobronchial fluid are below the values (14.4%, 
18.0% and 25.3%, respectively) recorded for tailing samples from a Welsh mine site 
(Wragg and Klinck, 2007). The large difference observed in bioaccessibility between these 
two different studies may be due to different Pb mineral forms in the samples or difference 
in chemical composition of the leaching liquids employed in the two studies. Wragg and 
Klinck (2007) employed sodium citrate, alkylbenzyldimthyammonium chloride, sulphuric 
acid diethylenetriaminepentaacetic acid that were absent in the tracheobronchial fluid 
used in this study. Though using a fluid similar to the one employed by Wragg and Klinck 
(2007) without alkylbenzyldimthyammonium chloride and diethylenetriaminepentaacetic 
acid but with formaldehyde and methanol, Jaggard (2012), observed very low 
bioaccessibility values for 6 mine tailing samples (0 to 0.5%). The tracheobronchial fluid 
developed in this study included antioxidants, large molecular mass proteins (mucin and 
albumin) and a surfactant lipid. Some of the components in the fluid used in this study 
have the potential to influence the dissolution kinetics of Pb (Gehr et al., 1994; Cross et 
al., 2001; Duranti et al., 2001; Thornton et al., 2008). Vousta and Samara, (2002) 
attributed the very low bioaccessibility (< 1 %) indicated by Pb from urban and industrial 
airborne particulate matter in serum stimulant fluid to the absence of strong Pb 
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complexant agents in their leaching fluid. The 4 Mitrovica smelter samples also exhibited 
very low mean (0.07%; range: 0.03 – 0.09 %) tracheobronchial bioaccessibility (Figure 
5.5). For the 24 contaminated soil samples it is difficult to find published literature data to 
compare with the mean Pb bioaccessibility of 5.50% (range: 0.53 -11.0 %).  
Figure 5.5: Boxplot of % mean tracheobronchial bioaccessibility for matrices 
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Comparison of oral and inhalation bioaccessibility has indicated the gastric phase with the 
highest bioaccessibility (Figure 5.6). Published scientific data have highlighted the 
intestine as the major site of Pb absorption in the digestive tract (Smith et al., 1978) and 
comparison of intestinal and tracheobronchial bioaccessibility data obtained in this study 
(Figure 5.6) have indicated more % bioaccessibility in the tracheobronchial fluid than in 
the intestinal fluid for samples: RM6, RM19, RM27, RM28, RM49, RM70, RM74 and 
BM11. About 40 % of inhaled Pb and 5-10 % of ingested Pb are absorbed in the  
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Figure 5.6: Plot of % Bioaccessibility of Pb in gastric, intestinal and tracheobronchial fluids  
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respiratory tract and digestive system respectively according to Mahaffey, (1977). If Pb 
bioavailability is related to its solubility as determined through the tracheobronchial 
bioaccessibility then health hazards associated with Pb exposure from Mitrovica may be 
appreciable through the inhalation route.  
The median bioaccessible Pb concentration observed in this study for smelter, soil and 
tailing samples in the tracheobronchial fluid are 58.0 mg/kg, 57.4 mg/kg and 10.2 mg/kg, 
respectively (Table 5.3). Lead total concentrations were higher in smelter wastes than 
soils, but both matrices indicated similar median bioaccessible Pb concentrations. 
Analysis of bioaccessible concentrations based on sampled locations indicated medians 
and ranges of 779 mg/kg (352 -1060), 186 mg/kg (9.80 – 355 mg/kg), 74.6 mg/kg (13.4 – 
301 mg/kg), 44.7 mg/kg (23.9 – 60.4 mg/kg) and 12.1 mg/kg (0.70 – 64.4 mg/kg) for 
Bosniak Mahalla, Mitrovica City Centre, IDPs, Roma Mahalla, Zharkov Potok and Gornje  
Figure 5.7: Boxplot of bioaccessible Pb in tracheobronchial fluid for sample locations 
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Polje, respectively (Figure 5.7). Bioaccessible Pb concentrations in the tracheobronchial 
fluid for the soil and smelter samples are positively correlated with aqua-regia soluble 
concentrations (Figure 5.8) with correlation coefficients of 0.862 (p-value 0.000) and 0.995 
(p-value 0.062), respectively. The correlation coefficient for the smelter waste samples is 
not statistically significant due to the limited samples used.  
To evaluate the indicative role of mineralogy on the tracheobronchial bioaccessibility of 
Pb, mineralogy data obtained for the sub samples (< 250 µm size fractions) were 
analysed against the tracheobronchial bioaccessibility data. The mean tracheobronchial 
bioaccessibility for samples having Pb in (1) anglesite-beudantile-cerussite-coronadite-
larnarkite minerals, (2) coronadite mineral and (3) no Pb-bearing mineral phase are 
indicated in Figure 5.9. Mean bioaccessibility of 0.28 % (range: 0.02 – 1.18 %), 2.45 % 
 
Figure 5.8: Scatterplot between total and bioaccessible Pb concentrations for matrices. 
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Smelter (n = 4), soil (n = 24) and tailings (n = 5) 
(range: 0.50 – 5.20 %) and 5.05 % (range: 3.60 – 6.50 %) are indicated for (1), (2) and (3) 
mineral phases, respectively. The lowest mean bioaccessibility (0.28%) indicated was for 
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the metallurgic waste samples. Ruby et al. (1999) have previously reported that Pb 
minerals are often present within the matrix of metallurgic waste. Anglesite, galena and 
cerussite mineral have previously been identified as minerals hosting Pb in air-pollution-  
Figure 5.9: Boxplot of Pb tracheobronchial % bioaccessibility and mineral assemblages 
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control (APC) residue from a Pb smelter at Pribram, Czech Republic (Ettler et al., 2009) 
and in urban road dust sediments from Manchester, UK (Barret et al., 2010). Voutsa and 
Samara (2002) have suggested that the leachability of metal fractions bound to particulate 
matter is strongly dependent on the chemical speciation; therefore the variance of 
tracheobronchial bioaccessibility observed in this study for three group of samples in 
terms of Pb chemical speciation is expected. Barret et al., (2010) have previously 
highlighted that Pb in fine fractions are sorbed to goethite, so it is possible that the 
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samples with no Pb bearing mineral that released more Pb into the leaching solution may 
be due such weak interactions between Pb and gangue minerals in the matrix. Indeed, the 
XRD determinations noted the presence goethite (Fe oxides) in this study (Table 3.7, 
Chapter 3). The observed trend for Pb encapsulated in mineral phases and those without 
encapsulation for the tracheobronchial bioaccessibility is consistent with that noted for the 
gastric phase bioaccessibility (Section 3.4.7). 
5.4.6 Risk assessment 
Human exposure to airborne contaminants can be estimated by calculation of respiratory 
uptake (Chen et al., 2011). The model used by Chen et al., (2011) considered the dose 
retained in the respiratory tract since some deposited particles are usually cleared, 
however chemical processes like leaching and dissolution are also relevant for the 
estimation of exposure dose (Oberdorster et al., 1994). In this study the chemical process 
in the tracheobronchial region of the respiratory tract were essentially mimicked by the 
tracheobronchial bioaccessibility test. The parameters used to evaluate inhalation 
exposure to Pb in Mitrovica, Kosovo are summarized in Table 5.5. 
Daily inhalation doses were estimated based on equation 5.1 and the results are listed in 
Table 5.6. As expected exposure doses are more for children than adults. The mean 
exposure doses calculated from the total Pb concentration in PM10 for children and adults 
were 0.3 µg kg-1BW d
-1 (range: 0.009 – 2.5 µg kg-1BW d
-1) and 0.16 µg kg-1BW d
-1 (0.005 – 1.3 
µg kg-1BW d
-1), respectively. The dose range based on exposure to total Pb concentrations 
observed in this study for children (0.009 – 2.5 µg kg-1BW d
-1) and adults (0.005 – 1.3 µg 
kg-1BW d
-1) are more than those published by Chen et al. (2011): children, 0.006 – 0.016 µg 
kg-1BW d
-1 and adults, 0.003 – 0.008 µg kg-1BW d
-1. The large dose difference between the 
two studies, particularly for the maximum values, is due to the large difference in the total 
Pb concentration recorded at the two different sites. The samples for Mitrovica (this study) 
indicated a minimum concentration of 274 mg kg-1 and a maximum concentration of 
72,843 mg kg-1, whilst the samples at Shanghai (Chen et al., 2011) indicated a minimum 
concentration of 142 mg kg-1 and a maximum concentration of 588 mg kg-1. Another factor 
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that may account for the range of exposure doses observed in the two studies is the 
assumed fraction of particulate matter retained in the respiratory tract; Chen et al., (2011) 
applied 0.75 for lung whilst in the study a fraction 0.35 was applied for the 
tracheobronchial compartment of the respiratory tract as proposed by Sturm, (2007). For a 
concentration range of 14 - 24 mg kg-1 Granero and Domingo (2002) estimated exposure 
doses of 0.0004 µg kg-1BW d
-1 and 0.0002 µg kg-1BW d
-1 for children and adults respectively, 
but they did not report considering retention factor in their estimations. For children, the 
exposure dose range recorded in this work for the total Pb concentration through 
inhalation (0.009 – 2.5 µg kg-1BW d
-1) compares with the range recorded through the oral 
route (0.29 – 88.7 µg kg-1BW d
-1) (Section 3.4.8) and this contradicts the general belief that 
exposure through inhalation is insignificant (WHO, 2010a). It appears the exposure dose 
available to receptors is rather influenced by the Pb concentrations in ambient particulate 
matter.  
Table 5.5: Variables used in calculating the exposure dose of Pb in PM10 
Parameter Description Adults Children (3 – 6years) 
AIR Inhalation rate expressed  (m3 d-1) 20a 10.1b 
BW Body weight expressed (kg) 70a 18.6b 
TR Tracheobronchial retention fraction 0.35c 0.35c 
SP Total suspended particulate matter 
in the atmosphere expressed (µg m-
3) 
181d 181d 
Cs Total or bioaccessible Pb 
concentration in PM10 expressed in 
(kg/kg) 
Appendix Q Appendix Q 
 
a – US EPA, 2008 
b – US EPA, 2011 
c – Sturm, 2007 
d – Arditsoglou and Samara, (2005) 
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Table 5.6: Daily inhalation exposure dose of Pb for children (3 – 6 years) and adults 
   
DI-Total 
(µg kg-1BW d
-1) 
DI-Bioaccessible 
(ng kg-1BW d
-1) 
SAMPLE ID ORIGIN Matrix Child Adult Child Adult 
RM6 Roma Mahalla Soil 0.018 0.010 1.10 0.60 
RM19 Roma Mahalla Soil 0.028 0.015 1.70 0.90 
RM27 Roma Mahalla Soil 0.029 0.011 2.10 1.10 
RM28 Roma Mahalla Soil 0.022 0.011 1.30 0.70 
RM42 Roma Mahalla Soil 0.031 0.016 1.80 1.00 
RM45 Roma Mahalla Soil 0.028 0.015 1.90 1.00 
RM49 Roma Mahalla Soil 0.017 0.009 0.80 0.40 
RM54 Roma Mahalla Soil 0.025 0.013 1.10 0.60 
RM66T1 Zharkov Potok  Tailings 0.160 0.085 0.03 0.01 
RM66T2 Zharkov Potok Tailings 0.180 0.097 0.40 0.20 
RM66T3 Zharkov Potok Tailings 0.130 0.071 1.70 0.90 
RM67 Osterode Soil 0.020 0.010 0.70 0.40 
RM69 Osterode Soil 0.200 0.100 10.0 5.40 
RM70 Cesmin lug Soil 0.074 0.040 3.50 1.80 
RM71 Cesmin lug Soil 0.160 0.085 5.00 2.60 
RM72 Cesmin lug Soil 0.086 0.045 0.50 0.20 
RM74 Cesmin lug Soil 0.160 0.084 1.60 0.80 
RM76 Gornje Polje Smelter Waste 0.740 0.390 0.30 0.10 
RM77(S/T) Gornje Polje Smelter Waste 2.50 1.30 2.20 1.20 
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RM77(W) Gornje Polje Smelter Waste 2.00 1.00 1.80 0.90 
BM3 Bosniak Mahalla Soil 0.470 0.250 18.0 9.60 
BM5 Bosniak Mahalla Soil 0.380 0.200 36.0 19.0 
BM9 Bosniak Mahalla Soil 0.320 0.170 35.0 19.0 
BM11 Bosniak Mahalla Soil 0.140 0.074 12.0 6.40 
BM21 Ibar River Bank Soil 0.009 0.005 0.30 0.20 
BM32 Zharkov Potok Tailings 0.100 0.054 0.02 0.01 
BM36 Zharkov Potok Tailings 0.870 0.460 0.50 0.30 
BM41 Mitrovica City Park Soil 0.082 0.043 6.40 3.40 
BM45 Road side Soil 0.180 0.097 12.0 6.40 
BM46 Mitrovica City Park Soil 0.021 0.011 0.60 0.30 
BM47 Ibar River Bank Soil 0.085 0.045 6.80 3.60 
BM49 Mitrovica City Center Smelter-public Waste 0.720 0.380 33.0 17.0 
BM50 Mitrovica City Park Soil 0.084 0.044 4.60 2.40 
 
DI-Total – calculated based on PM10 total Pb concentrations and bioaccessible  
DI-Bioaccessible – calculated based on PM10 bioaccessible Pb concentration 
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The mean exposure doses estimated from the bioaccessible Pb concentration in 
tracheobroncial fluid for children and adults were 6.30 ng kg-1BW d
-1 (range: 0.02 – 36.0 ng 
kg-1BW d
-1) and 3.30 ng kg-1BW d
-1 (0.01 – 19.0 ng kg-1BW d
-1), respectively. The exposure 
doses derivable from PM10 bioaccessible Pb concentrations are generally lower than 
those derivable from the PM10 total Pb concentrations by about two orders. ATSDR (2007) 
suggested that 95 % of particulate Pb deposited in the respiratory tract is absorbed but 
doses estimated in this study based on bioaccessible concentrations suggest potentially 
lower absorptions for the tracheobronchial compartment. If indeed that much fraction (95 
%) is actually absorbed as suggested by ATSDR (2007) in all compartments of the 
respiratory tract, then mechanisms other than bioaccessibility may have also contributed 
to Pb bioavailability. 
The results of the calculated HQ values for all samples are listed in Table 5.7. From the 
results children indicate a higher potential of non-cancer health risk than adults, as might 
be expected. The mean HQ derivable from the total Pb concentration in PM10 for children 
and adults were 4.32 (range: 0.13 – 36.0) and 2.26 (range: 0.07 – 19.0), respectively. 
With lower Pb total concentration range of 142 – 588 mg/kg and RfD value of 1.4 µg kg-
1
BW d
-1, Chen et al. (2011) reported mean HQs values of 0.007 (range:0.0004 – 0.011) and 
0.004 (range: 0.002 – 0.05) for children and adults respectively. The mean HQ derivable 
from the bioaccessible Pb concentration in tracheobroncial fluid for children and adults 
were 0.094 (range: 0.0003 – 0.52) and 0.047 (range: 0.0002 – 0.27) respectively. Based 
on total Pb concentration in PM10 all study sites except Roma Mahalla have indicated HQ 
values above 1; implying the possibility of negative health effects at those sites. The 
observation is consistent with the trend observed for the oral route where all sites except 
Roma Mahalla indicated HQ values > 1 (Section 3.4.8). However, using the bioaccessible 
Pb concentration in PM10 all samples indicated HQ values < 1, so technically below a HQ 
of concern (Shoaf et al., 1991) (because Pb even at very low concentrations can still 
impact negatively on human health, the exposure doses derivable from bioaccessible Pb 
are still relevant). Indeed looking at Table 5.7 many samples exceed the Viridor RfD. 
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Table 5.7: Hazard Quotients for a children (3 – 6 years) and adult receptors  
  
SAMPLE ID 
  
ORIGIN 
  
Matrix 
RFDa 
(µg kg-1BW d
-1)  
HQ 
DI-Total DI-Bioaccessible 
Child Adult Child Adult 
RM6 Roma Mahalla Soil 0.07 0.26 0.14 0.016 0.009 
RM19 Roma Mahalla Soil 
 
0.40 0.21 0.024 0.013 
RM27 Roma Mahalla Soil 
 
0.44 0.22 0.030 0.016 
RM28 Roma Mahalla Soil 
 
0.31 0.16 0.019 0.010 
RM42 Roma Mahalla Soil 
 
0.44 0.23 0.026 0.014 
RM45 Roma Mahalla Soil 
 
0.40 0.21 0.027 0.014 
RM49 Roma Mahalla Soil 
 
0.24 0.13 0.012 0.006 
RM54 Roma Mahalla Soil 
 
0.35 0.19 0.015 0.008 
RM66T1 Zharkov Potok Tailings 
 
2.30  1.20 0.0004 0.0002 
RM66T2 Zharkov Potok Tailings 
 
2.60  1.30 0.005 0.003 
RM66T3 Zharkov Potok  Tailings 
 
1.90  1.00 0.024 0.013 
RM67 Osterode Soil 
 
0.28 0.15 0.010 0.005 
RM69 Osterode Soil 
 
2.80 1.50 0.150 0.078 
RM70 Cesmin lug Soil 
 
1.10 0.56 0.050 0.026 
RM71 Cesmin lug Soil 
 
2.30 1.20 0.071 0.038 
RM72 Cesmin lug Soil 
 
1.20 0.65 0.007 0.004 
RM74 Cesmin lug Soil 
 
2.30 1.20 0.023 0.012 
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RM76 Gornje Polje Smelter Waste 
 
10.0  5.40 0.003 0.002 
RM77(S/T) Gornje Polje Smelter Waste 
 
36.0 19.0 0.032 0.017 
RM77(W) Gornje Polje Smelter Waste 
 
28.0 14.0 0.025 0.013 
BM3 Bosniak Mahalla Soil 
 
6.70 3.50 0.260 0.140 
BM5 Bosniak Mahalla Soil 
 
5.40 2.80 0.520 0.270 
BM9 Bosniak Mahalla Soil 
 
4.60 2.40 0.510 0.270 
BM11 Bosniak Mahalla Soil 
 
2.00 1.10 0.170 0.091 
BM21 Ibar River Bank Soil 
 
0.13 0.07 0.005 0.003 
BM32 Zharkov Potok Tailings 
 
1.50 0.77 0.0003 0.0002 
BM36 Zharkov Potok Tailings 
 
12.0 6.50 0.007 0.004 
BM41 Mitrovica City Park Soil 
 
1.20 0.62 0.091 0.048 
BM45 Road side Soil 
 
2.60 1.40 0.170 0.092 
BM46 Mitrovica City Park Soil 
 
0.30 0.16 0.009 0.005 
BM47 Ibar River Bank Soil 
 
1.20 0.64 0.097 0.051 
BM49 Mitrovica City Center 
Smelter-public 
Waste 
 
10.0 5.40 0.470 0.250 
BM50 Mitrovica City Park Soil 
 
1.20 0.63 0.066 0.035 
RfD - Reference dose  
a - TDI inhalation (VERIDOR, 2009) 
bold- indicating HQ values > 1 
DI-Total – calculated based on PM10 total Pb concentrations and bioaccessible  
DI-Bioaccessible – calculated based on PM10 bioaccessible Pb concentration 
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5.5 Summary 
A new in vitro tracheobronchial bioaccessibility protocol was applied to  Pb in PM10 
extracted from Pb-Zn smelter contaminated surface soils and metallurgic wastes as a 
means of evaluating the in vivo bioaccessibility Pb in the epithelial region of the airways 
and the significance of soil-dust resuspension in human health risk assessment. 
A wet method of extracting PM10 from soil/dust with de-ionized water was optimized and 
adapted to a laboratory bench scale and applied for the extraction < 10 µm particles from 
the Kosovo samples. Analysis of the extracted fractions for particle size distribution with 
Malvern light scattering particle size analyzer indicate that more than 84 % volume of the 
extracted is particles were < 10 µm. ICP-MS Pb data from this study indicate that < 1% of 
total Pb concentration was lost extractable by de-ionized water during PM10 extraction. 
The range of Pb total concentration in smelter wastes, soil and tailings investigated is 274 
– 72,843 mg/kg and the soil matrices as expected indicated the lowest maximum. 
The range of tracheobronchial bioaccessibility recorded in this study is 0.02 – 11.0 %, and 
tailings indicated the lowest range (0.02 – 1.20 %). Presently there are no human data to 
validate these data with. However, the range obtained with the formulated fluid closely 
approximates the range 0.17 to 10.7 % previously reported by Harris and Silberman 
(1988) for Pb in inhalable particulates (< 22 µm) extracted with canine serum (a biological 
fluid selected to mimic human airways lining liquid). The range Pb % bioaccessibility 
observed in this is study in the tracheobronchial fluid is below ranges published for similar 
matrices in Gamble’s solution (e.g. Wragg and Klinck, 2007), and the difference could be 
attributable to differences in the composition of the tracheobronchial and the Gamble’s 
fluids. The tracheobronchial fluid applied in this study contains large molecular weight 
proteins (e.g. albumin) that bind Pb in solution (Ruby et al., 1993) and thus can modify the 
solubility of Pb during leaching. About 21 % of the samples investigated indicated a higher 
bioaccessibility in the tracheobronchial fluid compared with the unified BARGE oral fluid 
(Wragg et al., 2009). 
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The exposure doses derivable from PM10 bioaccessible Pb concentrations are generally 
lower than those derivable from the PM10 total Pb concentrations by about two orders. For 
children, the exposure dose range recorded in this work for the total Pb concentration 
through inhalation (0.009 – 2.5 µg kg-1BW d
-1) compares with the range recorded through 
the oral route (0.29 – 88.7 µg kg-1BW d
-1) (Section 3.4.8) and this contradicts the general 
belief that exposure through inhalation is insignificant (WHO, 2010a). It appears the 
exposure dose available to receptors is rather influenced by the Pb concentrations in 
ambient particulate matter.  
The potential health effects due the inhalation of Pb at the site were estimated using the 
hazard quotient (HQ) method (USEPA, 2005).   Based on total Pb concentration in PM10 
all study sites, except Roma Mahalla, indicated HQ values above 1; implying the 
possibility of negative health effects at those sites. However using the tracheobronchial 
bioaccessible Pb concentration in PM10 all samples indicated HQ values <1.  
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Chapter 6: Modelling Blood Lead Concentration 
6.1 Introduction 
6.1.1 Risk modelling of chemicals 
The urge by humans to organize, categorize and explain the world around us has resulted 
in the application of predictive mathematical models in various fields of research. 
Mathematical toxicology modelling requires the development of algebraic and differential 
equations that can relate processes described by the equations and dynamic processes 
occurring in the animal system (Anderson et al., 1995). These models when used in 
conjunction with human sample data can facilitate interpretation and risk assessment 
(Clewell et al., 2008). Risk assessment based research in toxicology involves 
understanding the relationships linking an identified chemical hazard, exposure, and dose-
response effect. For exposure assessment presently there are models for environmental 
exposure, dietary exposure, consumer product exposure and occupational exposure 
(Fryer et al., 2006). For dose estimation there are models for ingestion, inhalation and 
dermal absorption pathways (Liu, 1994). Dose-response models are mathematical 
expressions employed for characterizing links between exposure and response for a given 
set of data (WHO, 2009a). 
6.1.2 Dose-response Modelling (DRM) 
Dose-response models can be simple (linear models) or extremely complicated (series of 
linked models) (WHO, 2009a). Dose-response modelling is a tool for human health risk 
assessment and it involves six basic steps; data selection, model selection, statistical 
linkage, parameter estimation, implementation, and evaluation (Teunis and Havelaar, 
2000; WHO, 2009a). Dose-response modelling for health effect endpoints includes the 
use of no observed effect levels (NOAEL) for deriving health based guidance values (e.g. 
ADI) (Allen et al., 1994; WHO, 2009a). Dose-response models are applied to a variety of 
studies (e.g. exposure and IQ, exposure and mortality, exposure and organ function). 
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Dose response models are classed as either continuous measures (describes relationship 
between dose and magnitude of response on a continuous scale in an individual), quantal 
responses (describes relationship between dose and frequency of a response in a 
population) counts, (describes the measurement of a discrete number of items in a single 
experimental unit) or ordered categorical measures (describes a measured value from a 
set of ordered values) (WHO, 2009a). Sometimes parameters like threshold, severity (e.g. 
percent change in body weight) and covariates (e.g. age, sex) are incorporated into the 
model for robustness. Biologically based dose-response models are designed to model 
the biological details that emerge from exposure to a toxicant, and an example is the 
physiologically based pharmacokinetic model that describes the distribution, metabolism, 
metabolite and mechanisms of a toxicant chemical (WHO, 2009a).  
6.1.2.1 Physiologically based pharmacokinetic (PBPK) models 
Typical physiologically based pharmacokinetic models for the behaviour of a chemical in 
humans are built from multiple compartments (tissues) linked by blood flow (Goyer et al., 
2004). The models are useful for performing route-to-route, exposure duration and high-
dose to low-dose, interspecies extrapolations where the data necessary for predicting risk 
to humans are not available or cannot be accessed due to ethical issues (USEPA, 2006; 
Hursthouse and Kowalczyk, 2009; WHO, 2010; Mumtaz et al., 2012). PBPK models are 
designed to serve as important adjuncts to studies of mode of action of a xenobiotic and 
determine its internal tissue concentration from multiple exposure routes and can predict 
the dose in target organs (Anderson, 2003; Goyer et al., 2004; USEPA, 2006; Mumtaz et 
al., 2012). Two major groups are available; those that estimate target organ/tissue dose of 
a chemical and the ones that incorporate local target organ bioactivation processes as 
part of the model (WHO, 2010b). 
PBPK models are applied in the selection and development of therapeutic agents, and in 
environmental risk assessment. For therapeutic agents the models are employed for the 
prediction of absorption, distribution, metabolism and excretion (Grass and Sinko, 2002; 
Theil et al., 2003). For environmental risk assessment chemical toxicity is the main 
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objective of observation (Rowland et al., 2004). While applying PBPK models in risk 
assessment processes for metals kinetic factors like oral bioavailability, inhalation 
bioavailability, cellular uptake, protein bind tendencies, incorporation into bone 
metabolism and excretion are usually considered (Goyer et al., 2004). PBPK models are 
designed with mathematical equations that are coded in specific software languages like 
Advanced Continuous Simulation language (ACSL), SIMUSOLVE, SIMULINK, MATLAB, 
STELLA, MATHEMATICA, ADAPT5, SAAMII, MCSIM and CMATRIC (Wen et al., 1999; 
Nestorov, 2003; Chiu et al., 2007; Bouzom et al., 2012).  In environmental risk 
assessment the ability of PBPK models to support cross-species extrapolation and 
describe relations between administered concentration of a xenobiotic and its biologically 
effective dose has encouraged their application (Clewell, 1995). 
A PBPK model for any given PHE is an integrated framework for addressing risk 
assessment issues as well as being a tool for hypothesis testing. Effective PBPK 
modelling requires an understanding of the mode of action and the form of the PHE 
responsible for the effect of greatest toxicological concern as this will facilitate the 
selection of appropriate dose metric (Goyer et al., 2003). A detailed overview of 
mathematical modelling for the risk assessment of metals in animals and humans has 
been conducted by Leung et al., (1995) and Curis et al., (2009). Models have been 
developed for different PHEs: Cr (VI) using rats and mice data (Kirman et al., 2012), Mn 
using data from rats and monkeys (Nong et al., 2009), Cd using data from animals and 
humans (Nordberg and Kjellstrom, 1979) As (III) / (V) using literature data from animals 
and man, and Pb using animal and human data (O’Flaherty, 1998; White et al., 1998). 
The models were developed to estimate toxic effects and tissue, organ and body fluid 
dosimetry of the PHEs of interest (Nordberg and Kjellstrom, 1979; O’Flaherty, 1998; White 
et al., 1998; Nong et al., 2009; Kirman et al., 2009). 
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6.1.2.2 PBPK models for Pb exposure 
For Pb there are four PBPK models commonly repeated in the literature; the Society for 
Environmental Geochemistry and Health (SEGH) model, the International Commission for 
Radiation Protection (ICRP) model, the O’Flaherty model and the Integrated Exposure 
Uptake Biokinetic (IEUBK) model for children. The SEGH model is an empirical 
relationship developed to compute soil Pb concentrations from blood data (Wixson and 
Davies, 1994; Davies, 2008). The model predicts that 99 % of human population blood Pb 
concentration is expected to be < 10 µg / dL following chronic exposure to soil or dust 
containing ≤ 300 mg/kg (Sheet et al., 2001). The model in its present state does not reflect 
bioavailality of Pb in different matrices consequently Wixson and Davies in a review of the 
model highlighted the need for consideration of bioavailabilty factor in future versions to 
reflect the influence of chemical forms of Pb different environmental matrices. 
The ICRP model is an age-specific kinetic model of lead metabolism in humans (Leggett, 
1993) based on information on the retention of 210Pb in beagles and humans following 
intravenous injection (Leggett and Eckerman, 1994). The ICRP model describes the time-
dependent distribution and excretion of Pb injected into blood or absorbed from the 
gastrointestinal tract/ or lung (Pound and Leggett, 1998). The ICRP model can be applied 
to children, adolescents and adults. Users have access to most model inputs and the 
software language is FORTRAN (Pound and Leggett, 1998). 
The O’Flaherty physiologically based computer model for Pb kinetics in children and 
adults was developed by Dr Ellen O’Flaherty (Beck et al., 2001). The model design was 
based on body weight and bone turnover, and consist of bone structure, age dependent 
metabolism, age dependent body growth, and the behaviour of Pb within the listed 
anatomic frameworks (O’Flaherty, 1995; 1998). Data adopted for the development of the 
model were from both animals and humans (O’Flaherty, 1998). The model allows the user 
to design exposure scenarios and alter default air, food, water, dust, and soil 
concentrations of Pb (O’Flaherty, 1995; 1998). Background exposure in the model is low 
and the output does not include estimates of population distribution (O’Flaherty, 1998). 
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Different versions of the models have been developed and applied to case studies with 
better interpretations (O’Flaherty, 1998). Since the model is built based on bone 
metabolism, the model output is suited for comparison with non invasive bone lead 
measurements taken via x ray fluorescence (Fleming et al., 1999). 
The Integrated Exposure Uptake Biokinetic (IEUBK) model for children (0 – 7 years) is a 
simulation model developed by the USEPA to estimate blood lead concentrations from 
multiple lead exposure pathways (White et al., 1998; USEPA, 2007a; USEPA, 2007b). 
Several modifications have been effected to the original version and the most current 
version (Windows) is a modification of the DOS-based IEUBK model (0.99d) following 
Independent Validation and Verification (IV&V) of the model (USEPA, 2002). The model is 
composed of the exposure, uptake, biokinetics and variability components with each 
component reflecting a unique aspect of the complete biologic process (White et al., 
1998). These components are employed to predict a distribution of blood lead 
concentrations corresponding to environmental concentrations. The uptake component 
models the process through which lead intake through inhalation or ingestion is 
transferred to the blood plasma (White et al., 1998). Uptake in the model is defined as the 
quantity of Pb absorbed from gut or lung into the systemic circulation of blood (White et 
al., 1998).  
Best estimates were selected as default parameters by USEPA for the design of the 
IEUBK model in order to minimize biases in predictions and the model identifies the 
environmental parameters that are required from the user for an individual child to be 
properly characterized (White et al., 1998). The IEUBK model predictions have been 
calibrated with both environmental and children’s blood lead levels to refine the ability of 
the model to yield reasonable estimates of blood levels in children (White et al., 1998; 
USEPA, 2007a). The developers of the IEUBK model have found it a valuable tool for 
multimedia exposures and it is the most used physiologically based pharmacokinetic 
model for estimating Pb in children (White et al., 1998; Pound and Leggett, 1998). The 
early version of model received positive review from the Science Advisory Board’s (SAB) 
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Indoor Air Quality and total Human Exposure Committee (USEPA, 1992) and the current 
version of the IEUBK model (Windows Version-32Bit) has been selected for application in 
this study. This version is widely in use in the literature (e.g. ATSDR, 2009; Gurgel et al., 
2010; Juhasz et al., 2011).   
6.2. IEUBK model bioavailability variable  
According to the model user guide, input data are air, dietary fraction, drinking water, soil / 
dust lead, maternal and gastrointestinal bioavailability (USEPA, 2007c). The performance 
of the IEUBK model depends on site-specific parameter inputs and site-specific soil-borne 
Pb bioavailability is one such important variable (USEPA, 2007d). The current default 
estimate for the bioavailability of soil and dust in the model is 30% (USEPA, 2007d; 
USEPA, 2007e). Pb absorption studies in humans (Maddaloni et al., 1998) and juvenile 
swine (Casteel et al., 1997) have indicated 26.2 % ± 8.1 and 58 – 74 %, respectively for 
their bioavailability values. Due to variability in soil bioavailability from different locations, 
the application of site-specific soil Pb bioavailability has been recommended for risk 
assessments (Casteel et al., 1997; USEPA, 2007c).  
Determination of Pb relative bioavailability (RBA) in animals has many potential 
advantages but this approach may not always be feasible, hence scientists have 
developed alternative cheap in vitro bioaccessibility (IVBA) protocols (Sections 2.4, 3.1.4, 
and 5.1.5) capable of estimating Pb bioaccessibility in soil and other soil-like matrices 
(USEPA, 2007c). The question ‘can bioavailability be substituted with bioaccessibility 
determinations in risk assessment’ is still not completely answered. The IEUBK model 
addresses issue of different bioavailabilities exhibited by Pb in different matrices by 
allowing alteration of this parameter during implementation (White et al., 1998; USEPA, 
2007c). The model bioavailability option for parameter input allows users to make 
adjustments to the default bioavailability absorption coefficient with site specific 
bioavailability data (USEPA, 2007c). The current model default bioavailability coefficient is 
based on water and food soluble lead acetate absolute bioavailability which assumed to 
have a 50 % absolute bioavailability based on its bioavailability (USEPA, 2007c). For 
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appropriate adjustments with site-specific IVBA data the user guide refers users to consult 
a supplementary document; OSWER 2985.7-77 (USEPA, 2007e). The guidance 
document on bioavailability provides relationship between relative bioavailability (RBA), 
absolute bioavailability (ABA) and gastric bioaccessibility (IVBA) in soils and soil-like 
materials sourced from mining sites. The relationship between RBA and IVBA is 
summarized by the following equation: 
RBA = 0.878 (IVBA) – 0.028                         (6.1) (US EPA, 2007e) 
Where IVBA is the in vitro bioaccessibility (%) 
The relationship between RBA and ABA is summarized in equation 6.2 (USEPA, 2007e): 
ABA soil = (50/100).RBA soil                                     (6.2) 
Where; 
ABA soil – Absolute bioavailability of Pb in soil and soil like matrix 
RBA soil – Relative bioavailability of Pb in soil and soil like matrix 
Modifications of default Pb bioavailability values with site-specific bioaccessibility data 
have been implemented in previous studies (e.g. Rieuwerts et al., 2000; Yu et al., 2006; 
Juhasz et al., 2011) without conversion ABA. In this study gastric and gastrointestinal 
bioaccessibility data were applied in place of the default ABA and also gastric 
bioaccessibility data was converted to site-specific ABA and used in place of the default 
as specified in model user guide.  
6.3 Model inputs and simulation 
6.3.1 Default and modified model inputs 
Details of soil (< 250 µm) Pb total concentrations, PM10 (< 10 µm) Pb total concentrations, 
gastric bioaccessibility (Gastric), calculated ABA and gastrointestinal (GI) bioaccessibility 
input data are provided in Table 6.1. The gastric and intestinal bioaccessibility data were 
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Table 6.1: Site-specific data applied for IEUBK modelling for children (< 6 years) blood Pb concentrations 
SAMPLE 
ID ORIGIN Matrix 
<10 µm Total 
(µg/g) 
< 250 µm Total 
 (µg/g) 
Gastric 
bioaccessibility 
(%) 
ABA*  
 
(%) 
Gastrointestinal 
bioaccessibility 
(%) 
RM6 Roma Mahalla Soil 535 441 82.5 36.2 bd 
RM19 Roma Mahalla Soil 814 655 60.3 26.5 1.50 
RM27 Roma Mahalla Soil 838 571 66.4 29.1 2.80 
RM28 Roma Mahalla Soil 628 471 57.3 29.1 3.40 
RM42 Roma Mahalla Soil 904 709 70.5 30.9 8.20 
RM45 Roma Mahalla Soil 825 624 89.2 39.1 10.7 
RM49 Roma Mahalla Soil 488 410 92.2 40.5 3.90 
RM54 Roma Mahalla Soil 722 579 64.4 28.3 27.3 
RM66T1 Zharkov Potok Tailings 4720 2080 bd NA bd 
RM66T2 Zharkov Potok Tailings 5380 1650 bd NA bd 
RM66T3 Zharkov Potok Tailings 3900 1510 5.80 2.53 bd 
RM67 Osterode Soil 576 571 61.1 26.8 4.00 
RM69 Osterode Soil 5770 4400 76.1 33.4 17.8 
RM70 Cesmin lug Soil 2160 1807 74.6 32.4 2.20 
RM71 Cesmin lug Soil 4690 3206 87.7 38.5 6.00 
RM72 Cesmin lug Soil 2510 2137 13.4 5.87 bd 
RM74 Cesmin lug Soil 4660 2600 40.0 17.5 bd 
RM76 Gornje Polje Smelter Waste 21400 12500 1.20 0.51 bd 
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RM77(S/T) Gornje Polje Smelter Waste 72800 47200 3.80 1.65 1.00 
RM77(W) Gornje Polje Smelter Waste 56900 46900 3.30 1.43 2.30 
BM3 Bosniak Mahalla Soil 13700 9210 35.1 15.4 33.5 
BM5 Bosniak Mahalla Soil 11000 8670 29.8 13.1 27.2 
BM9 Bosniak Mahalla Soil 9350 6190 37.0 16.2 19.7 
BM11 Bosniak Mahalla Soil 4100 2810 73.4 32.2 1.90 
BM21 Ibar River Bank Soil 274 167 63.5 27.9 12.0 
BM32 Zharkov Potok Tailings 2990 1330 5.20 2.27 1.50 
BM36 Zharkov Potok Tailings 25300 24800 15.1 6.61 6.90 
BM41 Mitrovica City Park Soil 2390 1550 86.5 38.0 44.7 
BM45 Road side Soil 5390 3240 78.8 34.6 55.8 
BM46 Mitrovica City Park Soil 620 430 55.2 24.2 20.5 
BM47 Ibar River Bank Soil 2480 1430 79.7 35.0 41.5 
BM49 
Mitrovica City 
Center 
Smelter-public 
Waste 20900 20500 45.0 19.7 46.0 
BM50 Mitrovica City Park Soil 2450 1340 76.8 33.7 23.2 
* - Calculated using Equation 6.1 and 6.2 given in Section 6.2. 
ABA – Absolute bioavailability 
 
164 
 
sourced from Section 3.4.5 and ABA values were derived from corresponding gastric 
bioaccessibility values as outline above in Section 6.2.1. Total Pb concentration data for 
the < 250 µm and < 10 µm size fractions were sourced from Sections 3.4.2 and 5.3.2, 
respectively. The site-specific gastric bioaccessibility, intestinal bioaccessibility and ABA 
values were  used to modify the model Pb default ABA value of 30%, such adjustments of 
the IEUBK model default bioavailability have been recommended (USEPA, 1999; USEPA, 
2007e; Zia et al., 2011) and implemented by previous studies (e.g Rieuwerts et al., 2000; 
Yu et al., 2006; Juhasz et al., 2011). The model default outdoor soil lead concentrations 
and default outdoor PM10 lead concentrations were modified with < 250 µm and < 10 µm 
total Pb concentration data respectively. The age group studied is < 6 years since children 
within this age bracket were highlighted as the group most affected by Pb poisoning in the 
IDP camps at Mitrovica (WHO, 2009b). 
Other default and site-specific inputs data are listed in Table 6.2. Default and site-specific 
adjusted inputs were employed for the bioavailable/bioaccessibility data in this study. The 
model default soil/dust Pb concentration of 200 mg/kg was adjusted with site-specific soil 
(< 250 µm) and dust (PM10).The model default air Pb concentration is set at 0.1 µg/ m
3 but 
provision is made to substitute the default with site-specific concentration data as is 
reflected in Table 6.2 based on air Pb data published by Arditsoglou and Samara 2005 for 
the study site.  
The default indoor lead concentration is set at 30 % of the outdoor Pb concentration and 
in the absence of site-specific data the default was applied. Model default for Pb 
concentration in drinking water is set at 4 µg/L and adjustments were not made since 
drinking water concentrations at the study site were not available. The model default 
soil/dust ingestion weighting factor is set at 45 % and the default was used for simulations 
in this study. Default ABA data for gut absorption from diet, water and soil/dust are 50, 50, 
30 % respectively and the model allows adjustments for the absorption variables. In study 
the default ABA data were used for the first two simulations (Run1 and run 2). For runs 3, 
4, and 5 the default ABA data for diet and drinking water were not adjusted
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Table 6.2 Other IEUBK input data for simulations 
Run Number 1 2 3 4 5 Basis 
Parameter 
Bioavailability data for 
soil/dust (%) 
ABAa 
30 
ABAa 
30 
Gs-s 
bioaccessibility 
ABAs-s GIs-s 
Bioaccesssibility 
USEPA, 1994c and 
Table 1 
Bioavailability data for 
Diet and water (%) 
ABAa 
50 
ABAa 
50 
ABAa 
50 
ABAa 
50 
ABAa 
50 
USEPA, 1994c 
 
Soil/dust Pb 
concentration data used 
< 250 µm < 10 µm < 250 µm < 250 µm < 250 µm Data in Table 1 
Air Pb concentration  
(µg/ m3) 
0.25s-s 0.25s-s 0.25s-s 0.25s-s 0.25s-s Arditsoglou and 
Samara, 2005 
Indoor air concentration 
(µg/ m3) (fraction of 
outdoor air 
concentration) 
30 %a 30 %a 30 %a 30 %a 30 %a USEPA, 1994c  
Drinking water 
concentration (µg/ L) 
4a 4a 4a 4a 4a USEPA, 1994c 
Soil/dust ingestion 
weighting factor 
45 %a 45 %a 45 %a 45 %a 45 %a USEPA, 1994c  
a – model default, s-s – site specific data listed in Table 6.1 
G – gastric, G-I - gastrointestinal
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but the default ABA input data were adjusted for soil with site-specific gastric bioaccessibility, 
ABA and gastrointestinal bioaccessibility data.  
6.3.2 Model Simulations 
Five simulation runs were performed:  
1. Run 1: using model default inputs and site-specific air Pb concentration, soil total Pb 
concentrations in < 250 µm fraction.  
2. Run 2: using model default inputs and site-specific air Pb concentration, < 10 µm Pb 
concentrations (used as a surrogate for outdoor dust concentrations). Resuspension 
of Pb from contaminated soil has been identified to be a significant factor driving 
seasonal child blood lead fluctuations because during dry periods Pb-enriched PM10 
dust disperses in the urban environment and enhances airborne Pb dust loading 
(Laidlaw et al., 2005). The relevance of dust to Pb contamination has also been 
highlighted in a recent report by the National Institute of Public Health and 
Environment-RIVM (Oomen and Lijzen, 2004).  
3. Run 3: using site specific air Pb concentration, site-specific gastric bioaccessibility 
(the gastric bioaccessibility data was used as an upper bound estimate of 
bioavailability) and soil total Pb concentrations (< 250 µm fraction).  
4. Run 4: using site specific air Pb concentration, calculated site-specific absolute 
gastric bioavailability (USEPA, 2007c) and total soil Pb concentrations (< 250 µm 
fraction). The range of ABA values (<0.51 – 40.5 %) obtained for samples in this 
study are consistent with values (<0.50 – 45.0 %) published by the U.S. National 
Research Council (National Academy of Science, 2005) for diverse Pb minerals 
obtained from mining megasites. 
5. Run 5: using site specific air Pb concentration, site-specific gastrointestinal 
bioaccessibility and soil total Pb concentration (< 250µm fraction).  
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6.4 Model simulation outputs and discussion  
6.4.1 Predicted blood Pb concentrations 
The outputs for Run 1, Run 2, Run 3, Run 4 and Run 5 are listed in Table 6.3. The predicted 
mean and range of blood Pb concentration are 23.6 µg/dL (2.7 – 102 µg/dL), 29.5 µg/dL (3.5 
– 132 µg/dL), 23.0 µg/dL (4.5 – 78.6 µg/dL), 13.7 µg/dL (1.8 – 48.6 µg/dL) and 14.4 µg/dL 
(1.1 – 79.7 µg/dL), for Run 1, Run 2, Run 3, Run 4 and Run 5, respectively (Figure 6.1). The 
median blood Pb concentration for Run 1, Run 2, Run 3, Run 4 and Run 5 are 13.6 µg/dL, 
20.1 µg/dL, 22.1 µg/dL, 12.7 µg/dL and 6.3 µg/dL, respectively (Figure 6.1). Run 2 
(simulation input: PM10 total Pb concentration and default ABA) yielded the highest mean and 
maximum predicted blood Pb concentration for children (Figure 6.1) based on the samples 
studied and this is expected since the input PM10 Pb total concentrations for Run 2 were 
more than the < 250 µm fraction Pb total concentrations applied for all other four runs. Run 4 
(simulation input: < 250 µm total Pb concentration and site-specific ABA) yielded the lowest 
mean and maximum predicted blood Pb concentration in children (Figure 6.1) based on the 
samples studied and this could be due the fact the site-specific ABA inputs for Run 4 are 
lower than the default ABA applied for Run 1 and Run 2, and the site-specific gastric 
bioaccessibility inputs for Run 3 (Table 6.1). However, the site-specific ABA inputs for Run 4 
are not lower than the site-specific gastrointestinal bioaccessibility inputs for Run 5 for all 
samples (Table 6.1) and this is reflected in the mean and median predicted Pb 
concentrations for both runs (Figure 6.1). The predicted mean blood Pb concentration for 
Run 4 (13.7 µg/dL) is more than Run 5 (14.4 µg/dL) but they are similar (Figure 6.1). 
However, the predicted median blood Pb concentration for Run 4 (12.7 µg/dL) is higher than 
that obtained for Run 5 (6.25 µg/dL) (Figure 6.1). Run 3 (simulation input: < 250 µm total Pb 
concentration and site-specific % gastric bioaccessibility) yielded the highest median blood 
Pb concentration and could be due the fact that the range of bioavailability input values for 
this run (bd – 92.2 %) is more than the range applied for Run 4 (bd – 40.5 %) and Run 5 (bd 
– 55.8 %), and the default (30 %) applied for Run 1 and Run 2 (Table 6.1).  Analysis of the  
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Table 6.3 Predicted blood Pb concentrations  
SAMPLE 
ID ORIGIN Matrix Predicted blood Pb concentration (µg / dL) 
      
Run 1 Run 2 Run 3 Run 4 Run 5       
RM6 Roma Mahalla Soil 5.2 6.0 11.1 5.9 NA 
RM19 Roma Mahalla Soil 6.9 8.1 11.6 6.3 1.1 
RM27 Roma Mahalla Soil 6.3 8.3 11.3 6.1 1.4 
RM28 Roma Mahalla Soil 5.4 6.7 8.8 5.3 1.4 
RM42 Roma Mahalla Soil 7.3 8.8 13.8 7.5 2.8 
RM45 Roma Mahalla Soil 6.7 8.2 15 8.1 3.1 
RM49 Roma Mahalla Soil 4.9 5.6 11.4 6.1 1.4 
RM54 Roma Mahalla  Soil 6.3 7.4 10.3 6 5.8 
RM66T1 Zharkov Potok Tailings 15.9 26.7 NA NA NA 
RM66T2 Zharkov Potok Tailings 13.6 28.9 NA NA NA 
RM66T3 Zharkov Potok Tailings 12.8 23.8 3.7 2.1 NA 
RM67 Osterode Soil 6.3 6.3 10.7 5.7 1.6 
RM69 Osterode Soil 25.6 30.1 43.8 27.3 18.4 
RM70 Cesmin lug Soil 14.5 16.3 26 15.2 2.2 
RM71 Cesmin lug Soil 21.1 26.6 39.7 24.6 6.7 
RM72 Cesmin lug Soil 16.2 18 9.1 4.8 NA 
RM74 Cesmin lug Soil 18.2 26.5 22.1 12.7 NA 
RM76 Gornje Polje Smelter waste 46.6 63.3 5.5 2.9 NA 
RM77(S/T) Gornje Polje Smelter waste 102 132 30.6 18.3 13 
RM77(W) Gornje Polje Smelter waste 101 114 28.1 16.6 22.6 
BM3 Bosniak Mahalla Soil 39.3 49.2 42.9 26.7 41.8 
BM5 Bosniak Mahalla Soil 38 43.4 37.8 23.3 35.9 
BM9 Bosniak Mahalla Soil 31.3 39.6 35.3 21.6 24.4 
BM11 Bosniak Mahalla Soil 19.4 24.6 33.3 20.3 2.6 
BM21 Bosniak Mahalla Soil 2.7 3.7 4.5 2.5 1.5 
BM32 Zharkov Potok Tailings 11.7 20.1 3.1 1.8 1.5 
BM36 Zharkov Potok Tailings 69.3 70 46.6 29.1 29.8 
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BM41 
Mitrovica City 
Centre Soil 13 17.5 26 15.3 17.1 
BM45 
Mitrovica City 
Centre Soil 21.2 28.9 37.6 23.2 30.9 
BM46 
Mitrovica City 
Centre Soil 5.1 6.6 8 4.3 3.8 
BM47 
Mitrovica City 
Centre Soil 12.3 17.9 23.7 13.7 15.4 
BM49 
Mitrovica City 
Centre Smelter waste 61.9 62.7 78.6 48.6 79.7 
BM50 
Mitrovica City 
Centre Soil 11.7 17.8 22.1 12.7 9.7 
 
 
Figure 6.1: Boxplot of predicted blood Pb concentrations for simulations 
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blood Pb concentrations predicted for children (< 6 years) from all five simulations have 
indicated mean and maximum levels that are above the CDC blood lead concern level (10 
µg/dL) for long-term health risk (CDC, 2005) from the samples investigated (Figure 6.1). The 
lowest median blood Pb concentration (6.2 µg/dL) indicated in this study from Run 5 has 
previously been associated with inverse full scale IQ and performance IQ scores for children 
below 6 years old after adjustments for potential confounding factors (Jusko et al., 2008). 
The lowest median blood Pb concentration though below the current level of concern (10 
µg/dL) is above the new level of concern (2.0 µg/dL) proposed by Gilbert and Weiss 2006 in 
a review based on new scientific data.  
To ascertain if linear relationships exist between the predicted blood Pb concentrations for 
the different simulations Pearson correlation analysis was conducted for pairs of IEUBK 
model predicted blood Pb concentrations and the results of the analyses are listed in Table 
6.4. The analysis of Run 1 (simulation input: < 250 µm fraction total Pb concentration and 
default ABA) and Run 2 (simulation input: PM10 total Pb concentration and default ABA) 
indicated strong positive correlation (R2 = 0.986, p = 0.000) (Table 6.4). The strong positive 
correlation observed between the blood Pb concentrations predicted for Run 1 and Run 2 
indicates that both size fractions (< 250 µm and < 10 µm) are relevant factors for children 
blood Pb concentrations at Mitrovica. Consistent with the observation about PM10 and blood 
Pb concentration in this study, Laidlaw et al. (2005) has also highlighted the relevance of 
PM10 derived Pb environmental loading in paediatric blood lead elevations. The analysis of 
Run 1 (simulation input: < 250 µm fraction total Pb concentration and default ABA) and Run 
3 (simulation input: < 250 µm fraction total Pb concentration and site-specific gastric 
bioaccessibility) indicated weak positive correlation (R2 = 0.542, p = 0.002) (Table 6.4). The 
weak correlation is expected because of the variance between the input bioavailability data 
for the two simulations. The gastric bioaccessibility input ranged from 1.2 – 92.2 % (Table 
6.1), whilst the bioavailability input data for run 1 was fixed at 30 % (Table 6.2) for all the 
samples. The analysis of Run 1 (simulation input: < 250 µm fraction total Pb concentration 
and default ABA) and Run 4 (simulation input: < 250 µm fraction total Pb concentration and 
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site-specific ABA) indicated same weak positive correlation (R2 = 0.542, p = 0.002) (Table 
6.4) because the site-specific ABA data were calculated from gastric bioaccessibility values. 
Analysis of Run 1 (simulation input: < 250 µm fraction total Pb concentration and default 
ABA) and Run 5 (simulation input: < 250 µm fraction total Pb concentration and site-specific 
gastrointestinal bioaccessibility) expectedly indicated weak positive correlation (R2 = 0.548, p 
= 0.004) (Table 6.4) because the site-specific gastrointestinal bioaccessibility values vary for 
individual samples whilst bioavailability data for Run 1 was same (30 %) for all samples. 
Since for Run 2 bioavailability input was also fixed at 30 %, correlation analysis of Run 2 with 
Run 3, Run 4 and Run 5 coefficients are also weak (Table 6.4). A strong correlation (R2 = 
0.875, p = 0.000) was obtained between Run 5 and Run 3, and Run 5 and Run 4. The 
correlations are same because the site-specific ABA values applied for run 4 were derived 
from the gastric bioaccessibility data used for Run 3. 
Table 6.4: Pearson correlation coefficient and p-values 
       Run 1  Run 2  Run 3  Run 4 
Run 2  0.986 
       0.000 
 
Run 3  0.542  0.481 
       0.002  0.006 
 
Run 4  0.542  0.482  0.999 
       0.002  0.006  0.000 
 
Run 5  0.548  0.497  0.875  0.875 
       0.004  0.010  0.000  0.000 
 
 
6.4.2 Predicted blood Pb concentrations from different matrices 
In this study the predicted mean blood Pb concentrations for Run 1 (simulation input: < 250 
µm fraction total Pb concentration and default ABA), Run 2 (simulation input: PM10 total Pb 
concentration and default ABA) and Run 5 (simulation input: < 250 µm fraction total Pb 
concentration and site-specific gastrointestinal bioaccessibility) indicated the order: smelter > 
tailings > soil (Figure 6.2). The high blood Pb levels predicted for smelter waste in this study 
is consistent with measured elevated blood Pb concentrations recorded by Trepka et al. 
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1997, Malcoe et al. 2002 and Paoliello et al. 2002 for children exposed to smelter waste. The 
reason for the observed order in Run 1 and Run 2 is attributable to the total Pb 
concentrations in the different matrices since the bioavailability input data for both runs is 
same (30 %) for all samples (Table 6.1). The order of Pb total concentrations for the < 250 
µm and PM10 fractions is smelter > tailings > soil. For the < 250 µm fraction the range of Pb 
total concentrations are 12500 – 47300 mg/kg, 1330 – 24800 mg/kg and 167 – 9210 mg/kg 
for smelter, tailings and soil, respectively. For the < 10 µm (PM10) fraction the range of Pb 
total concentrations are 20900 – 72800 mg/kg, 2990 – 25300 mg/kg and 274 – 13700 mg/kg 
for smelter, tailings and soil, respectively. Rieuwert et al. 2000 using the IEUBK model with 
similar inputs (e.g. Pb total concentrations and model default bioavailability coefficient) for 
smelter waste, garden soil and mine waste observed a similar order (smelter > garden soil > 
mine waste) for the predicted blood Pb concentrations. Unlike Run 1 and Run 2, Run 5 
simulation was based on variable site-specific gastrointestinal bioaccessibility input as ABA 
yet tailings indicated a higher mean blood Pb concentration than soil. This could be due the 
fact that only two tailing samples were modelled because of lack of gastrointestinal 
bioaccessibility data for others (bioaccessible Pb in gastrointestinal fluids were not 
detectable) (Table 6.1), and 1.5 and 29.8 µg/dL are the predicted blood Pb concentration. 
The mean blood Pb concentrations predicted based on soil and metallurgic waste derived 
inhalable particulates (PM10) total Pb concentrations (Section 5.3.4) and model default ABA 
input (30 %) (Run 2) were the highest for the smelter waste and mine tailings samples 
(Figure 6.2). This is because Pb total concentrations are higher in the PM10 fractions than in 
the < 250 µm fractions and all the other simulations were conducted based on the < 250 µm 
fraction Pb total concentration. That the simulations based on the inhalable particulates 
indicated very high blood Pb concentrations implies that at Mitrovica the inhalation pathway 
may also contribute to the childhood blood Pb elevation. Laidlaw et al. 2005 have suggested 
that Pb-rich PM10 dust disperses and causes elevated Pb dust loads. 
The predicted mean blood Pb concentrations for Run 3 (simulation input: < 250 µm fraction 
total Pb concentration and site-specific gastric bioaccessibility), and Run 4 (simulation input: 
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< 250 µm fraction total Pb concentration and site-specific ABA) indicated the order: smelter > 
soil > tailings (Figure 6.2). However, the < 250 µm fraction Pb total concentration used for 
both simulations (ranges: 12468 – 47260 mg/kg, 1330 – 24800 mg/kg and 167 – 9210 mg/kg 
for smelter, tailings and soil, respectively) indicated a contrary order (smelter > tailings > 
soil). The reason why soils indicated more blood Pb concentrations than the tailings even 
though the tailings have higher Pb total concentration is the inputted site-specific gastric 
bioaccessibility and ABA coefficients. The range of site-specific gastric bioaccessibility 
coefficients used is 1.2 – 45.0 %, 13.4 – 92.2 % and 5.8 – 15.1 % for smelter, soil and 
tailings, respectively. The range of site-specific ABA coefficients used is 0.5 – 19.7 %, 5.9 – 
40.5 % and 2.5 – 6.6 % for smelter, soil and tailings, respectively. In vivo bioavailability is a 
factor that significantly influences Pb absorption in human digestive tract (Ruby et al., 1993), 
therefore that soil which is associated with significantly higher bioavailability than tailing 
indicated higher blood Pb concentrations is expected. 
Figure 6.2: Boxplot of predicted blood Pb concentrations for matrices  
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Smelter waste: Run 1 (n = 4), Run 2 (n = 4), Run 3 (n = 4), Run 4 (n = 4), and Run 5 (n = 3) 
 Soil: Run 1 (n = 24), Run 2 (n = 24), Run 3 (n = 24), Run 4 (n = 24), Run 5 (n = 21) 
 Tailings: Run 1 (n = 5), Run 2 (n = 5), Run 3 (n = 3), Run 4 (n = 3), and Run 5 (n = 2)  
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The Run 1 simulations for smelter waste, soil and tailing samples have indicated mean blood 
concentrations 77.9 µg/dL (range: 46.5 – 102 µg/dL), 14.4 µg/dL (range: 2.7 -39.3 µg/dL) and 
24.7 µg/dL (range: 11.7 - 69.3 µg/dL), respectively. The Run 2 simulations for the smelter 
waste, soil and tailing samples have indicated mean blood concentrations 92.8 µg/dL (range: 
62.7 - 132 µg/dL), 18.0 µg/dL (range: 3.7 – 49.2 µg/dL) and 33.9 µg/dL (range: 20.1 – 70.0 
µg/dL), respectively. The Run 3 simulations for smelter, soil and tailing samples have 
indicated mean blood concentrations 35.7 µg/dL (range: 5.5 – 78.6 µg/dL), 21.5 µg/dL 
(range: 4.5 – 43.8 µg/dL) and 17.8 µg/dL (range: 3.1 – 46.6 µg/dL), respectively. The Run 4 
simulations for the smelter, soil and tailing samples have indicated mean blood 
concentrations 21.6 µg/dL (range: 2.9 - 48.6 µg/dL), 12.7 µg/dL (range: 2.5 – 27.3 µg/dL) and 
11.0 µg/dL (range: 1.8 – 29.3 µg/dL), respectively. The Run 5 simulations for the smelter, soil 
and tailing samples have indicated mean blood concentrations 38.4 µg/dL (range: 13.0 – 
66.7 µg/dL), 10.9 µg/dL (range: 1.1 – 41.8 µg/dL) and 15.6 µg/dL (range: 1.5 – 29.8 µg/dL), 
respectively.  
The range of blood concentrations (2.7 – 39.3 µg/dL) predicted for contaminated soil 
samples in this study with a total Pb concentration range of 167 – 9209 mg/kg and default 
ABA of 30 % (Run 1) are below the range of values 5.4 – 79.9 µg/dL reported by Aragon and 
Herrera (2012) for three soil samples obtained from the vicinity of a former foundry tailing 
dam with similar Pb concentration range (104 – 9650 mg / Kg) and same ABA input data.  
The difference is a reflection of the soil ingestion rate values applied in the studies. The soil 
ingestion rate for the age group (< 6 year) used in this study is 135 mg/d but Aragon and 
Herrera (2012) in their study used 300 mg/d, and the higher soil ingestion rate used by 
Aragon and Herrera (2012) accounts for higher levels they have reported. Rieuwert et al. 
(2000) have predicted a blood Pb concentration range of 5.5 – 14.4 µg/dL for 2 years old 
children exposed to metallurgic waste contaminated garden soils (range of total Pb 
concentration: 167 - 938 mg/kg) with the same model as simulated for Run 1. The lower 
blood Pb concentration range reported by Rieuwert et al. (2000) may be due the lower range 
of soil total concentrations applied in their work. 
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Yu et al. (2006) using site-specific mean bioaccessibility values; gastric (65 %) and intestinal 
(12 %) have reported blood Pb concentration ranges of 5 – 18 µg /dL and 4 – 11 µg/dL, 
respectively for vacuumed house dust on carpets in urban residences at New Jersey, USA. 
The total Pb concentrations modelled by Yu et al. (2006) ranged between 209 – 1770 mg 
/Kg. For thirteen soil samples with similar total Pb concentrations (167 – 1430 mg / Kg) in this 
study the ranges 4 – 24 µg /dL and 2 – 15 µg / dL were obtained for Run 3 (simulation input: 
< 250 µm fraction total Pb concentration and site-specific gastric bioaccessibility) and Run 5 
(simulation input: < 250 µm fraction total Pb concentration and site-specific gastrointestinal 
bioaccessibility) simulations. The higher blood Pb concentrations recorded from this study 
may be due the higher air Pb concentration (0.25 µgm-3) employed in this study compared to 
the default (0.1 µgm-3) used by Yu et al. (2006), and the variable gastric and gastrointestinal 
values used for individual samples (Table 6.1) in this study. 
6.4.3 Predicted blood Pb concentrations at the different study locations 
Results from this study have indicated blood Pb lead levels concentrations above the CDC 
blood Pb concern level (10 µg / dL) for long-term health risk (CDC, 2005) from all of the study 
locations except Roma Mahalla using one or more of the modelled scenarios (Figure 6.3). At 
Bosniak Mahalla with a population of about 1167 (OSCE, 2010), the predicted mean blood 
Pb concentrations for Run 1, Run 2, Run 3, Run 4, Run 5 simulations are 26 .1 µg /dL 
(range: 2.7 – 39.3 µg /dL), 32.1 µg /dL (range: 3.7 – 49.2 µg /dL), 30.8 µg /dL (range: 4.5 – 
42.9 µg /dL), 18.9 µg /dL (range: 2.5 – 26.7 µg /dL) and 21.2 µg /dL (range: 1.5 – 41.8 µg 
/dL), respectively (Figure 6.3).  
At Gornje Polje the predicted mean blood Pb concentrations based on Run 1, Run 2, Run 3, 
Run 4, and Run 5 simulations are 83.3 µg /dL (range: 46.6 – 102 µg /dL), 103 µg /dL (range: 
63.3 – 132 µg /dL), 21.4 µg /dL (range: 5.5 – 30.6 µg /dL), 12.6 µg /dL (range: 2.9 – 18.3 µg 
/dL) and 17.8 µg /dL (range: 13.0 – 22.6 µg /dL), respectively (Figure 6.3). All simulations 
based on total Pb concentrations at this location have indicated blood Pb concentrations 
above the level of concern. The Gornje Polje location though not a residential site is littered 
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with unconsolidated fine grain residue from initial heavy metal extraction processes and 
previous isotopic studies have identified these materials as the dominant source of Pb within 
soil and household dust at Cesmin lug and Osterode camps, where elevated empirical blood 
Pb concentrations have been reported (UNEP, 2010).  
Figure 6.3: Boxplot of predicted blood Pb concentrations for sample locations  
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Boniak Mahalla: (n = 5) 
Gornje Polje: Run 1, Run 2, Run 3 and Run 4 (n = 3), Run 5 (n = 2) 
IDP: Run 1, Run 2, Run 3 and Run 4 (n = 6), Run 5 (n = 4) 
Mitrovica City Centre: (n = 6) 
Roma Mahalla: Run 2, Run 3 and Run 4 (n = 8), Run 5 (n = 7)  
Zharkov Potok: Run 2, Run 3 and Run 4 (n = 5), Run 5 (n = 2) 
Samples collected at the internally displaced persons camps situated at Cesmin Lug and 
Osterode (camps are about 150 m apart) have indicated mean blood Pb concentrations 
based on Run 1, Run 2, Run 3, Run 4, and Run 5 simulations as 17.0 µg /dL (range: 6.3 – 
25.6 µg/dL), 20.6 µg /dL (range: 6.3 – 30.1 µg /dL), 25.2 µg /dL (range: 9.1 – 43.8 µg /dL), 
15.0 µg /dL (range: 4.8 – 27.3 µg /dL) and 7.2 µg /dL (range: 1.6 – 18.4 µg /dL), respectively 
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(Figure 6.3). The current human population is 1230 with pre-school (0-5 age) estimated as 
308 (OSCE, 2010). The IDP camps may have indicated the elevated blood Pb 
concentrations because they are downwind of Pb mine tailings and the existence of informal 
Pb smelting site adjacent the camps (Brown and Brooks, 2007). Blood surveillance 
programmes at the camps indicated blood Pb concentrations above acceptable levels 
(Brown and Brooks, 2007; Brown et al., 2010). After adjustments for potential confounders 
the mean blood Pb concentrations obtained for three different age groups (0 - 1.2, 0 – 2.5, 
and 0.3 – 6.6 years) were 15.6, 35.0 and 41.8 µg /dL, respectively (Brown et al., 2010). Also 
blood Pb surveillance conducted at Cesmin Lug in 2007 for children indicated blood 
concentrations > 45 µg/dL (Brown and Brooks, 2007). The adjusted mean blood Pb 
concentration (41.8 µg /dL) reported by Brown et al. 2010 for the age group of interest (0 – 6 
years) in this study is above the means of blood Pb concentrations predicted with the IEUBK 
model for all 5 simulations. The underestimation of the empirical blood Pb concentrations 
obtained at the study site is an indication that in addition to soil, other ingestible items and 
inhalation of soil-derived fine particulates may have contributed to children’s blood Pb 
concentrations at the site. A previous report has suggested vegetables, food and home 
grown poultry as alternate sources of Pb for the local population at Mitrovica (UNEP, 2010). 
However, the range of blood Pb concentrations predicted for the IDP children population (9.1 
– 43.8 µg/dL) in this study for Run 3 simulation (simulation inputs: < 250 µm fraction total Pb 
concentration and site-specific gastric bioaccessibility) is consistent with the range of 
adjusted means (15.6 – 41.8 µg/dL) reported by Brown et al. (2010) for age groups surveyed. 
The blood Pb concentration range predicted (4.8 – 27.3 µg /dL) for Run 4 simulations (based 
on site-specific ABA inputs, as suggested the model user guide) underestimated the 
empirical blood Pb data for the site. 
At Mitrovica City Centre the predicted mean blood Pb concentrations based on Run 1, Run 2, 
Run 3, Run 4, and Run 5 simulations are 20.9 µg /dL (range: 5.1 – 61.9 µg /dL), 25.2 µg /dL 
(range: 6.6 – 62.7 µg /dL), 32.7 µg /dL (range: 8.0 – 78.6 µg /dL), 18.9 µg /dL (range: 4.3 – 
48.6 µg /dL) and 26.1 µg /dL (range: 3.8 – 75.9 µg /dL), respectively (Figure 6.3). The mean 
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blood Pb concentrations predicted for all five scenarios at the City Centre are also above the 
blood Pb level of concern. Based on the elevated blood Pb concentrations predicted for this 
location, there is need for blood Pb surveillance beyond the IDP camps. Consistent with 
findings, previous data indicates 40 % of non-IDP residences have blood Pb concentrations 
higher than 10 µg / dL (UNEP, 2010).  
At Roma Mahalla- the designated site for resettlement of families from the IDP camps, the 
predicted blood Pb concentrations based on Run 1, Run 2, Run 3, Run 4, and Run 5 
simulations are 6.1 µg /dL (range: 4.9 – 7.3 µg /dL), 7.4 µg /dL (range: 5.6 – 8.8 µg /dL), 11.7 
µg /dL (range: 8.8 – 15.0 µg /dL), 6.4 µg /dL (range: 5.3 – 8.1 µg /dL) and 2.4 µg /dL (range: 
1.1 – 5.8 µg /dL), respectively (Figure 6.3). Except the blood Pb mean and maximum (11.7 
µg /dL and 15.0 µg /dL) predicted based on Run 3 (simulation input: < 250 µm fraction total 
Pb concentration and site-specific gastric bioaccessibility) all other simulations indicated 
levels below the blood Pb level of concern. Roma Mahalla has no obvious source of Pb 
exposure (Brown and Brooks, 2007) and expectedly indicated the lowest predicted blood Pb 
concentration in this study. However, even at these lower concentrations inverse 
associations have been found with full scale IQ (Lanphear et al., 2000; Cranfield et al., 2003; 
Jusko et al., 2008). For Pb toxicity issues at any site the Society of Brownfield Risk 
Assessment has recommended the index dose approach in setting HCV (SOBRA, 2012). 
At Zharkov Potok the predicted mean blood Pb concentrations based on Run 1, Run 2, Run 
3, Run 4, and Run 5 simulations are 24.7 µg /dL (range: 11.7 – 69.3 µg /dL), 33.9 µg /dL 
(range: 20.1 – 70.0 µg /dL), 17.8 µg /dL (range: 3.1 – 46.6 µg /dL), 11.0 µg /dL (range: 1.8 – 
29.1 µg /dL) and 15.6 µg /dL (range: 1.5 – 29.8 µg /dL), respectively (Figure 6.3). This site is 
predominantly a tailings impoundment situated upstream of the Gornje Pornje and Mitrovica 
(Section 3.2), and is a significant source of airborne heavy metals for nearby human 
residents during dry periods (UNEP, 2010). The impoundment is adjacent the Kelmendi 
community and is only about 800 m from Mitrovica (WBEP, 2010) so the elevated blood Pb 
concentration observed at Mitrovica City Centre may have resulted from atmospheric 
deposition from this site.  
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6.5 Summary and limitations 
6.5.1 Summary 
In 2007 based on the childhood Pb poisoning problems at Mitrovica the US State 
Department, U.S. Oil and Gas PLC (USOP) and United States Agency for International 
Development (USAID) requested CDC to recommend future needs for preventing Pb 
poisoning among children (Brown and Brooks, 2007). One of the recommendations by CDC 
was the need for more data on Pb poisoning at Mitrovica because absence of relevant data 
on the gravity of the Pb poisoning problem has hampered decision making (Brown and 
Brooks, 2007). This chapter is an attempt to compensate for the lack of comprehensive 
childhood blood Pb data for the larger Mitrovica site, since recent published data (Brown and 
Brooks, 2007; Brown et al., 2010) is focused on the Roma population at the IDP camps.  
The mean blood Pb concentration obtained for all study locations are listed in Table 6.5. 
Except Roma Mahalla the predicted mean blood concentrations all other locations for most of 
the simulations are above the current CDC blood Pb of level of concern (10 µg/dL). At Roma  
Table 6.5: Modelled and empirical blood concentrations 
Locations Run 1 Run 2 Run 3 Run 4 Run 5 Measured data  
 (µg/dL) 
Bosniak Mahalla 26.1 32.1 30.8 18.9 21.2 20 – 40a 
Gornje Polje 83.3 103 21.4 12.6 17.8  
IDP camps 17.0 20.6 25.2 15.0 7.2 20 – 40a, 15.6 – 41.8b 
City Centre 20.9 25.2 32.7 18.9 26.1 20 -40a 
Roma Mahalla 6.1 7.4 11.7 6.4 2.4 20 – 40a 
Zharkov Potok 24.7 33.9 17.8 11.0 15.6  
a - Factor-Litvak et al. (1999). 
 b – Brown et al., 2010. 
Mahalla- the designated site for resettlement of families from the IDP camps excluding Run 3 
(based on gastric bioaccessibility) all predicted mean and maximum blood Pb concentrations 
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are below the current CDC blood Pb of level of concern (10 µg/dL). Among the matrices 
investigated at the site smelter waste indicated the highest predicted blood Pb 
concentrations. The smelter wastes may be one of the major sources of childhood Pb 
poisoning at Mitrovica since most of the residential areas studied are downwind of 
metallurgic waste (Brown and Brooks, 2007).  
Blood Pb surveillance conducted at the IDP camps between 2005 and 2007 indicated that 30 
% of the children had blood Pb concentration > 45 µg/dL (a level recommended for chelation 
therapy) (Brown and Brooks, 2007). Another study at the camps reported mean blood Pb 
concentrations of 15.6, 35.0 and 41.8 µg /dL for 0 - 1.2, 0 – 2.5, and 0.3 – 6.6 years 
respectively, (Brown et al., 2010). The IEUBK predicted range of mean blood Pb 
concentrations for the IDP camps though lower (15.0 – 25.2 µg/dL) is consisted with the 
empirical mean blood Pb of concentrations range (15.6 – 41.8 µg/dL) reported by Brown et 
al., 2010 for the camps. For the wider Mitrovica, Factor-Litvak et al. (1999) have reported 
measured mean blood Pb concentration range of 20 – 40 µg/dL (n = 577) for the age range 
of interest in this study. Similar mean blood Pb concentration ranges (21.2 – 32.1 µg/dL) 
(excluding Run 4), (20.6 – 25.2 µg/dL) (excluding Run 1, 4 and 5), and (20.9 – 32.7 µg/dL) 
(excluding Run 4) for Bosniak Mahalla, IDP camps and Mitrovica City Centre, respectively 
were predicted. 
Model simulation based on exposures to soil Pb alone underestimated the empirical blood 
concentrations recorded at the site by Factor-Litvak et al., (1999) and Brown et al., (2010). 
Garden vegetables, fruits and poultry meat have been found to have elevated Pb levels at 
the study area (Montec, 2007). The underestimation could be due exposures through 
sources other than soil. It has been suggested that consistent exposure to environmental Pb 
sources increases blood Pb concentration until age 6 year before decline (Factor-Litvak et 
al., 1999), thus the higher empirical blood Pb concentrations obtained at the residential 
locations may have possibly accumulated over time. The higher empirical blood Pb 
concentrations may also have resulted from contributions via inhalation of contaminated fine 
particulates and previous report by Laidlaw et al. 2005 supports the view that inhalation and 
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ingestion pathways are responsible for childhood Pb exposure. Also comparison of Pb 
gastrointestinal bioaccessibility for the < 250 µm fraction and tracheobronchial 
bioaccessibility for the PM10 fraction of the 33 samples modelled (Section 5.3.3) indicated 
similar bioaccessibility for some samples, so inhalation of the PM10 fraction could provide 
large quantity soluble Pb for absorption into the systemic circulation. 
6.5.2 Limitation of using the IEUBK model  
The IEUBK model is a considered to be a reliable tool for predicting children blood Pb 
concentrations for residential, public and commercial settings and has been validated and 
calibrated severally (Mushak, 1998; USEPA, 2011). However, results from the model may 
not be accurate where site-specific data differ from the model defaults. If the site-specific 
soil/dust intake rates, contributions from diet and water for children differs from the model 
default inputs the model output may vary from measured blood Pb concentration (Mushak, 
1998; USEPA, 2011).  
Variability in socioeconomic factors like poverty, personal hygiene, parental education and 
occupation of family members have been highlighted as possible limitations (Factor et al., 
1999; Brown et al., 2010). The approach implemented for bioavailability input is also a 
source of limitation. The application of model default bioavailability for samples without 
consideration site-specific can could predict blood Pb level that are not consistent with 
measured data. Also in vitro bioavailability testing methods could yield bioavailability data 
that are not accurate and could be a limitation. 
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Chapter 7: Conclusion and future work 
7.1 Conclusion 
A critical review of published literature on human respiratory tract lining fluids, human 
anatomy and upper respiratory physiology has facilitated the formulation of a 
tracheobronchial fluid and the development of an in vitro inhalation bioaccessibility protocol 
for Pb in PM10 fractions. In addition to the typical inorganic salts that are presently employed 
for the preparation of in vitro inhalation fluids the new formulation consist of surfactant, 
antioxidant and lubricating proteins that are present in healthy human airway 
tracheobronchial compartment. Some of the included proteins have the capacity to change 
the dissolution kinetics of Pb in aqueous media. Method development results suggest that 
tracheobronchial bioaccessibility is maximised after 96 hours and the influence of metal-
binding proteins is highlighted. 
The method has been applied to soil and metallurgic waste derived PM10 as a means of 
estimating Pb exposure from re-suspended surface soil and metallurgic waste at Mitrovica, 
Kosovo where high total suspended solids prevail in the ambient environment. Mitrovica is 
an area of particular concern with exposure to Pb. As part of the application a water-based 
sedimentation method for extracting fine particles from bulk samples was optimised and 
applied for extracting PM10 fractions from samples and quality control checks have indicated 
the suitability of the method for Pb studies. For the Mitrovica samples the in-vitro 
tracheobronchial bioaccessibility ranged between 0.02 to 11.0% across a range of topsoils, 
smelter wastes and mine tailings and samples without Pb-bearing mineral phases indicated 
the highest mean % tracheobronchial bioaccessibility. 
As part this study for the ingestion pathway the Unified Bioaccessibility Method was applied 
to 6 smelter, 52 soil and 5 tailing samples from Mitrovica. Mass recoveries were good and 
accuracies for the certified PHEs (i.e. As and Pb) were within certified range. Among the 
matrices investigated smelter waste indicated the highest mean and maximum total and 
bioaccessible concentrations for As, Cd, Cu, Pb and Zn, and tailings for Mn. XRD analysis 
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for mine tailings, smelter and soil samples also indicated higher heavy mineral yields for the 
metallurgic waste samples. The order of % bioaccessibility in the gastric phase is Pb > Cd > 
Mn > Zn > Cu > As and the gastrointestinal phase is Cu > As > Mn > Cd > Pb > Zn. The % 
oral bioaccessibility patterns for PHEs in all samples when analysed is far from simple with 
some PHEs indicating bioaccessibility from circa 0 to 100 %. The grouping of samples based 
on matrix yielded a narrower range of bioaccessibility for the tailings but the smelter and soil 
samples still indicated large ranges for most of the PHEs investigated.  
The grouping of samples according to mineral phases identified by XRD analysis yielded 
narrower ranges of % bioaccessibility. XRD analysis result indicates that the metallurgic 
waste samples are associated with mineral assemblages (e.g. arsenian pyrite, beudantile, 
galena, manganite and anglesite), whilst soil mineralogy appears to be dominated by Fe/Fe 
oxide minerals (hematite and goethite). PHEs in readily bioaccessible forms, as indicated in 
the surface soils with no XRD identifiable PHE mineral phases, indicated the highest % 
bioaccessibility for most of the PHEs studied. Most of the geogenically-derived PHEs (e.g. 
tailing samples) indicated lower % bioaccessibility. Therefore mineralogy amid other physico-
chemical factors may have strong influence on the fraction of ingested soil-bound PHEs 
available for absorption in the digestive system. 
Quantification of the potential human exposure risk associated with the ingestion of soil-
associated PHEs indicates that on average, 0.01 µg Cd kg-1 BW d-1, 0.15 µg Cu kg-1 BW d-1, 
2.37 Mn kg-1 BW d-1, 0.08 µg As kg-1 BW d-1, 7.71 µg Pb kg-1 BW d-1, and 2.68 µg Zn kg-1 BW 
d-1 could be bioaccessible following ingestion of PHE-rich soils in the Mitrovica region, with 
Pb, and to a lesser extent As, indicating the likely possibility of local populations exceeding 
the recommended tolerable daily intake. Also quantification of the potential human exposure 
risk associated with inhalation indicates that on average 0.0063 µg Pb kg-1 BW d-1 could be 
bioaccessible following inhalation of Pb-rich PM10 re-suspended from surface soil and 
metallurgic waste in the Mitrovica region. 
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To generate comprehensive childhood blood Pb data for Mitrovica the IEUBK model 
(IEUBKwin version) was used to predict childhood blood concentrations. With site-specific 
and model default bioavailability inputs four simulations were undertaken on ingestible (< 250 
µm) Pb total concentrations and one on PM10 fraction Pb total concentration. For the 
ingestible fraction all four simulations predicted mean blood Pb concentrations range 
between 13.7 – 23.6 µg/dL. For the PM10 fraction 29.5 µg/dL was predicted as the mean 
blood Pb concentration. All the simulations indicated mean blood Pb concentrations that are 
above the current CDC level of concern (10 µg/dL). However, all predicted blood Pb 
concentration means are below the measured range for the site, and the under-prediction is 
suggestive that other ingestible items (e.g. diet and water) and pathways (e.g. inhalation) 
may have contributed to childhood Pb burden at Mitrovica. With 21 % of the samples 
investigated having indicated higher bioaccessibility in the tracheobronchial fluid than in the 
gastrointestinal fluid (UBM) the potential role of the inhalation is further highlighted. 
7.2 Key implications arising from this study 
 The highly bioaccessible nature of soil-bound PHEs at Mitrovica highlights the need 
for appropriate environmental management approaches that limit the exposure of 
local populations to these contaminated soils. 
 The application of the IEUBK model to mine wastes with model default bioavailability 
input (30 %) may be overestimating the actual childhood blood Pb concentrations, 
since data from this study indicate lower site-specific in vitro bioavailability values for 
mine waste. 
 Comparison of % bioaccessibility data from different regions of the world should be 
conducted alongside mineralogy data. 
 Future childhood blood Pb level surveillance studies in Mitrovica should not be 
restricted to IDP camp children alone, but all residential towns at Mitrovica since data 
from this study suggest widespread childhood Pb burden. 
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 There is need to also conduct childhood As burden surveillance as data from this 
study has indicated daily intake dose above threshold concentrations. 
 There is need for the containment of exposed metallurgic wastes at Mitrovica, since 
they indicated the potential for higher daily intake concentrations than soils for most 
of the PHEs studied. 
 There is need for appropriate environmental management approaches that limit re-
suspension of dust from surfaces as PM10 derived from samples have indicated 
elevated concentrations of Pb. 
 There is need to analyse food items from the site for the estimation of PHE intake 
from this source since soil alone underestimates empirical childhood Pb burden at 
Mitrovica. 
 The designated resettlement site (Roma Mahalla) based on this thesis appears the 
most appropriate since the site indicated the lowest possible health risk for most of 
the PHEs investigated.  
7.3 Future work 
The in vitro respiratory tract lining fluid, designed by pathfinders like James Gamble, appears 
not to have been adequately updated based on recent scientific data (e.g. proteome of 
airway fluids) as is the case with the in vitro digestive fluids. Presently different fluids exist for 
the different compartments of the digestive system (e.g. stomach and intestine). Such 
specialized fluids are also needed for the different compartments of human respiratory tract. 
Inter-laboratory testing of existing inhalation bioaccessibility protocols and more collaborative 
studies are required to identify and develop a robust method that can be readily employed. 
There is a need for the in vivo validation of the tracheobronchial bioaccessibility protocol 
developed in this thesis and the development of certified reference materials for inhalation 
bioaccessibility. 
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More studies should be conducted on the role of PHEs mineralogy in both oral and inhalation 
bioaccessibility. It is also important to understand the behaviour of individual particulate 
matter when subjected to chemical alterations that mimic in situ chemical processes in the 
ambient environmental media. Differential individual particle analysis (DIPA) is an emerging 
tool for investigating the behaviour of environmental particles under simulated ambient 
chemical conditions (Hunt and Johnson, 2011). Future studies on inhalable particles should 
include DIPA. As a follow-up from this thesis subsamples have been submitted for DIPA at 
the laboratory of Prof. A. Hunt, Arlington, Texas, USA. Composition and morphological data 
from DIPA may facilitate better understaning of the initial molecular-scale speciation of Pb 
particles and their transformations in synthetic body fluids employed in this study. DIPA data 
may indicate possible in situ chemical products responsible for the varying bioaccessibility 
observed for different samples in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
187 
 
References 
Abbey, D.E., Nishino, N., McDonnel, W.F., Burchette, R.J., Knutsen, S.F., Beeson, W.L., and 
Yang, J.X., (1999) Long-term inhalable particles and other air pollutants related to mortality in 
non-smokers. American Journal of Respiratory and Critical Care Medicine 159, 373-382. 
Abrahams, P.W. (2002) Soils: their implications to human health. Science of the Total 
Environment 291, 1-32. 
Abrahams, P.W., (1997) Geophagy (soil consumption) and iron supplementation in Uganda. 
Tropical Medicine & International Health 2, 617-623. 
Abrahams, P.W., (1999) The chemistry and mineralogy of three Savanna lick soils. Journal 
of Chemical Ecology 25, 2215-2228. 
Abrahams, P.W., (2012) Involuntary soil ingestion and geophagia: A source and sink of 
mineral nutrients and potentially harmful elements to consumers of earth materials. Applied 
Geochemistry 27, 954-968. 
Abrahams, P.W., Follansbee, M.H., Hunt, A., Smith, B., and Wragg, J., (2006) Iron nutrition 
and possible lead toxicity: An appraisal of geophagy undertaken by pregnant women of UK 
Asian communities. Applied Geochemistry 21, 98-108. 
Afeiche, M., Peterson, K.E., Sanchez, B.N., Cantonwine, D., Lamadrid-Figueroa, H., 
Schnaas, L., Ettinger, S.A., Hernandez-Auila, M., Hu, H., and Tellez-Rojo, M.M., (2011) 
Prenatal lead exposure and weight of 0- to 5-year-old children in Mexico city. Environmental 
Health Perspectives 119, 1436-1441. 
Ajmone-Marsan, F., Biasioli, M., Kralj, T., Grcman, H., Davidson, C.M., Hursthouse, A.S., 
Madrid, L., and Rodrigues, S., (2008) Metals in particle-size fractions of soils of five 
European cities. Environmental Pollution 152, 73-81. 
Al-Abed, S.R., Jegadeesan, G., Purandare, J., and Allen, D., (2007) Arsenic release from 
iron rich mineral processing waste: Influence of pH and redox potential. Chemosphere 66, 
773-782. 
Alinnor, I.J., (2007) Adsorption of heavy metal ions from aqueous solution by fly ash. Fuel 86, 
853-857. 
Allen, B.C., Karlock, R.J., Kimmel, C.A., and Faustman, E.M., (1994) Dose-response 
assessment for developmental and applied toxicity: III Statistical models. Fundamental and 
Applied Toxicology 23, 496-509. 
188 
 
Almeida, S.M., Pio, C.A., Freitas, M.C., Reis, M.A., and Trancoso, M.A., (2005) Source 
apportionment of fine and coarse particulate matter in sub urban area at the western 
European coast. Atmospheric Environment 39, 3127-3138.  
Amato, F., Pandolfi, M., Viana, M., Querol, X., Alastuey, A., and Moreno, T., (2009) Spatial 
and chemical patterns of PM10 in road dust deposited in urban environment. Atmospheric 
Environment 43, 1650-1659. 
Anderson, L., and Hunter, C.L., (2006) Quantitative mass spectrometric multiple reaction 
monitoring assays for major plasma proteins. Molecular & Cellular Proteomics 5, 573-588. 
Anderson, M.E., (2003) Toxicokinetic modelling and its applications in chemical risk 
assessment. Toxicology Letters 138, 9-27. 
Anderson, M.E., Clewell, H.J., and Frederick, C.B., (1995) Contemporary issues in 
toxicology: Applying simulation modelling to problems in toxicology and risk assessment- A 
short perspective. Toxicology and Applied Pharmacology 133, 181-187. 
Angerer J., and Gundel, J., (1996) Biomonitoring and occupational medicine. Possibilities 
and Limitations. Annali Desllistuto Superiore di Sanita 32, 199-206. 
Angerer, J., Ewers, U., and Wilhelm, M., (2007) Human biomonitoring: State of the art. 
International Journal of Hygiene and Environmental Health 210, p201-228. 
Ansoborlo, E., Chalabreysse, J., Escallon, S., and Henge-Napoli, M.H., (1990) In vitro 
solubility of uranium tetrafluoride with oxidizing medium compared with in vivo solubility in 
rats. International Journal of Radiation Biology 58, 681-689. 
Antonijevic, M.M., and Bogdanovic, G.D., (2004) Investigation of leaching of chalcopyrite ore 
in acidic solutions. Hydrometallurgy 73, 245-256. 
Aragon, C.V., and Herrera, T.A., (2012) Risk analysis of a residential area close to the tailing 
dam of an ex-foundry. Environmental Progress and Sustainable Energy DOI: 
10.1002/ep.11701. 
Arakawa, T., and Timasheff, S.N., (1982) Preferential interactions of proteins with salts in 
concentrated solutions. Biochemistry 21, 6545-6552 
Arditsoglou, A., and Samara, C., (2005) Levels of suspended particulate matter and major 
trace elements in Kosovo: a source identification and apportionment study. Chemosphere 
59, 669-678. 
189 
 
Artelt, S., Kock, H., Nachtigall, D., and Heinrich, U (1998) Bioavailability of platinum emitted 
from automobile exhaust. Toxicology Letters 96-97, 163-167. 
ATSDR (2007) ToxGuide for lead. United States Department of Health and Services, Public 
Health Service, Agency for Toxic Substances and Disease Registry. Available at URL: 
http://www.atsdr.cdc.gov/toxguides/toxguide-13.pdf  accessed January 10, 2013. 
Bacon, J.R., and Dinev, N.S., (2005) Isotopic characterisation of lead in contaminated soils 
from the vicinity of a non-ferrous metal smelter near Plovdiv, Bulgaria. Environmental 
Pollution 134, 247-255. 
Baconnais, S., Zahm, J.M., Kilian, L., Bonhomme, P., Gobillard, D., Perchet, A., Puchelle, E., 
and Balossier, G., (1998) X-ray microanalysis of native airway surface liquid collected by 
cryrotechnique. Journal of Microscopy 191, 311-319. 
Bagic, C., Bozkurt, A.I., Cakmak, E.A., Can, S., and Cengiz, B., (2004) Blood lead levels of 
battery and exhaust workers and their pulmonary function tests. International Journal of 
Clinical Practice 58, 568-572. 
Bakker, A.J. (1988) Immunoturbidimetry of urinary albumin: prevention of adsorption of 
albumin; influence of other urinary constituents. Clinical Chemistry 34, 82-86. 
Bansil, R., and Turner, B.S., (2006) Mucin structure, aggregation, physiological functions and 
biomedical applications. Current Opinion in Colloid & Interface Science 11, 164-170. 
Bansil, R., Stanley, E., and LaMont, J.T., (1995) Mucin biophysics. Annual Review of 
Physiology 57, 635-657. 
Barnes, D.G., Dourson, M., Preuss, P.,  Bellin, J., Derosa, C., Engler, R., Erdeich, L., Farber, 
T., Fenner-Crisp, P., Francis, E., Ghali, G., Hill, R., Irene, S., Marcus, W., Patrick, D., Perlin, 
S., Revesz, A., Rubenstein, R., Stara, J., Wiltse, J., and Zaragosa, L., (1988) Reference 
dose (RfD): description and use in health risk assessment. Regulatory Toxicology and 
Pharmacology 8, 471-486. 
Barr B.D., Wang, R.Y., and Needham, L.L., (2005) Biologic monitoring of exposure to 
environmental chemicals throughout the life stages: Requirements and issues for 
consideration for the National Children’s Study. Environmental Health Perspectives 113, 
1083-1091. 
Barret, J.E.S., Taylor, K.G., Hudson-Edwards, K.A., and Charnock, J.M., (2010) Solid-phase 
speciation of Pb in urban road dust sediment: a XANES and EXAFS study. Environmental 
Science and Technology 44, 2940-2946. 
190 
 
Basteson, T.F., and Schwartz, T., (2004) Who is sensitive to the effect of particulate air 
pollution on mortality, a case-crossover analysis of effect modifiers. Epidemiology 15, 143-
149. 
Beck, B.D., Mattuck, R.L., Bower, T.S., Cohen, J.T., and O’Flaherty, E., (2001) The 
development of a stochastic physiologically-based pharmacokinetic model for lead. Science 
of the Total Environment 274, 15-19. 
Becker, S., Fenton, M.J., and Soukup, J.M., (2002) Involvement of Microbial Compactments 
and Toll-like Receptors 2 and 4 in Cytokine Response to Air Pollution Particles, American 
Journal of Respiratory Cell and Molecular Biology 27, 611-618. 
Beeston, M.P., Elteren, J.T.V., Selih, V.S., and Fairhurst, R., (2010) Characterisation of 
artificially generated PbS aerosols and their use within a respiratory bioaccessibility test. 
Analyst 135, 351-357. 
Behera, S.N., Sharma, M., Dikshit, O., and Shukla, S.P., (2011) GIS-based emission 
inventory, dispersion modelling, and assessment for source contributions of particulate 
matter in urban environment. Water, Air, & Soil Pollution 218, 423-436. 
Behndig, A.F., Mudway, I.S., Brown, J.L., Stenfors, N., Helleday, R., Duggan, S.T., Wilson, 
S.J., Boman, C., Cassee, F.R., Frew, A.J., Kelly, F.J., Sandstrom, T., and Blomberg, A., 
(2006) Airway antioxidant and inflammatory responses to diesel exhaust exposure in healthy 
humans. European Respiratory Journal 27, 359-365. 
Benedik, L., Pinter, H., and Byrne, A.R., (1999) The leachability of some natural and man-
made radionuclides from soil and sediment on acid attack. Journal of Radioanalytical and 
Nuclear Chemistry 240, 859-865. 
Berglund, M., Elinder, C-G., and Jarup, L., (2001) Human exposure assessment: an 
introduction. WHO/SDE/OEH/013. Available at URL: 
http://ki.se/ki/jsp/polopoly.jsp?d=28916&a=9361&l=en  accessed January 10, 2013. 
Berlinger, B., Ellingsen, D.G., Naray, M., Zaray, G., and Thomassen, Y., (2008) A study of 
the bioaccessibility of welding fumes. Journal of Environmental Monitoring 10, 1448-1453. 
Bi, X., Feng, Y., Wu, J., and Zhu, T., (2007) Source apportionment of PM10 in six cities of 
northern China. Atmospheric Environment 41, 903-912. 
Bird, G., Macklin, M.G., Brewer, P.A., Zaharia, S., Balteanu, D., Driga, B., and Serban, M., 
(2009) Heavy metals in potable groundwater of mining-affected river catchments, 
northwestern Romania. Environmental Geochemistry and Health 31, 741-758. 
191 
 
Birke, M., and Rauch, U., (2000) Urban geochemistry: investigations in the Berlin 
metropolitan area. Environmental Geochemistry and Health 22, 233-248. 
Birmili, W., Allen, A.G., Bary, F., and Harrison, R.M., (2006) Trace metal concentrations and 
water solubility in size-fractionated atmospheric particles and influence of road traffic. 
Environmental Science & Technology 40, 1144-1153. 
Bjerregaard, P., and Hansen, J.C., (2000) Organochlorines and heavy metals in pregnant 
women from Disko Bay area in Green land, Science of the Total Environment 245, 195-202. 
Blake, G.R., and Hartge, K.H., (1986) Particle Density. In Kute, A., (ed) Methods of soil 
analysis. Part 1-Physical and mineralogical methods second edition. American Society of 
Agronomy, Madison WI. 
Bollhofer, A., and Rosman, K.J.R., (2000) Isotopic source signatures for atmospheric lead: 
the southern hemisphere. Geochimica et Cosmochimica Acta 64, 3251-3262. 
Borgna, L., Di Lella, L.A., Nannoni, F., Pisani, A., Pizzetti, E., Protano, G., Riccobono, F., 
and Rossi, S., (2009) The high contents of lead in soils of northern Kosovo. Journal of 
Geochemical Exploration 101, 137-146. 
Borm, P., Klassing, F.C., Laudry, T.D., Mouldgil, B., Pauluhn, J., Thomas, K., Trotter, R., and 
Wood, S., (2006) Research strategies for safety evaluation of nanomaterials, part V: role of 
dissolution in biological fate and effects of nanoscale particles. Toxicological Sciences 90, 
23-32. 
Bosso, S.T., Enzweiler, J., and Angelica, R.S., (2008) Lead bioaccessibility in soil and mine 
waste after immobilization with phosphate, Water, Air, & Soil Pollution 195, 257-273. 
Bouzom, F., Ball, K., Perdaem, N., and Walter, B., (2012) Physiologically based 
pharmacokinetic (PBPK) modelling tools: how to fit with our needs? Biopharmaceutics and 
Drug Disposition 33, 55-71. 
Bradi, H.B., (2004) Adsorption of heavy metal ions in soils and soil constituents. Journal of 
Colloid and Interface Science 277, 1-18. 
Bredberg, A., Gobom, J., Almstrand, A-C., Larsson, P., Blennow, K., Olon, A-C., and 
Mirgorodskaya, E., (2012) Exhaled endogenous particles contain lung proteins. Clinical 
Chemistry 58, 431-440. 
192 
 
Bredow, C.V., Birrer, P., and Griese, M., (2001) Surfactant Proteins A and other 
bronchoalveolar lavage fluid proteins are altered in cystic fibrosis. European Respiratory 
Journal 17, 716-722. 
BreruBe, K., Aufderheide, M., Breheny, D., Clothier, R., Combes, R., Duffin, R., Forbes, B., 
Gaca, M., Gray, A., Hall, I., Kelly, M., Lethem, M., Liebsch, M., Merolla, L., Moein, J-P., 
Seagrave, J., Swartz, M.A., Tetley, T.D., and Umachandran, M., (2009) In vitro models of 
inhalation toxicity and disease. The Report of a FRAME Workshop. Alternatives to 
Laboratory animals 37, 89-141. 
Broadway, A., Cave, M.R., Wragg, J., Fordyce, F.M., Bewley, R.J.F., Graham, M.C., 
Ngwenya, B.T., and Farmer, J.G., (2010) Determination of the bioaccessibility of chromium in 
Glasgow soil and the implications for human health risk assessment. Science of the Total 
Environment 409, 267-277. 
Bromberg, L.E., and Barr, D.P., (2000) Self-association of mucin. Biomacromolecular 1, 325-
334 
Brown, J.M., and Brook, B., (2007) Recommendations for preventing lead poisoning among 
the internally displaced Roma population in Kosovo from the Centre for Disease Control and 
Prevention. Available at URL:  http://www.cdc.gov/nceh/lead/publications/kosovoreport.pdf  
accessed January 10, 2013. 
Brown, M.J., McWeeney, G., Kim, R., Tahirukaj, A., Bulat, P., Slya, S., Savic, Z., Amitai, J., 
Dignam, T., and Kaluski, D.N., (2010) Lead poisoning among internally displaced Roma, 
Ashkali and Egytian children in the United Nations-Administered province of Kosovo. 
European Journal of Public Health 20, 288-292. 
Brown, P., Jones, T., and BeruBe, K., (2011) The internal microstructure and Fibrous 
mineralogy of fly ash from coal-burning power stations. Environmental Pollution 159, 3324-
3333. 
Brunekreef, B., and Forsberg, B., (2005) Epidemiological evidence of effects of coarse 
airborne particles on health. European Respiratory Journal 26, 309-318 
Buhre, BJ.P., Hinkley, J.T., Gupt, R.P., Nelson, P.F., and Wall, T.F., (2006) Fine ash 
formation during combustion of pulverised coal-coal property impact. Fuel 85, 185-193. 
Bunger, H., and Pison, U., (1995) Quantitative analysis of pulmonary surfactant 
phospholipids by high-performance liquid chromatography and light scattering detection. 
Journal of Chromatography B 672, 25-31. 
193 
 
Buschmann, J., Berg, M., Stengel, C., and Sampson, M.L., (2007) Arsenic and manganese 
contamination of drinking water resources in Cambodia: coincidence of risk areas with low 
relief topography. Environmental Science & Technology 41, 2146-2152. 
Button, M., Watts, M.J., Cave, M.R., Harrington, C.F., and Jenkin, G.T., (2009) Earthworms 
and in vitro physiologically-based extraction test: complementary tool for holistic approach 
towards understanding risk risk at arsenic-contaminated sites. Environmental Geochemistry 
and Health 31, 273-282. 
Cadwell, R.A., Crubb, B.R., Tarran, R., Boucher, R.C., Knowles, M.R., and Barker, P.M., 
(2002) In vivo airway surface liquid Cl- analysis with solid-state electrodes. Journal of 
General Physiology 119, 3-14. 
Canepari, S., Astolfi, M.L., Moretti, S., and Curini, R., (2010) Comparison of extracting 
solutions for elemental fractionation in airborne particulate matter. Talanta 82, 834-844. 
Canepari, S., Cardarelli, E., Giuliano, A., and Pietrodangelo, A., (2006) Determination of 
metals, metalloids and non-volatile ions in airborne particulate matter by a new two-step 
sequential leaching procedure: part A: experimental design and optimization. Talanta 69, 
581-587. 
Canfield, R.L., Henderson, S.R., Corry-Sclehta, D.A., Cox, C., Jusko, T.A., and Lanphear, 
B.P., (2012) Intellectual impairment in children with blood lead concentrations below 10 μg 
per decilitre. The New England Journal of Medicine 348, 1517-1526. 
Cantin, A.M., North, S.L., Hubbard, R.C., and Crystal, R.G., (1987) Normal alveolar epithelial 
lining fluid contains high levels of glutathione. Journal of Applied Physiology 63, 152-157 
Cao, X., Bansil, R., Bhaska, R., Turner, B.S., LaMont, T., Niu, N., and Afdhal, N.H., (1999) 
pH dependent conformational change of gastric mucin lead to sol-gel transition. Biophysical 
Journal 76, 1250-1258. 
Carlon, C., (Ed) (2007) Derivation methods of soil screening values in Europe: A review and 
evaluation of national procedures towards harmonization. European Commission, Joint 
Research Centre, Ispra. EUR 22805 –EN. Available at URL: 
http://eusoils.jrc.ec.europa.eu/esdb_archive/eusoils_docs/other/EUR22805.pdf  accessed 
January 10, 2013. 
Casteel, S.W., Cowart, R.P., Weis, C.P., Henningsen, G.M., Hoffman, E., Brattin, W.J., 
Guzman, R.E., Starost, M.F., Payne, J.T., Stochham, S.L., Becker, S.V., Drexler, J.W., and 
Turk, J.R., (1997) Bioavailability of lead to juvenile swine dosed with soil from the Smuggler 
Mountain NPL site of Aspen Colorado. Fundamental and Applied Toxicology 36, 177-187 
194 
 
Castro-Larragitia, J., Kramar, U., and Puchelt, H., (1997) 200 years of mining activities at La 
Paz / San Luis Potosi / Mexico – consequences for environment and geochemical 
exploration. Journal of Geochemical Exploration 58, 81-91. 
Caussy, D., Gochfeld, M., Gurzau, E., Neagu, C., and Ruedel, H., (2003) lessens from case 
studies of metals: investigating exposure, bioavailability, and risk. Ecotoxicology and 
Environmental Safety 56, 45-51. 
Cave, M.R., Wragg,J., Palumbo, B., and Klinck, B.A., (2003) Measurement of the 
bioaccessibility of arsenic in UK soils. R&D Technical Report P5 – 062/TR02. Environment 
Agency Bristol, UK. 
CDC. Preventing Lead Poisoning in Young Children Centres for Disease Control and 
Prevention, Atlanta: CDC; 2005. Available at URL:  
http://pediatrics.aappublications.org/content/120/5/e1285.full.pdf  accessed 12 February, 
2013. 
CEN (1993). Workplace Atmospheres - Size Fraction Definitions for Measurement of 
Airborne Particles. European Standard EN 481, European Standardization Committee 
(CEN), Brussels. 
Censi, P., Zuddas, P., Randazzo, L.A., Tamburo, E., Speziale, S., Cuttitta, A., Punture, R., 
Arico, P., and Santagata, R., (2011) Sources and nature of inhaled atmospheric dust from 
trace element analyses of human bronchial fluids. Environmental Science & Technology 45, 
6262-6267. 
Censi, P., Zuddas, P., Randazzo, L.A., Tamuro, E., Speziale, S., Cuttitta, A., Punturo, R., 
Arico, P., and Santagata, R., (2011) Source and nature of inhaled atmospheric dust from 
trace element analyses of human bronchial fluids. Environmental Science & Technology 45, 
6262-6267 
Cesari, D., Contini, D., Genga, A., Siciliano, M., Elefante, C., Baglivi, F., and Daniel, L., 
(2012) Analysis of raw soils and their resuspended PM10 fractions: characterization of source 
profiles and enrichment factors. Applied Geochemistry 27, 1238-1246. 
Chapman M.J., Goldstein, S., Lagrange, D., and Laplaud, P.M., (1981) A density gradient 
ultracentrifugal procedure for isolation of the major lipoprotein classes for human serum. 
Journal of Lipid Research 22, 339-358. 
Charlet, L., Chapron, Y., Faller, P., Kirsch, R., Stone, A.T., and Baveye, P.C., (2012) 
Neurodegenerative diseases and exposure to environmental metals Mn, Pb and Hg. 
Coordination Chemistry Reviews 256, 2147-2163. 
195 
 
Chen, L.C., and Lippmann, M., (2009) Effect of metals within ambient air particulate matter 
(PM) on human health. Inhalation Toxicology 21, 1-31. 
Chen, Y., Wang, J., Shi, G., Sun, X., Chen, Z., and Xu, S., (2011) Human health risk 
assessment of lead pollution in atmosphere deposition in Baoshan district, Shanghai. 
Environmental Geochemistry and Health 33, 515-523. 
Cheng, L., Sandhu, H.S., Angle, R.P., and Myrick, R.H., (1998) Characteristic of Inhalable 
Particulate Matter in Alberta Cities, Atmospheric Environment  32, 3835-3844. 
Chiu, W.A., Barton, H.A., Dewoskin, R.S., Schlosser, P., Thompson, C.M., Sonaware, B., 
Lipscomb, J.C., Krishnan, K., (2007) Evaluation of Physiologically based Pharmacokinetic 
models for use in risk assessment. Journal of Applied Toxicology 27, 218-237. 
Cho, H., Oh, D., and Kim, K., (2005) A study on removal characteristics of heavy metals from 
aqueous solution by fly ash. Journal of Hazardous Materials 127, 187-195. 
Christensen, V.R., Jensen, S.L., Guldberg, M., and Kamstrup, O., (1994) Effect of chemical 
composition of man-made vitreous fibres on the rate of dissolution in vitro at different pHs. 
Environmental Health Perspectives 102, 83-86. 
Churg, A., and Brauer, M., (1997) Human lung Parenchyma Retains PM2.5. American Journal 
of Respiratory and Critical Care Medicine 155, 2109-2111 
Clewell III, H.J., (1995) The application of physiologically based pharmacokinetic modelling in 
human risk assessment of hazardous substances. Toxicology Letters 79, 207-217. 
Clewell III, H.J., Tan, Y.M., and Campbell, J.L., (2008) Quantitative interpretation of human 
biomonitoring data. Toxicology and Applied Pharmacology 231, 122-133. 
Clewell, R.A., and Gaarhart, J.M., (2002) Pharmacokinetics of toxic chemicals in breast milk: 
use of PBPK models to predict infant exposure. Environmental Health Perspectives 110, 33-
337. 
Cloquet, C., Carignan, J., Libourel, G., Sterckeman, T., and Perdrix, E., (2006) Tracing 
source pollution in soils using cadmium and lead isotopes. Environmental Science & 
Technology 40, 2525-2530. 
Collier C.G., Pearce, M.J., Hodgson, A., and Ball, A., (1992) Factors affecting the in vitro 
dissolution rate of cobalt oxide. Environmental Health Perspectives 97, 109-113. 
196 
 
Colombo, C., Monhenmius, J., and Plant, J.A., (2008) The estimation of bioavailabilities of 
platinium, palladium and rhodium in vehicle exhaust catalyst and road dust using 
physiologically based extraction test. Science of the Total Environment 389, 46-51. 
Committee on Biological Markers of the National Research Council, (1987) Biological 
markers in environmental health research. Environmental Health Perspectives 74, 3-9. 
Cooper, B., Creeth, J.M., and Donald, A.S.R., (1985) Studies of the limited degradation of 
mucus glycoproteins. The mechanism of the peroxide reaction. Biochemistry Journal 228, 
615-626. 
Costa, C., Reis, A.P., Ferraira da Silva, E., Rocha, F., Patinha, C., Dias, A.C., Sequeira, C., 
and Terroso, D., (2012) Assessment of the control exerted by soil mineralogy in the fixation 
of potentially harmful elements in urban soils of Lisbon, Portugal. Environmental Earth 
Sciences 65, 1133-1145. 
Countess, R.J., Wolff, G.T., and Cadle, S.H., (1980) The Denver winter aerosol: a 
comprehensive chemical characterisation. Journal of Air Pollution Control Association 30, 
1194-1200. 
Craig, D.K., Brain, J.D., Cuddihy, R.G., Phalen R.F., Swift, D.L., and Stuart, B.O., (1882) 
Implications of the Dosimetric Model for the respiratory system on limit for intake of 
radionuclides by workers (ICRP Publication,30), The Annals of Occupational Hygiene (26) 
pp. 163-176. 
Cranfield, R.L., Henderson Jr, C.R., Cory-Slechta, D.A., Cox, C., Jusko, T.A., and Lanphear, 
B.P., (2003) Intellectual impairment in children with blood lead concentrations below 10 µg 
per decilitre. The New England Journal of Medicine 348, 1517-1526. 
Cross, C.E., Louie, S., Kwack, S., Wong, P., Sharanya, R., and Vliet, A.V.D., (2001) 
Atmospheric oxidants and respiratory tract surfaces, Fuchs, J., and Packer, L., (Eds.), 
Environmental Stressors in Health and Desease, Mercel Decker, Inc, New York, 225-236. 
Cross, C.E., van der Vliet, A., O’Neill, C.A., Louie, S., and Halliwell, B., (1994) Oxidants, 
antioxidants, and respiratory tract lining fluids. Environmental Health Perspectives 102, 185-
191. 
Crossgrove, J., and Zheng, W., (2004) Manganese toxicity upon overexposure. NMR in 
Biomedicine 17, 544-553. 
Curis, E., Nicholis, I., Bensaci, J., Deschamps, P., and Benazeth, S., (2009) Mathematical 
modelling in metal metabolism: overview and perspectives. Biochimie 91, 1238-1254. 
197 
 
Datta, R., and Sarker, D., (2005) Consideration of soil properties in assessment of human 
health risk from exposure to arsenic-enriched soils. Integrated Environmental Assessment 
and Management 1, 55-59. 
Daviies, N.M., and Feddah, M.R., (2003) A novel method for assessing dissolution of aerosol 
inhaler products. International Journal of Pharmaceutics 255, 175-187. 
Davis, A., Ruby, M.V., Bloom, M., Schoof, R., Freeman, G., and Bergstrom, P.D., (1996) 
Mineralogic constraints on the bioavailability of arsenic in smelter-impacted soils. 
Environmental Science & Technology 30, 392-399. 
DEFRA - Department for Environment Food and Rural Affairs (2011a) Code of practice for 
agricultural use of sewage sludge. Available at URL:  
http://adlib.everysite.co.uk/adlib/defra/content.aspx?id=000IL3890W.16NTC17O1X82UF  
accessed January 10, 2013. 
DEFRA - Department for Environment Food and Rural Affairs (2011b) Guidelines for 
environmental risk assessment and management (Green Leaves III). Available at URL:   
http://www.defra.gov.uk/publications/files/pb13670-green-leaves-iii-1111071.pdf accessed 
January 8, 2013. 
Del Rio-Salas, R., Ruiz, J., De la O-Villanueva, M., Valecia-Moreno, M., Moreno-Rodriguez, 
V., Gomez-Alvarez, A., Grijalva, T., Mendivil, H., Pas-Moreno, F., and Meza-Figueroa, D., 
(20120 Tracing geogenic and anthropogenic sources in urban dusts: insights from lead 
isotopes. Atmospheric Environment, 60, 202-210. 
Dennis, I.A., Coulthard, T.J., Brewer, P.A., and Macklin, M.G., (2009) The role of floodplains 
in attenuating contaminated sediment fluxes in formerly mined drainage basins. Earth 
Surface Processes and Landforms 34, 453-466. 
Denys, S., Tack, K., Caboche, J., and Delalain, P., (2009) Bioaccessibility, solid phase 
distribution, and speciation of Sb in soil and in digestive fluids. Chemosphere 74, 711-716 
Department of Toxic Substances Control (2004) Draft lead report. Available at URL: 
http://www.dtsc.ca.gov/HazardousWaste/upload/HWMP_REP_dLead-Rep.pdf  accessed 
January 10, 2013. 
DETR - Department of the Environment, Transport and the Regions (2000) Guidelines for 
environmental risk assessment and management. Available at URL:  
http://www.leadammunitiongroup.co.uk/pdf/Environmental%20Risk.pdf   accessed January 8, 
2013. 
198 
 
Doriguetto, A.C., and Fernandes, N.G., (1999) Manganese-rich natural franklinite. Acta 
Crystallographica C55, 1751-1753. 
Dourson, M.L., Pelter, S.P., and Robinson, D., (1996) Evolution of science-based uncertainty 
factors in noncancer risk assessment. Regulatory Toxicology and Pharmacology 24, 108-120 
Drahota, P., and Filippi, M., (2009) Secondary arsenic minerals in the environment: a review. 
Environment International 35, 1243-1255. 
Drysdale, M., Bjorklund, K.L., Jamieson, H.E., Weinstein, P., Cook, A., and Watkins, R.T., 
(2012) Evaluating the respiratory bioaccessibility of nickel in soil through the use of simulated 
lung fluid. Environmental Geochemistry and Health 34, 279-288. 
Dudka, S., Piotrowska, M., and Witek, T., (1995) Trace metal contamination of soils and crop 
plants by mining and smelting industry in upper Silesia, south Poland. Journal of 
Geochemical Exploration 52, 237-250. 
Duranti, M., Scarafoni, A., Cataldo, A.D., and Sessa, F., (2001) Interaction of metal ions with 
lupin seed conglutin . Phytochemistry 56, 529-533. 
Eckel, W.P., Roninowitz, M.B., and Foster, G.D., (2002) Investigation of unrecognized former 
secondary lead smelting sites: confirmation by historical sources and elemental ratios in soil. 
Environmental Pollution 117, 273-279. 
Edsbacker, S., and Johansson, C-J., (2006) Airway selectivity: an update of pharmacokinetic 
factors affecting local and systemic disposition of inhaled steroids. Basic & Clinical 
Pharmacology & Toxicology 98, 523-536. 
Effros, R.M., Peterson, B., Casaburi, R., Su, J., Dunning, M., Torday, J., Biller, J., and 
Shaker, R (2005) Epithelial lining fluid solute concentrations in chronic obstructive lung 
disease patients and normal subjects. Journal of Applied Physiology 99, 1286-1292. 
Efthimious, J., Higenbottam, T., Holt, D., and Cochrane, G.M., (1982) Plasma concentration 
of lignocaine during fibreoptic bronchoscopy. Thorax 37, 68-71. 
Eggleton, J., and Thomas, K.V., (2004) A review of factors affecting the release and 
bioavailability of contaminants. Environment International 30, 973-980. 
Ehrhardt, C., Forbes, B., and Kim, K-J., (2008b) Chapter 10: In vitro models of trachea-
bronchial epithelium. In: Drug absorption studies: In situ, in vitro, and in slico models, p 235 – 
249. (Edit; Ehrhardt, C., Kim, K-J.,) Springer, US. 
199 
 
Ehrhardt, C., Laue, M., and Kim, K-J., (2008a) In vitro models of the alveolar epithelial 
barrier. Drug Absorption Studies, Biotechnology: Pharmaceutical Aspect VII, 258-282. 
Elad, D., Wolf, M., and Keck, T., (2008) Air-conditioning in the human nasal cavity. 
Respiratory Physiology & Neurobiology 163, 121-127. 
Ellis, K.J., (2000) Human body composition: in vivo methods. Physiology Reviews 80, 649-
680. 
Engel, R.E., Hammer, D.I., Horton, R.J.M., Lane, N.M., and Plumlee, L.A., (1971) 
Environmental lead and public health. United States Environmental Protection Agency. Air 
Pollution Control Office Research Triangle Park, N.C. Air Pollution Control office publication 
No. AP-90. Available at URL:   http://nepis.epa.gov/Adobe/PDF/20013K8J.PDF   accessed 
January 10, 2013. 
Englert, N., (2004) Fine particles and human health - A review of epidemiological studies. 
Toxicology Letters 149, 235-242. 
Environment Agency (2002a) The Contaminated Land Exposure Assessment (CLEA) model: 
Technical basis and algorithms, CLR10. Environment Agency, Bristol. 
Environment Agency (2002b) SGV 10 Guideline value for lead contamination in soil: R&D 
Publications CLR7-10. Available at URL:  http://www.environment-
agency.gov.uk/static/documents/Research/SCHO0309BPQM-e-e.pdf   accessed January 8, 
2013.  
Environment Agency (2005) Environment Agency’s Science Update on the use of 
bioaccessibility testing in risk assessment of land contamination. Available at URL: 
http://www.environment-agency.gov.uk/static/documents/2-science_update_1284046.pdf  
accessed January 8, 2013. 
Environment Agency (2007) In vitro Bioaccessibility Testing: Current science and way 
forward- Science Update 2. Available at URL:  http://www.environment-
agency.gov.uk/static/documents/3-science_update_02_1793841.pdf   accessed January 8, 
2013.  
Environment Agency (2009a) Updated technical background to the CLEA model: Science 
Report: SC050021/SR3. Available at URL:   http://www.environment-
agency.gov.uk/static/documents/Research/CLEA_Report_-_final.pdf   accessed January 6, 
2013. 
200 
 
Environment Agency (2009b) Contaminants in soil: updated collation of toxicological data 
and intake values for humans. Inorganic arsenic. Science Report: SC050021/TOX 1. Bristol: 
Environment Agency. Available at URL:  http://a0768b4a8a31e106d8b0-
50dc802554eb38a24458b98ff72d550b.r19.cf3.rackcdn.com/scho0409bpvw-e-e.pdf   
accessed January 10, 2013. 
Environment Agency (2009c) Contaminants in soil: updated collation of toxicological data 
and intake values for humans. Cadmium. Science Report: SC050021/TOX 3. Bristol: 
Environment Agency. Available at URL:  http://www.environment-
agency.gov.uk/static/documents/Research/SCHO0709BQRQ-E-E.pdf   accessed January 8, 
2013. 
Environment Agency (2009d) Human health toxicological assessment of contaminants in 
soil. Science Report – Final SC050021/SR2. Available at URL:  http://www.environment-
agency.gov.uk/static/documents/Research/TOX_guidance_report_-_final.pdf   accessed 
January 8, 2013. 
Etter, V., Kribek, B., Majer, V., Knesi, I., and Mihaljevic, M., (2012) Differences in the 
bioaccessibility of metals/metalloids in soils from mining and smelting areas (copperbelt, 
Zambia). Journal of Geochemical Exploration 113, 68-75. 
Ettler, V., Vrtiskova, R., Mihaljevic, M., Sebek, O., Grygar, T., and Drahota, P., (2009) 
Cadmium lead and zinc leaching from smelter fly ash in simple organic acids – simulator of 
rhizospheric soil solutions. Journal of Hazardous Materials 170, 1264-1268. 
European Commission (2001) Pollutants in urban waste water and sewage sludge. Available 
at URL:   http://ec.europa.eu/environment/waste/sludge/pdf/sludge_pollutants.pdf  accessed 
January 6, 2013. 
European Environment Agency (2011a) Air quality in Europe – 2011 report. EEA technical 
report No 12/2011. Available at URL:  http://www.isciii.es/ISCIII/es/contenidos/fd-el-
instituto/fd-organizacion/fd-estructura-directiva/fd-subdireccion-general-servicios-aplicados-
formacion-investigacion/fd-centros-unidades/fd-centro-nacional-sanidad-
ambiental/Air_quality_in_Europe-2011_EEA_12_2011.pdf  accessed January 10, 2013.  
European Environment Agency (2011b) Particulate matter (PM10) 2009. Annual limit value for 
the protection of human health. http://www.eea.europa.eu/data-and-maps/figures/particulate-
matter-pm10-annual-limit-value-for-the-protection-of-human-health-3. 
201 
 
Factor-Litvak, P., Wasserman, G., Kline, J.K., and Graziano, J., (1999). The Yugoslavia 
perspective study of environmental lead exposure. Environmental Health Perspective 107, 9-
15. 
Falta, T., Limbeck, A., Koellenserger, G., and Hann, S., (2008) Bioaccessibility of selected 
trace metals in urban PM2.5 and PM10 samples: a model study. Analytical and Bioanalytical 
Chemistry 390, 1149-1157. 
FAO/WHO, 1987. Evaluation of certain food additives and contaminants. 30th meeting of the 
joint FAO/WHO expert committee on food additives. World Health Organisation food 
additives series no.21; Geneva. Available at URL: 
http://whqlibdoc.who.int/trs/WHO_TRS_751.pdf   accessed January 10, 2013.  
Farmer, J.G., Broadway, A., Cave, M.R., Wragg, J., Fordyce, F.M., Graham, M.C., Ngwenya, 
B.T., and Bewley, R.J.F., (2011) A lead isotopic study of the human bioaccessibility of lead in 
urban soils from Glasgow, Scotland. Science of the Total Environment 409, 4958-4965. 
Feiler, A.A., Sahlholm, A., Sandberg, T., and Caldwell, K.D., (2007) Adsorption and 
viscoelastic properties of fractionated mucin (BSM) and bovine serum albumin (BSA) studied 
with quartz crystal microbalance (QCM-D). Journal of Colloid and Interface Science 315, 
475-481. 
Ferguson, C.C., (1999) Assessing risk from contaminated sites: policy and practice in 16 
European countries. Land Contamination & Reclamation 7, 33-54. 
Fewtrell, l.T., Pruss-Ultun, A., Landrigan, P., and Ayuso-Mateos, J.L., (2004) Estimating the 
global burden of mild mental retardation and cardiovascular diseases from environmental 
lead exposure. Environmental Research 94, 120-133. 
Fick Jr, R.B., Naegel, G.P., Squier, S.U., Wood, R.E., Gee, B.L., and Reynolds, H.Y., (1984) 
Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic 
antibody causing defective opsonophagocytosis. Journal of Clinical Investigation 74, 236-248 
Finbeiner, W.E., (1993) Physiology and pathology of tracheobronchial glands. Respiratory 
Physiology 118, 77-83. 
Fisher, H., and Widdecombe, J.H., (2006) Mechanism of acid and base secretion by airway 
epithelium. Journal of Membrane Biology 211, 139-150. 
Fleming, D.E.B., Chettle, D.R., Webber, C.E., and O,Flaherty, E.J., (1999) The O’Flaherty 
model of lead kinetics: An evaluation using data from smelter population. Toxicology and 
Applied Pharmacology 161, 100-109. 
202 
 
Foreign and Commonwealth Office (2010) Geochemical assessment of soils in Roma 
Mahalla, Mitrovica, Kosovo: Implications for the proposed resstlement of families presently 
living in the Osterode and Cesmin Lug camps. FLUVIO- Institute of Geography and Earth 
Sciences University of Wales. Fluvio report 2010/02/66. Available at URL:  
http://www.parliament.uk/deposits/depositedpapers/2010/DEP2010-0688.pdf   accessed 
January 6, 2013. 
Formenti, P., Schutz, L., Bakanski, Y., Desboeufs, K., Ebert, M., Kandler, K., Petzold, A., 
Scheuvens, D., Weinbruch, S., and Zhang, D., (2011) Recent progress in understanding 
physical and chemical properties of African and Asian mineral dust. Atmospheric Chemistry 
and Physics 11, 8231-8256. 
Fowler, D., Cape, N., Coyle, M., Flechard, C., Kuylenstierna, J., Hicks, K., Derwent, D., 
Johnson, C., and Stevenson, D., (1999) the global exposure of forests to air pollutants. 
Water, Air & Soil Pollution, 116, 5-32. 
Freeze, R.A., and Cherry, J.A., (1979) Groundwater. Englwood Cliffs, New Jersey: Prentice-
Hall International, New Jersey. 
Frese, S.D., Klitgaard, R., and Pedersen, E.K., (2004) Environmental management in 
Kosovo – heavy metal emission from Trepca. Available at URL:   
http://www.rucsdigitaleprojektbibliotek.dk/bitstream/1800/210/1/Environmental_management
_in.pdf   accessed January 6, 2013. 
Fryer, M., Collins, C.D., Ferrier, H., Colvile, R.N., and Nieuwenhuiysen, M.J., (2006) Human 
exposure modelling for chemical risk assessment: a review of current approaches and 
research and policy implications. Environmental Sciences & Policy 9, 261-274. 
Fubini, B., and Arean, O., (1999) Chemical aspect of the toxicity of inhaled mineral dusts. 
Chemical Society Review 28, 373-381. 
Fytianos, K., Katsianis, G., Triantafyllou, P., and Zachariadis, G., (2001) Accumulation of 
heavy metals in vegetables grown in an industrial area in relation to soil. Bulletin of 
Environmental Contamination and Toxicology 67, 423-430. 
Gal, J., Hursthouse, A.S., and Cuthbert, S.J., (2006) Chemical availability of arsenic and 
antimony in industrial soils. Environmental Chemistry Letters 3, 149-153. 
Gallacher J.E.J., Elwood P.C., Philips K.M., Davies B.E., Ginnever R.C., Toothill C. And 
Jones D.T. (1984) Vegetable consumption and blood lead concentrations, Journal of 
Epidemiology and Community Health 38, 173-176. 
203 
 
Gallup, D.L., (2006) Reducing the leachable lead content of used oil filter paper. 
Environmental Progress 15, 62-68. 
Garcia, J.H., Li, W-W., Arimoto, R., Okrasinsk, R., Greenlee, J.,  Walton, J., Schloesslin, C., 
and Sage, S., (2004) Characterisation and implication of potential fugitive dust dust sources 
in Paso del Norte region. Science of the Total Environment 325, 95-112. 
Garza, A., Vega, R., and Soto, E., (2006) Cellular mechanisms of lead neurotoxicity. Medical 
Science Monitor 12, RA57-65. 
Gbefa, B.K., Entwistle, J.A., and Dean, J.R., (2011) Oral bioaccessibility of metals in an 
urban catchment, Newcastle upon Tyne. Environmental Geochemistry and Health 33, 167-
181. 
Gehr, P., Geiser, M., Hof, V.I., and schurch, S., (2000) Surfactant-ultrafine particles 
interactions: what we can learn from Pm10 studies. Philosophical Transaction of the Royal 
Society of London A 358, 2707-2718. 
Gehr, P., Schurch, S., Hof, V.I., and Geiser, M., (1994) Inhaled particles deposited in the 
airways are displaced towards the epithelium. The Annals of Occupational Hygiene 38, 197-
202. 
Gelencser, A., Kovats, N., Toroczi, B., Rostasi, A., Hoffer, A., Imre, K., Nyiro-Kosa, I., 
Csakberenyi-Malasics, D., Toth, A., Czitrvszky, A., Nagy, A., Acs, A., Kovacs, A., Ferincz, A., 
Hertyani, Z., and Posfai, M., (2011) The red mud accidedent in Ajka (Hungary): 
characterisation and potential health effects of fugitive dust. Environmental Science & 
Technology 45, 1608-1615. 
Gilbert, S.G., and Weiss, B., (2006) A rational for lowering the blood lead action level from 10 
to 2 µg/dL. Neurotoxicity 27, 693-701. 
Gill, T.E., Zobeck, T.M., and Stout, J.E., (2006) Technologies for laboratory generation of 
dust from geological materials. Journal of Hazardous Materials 132, 1-13. 
Goosens, D., (2012) An method for dry extracting large volumes of fine particulate matter 
from bulk soil samples. Air Quality, Atmosphere & Health 5, 425-431. 
Goossens, D., and Buck, B., (2009) Dust emission by off-road driving: experiments on 17 
arid soil types, Nevada, USA. Geomorphology 107, 118-138. 
Goyer, R., Golub, M., Choudhury, H., Hughes, M., Kenyon, E., and Stifelman, M., (2004) 
Issue paper on human health effects of metal. Available at URL:  
204 
 
http://www.epa.gov/raf/publications/pdfs/HUMANHEALTHEFFECTS81904.PDF   accessed 
January 6, 2013. 
Goyer, R.A., (1993) Lead toxicity: current concerns. Environmental Health Perspectives 100, 
177-187. 
Grandjean, P., and Langrigan, P.J., (2006) Developmental neurotoxicity of industrial 
chemicals. Lancet 368, 2167-2178. 
Granero, S., and Domingo, J.L., (2002) Levels of metals in soils of Alcala de Henares, Spain: 
human health risk. Environment International 28, 159-164. 
Grass, G.M., and Sinko, P.J., (2002) Physiologically-based pharmacokinetic simulation 
modelling. Advanced Drug Delivery Reviews 54, 433-451. 
Gray, C.W., Mclaren, R.G., Roberts, A.H.C., and Condron, L.M., (1999) Solubility, sorption 
and desorption of native and added cadmium in relation to properties of soils in New 
Zealand. European Journal of Soil Science 50, 127-137. 
Gray, H., (1918; 2000) Anatomy of the human body. Lea & Febiger, Philadelphia, Bartleby. 
Available at URL: http://www.bartleby.com/107/   accessed January 14, 2013. 
Gray, J.E., Plumlee, G.S., Morman, S.A., Higueras, P.L., Crock, J.G., Lowers, H.A., and 
Witten, M.L., (2010) In vitro studies evaluating leaching of mercury from mine waste calcine 
using simulated human body fluids. Environmental Science & Technology 44, 4782-4788. 
Gray, T., Coakley, R., Hirsh, A., Thornto, D., Kirkham, S., Koo, J-S., Burch, L., Boourcher, 
R., and Nettesheim, P., (2004) Regulatoin of MUC%AC mucin secretion and airway surface 
liquid metabolism by IL-Iβ in human bronchial epithelia. American Journal of Physiology – 
Lung Cellular and Molecular Physiology 286, L320-L330. 
Gray, V.A., Hickey, A.J., Balmer, P., Davies, N.M., Dunbar, C., Foster, T.S., Olsson, B.L., 
Sakagam, M., Shah, V.P., Smurthwaite, M.J., Veranth, J.M., and Zaidi, K., (2008) The 
inhalation Ad Hoc Advisory Panal for the USP performance tests of inhalation dosage forms. 
Pharmacopeial Forum 34, 1068-1074. 
Gregory, T.J., Lonmore, W.J., Moxley, M.A., Whitsett, J.A., Reed, C.R., Fowler, A.a., 
Hudson, L.D., Maunde, R.J., Crim, C., and Hyer, T.m., (1991) Surfactant chemical 
composition and biophysical activity in acute respiratory distress syndrome. The Journal of 
Clinical Investigation 88, 1976-1981. 
205 
 
Greiff, L., Wollmer, P., Erjefalt, I., Pipkorn, U., and Perssson, C.G., (1990) Clearance og 
99mTc DTPA from guinea pig nasal, tracheobronchial, and bronchoalveolar airways. Thorax 
45, 841-845. 
Griese, M., (1999) Pulmonary surfactant in health and human lung diseases: state of the art. 
European Respiratory Journal 13, 1455-1476. 
Guney, M., Zagury, G.T., Dogan, N., and Onay, T., (2010) Exposure assessment and risk 
characterisation from trace elements following soil ingestion by children exposed to 
playgrounds, parks and picnic areas. Journal of Hazardous Materials 182, 656-664. 
Gupta, A.K., Karar, K., and Srivastava, A., (2007) Chemical mass balance source 
apportionment of PM10 and TSP in residential and industrial sites of an urban region of 
Kolkata, India. Journal of Hazardous Materials 142, 279-287. 
Gupta, S.K., Vollmer, M.K., and Krebs, R., (1996) The importance of mobile, mobilisable and 
pseudo total heavy metal fractions in soil for three-level risk assessment and risk 
management, The Science of the Total Environment 178, 11-20. 
Hallman M., Spragg, R., Harrell, J.H., Moser, K.M., and Gluck, L., (1982) Evidence of lung 
surfactant abnormality in respiratory failure. Study of bronchoalveolar lavage phospholipids, 
surface activity, phospholipase activity and plasma myoinositol.  Journal of Clinical 
Investigation 70, 673-683. 
Hamm, H., Kroegel, C., and Hohlfield, J., (19960 Surfactant: a review of its functions and 
relevance in adult respiratory disorders. Respiratory Medicine 90, 251-270. 
Harmsen, J., (2007) Measuring bioavailability: from scientific approach to standard methods. 
Journal of Environmental Quality 36, 1420-1428. 
Harrington, J.M., Bargar, J.R., Jarzeck, A.A., Roberts, J.G., Sombers, L.A., and Duckwortt, 
O.W., (2012) Trace metal complexation by the triscatecholate siderophore protochelin: 
structure and stability. Biometals 25, 393-412. 
Harris, W., and White, G.N., (2007) X-ray diffraction techniques for soil mineral identification: 
In Methods for soil analysis, Part 5: Mineralogy Methods p 81 (edit) Ulery, A.L., Drees, L.R., -
Soil Science of America, USA.  
Harris, W.R., and Silberman, D., (1983) Time-dependent leaching of coal ash by chelating 
agents. Environmental Science & Technology 17, 139-146. 
Harris, W.R., and Silberman, D., (1988) leaching of metal ions from fly ash by canine serum. 
Environmental Science & Technology 22, 109-112. 
206 
 
Harrison, R.M., and Jone, M., (1995) The chemical composition of airborne particles in the 
UK atmosphere. Science of the Total Environment 168, 195-214. 
Harrison, R.M., and Yin, J., (2000) Particulate matter in the atmosphere: which particle 
properties are important for its effects on health? Science of the Total Environment 249, 85-
101. 
Haye, S.M., Webb, S.M., Bargar, J.R., O’day, P.A., Maier, R.M., and Chorover, J., (2012) 
Geochemical weathering increases lead bioaccessibility in semi-arid mine tailings. 
Environmental Science & Technology, 46, 5834-5841. 
Hemond, H.F., and Solo-Gabriele, H.M., (2004) Children’s exposure to arsenic from CCA-
treated wooden decks and playground structures. Risk Analysis 24, 51-64. 
Hemelmann, F., and Schmidt, E., (2004) Methods for characterizing the dustiness estimation 
of powders. Chemical Engineering & Technology 27, 844-847. 
Hering, S.V., (1995) Impactors, cyclones and other inertial and gravitational collectors- 
Sampling instruments of atmospheric contaminants: 8th ed Cohen, B., Hering, S.V., editors. 
Cininnati (OH): American Conference of Governmental Industrial Hygienist. Available at 
URL:  
http://www.industrialventilation.net/ClassDownloads/IHS_725/L11%20Impactor%20Data%20
Reduction/impactorscyclonesch14p1.pdf   accessed January 5, 2013. 
Hernandez, L., Probst, A., Probst, J.L., and Ulrich, E., (2003) Heavy metal distribution in 
some French forest soils: evidence for atmospheric contamination. Science of the Total 
Environment 312, 195-219. 
Hettiarachchi, G.M., and Pierzynski, G.M., (2002) In Situ stabilization of soil lead using 
phosphorus and manganese oxides: influence of plant growth. Journal of Environmental 
Quality 31, 564-572. 
Hettiarachchi, G.M., Pierzynski, G.M., and Ransom, M.D., (2000) In situ stabilization of soil 
lead using phosphorus and manganese oxide. Environmental Science & Technology, 34, 
4614-4619. 
Hhodeir, M., Shamy, M., Alghamdi, M., Zhong, M., Sun, H., Costa, M., Chen, L-C., and 
Maciejczyk, P., (2012) Source apportionment and elemental composition of PM2.5 and PM10 
in Jeddah city, Saidi Arabia. Atmospheric Pollution Research 3, 331-340. 
Hilts, S.R., (2003) Effect of smelter emission reduction on children’s blood lead levels. The 
Science of the Total Environment 303, 51-58.  
207 
 
Ho, K.F., Lee, S.C., Chow, J.C., and Watson, J.G., (2003) Characterisation of PM10 and 
PM2.5 source profile for fugitive dust in Hong Kong. Atmospheric Environment 37, 1023-1032. 
Hoffman, T., and Schuwirth, N., (2008) Zn and Pb release of sphalerite (ZnS)-bearing mine 
waste tailings. Journal of Soils and Sediments 8, 433-441. 
Hoffman, W., and Asgharian, B., (2003) The effect of lung structure and mucociliary 
clearance and particle retention in human and rat lungs. Toxicological Sciences 73, 448-456. 
Holliday, A.H., (2000) Gamble and Darrow: pathfinders in body fluid physiology and fluid 
therapy for children, 1914-1964. Pediatric Nephrology 15, 317-324. 
Holmen, J.M., Karlssen, N.G., Abdullah, L.H., Randell, S.H., Sheehan, J.K., Hansson, G.C., 
and Davis, W., (2004) Mucins and their O-glycan from human bronchial epithelial cell 
cultures. American Journal of Physiology – Lung Cellular and Molecular Physiology 287, 
L824-L834. 
Hopper, J.F., (1991) Regional source discrimination of atmospheric aerosols in Europe using 
the isotopic composition of Lead. Tellus 43B, 45-60. 
Horiba Scientific (2012) A guidebook to particle size analysis. Available at URL:  
http://www.horiba.com/fileadmin/uploads/Scientific/Documents/PSA/PSA_Guidebook.pdf   
accessed January 6, 2013. 
Hu, H., Shine, J., and Wright, R.O., (2007) The challenge posed to children’s health by 
mixtures of toxic waste: the Tar Creek Superfund site as a case study. Pediatric Clinics of 
North America 54, 154-172. 
Hu, X., Zhang, Y., Luo, J., Wang, T., Lian, H., and Ding, Z., (2011) Bioaccessibility and 
health risk of arsenic, mercury and other metals in urban street dust from a mega-city, 
Nanjing, China. Environmental Pollution 159, 1215-1221. 
Hudson-Edwards, K.A., Schell, C., and Macklin, M.G., (1999) Mineralogy and geochemistry 
of alluvium contaminated by metal mining in Rio Tinto area, southwest Spain. Applied 
Geochemistry 14, 1015-1030. 
Hull, J., Skinner, W., Robertson, C., and Phelan, P., (1998) Elemental content of airway 
surface liquid from infants with cystic fibrosis. American Journal of Respiratory and Critical 
Care Medicine 157, 10-14. 
Human Right Watch (2009) Kosovo: poisoned by lead – a health and human right crisis in 
Mitrovica’s Roma camps. Available at URL:  
208 
 
http://www.hrw.org/sites/default/files/reports/kosovo0609webwcover_0.pdf   accessed 
January 5, 2013. 
Hunt, A., and Johnson, D.L., (2011) Differential individual particle analysis (DIPA): 
applications in particulate matter characterization. Journal of Environmental Quality 40, 742-
750. 
Hur, S.J., Lim, B.O., Decker, E.A., and McClements, D.J., (2009) In vitro human digestion 
models for food applications. Food Chemistry 125, 1-12. 
Hursthouse, A., and Kowalczyk G., (2009) Transport and dynamics of toxic pollutant in the 
natural environment and their effect on human health: research gap and challenge. 
Environmental Geochemistry and Health 31, 165-187. 
Hursthouse, A.S., (2001) The relevance of speciation in remediation of soils and sediments 
contaminated by metallic elements – an overview and examples from Central Scotland, UK. 
Journal of Environmental Monitoring 3, 49-60. 
Hwang, Y.H., Bornschein, R.L., Grote, J., Menrath, W., and Roda, S., (1997) Environmental 
arsenic exposure of children around a former copper smelter site. Environmental Research 
72, 72-81. 
Intawongse, M., and Dean, J.R., 2006. In vitro testing for assessing oral bioaccessibility of 
trace metals in soils and food samples. Trends in Analytical Chemistry 25, 876-886. 
International Programme on Chemical Safety (ICPS) (2004) ICPS risk assessment 
terminology part 1: IPCS/OECD key generic terms used in chemical hazard risk assessment. 
Available at URL:    http://www.inchem.org/documents/harmproj/harmproj/harmproj1.pdf    
accessed January 5, 2013. 
Iordanidis, A., Bukman, J., Triantafyllou, A.G., and Asvesta, A., (2008) ESEM-EDX 
characterisation of airborne particles from an industrialised area of northern Greece. 
Environmental Geochemistry and Health 30, 391-405. 
IPCS (1995) Inorganic lead. World Health Organisation, Geneva. International Programme 
on Chemical Safety (Environmental Health Criteria 165); 
http://www.inchem.org/documents/ehc/ehc/ehc165.htm last visited 10/01/13. 
Isaure, M-P., Manceau, A., Geoffroy, N., Laboudigue, A., Tamura, N., and Marcus, M.A., 
(2005) Zinc mobility and speciation in soil covered by contaminated dredged sediment using 
micrometer-scale and bulk-averaging X-ray fluoresence, absorption and diffraction 
techniques. Geochimica et Cosmochimica Acta 69, 173-1198. 
209 
 
ISO (1995). Air Quality - Particle Size Fraction Definitions for Health-related Sampling. ISO 
Standard 7708. International Organization for Standardization (ISO), Geneva. 
Jackson, M.L., (1979) Soil Chemical Analysis-Advanced Course. 2nd edn. Winsconsin-
Madison: Parallel Press, University of Wisconsin Libraries, USA. 
Jaggard, H.N., (2012) Mineralogy characterisation of tailings and respirable dust from lead-
rich mine waste and its control on bioaccesssibility. A Thesis submitted to the Department of 
Geological Sciences and Geological Engineering, Queen’s University, Kingston, Ontario, 
Canada. 
James, A.C., Greenhalgh, J.R., and Smith, H., (1997) Clearance of lead-212 ions from rabbit 
bronchial epithelium to blood. Physics in Medicine and Biology 22, 932-948 
Jamieson, H.E., Walker, S.R., Faweett, S.E., Lanzirotti, A., Rasmussen, P.E., Beauchemin, 
S., and Parsons, M., (2007) Direct identification of metal compounds in contaminated soil 
mine tailings and house dust using synchrotron-based methods, ISEA Bioavailability 
Symposium Durham, North Carolina, U.S. Environmental Protection Agency. Available at 
URL:  
http://www.epa.gov/superfund/bioavailability/pdfs/finaliseabioavailabilitysymposiumproceedin
gs.pdf   accessed January 4, 2013. 
Janssen, N.A.H., Schwartz, J., Zanobetti, A., and Suh, H.H., (2002) Air conditioning and 
source-specific particles as modifiers of the effect of PM10 on hospital admissions for heart 
and lung disease. Environmental Health Perspectives 110, 43-49. 
Jeffery, P.K., and Li, D., (1997) Airway mucosa: secretory cells, mucus and mucin genes. 
European Respiratory Journal 10, 1655-1662. 
Jiang, J., Oberdorster, G., and Biswas, P., (2009) Characterisation of size, surface charge, 
and agglomeration state of nanoparticle dispersion for toxicological studies. Journal of 
Nanoparticle Research 11, 77-89. 
Johansson, J., Curstedt, T., and Robertson, B., (1994) The proteins of the surfactant system. 
European Respiratory Journal 7, 372-391. 
Joris, L., Dab, I and Quinton, P.M., (1993) Elemental composition of human airway surface 
fluid in healthy and diseased airways. American Review of Respiratory Disease 148, 1633-
1637. 
210 
 
Juhasz, A., Weber, J., and Smith, E., (2007) Impact of soil particle size and bioaccessibility 
on children and adult lead exposure in peri-urban contaminated soils. Journal of Hazardous 
Materials 186, 1870-1879.. 
Juhasz, A.L., Weber, J., and Smith, E., (2011) Impact of soil particle size and bioaccessibility 
on children and adult lead exposure in peri-urban contaminated soils. Journal of Hazardous 
Materials 186, 1870-1879. 
Julien, C., Esperanza, P., Bruno, M., and Alleman, L.Y., (2011) Development of an in vitro 
method to estimate lung bioaccessibility of metals from atmospheric particles. Journal of 
Environmental Monitoring 13, 621-630. 
Julvez, J., and Granjean, P., (2009) Neurodevelopmental toxicity risks due to occupational 
exposure to industrial chemicals during pregnancy. Industrial Health 47, 459-468. 
Jumblatt, M.M., Makenzie, R.W., and Jumblatt, J.E., (1999) MUC5AC mucin is a component 
of human procorneal tear Film. Investigative Ophthalmology & Visual Science 40, 43-49. 
Jung, M.C., and Thornton, I., (1996) Heavy metal contamination of soils and plants in the 
vicinity of a lead - zinc mine, Korea. Applied Geochemistry 11, 53-59. 
Jurjovec, J., Ptacek, C.J., and Blowes, D.W., (2002) Acid neutralization mechanisms and 
metal release in mine tailings: A laboratory column experiment. Geochimica et 
Cosmochimica Acta 66, 1511-1523. 
Jusko, T.A., Henderson Jr, C.R., Lanphhear, B.P., Cory-Slecha, D.A., Pearson, P.J., and 
Canfield, R.L., (2008) Blood lead concentrations < 10µg /dL and child intelligence at 6 years 
of age. Environmental Health Perspectives 116, 243-248. 
Kamarek, M., Chrastny, V., and Stichova, J., (2007) Metal/metalloid contamination and 
isotopic composition of lead in edible mushrooms and forest soils originating from a smelter 
area. Environment International 33, 677-684. 
Kamberi, B., Hoxha, V., Kaiku, L., and Pert, L.C., (2009) The manganese content of human 
permanent teeth. ACTA Stomatologica Croatica 43, 83-88. 
Kamberi, B., Kqiku, L., Hoxha, V., and Dragusha, E., (2011) lead concentrations in teeth from 
people living in Kosovo and Austria. Collegium Antropologicum 35, 70-82. 
Kanapilly, G.M., Raabe, O.G., Goh, G.H.T., and Chimenti, R.A., (1973) Measurement of in 
vitro dissolution of aerosol particles for comparison to in vivo dissolution in the lower 
respiratory tract after inhalation. Health Physics 24, 497-507. 
211 
 
Kao, A.S., and Friedlander, S.K., (1995) Frequency distributions of PM10 chemical 
components and their sources. Environmental Science & Technology 29, 19-28. 
Karadas, C., and Kara, D., (2011) In vitro gastrointestinal method for assessment of heavy 
metal bioavailability in contaminated soils. Environmental Science and Pollution Research 
18, 620-628. 
Karem, E., Bistritzer, T., Hanukoglu, A., Hofman, T., Zhou, Z., Bennet, W., Maclaughlin, E., 
Barker, P., Nash, M., Quittell, L., Boucher, R., and Knowles, M.R., (1999) Pulmonary 
epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. 
The New England Journal of Medicine 341, 156-162. 
Kaufman, E., and Lamster, I.B., (2002) The diagnostic applications of saliva – a review. 
Critical Reviews in Oral Biology and Medicine 13, 192-212. 
Kaya, A., and Oren, A.H., (2005) Adsorption of zinc from aqueous solutions to bentonite. 
Journal of Hazardous Minerals 125, 183-189. 
Keck, T., Leiaker, R., Klotz, M., Lindermann, J., Riechelmann, H., and Rettinger H., (2000) 
Detection of particles within the nasal airways during respiration. European Archives of Oto-
Rhino-Laryngology 257. 493-497. 
Keeler, G.J., Dvonch, T., Yip, F.Y., Parker, E.A., Isreal, B.A., Marsik, F.J., Morishita, M., 
Barres, J.A., Robin, T.G., Brakefield-Cadwell, W., and Sam, M., (2002) Assessment of 
personal and community-level exposure to particulate matter among children with asthma 
(CAAA). Environmental Justice 110, 173 – 181. 
Kelly, F.J., (1999) Glutathione: in defence of the lung. Food and Chemical Toxicology 37, 
963-966. 
Kelly, F.J., and Tetley, T.D., (1997) Nitrogen dioxide depletes uric acid and ascorbic acid but 
not glutathione from lung lining fluid. Biochemical Journal 325, 95-99. 
Kendall, M., (2007) Fine airborne particles (PM2.5) sequester lung surfactant and amino acids 
from human ling lavage. American Journal of Physiology - Lung Cellular and Molecular 
Physiology 293, 1053-1058. 
Kesimer, M., Kirkham, S., Pickles, R.J., Henderson, A.G., Alexis, N.E., DeMaria, G., 
Thornton, D.J., and Sheehan, J.K., (2009) Tracheobronchial air-liquid interface cell culture: a 
model for innate mucosal defence of the upper airways? American Journal of Physiology - 
Lung Cellular and Molecular Physiology 296, L92-L100. 
212 
 
Khanvilka, K., Donovan, M.D., and Flanagan, D.R., (2001) Drug transfer through mucus. 
Advanced Drug Delivery Reviews 48, 173-193. 
Kim J. (1999) Kosovo conflict chronology: September 1998 – March 1999. Congressional 
Research Service. Available at URL:   
http://www.au.af.mil/AU/AWC/AWCGATE/crs/rl30127.pdf  accessed January 5, 2013. 
Kim, C.S., Wilson, K.M., and Rytuba, J.J., (2011) Particle-size dependence on metal(loid) 
distribution in mine wastes: implications for water contamination and human exposure. 
Applied Geochemistry 26, 484-495. 
Kim, K.H., Sekiguchi, K., Kudo, S., and Sakamoto, K., (2011) Characteristics of atmospheric 
elemental carbon (char and soot) in ultrafine and fine particles in a roadside environment, 
Japan. Aerosol and Air Quality Research 11, 1-12. 
Kim, K.P., Wu, C.Y., Birky, B.K., and Bolch, W., (2007) Tenorm aerosol in Florida phosphate 
industry - assessment of lung fluid solubility and annual effective dose to workers. Radiation 
Protection Dosimetry 123, 41-45. 
Kirkham, P., and Rahman, I., (2006) Oxidative stress in asthma and COPD: antioxidants as a 
therapeutic strategy. Pharmacology & Therapeutics 111, 476-494. 
Kirman, C.R., Hays, S.M., Aylward, L.L., Suh, M., Harris, M.A., Thompson, C.M., and Haws, 
L.C., (2012) Physiologically based pharmacokinetic model for rat and mice orally exposed to 
chromium. Chemico-Biological-Interaction 200, 45-64. 
Knowles, M.R., Robinson, J.M., Wood, R.E., Pue, C.A., Mentz, W.M., Wager, G.C., Gatzy, 
J.T., and Boucher, R.C., (1997) Ion composition of low-molecular-mass antioxidant 
concentrations in human respiratory tract lining fluids. The Journal of Clinical Investigation 
100, 2588-2595. 
 Koa, S.A., and Friedlander, S.K., (1995) Frequency distribution of PM10 chemical 
components and their sources. Environmental Science & Technology 29, 19-28. 
Kobayashi, E., Suwazono, Y., Dochi, M., Honda, R., Kido, T., and Nakagawa, H., (2009) 
Influence of drinking and/or cooking with Jinzu River water on the development of Itai-Itai 
Disease. Biological Trace Element Research 129, 46-57. 
Kocourkova, E., Sracek, O., Houzar, S., Cempirek, J., Losso, Z., Filip, J., and Hrselova, P., 
(2011) Geochemical and mineralogical control on the mobility of arsenic in waste rock pile at 
Dlouha Ves, Czech Republic. Journal of Geochemical Exploration 110, 61-73. 
213 
 
Kogarko, L.N., Kurat, G., and Ntaflos, T., (2007) Henrymeyerite in the metasomatized upper 
mantle of eastern Antartica. The Canadian Mineralogist 45, 497-501. 
Kong, S., Ji, Y., Lu, B., Chen, L., Han, B., Li, Z., and Bai, Z., (2011) Characterization of PM10 
source profiles for fugitive dust in Fushun-a city famous for coal. Atmospheric Environment 
45, 5351-5365. 
Kovouras I.G., Koutrakis, P., Cereceda-balic, F., and Oyola, P., (2001) Source 
apportionment of PM10 and PM2.5 in five Chilean cities using factor analysis. Journal of the Air 
& Waste Management Association 15, 451-464. 
Kraishen, M.A.M., Al-degs, Y.S., and Maninn W.A.M., (2004) Remediation of wastewater 
containing heavy metals using raw and modified diatomite. Chemical Engineering Journal 99, 
177-184. 
Kulkarni, N., Pierse, N., Rushton, L., and Grigg, J., (2006) Carbon in airway microphagees 
and lung function in children. The New England Journal of Medicine 355, 21-30. 
Laidlaw, M.A.S., and Fillippelli, G.M., (2008) Resuspension of urban soils as a persistent 
source of lead poisoning in children: a review and new direction. Applied Geochemistry 23, 
2021-2039. 
Laidlaw, M.A.S., Mielke, H.W., Filippelli, G.M., Johnson, D.L., and Gonzales, C.R., (2005) 
Seasonality and children’s blood lead levels: Developing a predictive model using climatic 
variables and bllod lead data from Indianapolis, Indiana, Syracuse, New York, and New 
Orleans, Louisiana (USA). Environmental Health Perspectives 113, 793-800. 
Laidlaw, M.A.S., Zahran, S., Mielke, H.W., Taylor, M.P., and Fillippelli, G.M., (2012) Re-
suspension of Pb contaminated urban soil as a source of atmospheric lead in Birmingham, 
Chicago, Detroit and Pittsdurg, USA. Atmospheric Environment 49, 302-310. 
Lam, S., LeRiche, J.C., and Kijek, K., (1985) Effect of filtration and concentration on the 
composition of bronchoalveolar lavage fluid. Chest 87, 740-742. 
Lamb, D.T., Ming, H., Megharaj, M., and Naidu, R., (2009) Heavy metal (Cu, Zn, Cd and Pb) 
partitioning and bioaccessibility in uncontaminated and long-term contaminated soils. Journal 
of Hazardous Materials 171, 1150-1158.  
Lamb, M.R., Janevic, T., Liu, X., Cooper, T., Kline, J., and Factor-Litvak, P., (2008) 
Environmental lead exposure, maternal thyroid function, and childhood growth. 
Environmental Research 106, 195-202. 
214 
 
Lamer, C., Beco, V.D., Soler, P., Calvat, S., Gagon, J-Y., and Dombret, M-C., (1993) 
Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in 
critically ill patients. Antimicrobial Agents and Chemotherapy 37, 281-286. 
Landner, L., and Reuther, R., (2004) Metals in society and in the environment. A critical 
review of current knowledge on fluxes, speciation, bioavailability and risk to adverse effects 
of copper, chromium, nickel and zinc. Kluwer Academic Publishers, New York.  
Landrigan, P.J., (1989) Toxicity of lead at low dose. British Journal of Industrial Medicine 46, 
593-596 
Landrigan, P.J., and Todd, A.C., (1994) Lead poisoning. Western Journal of Medicine 161, 
153-159. 
Langford, J.I., Louer, D., (1996) Powder diffraction. Reports on Progress in Physics 59, 
p131-234. 
Lanphear, B.P., and Roghmann, K.J. (1997) Pathways of lead exposure in urban children, 
Environmental Research 74, 67-73. 
Lanphear, B.P., Dietrich, K., Auinger, P., and Cox, C., (2000). Cognitive deficits associated 
with blood lead concentrations < 10 µg / dL in US children and adolescents. Public Health 
Reports 115, 521-529. 
Lanphear, B.P., Hornung, R., Ho, M., Howard, C.R., Eberle, S., and Knauf, K., (2002) 
Environmental lead exposure during early childhood, Journal of Pediatrics 140, 40-47. 
Latawiec, A.E., Simmons, P., and Reid, B.J., (2010) Decision-makers perspectives on the 
use bioaccessibility for risk based regulation of contaminated land. Environment International 
36, 383-389. 
Lee, D.M., and Alaupovic, P., (1970) Studies of the composition and structure of plasmas 
lipoproteins: Isolation, composition, immunochemical characterisation of low density 
lipoproteins subfractions of human plasma. Biochemistry 9, 2244-2252. 
Lee, G., Bigham, J.M., and Faure, G., (2002) Removal of trace metals by coprecipitation with 
Fe, Al and Mn from natural waters contaminated with acid mine drainage in Ducktown mining 
district, Tennessee. Applied Geochemistry 17, 569-581. 
Lee, S., Muller, M., Rezwan, K., and Spencer, N.D., (2005) Porcine gastric mucin (PGM) at 
the water / poly (methylsiloxane) (PDMS) interface: influence of pH and ionic strength on its 
conformation, adsorption, and aqueous lubrication properties. Langmuir 21, 8344-8353. 
215 
 
Lee, S-W., Lee, B-T., Kim, J-Y., and Kim, K-W., (2006) Human risk assessment for heavy 
metals and As contamination in abandoned metal mine areas, Korea. Environmental 
Monitoring and Assessment 119, 233-244. 
Leggett, R.W., (1993) Age-specific Kinetic model of lead metabolism in humans. 
Environmental Health Perspectives 101, 598-616. 
Leggett, R.W., and Eckerman, K.F., (1994) Evolution of the ICRP’s biokinetic models. 
Radiation Protection Dosimetry 53, 147-155. 
Lenschow, P., Abraham, H-J., Kutzer, K., Lutz, M., PreuB, J-D., and Reichenbacher, W., 
(2001) Some ideas about the sources of PM10. Atmospheric Environment 35, 523-533. 
Leung, A.O.W., Duzgoren-Aydin, N.S., Cheung, K.C., and Wong, M.H., (2008) Heavy metals 
concentrations of surface dust from e-waste recycling and its human health implications in 
southeast China. Environmental Science and Technology 42, 2674-2680. 
Leung, H-W., and Paustenbach, D.J., (1995) Physiologically based pharmacokinetic and 
pharmacodynamic modelling in health risk assessment and characterization of hazardous 
substances. Toxicology Letters 79, 55-65. 
Li, N., Wang, N., Zheng, J., Liu, M., Lever, O.W., Erickson, P.M., and Li, L., (2005) 
Characterisation of human tear proteome using multiple proteomic analysis techniques. 
Journal of Proteome Research 4, 2052-2061. 
Li, S-N., Lundgren, D.A., and Rovell-Rixx, D., (2000) Evaluation of six inhalable aerosol 
samplers. American Industrial Hygiene Association 61, 506-516. 
Li, T., Dong, Z., Wang, X., Qian, G., and Luo, W., (2008) Seasonal variations in dustfall and 
its iron content over north China. Advances in Atmospheric Science 25, 467-473. 
Lide, D.R., (1988) CRC Handbook Chemistry and Physics, 69th Edn. CRC Press, Inc. Boca 
Raton, Florida. 
Lillehoj, E.P., and Kim, K.C., (2002) Airway mucus: its components and function. Archives of 
Pharmacal Research 6, 770-780. 
Lim, H-S., Lee, J-S., Chon, H-T., and Sager, M., (2008) Heavy metal contamination and 
health risk assessment in the vicinity of abandoned Songcheon Au-Ag mine in Korea. 
Journal of Geochemical Exploration 96, 223-230. 
216 
 
Lim, J-M., LeeJ-M., Moon, J-H., Chung, Y-S., and Kim, K-H., (2010) Source apportionment of 
PM10 at a small industrial area using positive matrix factorization. Atmospheric Research 95, 
88-100. 
Lin, C.G., Schaider, L.A., Brabander, D.J., and David, A., (2010) Pediatic lead exposure from 
imported Idian spices and cultural powders. Pediatric 125, 828-835. 
Lioy, P.J., (1990) Assessing total human exposure to contaminants: a multidisciplinary 
approach. Environmental Science & Technology 24, 938-945. 
Lippmann, M., Yeates, D.B., and Albert, R.E., (1980) Deposition, retention and clearance of 
inhaled particles, British Journal of Industrial Medicine 37, 337-362. 
List, S.J., Findlay, B.P., Forstner, G.G., and Forstner, J.F., (1978) Enhancement of the 
viscosity of mucin by serum albumin. Biochemical Journal 175, 565-571. 
Liu, D., (1994) Review of mathematical models for health risk assessment: VII. Chemical 
dose. Environmental Software 9, 153-160. 
Ljung, K., Siah, W.S., Devine, B., Maley, F., Wensinger, A., Cook, A., and Smirk, M., (2011) 
Extracting dust from soil: improved efficiency of previously published process. Science of the 
Total Environment 410-411, 269-270. 
Ljung, K., Torin, A., Smirk, M., Maley, F., Cook, A., and Weinstein, P., (2008) Extracting dust 
from soil: a simple solution to a tricky task. Science of the Total Environment 407, 589-593. 
Lohninger, A., Saizer, H., Simbruner, G., Hussien, P., and Martin, G., (1983) Relationships 
among human amniotic fluid dipalmitoyl lecitin, postpartum respiratory compliance, and 
neonatal respiratory distress syndrome. Clinical Chemistry 29, 650-655. 
Lucchini, R.G., Martin, C.J., and Doney, B.C., (2009) From manganism to manganese-
induced parkinsonism: A conceptual mdel based on the evolution of exposure. 
Neuromolecular Medicine 11, 311-321. 
Luo, X.S., Yu, S., and Li, X.D., (2011) Distribution, availability, and sources of trace metals in 
different particle size fractions of urban soils in Hong Kong: Implications for assessing the 
risk to human health, Environmental Pollution 159, 1317-1326. 
Maddaloni, M., Lolacono, N., Manton, W., Blum, C., Drexler, D., and Graziano, J., (1998) 
Bioavailability of soil borne lead in adults by stable isotope dilution. Environmental Health 
Perspectives 106, 1589-1594. 
217 
 
Mahaffey, K.R., (1977) Quantities of lead producing health effects in humans: sources and 
bioavailability. Environmental Health Perspectives 19, 285-295. 
Manoli, E., Voutsa, D., and Samara, C., (2002) Chemical characterization and source 
identification/apportionment of fine and coarse air particles in Thessaloniki, Greece. 
Atmospheric Environment 36, 949-961. 
Marcazzan, G.M., Ceriani, M., Valli, G., and Vecchi, R., (2003) Source apportionment of 
PM10 and PM2.5 in Milan (Italy) using receptor modelling. Science of the Total Environment 
317, 137-147. 
Margues, M.C.R., Leobenberg, R., and Almukainzi, M., (2011) Simulated biological fluids 
with possible application in dissolution testing. Dissolution Technology 18, 15-28. 
Markiewicz-patkowska, J., Hursthouse, A., and Przybyla-Kij, H., (2005) The interaction of 
heavy metals with urban soils: sorption behaviour of Cd, Cu, Cr, Pb and Zn with a typical 
mixed brownfield deposit. Environment International 31, 513-521. 
Marsh, J.W., and Birchall, A., (1999) Determination of lung-to-blood adsorption rates for lead 
and bismuth which are appropriate for randon progeny. Radiation Protection Dosimetry 83, 
331-337. 
Martínez López, J., Llamas Borrajo, J., de Miguel García, E., Rey Arrans, J., Hidalgo 
Estévez, M.C., and Sáez Castillo, A.J., (2008) Multivariate analysis of contamination in the 
mining district of Linares (Jaén, Spain). Applied Geochemistry 23, 2324-2336. 
Martuzevicus, D., Kliucininkas, L., Prasauskas, T., Krugly, E., Kauneliene, V., and 
Strandberg, B., (2011) Resuspension of particulate matter and PAHs from street dust. 
Atmospheric Environment 45, 310-317. 
Matocha, C.J., Elzinga, E,J., and Sparks, D.L., (2001) Reactivity of Pb (II) at the Mn (III, IV) 
(oxyhydr)oxide-water interface. Environmental Science & Technology 35, 2967-2972. 
Mattson, S.M., (1994) Glass fibre dissolution in simulated lung fluid and measures needed to 
improve constituency and correspondence to in vivo dissolution. Environmental Health 
Perspectives 102, 87-90. 
McConnel, M.L., (1981) Particle size determination by quasielastic light scattering. Analytical 
Chemistry 53, 1007-1018. 
Mckone, T.E., Ryan, P.B., and Ozkaynak, H., (2008) Exposure information in environmental 
health: current opportunities and future directions for particulate matter, ozone and other air 
218 
 
pollutants. Lawrence Berkeley National Laboratory, University of California. Available at URL:   
at http://escholarship.org/uc/item/1fz7z2f1    accessed January 10, 2013. 
McShane, D., Davies, J.C., Davies, M.G., Bush, A., Geddes, D.M., and Alton, E.W., (2003) 
Airway surface pH in subjects with cystic fibrosis. European Respiratory Journal 21, 37-42. 
Menezes-Filho, J.A., Bouchhard, M., Sarcinelli, P.D.N., and Moreira, J.C., (2009) Manganese 
exposure and neuropsychological effect on children and adolescents: a review. Pan 
American Journal of Public Health 26, 541-548. 
Meunier, L., Walker, S.R., Wragg, J., Parsons, M,B., Koch, I., Jamieson, H.E., and Reimer, 
K.J., (2010) Effect of soil composition and mineralogy on bioaccessibility of arsenic from 
tailings and soil in gold mine district of Nova Scotia. Environmental Science & Technology 
44, 2667-2674. 
Mickle, M.H., (1998) Structure, use and validation of the IEUBK model. Environmental Health 
Perspectives 106, 1531-1534. 
Midander, K., Wallinder, I.O., and Leygraf, C., (2007) In vitro studies of copper release from 
powder particles in synthetic biological media. Environmental Pollution 145, 51-59. 
Mielke, H.W., and Reagan, P., (1998) Soil is an important pathway of human lead exposure, 
Environmental Health Perspectives 106, 217-229. 
Mielke, H.W., Gonzales, C.R., and Mielke, P.W. Jr., (2011) The continuing impact of lead 
dust on on children’s blood lead: comparison of public and private properties in New Orleans, 
Environmental Research 111, 1164-1172. 
Miller, F.J., Gardner, D.E., Graham, J.A., Lee Jr, R.E., Wilson, W.E., and Bachmann, J.D.,  
(1979) Size considerations for establishing a standard for inhalable particles. Journal of Air 
Pollution Control Association 29, 610-615. 
Miller, R.M., (1995) Biosurfactant-facilitated remediation of metal-contaminated soils. 
Environmental Health Perspectives 103, 59-62. 
Miserocchi, G., (1997) Physiology and pathophysiology of pleural fluid turnover. European 
Respiratory Journal 10, 219-225. 
MonTec, 2007. Environmental assessment and remedial action plan (EARAP): Stan 
Trig/Stari Trg and Artana/Novo Brdo Mines, Kosovo. Available at URL:   
http://www.kosovo.undp.org/repository/docs/environment%20report.pdf. Accessed January 
5, 2013. 
219 
 
Moore, J.N., and Luoma, S.N., (1990) Hazardous wastes from large-scale metal extraction: A 
case study. Environmental Science & Technology 24, 1278-1285. 
Moreno, N., Viana, M., Pandelfi, M., Alastuey, A., Querol, X., Chinchon, S., Pinto, J.F., 
Torres, F., Diez, T.M., and Saez, J., (2009) Determination of direct and fugitive emissions in 
Mediterranean habour by means of classic and novel tracer methods. Journal of 
Environmental Management 91, 133 – 141. 
Moreno, T., Querol, X., Alastuey, A., Minguillon, M.C., Pey, J., Rodriguez, S., Miro, J.V., 
Felis, C., and Gibbons, W., (2007) Recreational atmospheric pollution episodes: inhalable 
metalíferous particles from firework displays. Atmospheric Environment 41, 913-922. 
Morris, C., Sieve, B., and Bullen, H., (2008) Introduction to x-ray diffraction (XRD). Basic 
theory: instrument design. Available at URL:   
http://www.asdlib.org/onlineArticles/ecourseware/Bullen_XRD/XRDModule_Theory_Instrume
nt%20Design.htm  accessed January 5, 2013. 
Morrison, A.L., and Gulson, B.L., (2007) Preliminary findings of chemistry and 
bioaccessibility in base metal smelter slags. Science of the Total Environment 382, 30-42. 
Morton, T (2012) Kosovo Gypsies living in ‘toxic’ camps. CNN.com. available at URL:   
http://www.cnn.co.uk/2012/01/12/world/europe/vice-guide-to-balkans/index.html   accessed 
January 5, 2013. 
Moss, O.R., (1979) Simulant of lung interstitial fluid. Health Physics 36, 447-448. 
Mudway, I.S., Blomberg, A., Frew, A.J., Holgate, S.T., Sandstrom, T., and Kelly, F.J., (1999) 
Antioxidant consumption and repletion kinetics in nasal lavage fluid following exposure of 
healthy human volunteers to ozone. European Respiratory Journal 13, 1429-1438. 
Muhle, H., and Mangelsdorf, I., (2003) Inhalation toxicity of mineral dust particles: critical 
appraisal of endpoint and study design. Toxicology Letters 140-141, 223-228.  
Mumtaz, M., Fisher, J., Blout, B., and Ruiz, P., (2012) Application of physiologically based 
pharmacokinetic models in chemical risk assessment. Journal of Toxicology DOI: 
10.1155/2012/904603. 
Nagler, R.M., Klein, I., Zarzhevsky, N., Drigues, N., and Reznick, A.Z., (2002) 
Characterisation of the differentiated antioxidant profile of human saliva. Free Radical 
Biology and Medicine 32, 268-277. 
220 
 
Nannoni, F., Protano, G., and Riccobona, F., (2011) Fractionation and geochemical mobility 
of heavy elements in soils of a mining area in northern Kosovo. Geoderma 161, 63-73. 
Nathanail, C.P., (2005) Generic and site-specific criteria in assessment of human health risk 
from contaminated soil. Soil Use and Management 21, 500-507. 
Nathanail, C.P., McCaffery, C., Ashmore, M.R., Cheng, Y., Gillett, A., Ogden, R., Scott, D., 
(2009) The LQM/CIEH Generic Assessment Criteria for Human Health Risk Assessment. 
Land Quality Press, Nottingham, UK. 
National Academy of Sciences. Human Health Risk Assessment: Lead Exposure and Uptake 
– use of the IEUBK. Chapter six in Superfund and Mining Megasites – lessions from the 
Couer d’ Alene River Basin. Washington D.C: National Academic Press; 2005, Available at 
URL:  http://www.epa.gov/superfund/accomp/coeur/pdfs/ch6.pdf   accessed December 15, 
2012. 
Needham, L.L., Ozkaynak, H., Whyat, R.M., Barr, D.B., Wang, R.Y., Naeher, L, L., Akland, 
G., Baahadori, T., Bradman, A., Fortmann, R., Liu, L-J.S., Morandi, M., O’Rourke, M.K., 
Thomas, K., Quackenboss, J., Ryan, P.B., and Zartarian, V., (2005) Exposure assessment in 
the national children’s study: introduction. Environmental Health Perspectives 113, 1076-
1082. 
Needleman, H.L., Schell, A., Bellinger, D., Leviton, A., and Allred, E.N., (1990) Thelong-term 
effects of exposure to low doses of lead in childhood – an 11-year follow-up report. The New 
England Journal of Medicine 322, 83-88. 
Negral, L., Moreno-Grau, S., Moreno, J., Querol, X., Viana, M.M., and Alastuey, A., (2008) 
Natural and antropogenic contributions to PM10 and PM2.5 in an urban área in western 
Meditterranean coast. Water, Air & Soil Pollution 192, 227-238. 
Nestorov, I., (2003) Whole body pharmacokinetic models. Clinical Pharmacokinetics 43, 883-
908. 
Neurohr, C., Lenz, A0-G., Leuchte, D.H., Kolbe, T., and Behr, J., (2003) Glutamate-cysteine 
ligase modulatory subunit in BAL alveolar microphages of healthy smokers. European 
Respiratory Journal 22, 82-87. 
Ng, V., Cho, P., and To, C-H., (2000) Tear proteins of normal young Hong Kong Chinese. 
Graefe’s Archives for Clinical and Experimental Ophthalmology 238, 738-745. 
221 
 
Ng, V., Cho, P., Wong, F., and Can, Y (2001) Variability of tear protein levels in normal 
young adults: Diurnal (day time) variation. Graefe’s Archives for Clinical and Experimental 
Ophthalmology 239, 257-263. 
Nimfopoulos, M.K., and Pattrick, R.A.D., (1991) Mineralogical and textural evolution of the 
economic manganese mineralisation in western Rhodope Massif, N. Greece. Mineralogical 
Magazine 55, 423-434. 
Niu, J., Rasmussen, P.E., Hassan, N.M., and Vincent, R., (2010) concentration distribution 
and bioaccesssibility of trace element in nano and fine urban particulate matter: influence of 
particle size. Water, Air & Soil Pollution 213, 211-225. 
Nong, A., Taylor, M.D., Clewell III, H.J., Dorman, D.C., and Anderson, M.E., (2009) 
Manganese tissue dosimetry in rats and monkeys: Accounting for dietary and inhaled Mn 
with physiologically based pharmacokinetic modelling. Toxicology Sciences 108, 22-34. 
Noppen, M., Waele, M.D., Li, R., Cucht, K.V., D’Haese, H., Gerlo, E., and Vincken, W., 
(2000) Volume and cellular content of normal pleural fluid in humans examined by pleural 
lavage. American Journal of Respiratory and Critical Care Medicine 162, 1023-1026. 
Nordberg G.F., and Kjellstrom, T., (1979) Metabolic model for cadmium in man. 
Environmental Health Perspectives 28, 211-217. 
Nortcliff, S., (2002) standardisation of soil quality attributes. Agriculture, Ecosystem & 
Environment 88, 161-168. 
Nowak, B., and Kozlowski, H., (1998) Heavy metals in human hair and teeth: The correlation 
with concentrations in the environment, Biological Trace Element Research 62, 213-228. 
Nriagu, J.o., Pacyna, J.M., (1988) Quantitative assessment of worldwide contamination of 
air, water and soil by trace metal metals. Nature 333, 134-139. 
Nygard, T., Steinnes, E., and Royset, O., (2012) Distribution of 32 elements in organic 
surface soils: contribution from atmospheric transport of pollutants and natural sources. 
Water, Air & Soil Pollution 223, 699-713. 
O’Flaherty, E.J., (1995) Physiologically based models for bone-seeking elements: V. Lead 
absorption and disposition in childhood. Toxicology and Applied Pharmacology 131, 297-308 
O’Flaherty, E.J., (1998) A physiologically based kinetic model for lead in children and adults. 
Environmental Health Perspectives 106, 1495-1503. 
222 
 
Oberdorster, G., Ferin, J., and Lehnert, B.E., (1994) Correlation between particle size, in vivo 
particle persistence and lung injury. Environmental Health Perspectives 102, 173-179. 
Occupational and Environmental Health (OEH) The Department of the Protection of the 
Human Health. World Health Organisation (WHO) (1999). Prevention and Control Exchange 
(PACE). Hazard Prevention and Control in Workplace Environment – Airborne Dust. 
Available at URL:  www.who.int/occupational_health/publications/en/oehairbornedust.pdf  
accessed December 15, 2012. 
Ohmsen, G.G., (2001) Characterisation of fugitive materials within a primary lead smelter. Air 
& Waste Management Association 51, 1443-1451. 
Okorie, A., Entwistle, J., and Dean, J.R., (2011) The application of in vitro gastricintestinal 
extraction to assess oral bioaccessibility of potentially toxic elements from an urban 
recreational site. Applied Geochemistry 26, 789-796.. 
Okorie, A., Entwistle, J., and Dean, J.R., (2012) Estimation of daily intake of potentially toxic 
elements from urban street dust and role of oral bioaccessibility testing. Chemosphere 86, 
460-467. 
Olias, M., Nieto, J.M., Sarmiento, A.M., Ceron, J.C., and Canovas, C.R., (2004) Seasonal 
water quality variations in a river affected by acid mine drainage: the Odiel River (south West 
Spain). Science of the Total Environment 333, 267-281. 
Oomen, A.G., and Lijzen, J.P.A., (2004) Relevancy of human exposure via house dust to the 
contaminants lead and asbestos. RIVM report 711701037/2004. Available at URL: 
http://rivm.openrepository.com/rivm/bitstream/10029/9070/1/711701037.pdf  accessed 
January 10, 2013. 
Oomen, A.G., Hack, A., Minekus, M., Zeijdner, E., Cornelis, C., Schoeters, G., Verstraete, 
W., Wiele, T.V., Wragg, J., Rompelberg, C.J.M., Sips, A.J.A.M., and Wijnen, J.H.V., (2002) 
Comparison of five in vitro digestion models to stusdy the bioaccessibility of soil 
contaminants, Environmental Science and Technology 36, 3326-3334.  
Oppenheim, F.G., Salih, E., Siqueira, W.L., Zhang, W., and Helmerhorst, E.J., (2007) 
Salivary proteome and its genetic polymorphisms. Annals of the New York Academy of 
Science 1098, 22-50. 
Organization for Security and Co-operation in Europe (OSCE) (2010) Kosovo communities 
profiles. Available at URL:  http://www.osce.org/kosovo/75450   accessed January 7, 2013 
223 
 
Pak, Y-S., Oh, A., Kho, L., and Pack, D., (2012) Lung function decline and blood lead among 
residents nearby to industrial complex. International Archives of Occupational and 
Environmental Health 85, 951-959. 
Paoletti, L., Berardis, B.D., and Diociaiuti, M., (2002) Physico-chemical characterisation of 
the inhalable particulate matter (PM10) in an urban area: an analysis of the seasonal trend. 
Science of the Total Environment 292, 265-275. 
Paoliello, M.M.B., Capitani, E.M.D., da Cunha, F.G., Matsuo, T., Carvalho, M.F., Sakuma, A., 
and Figueiredo, B.R., (2002) Exposure of children to lead and cadmium from mining area of 
Brazil. Environmental Research 88, 120-128. 
Park, S.K., O’Neill, M.S., Vokonas, P.S., Sparrow, D., Wright, R.O., Coull, B., Nie, H., and 
Schwartz, J., (2008) Air pollution and Heart rate variability: Effect modification by chronic 
lead exposure. Epidemiology 19, 111-120. 
Park, Y.J., and Heo, J., (2002) Vitrification of fly ash from municipal solid waste incinerator. 
Journal of Hazardous Materials 91, 83-93. 
Parker, J.D., Akinbami, L.J., Wooddruff, T.J., (2009) Air pollution and childhood respiratory 
allergies in the United States. Environmental Health Perspectives 117, 140-147. 
Patocka, J., and Cerny, K., (2003) Inorganic lead toxicity. Acta Medica 46, 67-72. 
Patton, J.S., and Byron, P.R., (2007) Inhaling medicines: developing drugs to the body 
through the lungs. Nature Reviews Drug Discovery 6, 67-74. 
Paustenbach, D., and Galbraith, D., (2006) Biomonitoring and biomarkers: Exposure 
assessment will never be the same. Environmental Health Perspectives 114, 1143-1149. 
Pelfrene, A., Douay, F., Richard, A., Roussel, H., and Girondelot, B., (2012) Assessment of 
potential health risk for inhabitants living near a former lead smelter. Part 2: site-specific 
human health risk assessment of Cd and Pb contamination in kitchen gardens. 
Environmental Monitoring and Assessment  DOI: 10.1007/s10661-012-2767-x. 
Pelfrene, A., Waterlot, C., Mazzuca, M., Nisse, C., Bidar, G., and Douay, F., (2011) 
Assessing Cd, Pb, Zn human bioaccessibility in smelter-contaminated agricultural topsoils 
(northern France). Environmental Geochemistry and Health 33, 477-493. 
Penden, D.B., Hohman, R., Brown, M.E., Mason, R.T., Berkebile, C., Fales, H.M., and 
Kaliner, M.A., (1990) Uric acid is a major antioxidant in human nasal airway secretions. 
Proceedings of the National Academy of Sciences 87, 7638-7642. 
224 
 
PerkinElmer (2011) The 30-minutes guide to ICP-MS. Available at URL: 
http://www.perkinelmer.co.uk/PDFs/Downloads/tch_icpmsthirtyminuteguide.pdf  accessed 
December 15, 2012. 
Pikkanen, T.A., Loukkola, K., Korhonen, C.H., Aurela, M., Makela, T., Hillam, R.E., Aarnio, 
P., Koskentalo, T., Kousa, T., and Maenhaut, W., (2001) Sources and chemical composition 
of atmospheric fine and coarse particles in the Helsinki area. Atmospheric Environment 35, 
5381-5391. 
Pilkington, E.S., and Warren, L.J., (1979) Determination of heavy metal distribution in marine 
sediments. Environmental Science & Technology 13, 295-299. 
Pina, A.A., Villasenor, G.T., Jacinto, P.S., and Fernandez, M.M., (2002) Scanning and 
transmission electron microscope of suspended lead-rich particles in air of Luis Potosi, 
Mexico. Atmospheric Environment 36, 5235-5243. 
Pinitore, J.N.E., Clague, J.W., Amaya, M.A., Maciejewska, B., and Reynoso, J.J., (2009) 
Urban airborne lead: x-ray absorption spectroscopy establishes soil as dominant source. 
Plos one 4 (e5019), 1-8 . 
Pires, A., Fortuna, A., Alves, G., and Falcao, A., (2009) Intranasal drug delivery: how, why 
and what for? Journal of Pharmaceutical Sciences 12, 288-311. 
Piso, U., Gono, E., Joka, T., Obertacke, U., and Obladen, M., (1986) High-performance 
Liquid chromatography of adult human bronchoalveolar lavage: assay for phospholipid lung 
profile. Journal of Chromatography B: Biomedical Sciences and Applications 377, 79-89. 
Plant, J., Smith, D., Smith, B., and Williams, L., (2001) Environmental geochemistry at the 
global scale. Applied Geochemistry 16, 1291-1308. 
Plumlee, G.S., and Ziegler, T.L., (2005) The Medical Geochemistry of Dusts, Soil and other 
Earth Materials. In Environmental Geochemistry; Sherwood Lollar, B., Ed; Elsevier: 
Amsterdam, 9, 263-310. 
Plumlee, G.S., Norman, S.A., and Zieler, T.L., (2006) The toxicological geochemistry of earth 
materials: An overview of the processes and the Multidisciplinary methods used to 
understand them, Reviews in Mineralogy & Geochemistry 64, 5-57. 
Poggio, L., Vrscaj, B., Hepperle, E., Schulin, R., and Marsan, F.A., (2008) Introducing a 
method of human health risk evaluation for planning and soil quality management of heavy 
metals-polluted soils- an example from Grugliasco (Italy). Landscape and Urban Planning 88, 
64-72. 
225 
 
Poggio, L., Vrscaj, B., Schulin, R., Hepperle, E., and Marsan, F.A., (2009) Metals pollution 
and human bioaccessibility of topsoils in Grugliasco (Italy). Environmental Pollution 157, 680-
689. 
Polat, H., and Erdogan, D., (2007) Heavy metal removal from waste waters by ion flotation. 
Journal of Hazardous Materials 148, 267-273. 
Pope, C.A., Burnett, R.T., Thun, M.J., Calle, E.E., Krewski, D., Ito, K., and Thurston, G.D., 
(2002) Lung cancer, cardiopulmonary mortality and long-term exposure to fine particulate air 
pollution. Journal of the American Medical Association 287, 1132-1141. 
Popescu, I., Biasioli, M., Ajmone-Marsan, F., and Stannescu, R., (2012) Liability of potentially 
toxic elements in soil affected by smelting activities. Chemosphere 90, 820-826. 
 Possmayer, F., Nag, K., Rodriguez, K., Qanbar, R., and Schurch, S., (2001) Surface activity 
in vitro: role of surfactants proteins. Comparative Biochemistry and Physiology Part A: 
Molecular & Integrative Physiology 129, 209-220. 
Pound, J.G., and Leggett, R.W., (1998) the ICRP age-specific biokinetic model for lead: 
Validation, empirical comparisons, and explorations. Environmental Health Perspectives 106, 
1505-151. 
Pouschat, P., and Zagury, G.J., (2006) In vitro gastricintestinal bioavailability of arsenic in 
soils collected near CCA-treated utility poles. Environmental Science & Technology 40, 
4317-4323. 
Prathumratana, L., Kim, R., and Kim, K.W., (2008) Heavy metal contamination of the mining 
and smelting district in Mitrovica Kosovo. Proceedings of the International symposia on 
Geoscience Resources and Environments of Asian Terraces, 479-482. 
Puchelle, E., Bajolet, O., and Abely, M., (2002) Airway mucus in cystic fibrosis. Paediatric 
Respiratory Review 3, 115-119 
Qin, Y., and Oduyemi, K., (2003) Atmospheric aerosol source identification and estimates of 
source contributions to air pollution in Dundee, UK. Atmospheric Environment 37, 1799-1809 
Querol, X., Alastuey, A.., Rodriguez, Z., Piana, F., Ruiz, C.R., Cots, N., Messague, G., and 
Pilg, O., (2001) PM10 and PM2.5 source apportionment in Barcelona metropolitan area 
Catalonia, Spain. Atmospheric Environment 35, 6407-6419. 
Ramsey, M.H., (2009) Uncertainty in the assessment of hazard, exposure and risk. 
Environmental Geochemistry and Health 31, 205-217. 
226 
 
Rawle, A., (2000) Basic principles of particle size analysis. Available at URL:  
http://golik.co.il/Data/BasicPrinciplesofParticlesize_1126925513.pdf  accessed January 8, 
2013. 
Razo, I., Carrizales, L., Castro, J., Diaz-Barriga, F., and Monroy, M., (2003) Arsenic and 
heavy metal pollution of soil, water and sediments in a semi-arid climate mining area in 
Mexico. Water, Air, and Soil Pollution 152, 129-152. 
Reddy, M.S., (1992) Human tracheobronchial mucin: purification and binding to 
pseudomonas aeruginosa. Infection and Immunity 60, 1530-1535. 
Reznik, G.K., (1990) Comparative anatomy, physiology, and function of the upper respiratory 
tract. Environmental Health Perspectives 85, 171-176. 
Richard, J., Winzler, L., and Smyth, I.R., (1948) Studies on the mucoproteins of human 
plasma. II. Plasma mucoprotein levels in cancer patients. Journal of Clinical Investigation 27, 
617-619. 
Richaud, R., Laschas, H., Healey, A.E., Reed, G.D., Haines, J., Jarvis, K.E., Herod, A.A., 
Dugwell, D.R., Kandiyoti, R., (2000) Trace element analysis of gasification plant samples by 
i.c.p-m.s.: validation by comparison of results from two laboratories. Fuel 79, 1077-1087. 
Rieuwerts, J.S., Farago, M.E., CIKRT, M., and Bencko, V., (2000) Differences in lead 
bioavailability between smelting and a mining area. Water, Air and Soil Pollution 122, 203-
225. 
Rieuwerts, J.S., Searle, P., and Buck, R., (2006) Bioaccessible arsenic in the home 
environment in southwest England. Science of the Total Environment 371, 89-98. 
Ringer, N.J., Selvakumar, R., Woodward, H.D., Bhavanandar, V.P., and Davidson, E.A., 
(1988) Protein components of human tracheobronchial mucin: partial characterization of 
closely associated 65-kildalton protein. Biochemistry 27, 8056-8063. 
Ringer, N.J., Selvakumar, R., Woodward, H.D., Simet, I.M., Bhavanandar, V.P., and 
Davidson, E.A., (1987) Structure of canine tracheobronchial mucin glycoprotein. 
Biochemistry 26, 5322- 5328. 
Roels, H.A., Buchet, J-P., Lauwery, R., Claeys-Thorea, F., Lafontaine, A., van Overschelde, 
J., and Verduyn, G., (1978) Lead and cadmium absorption among children near a nonferrous 
metal plant: A follow-up study of a test case. Environmental Research 15, 290-308. 
227 
 
Roemer, W., HoeK, G., BruneKreef, B., Clench-Aas, J., Forsberg, B., Pekkeanen, J., and 
Schutz, A., (2000) PM10 elemental composition and acute respiratory health effects in 
European children (PEACE project). European Respiratory Journal 15, 553-559. 
Romero, F.M., Armienta, M.A., Gonzalez-Harnandez, G., (2007) Solid-phase control on the 
mobility of potentially toxi elements in an aboundoned lead/zinc tailings impoundment, 
Taxco, Mexico. Applied Geochemistry 22, 109-127. 
Rose, M.C., and Voynow, J.A., (2006) Respiratory tract mucin genes and micin glycoproteins 
in health and disease. Physiology Reviews 86, 245-278. 
Rose, M.C., Lynn, W.S., and Kaufman, B., (1979) Resolution of the major components of 
human lung mucosal gel and their capabilities for reaggregation and gel formation. 
Biochemistry 18, 4030-4037. 
Roussel, C., Neel, C., and Bril, H., (2000) Minerals controlling arsenic and lead solubility in 
an abandoned gold mine tailings. Science of the Total Environment 263, 209-219. 
Roussel, H., Waterlot, C., Pelfrene, A., Pruvot, C., Mazzuca, M., and Douay, F., (2010) Cd, 
Pb and Zn oral  bioaccessibility of urban soils contaminated in the past by atmospheric 
emissions from two lead and zinc smelters. Archives of Environmental Contamination and 
Toxicology 58, 945-954.  
Rowland M., Balant, L., and Peck, C., (2004) Physiologically based pharmacokinetics in drug 
development and regulatory science: A workshop report (Georgetown University 
Washington, DC, May 29-30, 2002). Available at URL:  http://www.aapspharmsci.org 
accessed January 5, 2013. 
Ruby, M.V., Davis, A., Link, T.E., Schoof, R., Chaney, R.L., Freman, G.B., and Bergstrom, 
P., (1993) Development of an in vitro screening test to evaluate the in vivo bioaccessibility of 
ingested mine-waste lead. Environmental Science & Technology 27, 2870-2877. 
Ruby, M.V., Davis, A., Schoof, R., Eberle, S., and Sellstone, C.M., (1996) Estimation of lead 
and arsenic bioavailability using a physiologically based extraction test. Environmental 
Science & Technology 30, 422-430. 
Ruby, M.V., Schof, R., Brattin, W., Goldade, M., Harnois, P.M., Mosby, D.E., Casteel, S.W., 
Berti, W., Carpenter, M., Edwards, D., Cragin, D., and Chappel, W., (1999) Advances in 
evaluating the oral bioavailability of inorganic in soil for use in human health risk assessment. 
Environmental Science & Technology 33, 3697-3705. 
228 
 
Ruiz, P., Ray, M., Fisher, J., and Mumtaz, M., (2011) Physiologically based pharmacokinetic 
(PBPK) toolkit for environmental pollutants. International Journal of Molecular Sciences 12, 
7467-7480. 
Runow, K-D., (2005) Investigation of the heavy metal load in refugee camps with Mitrovica in 
Kosovo: results of the hair analyses. 24th Annual International Symposium on Man and His 
Environment in Health and Disease, 54-55. Available at URL: 
http://www.aehf.com/articles/symposia%20PDF/2006.pdf  accessed January, 25 2013. 
Russel, A.G., and Brunekreek, B., (2009) A focus on particulate matter and health. 
Environmental Science & Health 43, 4620-4625. 
Sakagami, M., Kinoshita, W., Sakon. K., Sato, J-I., and Makino, Y., (2002) mucoadhesive 
beclomethasone microsphere for powder inhalation: their pharmacokinetics and 
pharmacodynamics evaluation. Journal of Controlled Release 80, 207-218. 
Salvador, P., Artinano, B., Alonso, D.G., Querol, X., and Alastuey, A., (2004) Idendification 
and characterization of sources of PM10 in Madrid (Spain) by statistical method. Atmospheric 
Environment 38, 435-447. 
Samet, J.M., and Chen, P.W., (1994) The role of airway mucus in pulmonary toxicology. 
Environmental Health Perspectives 102, 89-103. 
Santo, M.D., Gomez, D., Dowidowski, L., Gautier, E., and Smichowski, P., (2009) 
Determination of water soluble and insoluble compounds in size classified airborne 
particulate matter. Microchemical Journal 91, 133-139. 
Sarker, D., Quazi, S., Makris, K.C., Datta, R., and Khairom, A., (2007) Arsenic 
bioaccessibility in soil amended with with drinking-water treatment residuals in the presence 
of phosphorus fertilizer. Archives of Environmental contamination and Toxicology 53, 329-
336.  
Schaider, L.A., Senn, D.B., Brabander, D.J., McCarthy, K.D., and Shine, J.P., (2007) 
Characterization of zinc, lead, and cadmium mine waste: implications for transport, exposure 
and bioavailability. Environmental Science & Technology 41, 4164-4171. 
Scheckel, K.G., Chaney, R.L., Basta, N.T., and Ryan, J.A., (2009) Advances in assessing 
bioavailability of metal(liod)s  in contaminated soils. Advances in Agronomy 17, 409-439. 
Schelwald, R.A., (2001) BARGE, Bioavailability Research Group Europe: European co-
ordination on risk assessment of soils. Land Contamination & Reclamation 9, 107-108. 
229 
 
Schenkel, L.C.P.M., Veerman, E.C.I., and Amerongen, A.V.N., (1995) Biochemical 
composition of human saliva in relation to other mucosal fluids. Critical Reviews in Oral 
Biology & Medicine 6, 161-175. 
Schild, D., Pflaum, R., Sattler, K., and Recknagel, E., (1987) Stability of free intermetallic 
compound clusters: lead / antimony and bismuth / antimony. Journal of Physical Chemistry 
91, 2649-2653. 
Schmitt, N., Philion, J.J., Larsen, A.A., Harnadek, M., and Lynch, A.J., (1979) Surface soil as 
a potential source of lead exposure for young children. Canadian Medical Association 
Journal 121, 1474-1478. 
Schnaas, L., Rothenberg, S.J., Perroni, E., Martinez, S., and Hernandez, C., (2000) 
Temporal pattern in the effect of postnatal blood lead level on the intellectual development of 
young children. Neurotoxicology and Teratology 22, 805-810.  
Schock, B.C., Koostra, J., Kwack, S., Hackman, R.M., van der Vliet, A., and Cross, C.E., 
(2004) Ascorbic acid in nasal and trecheobronchial airway lining fluids. Free Radical Biology 
& Medicine 37, 1393-1401. 
Schulin, R., Curchod, F., Mondeshka, M., Daskalova, A., and Keller, A., (2007) Heavy metal 
contamination along a soil transect in the vicinity of the iron smelter of Kremikovtzi (Bulgaria). 
Geoderma 140, 52-61. 
Schwartz, J., (1991) Lead, blood pressure, and cardiovascular diseases in men and women. 
Environmental Health Perspectives 91, 71-75. 
Sedman, R.M., (1989) The development of applied action levels for soil contact: A scenario 
for exposure of humans to soil in residential setting. Environmental Health Perspectives 79, 
291-313. 
Senesi, G.S., Baldassarre, G., Senesi, N., and Radina, B., (1999) Trace element inputs into 
soils by anthropogenic activities and implications for human health. Chemosphere 39, 343-
377. 
Sexton, K., Needham, L.L., and Pirkle, J.L., (2004) Human monitoring of environmental 
chemicals. American Scientist 92, 38-45. 
Shaider, L.A., Senn, D.B., Brabander, D.J., McCarthy, K.D., and Shine, J.P., (2007) 
characterisation of zinc, lead and cadmium in mine waste: implications for transport, 
exposure, and bioavailability. Environmental Science & Technology 41, 4164-4171. 
230 
 
Shao, L., Li, W., Xiao, Z., and Sun, Z., (2008) The mineralogy and possible sources of spring 
dust particles over Beijing. Advances in Atmospheric Science 25, 395-403. 
Shoaf, C.R., (1991) Current assessment practices for noncancer end points. Environmental 
Health Perspectives 95, 111-119. 
Sialelli, J., Davidson, C.M., Hursthouse, A.S., and Ajmone-Marsan, F., (2011) Human 
bioaccessibility of Cr, Cu, Ni, Pb and Zn in urban soils from the city of Torino, Italy. 
Environmental Chemistry letters 9, 197-202. 
Sialelli, J., Urquhart, G.J., Davidson, C.M., and Hursthouse, A.S., (2010) Use of a 
physiologically based extraction test to estimate the human bioaccessibility of potentially 
toxic elements in urban soils from the city of Glasgow, UK. Environmental Geochemistry and 
Health 32, 517-527. 
Silva, L.F.O., Ward, C.R., Hower, J.C., Izquierdo, M., Waaders, F., Oliviera, M.LS., Li, Z., 
Hatch, R.S., Querrol;, X., (2010) Mineralogy and leaching characteristics of coal ash from 
major Brazilian power plant. Coal Combustion and Gasification Products 2, 51-65. 
Simonetti, A., Gariepy, C., and Carignan, J., (2003) Tracing sources of atmospheric pollution 
in western Canada using the Pb isotopic composition and heavy metal abundances of 
epiphytic lichens. Atmospheric Environment 37, 2853-2865. 
Skeaff, J.M., Thibault, Y., and Hardy, D.J., (2011) A new method for characterisation and 
quantitative speciation of base metal smelter stack particulates. Environmental Monitoring 
and Assessment 177, 165-192. 
Smith, C.M., Deluca, H.F., Tanaka, Y., and Mahaffey, K.R., (1978) Simulation of lead 
absorption by vitamin D administration. The Journal of Nutrition 108, 843-847. 
Smith, E., Weber, J., and Juhasz, A.L., (2009) Arsenic distribution and bioaccessibility across 
particle fractions in historically contaminated soils. Environmental Geochemistry and Health 
31, 85-92. 
SNIFFER (2003) Method for deriving site-specific human health assessment criteria for 
contaminants in soils, Report: LQ01. Scotland and Northern Ireland for Environmental 
Research, Edinburg, Scotland. 
Society of Brownfield Risk Assessment (SoBRA) (2012) Summer workshop of lead in soil the 
key issues. Available at URL: http://www.sobra.org.uk/resources-SoBRA-reports . 
231 
 
Son, Y-J., and McConville, J.T., (2009) Development of a standardized dissolution test 
method for inhaled pharmaceutical formulations. International Journal of Pharmaceutics 382, 
15-22. 
Sonawane, B.R., (1995) Chemical contaminants in human milk: an overview, Environmental 
Health Perspectives 103, 197-205.  
Sonmez, O., and Pierzynski, G.M., (2005) Phosphorus and manganese oxides on soil lead 
bioaccessibility: PBET and TCLP. Water, Air and Soil Pollution 166, 3-16. 
Sostaric, S.B., Palinkas, L.A., Topa, D., Spangenberg, J.E., and Prochaska, W., (2011) 
Silver-base metal epithermal types of deposit Crnac, Rogozna Mts., Kosovo. Part 1: Ore 
mineral geochemistry and sulfur isotope study. Ore Geology Reviews 40, 65-80. 
Southam, G., and Beveridge, T.J., (1992) Enumeration of Thiobacilli within pH neutral and 
acidic mine tailings and their role in the development of secondary mineral soil. Applied and 
Environmental Microbiology 58, 1904-1912. 
Spear, T.M., Svee, W., Vincent, J.H., and Stanisich, N., (1998) Chemical speciation of lead 
dust associated with primary lead smelting. Environmental Health Perspectives 106, 565-571 
Stafilov, T., Aliu, M., and Saju, R., (2010) Arsenic in surface soils affected by mining and 
metallurgical processing in K. Mitrovica Region, Kosovo. International Journal of 
Environmental Research and Public Health 7, 4050-4061.  
Stenbounova, L.V., Adamcakova-Dodd, A., Kim, J.S., Park, H., O’Shaughnessy, P.T., 
Grassian, V.H., and Thorne, P.S., (2011) Nanosilver induces minimal lung toxicity or 
inflammation in a subacute murine inhalation model. Particle and Fibre Toxicology 8, DOI: 
10.1186/1743-8977-8-5. 
Stewart, M.A., Jardine, P.M., Barnett, M.O., Mehlhorn, L.K., Hyder, L.K., and McKay, L.D., 
(2003) Influence of soil geochemical and physical properties on the sorption and 
bioaccessibility of chromium III. Journal of Environmental Quality 32, 129-137. 
Stopford, W., Turner, J., Cappellini, D., and Brock, T., (2003) Bioaccessibility testing of cobalt 
compounds. Journal of Environmental Monitoring 5, 675-680. 
Sturm, R., (2007) A computer model for clearance of insoluble particles from the 
tracheobronchial tree of the human lung. Computers in Biology and Medicine 37, 680-690. 
232 
 
Su, T.J., Lu, J.R., Thomas, R.K., Cui, Z.F., and Penfold, J., (1998) The conformational 
structure of bovine serum albumin layers adsorbed at the silica-water interface. Journal of 
Physical Chemistry B 102, 8100-8108. 
Sukreeyapongse, O., Holm, P.E., Strobel, B.W., Panichsakpatana, S., Magrid, J., and 
Hansen, H.C.B., (2002) pH-dependent release of cadmium, copper and lead from natural 
and sludge-amended soils. Journal of Environmental Quality 31, 1901-1909. 
Sun, G., Crissman, K., Norwood, J., Richards, J., Slade, R., and Hatch, G.E., (2001) 
Oxidative interactions of synthetic lung epithelial ling fluid with metal-containing particulate 
matter. American Journal of Physiology – Lung Cellular and Molecular Physiology 281, L807-
L815. 
Sun, M.L., and Tilton, R.D., (2001) Adsorption of protein / surfactant complex at the air / 
aqueous interface. Colloids and Surfaces B: Biointerfaces 20, 281-293. 
Sun, Y., Zhuang, G., Wang, Y., Han, L., Guo, J., Dan, M., Zhang, W., Wang, Z., and Hao, Z., 
(2004) The air-borne particulate pollution in Beijing – concentration, composition, distribution 
and sources. Atmospheric Environment 38, 5991-6004. 
Sunderman, F.W. Jr., (2001) Review: Nasal Toxicity, Carcinogenicity and Olfactory Uptake of 
metals. Annals of Clinical & Laboratory Science 31, 3-24. 
Syla, A., Veliu, A., Musa, M., and Kafexholli, B., (2009) Monitoring of particles PM10 and 
PM2.5 in the Mitrovica urban atmosphere. European Aerosol Conference 2009, Kalsruhe 
Germany. Abstract: T150A06. Available at URL: 
http://www.gaef.de/EAC2009/EAC2009abstracts/T15%20Special%20Session%203/T150A06
.pdf  accessed January 25, 2013. 
Takaya, M., Shinohara, Y., Serita, F., Ono-Ogasawara, M., Otaki, N., Toya, T., Takata, A., 
Yoshida, K., and Kohyama, N., (2006) Dissolution of functional materials and rare earth 
oxides into pseudo alveolar fluid. Industrial Health 44, 639-644. 
Takenaka, S., Kang, E., Roth, C., Schulz, H., Ziesenis, A., Heinmann, U., Schramel, P., and 
Heyder, J., (2001) Pulmonary and systemic distribution of inhaled ultrafine silver particles in 
rats. Environmental Health Perspectives 109, 547-551. 
Tannenbaum, L.V., (2005) A critical assessment of the ecological risk assessment process: a 
review of misplaced concepts. Integrated Environmental Assessment and Management 1, 
66-72. 
233 
 
Task Group on Lung Dynamics (1966) Deposition and retention models for internal dosimetry 
of the human respiratory tract. Health Physics 12, 173-207. 
Taunton, A.E., Gunter, M.E., Druschel, G.K., and Wood, S.A., (2010) Geochemistry in the 
lung: reaction-path modelling and experimental examination of rock forming minerals under 
physiologic conditions. American Mineralogist 95, 1624-1635. 
Tchounwou, P.B., Centeno, J.A., and Patlolla, A.K., (2004) Arsenic toxicity, mutagenesis, 
and carcinogenesis- a health risk assessment and management approach. Molecular and 
Cellular Biochemistry 255, 47-55. 
Telisman, S., Colak, B., Pizent, A., Jurasovic, J., and Cvitkovic, P., (2007) Reproductive 
toxicity of low-level lead exposure in men. Environmental Research 105, 256-266. 
Terzano, R., Spagnuolo, M., Vekemans, B., Nolf, W.D., Janssens, K., Falkenberg, G., Fiore, 
S., and Ruggiero, P., (2007) Assessing the origin and fate of Cr, Ni, Zn, Pb & V in industrial 
polluted soil by combined microspectroscopic techniques and bulk extraction methods. 
Environmental Science & Technology 41, 6762-6769. 
Teunis, P.F.M., and Havelaar, P.J., (2000) The Beta Poisson dose-response model is not a 
single-hit model. Risk Analysis 20, 513-520. 
The Ministry of Housing, Spatial planning and Environment. Directorate-general for 
Environmental Protection. Department of Soil Protection. The Netherlands. Available at URL:  
http://www.contaminatedland.co.uk/std-guid/dutch-l.htm  accessed January 4, 2013. 
Theil, F-P., Guentert, T.W., Haddad, S., and Poulin, P., (2003) Utility of physiologically based 
pharmacokinetic models to drug development and rational drug discovery candidate 
selection. Toxicology Letters 138, 29-49. 
Thermo Scientific (2007) US EPA SW-846 method 6020A using the X Series 2 ICP-MS. 
Application note: 40619. Available at URL:   
https://www.thermo.com/eThermo/CMA/PDFs/Product/productPDF_57336.PDF  accessed 
January 5, 2013. 
ThermoFisher Scientific (2007) From first principles: an introduction to the ICP-MS 
technique. Available at URL:   
http://www.thermo.com/eThermo/CMA/PDFs/Various/File_2512.pdf  accessed January 5, 
2013. 
Thomas, R., (2004) Practical guide to ICP-MS. Marcel Dekker, Inc New York, USA. 
234 
 
Thornton, D.J., Rousseau, K., and McGuckin, M.A., (2008) Structure and function of 
polymeric mucins in airways mucus. Annual Review of Physiology 70, 459-486. 
Thornton, I., Davies, D.J.A., Watt, J.M., and Quinn, M.J., (1990) Lead exposure in young 
children from dust and soil in the United Kingdom. Environmental Health Perspectives 89, 
55-60. 
Tian, G., and Longest, P.W., (2010) Transient absorption of inhaled vapour into multilayer 
mucus – tissue – blood system. Annals of Biochemical Engineering 38, 517-536. 
Titanen, P., Tomonen, K.L., Ruskanen, J.J., Mirme, A., and Pekkanen, J., (1999) Fine 
particulate air pollution, resuspended road dust and rspiratory health among symptomatic 
children. European Respiratory Journal 13, 266-273. 
Todoroff, J., and Vanbever, R., (2011) Fate of nanomedicines in the lungs. Current Opinion 
in Colloid & Interface Science 16, 246-254. 
Tong, S., von Schirnding, Y.E., and Paramontol (2000) Environmental lead exposure: A 
public health problem of global dimensions, Bulletin of the World health Organisation 78, 
1068-1077. 
Tordoff, G.M., Baker, A.J.M., and Willis, A., (2000) Current approaches to the revegetation 
and reclamation of metalliferous mine waste. Chemosphere 41, 219-228. 
Trepka, M.J., Heinrich, J., Krause, C., Shulz, C., Lippod, U., Meyer, E., and Wichmann, H-E., 
(1997) The internal burden of lead among children in a smelter town – a small area analysis. 
Environmental Research 72, 118-130. 
Turner, A., Singh, N., and Richard, J.P., (2009) Bioaccessibility of metals in soil and dust 
contaminated by marine antifouling paint particles. Environmental Pollution 159, 1526-1532. 
Twining, J., McGlinn, P., Loi, E., Kath, S., and Giere, R., (2005) Risk ranking of bioaccessible 
metals from fly ash dissolved in simulated lung and gut fluids. Environmental Science and 
Technology 39, 7749-7756. 
Udachin, V., Williamson, B.J., Purvis, O.W., Spiro, B., Dubbin, W., Brooks, S., Coste, B., 
Herrington, R.J., and Mikhailova, I., (2003) Assessment of environmental impacts of active 
smelter operations and abandoned mines in Karabash, Ural mountain of Russia. Sustainable 
Development 11, 133-142. 
United Nations Environment Programme (UNEP) (2010). Case study on lead and heavy 
metal contamination in Mitrovica, Kosovo – Environmental risks from abandoned mining and 
235 
 
mineral processing operations in Northern Kosovo. Review and data analysis: First draft. 
Available at URL:  
http://www.chem.unep.ch/pb_and_cd/documents/unep_mitrovica_case_study.pdf  accessed 
January 6, 2013. 
United Nations Interim Administration Mission in Kosovo (UNMIK) (2003) Regulation No. 
2003/9 – On the promulgation of law adopted by the Assembly of Kosovo on environmental 
protection. Available at URL:  http://www.unmikonline.org/regulations/2003/RE2003_09.pdf  
accessed January 4, 2013. 
United States Environmental Protection Agency (1986) Guidelines for carcinogen risk 
assessment - EPA/630/r-00/004. Available at URL: 
http://www.epa.gov/raf/publications/pdfs/CA%20GUIDELINES_1986.PDF  accessed 
November 20, 2012. 
United States Environmental Protection Agency (1989) Risk assessment guidance for 
Superfund volume 1 Human health evaluation manual (Part A): EPA/540/1-89/002. Available 
at URL:  http://rais.ornl.gov/documents/HHEMA.pdf  accessed January 5, 2013. 
United States Environmental Protection Agency (1991) Risk assessment guidance for 
Superfund volume I: Human health evaluation manual supplemental guidance, “Standard 
default exposure factors”. Interim final. OSWER directive 9285.6-03 
http://www.epa.gov/oswer/riskassessment/pdf/oswer_directive_9285_6-03.pdf. 
United States Environmental Protection Agency (1992) Science Advisory Board’s review of 
the Uptake Biokinetic model for lead. Office of the Administrator Science Advisory Board: 
EPA-SAB-IAQC-92-016. Available at URL:   
http://yosemite.epa.gov/sab/sabproduct.nsf/DB3B9334159580BA852573230064527C/$File/
BIOKINETIC+MODEL+++++IAQC-92-016_92016_5-9-1995_108.pdf  accessed January 4, 
2013. 
United States Environmental Protection Agency (1994a) Region 8 superfund technical 
guidance:  Model statement work for RI/FS baseline risk assessments of human health. 
Available at URL:  http://www.epa.gov/region8/r8risk//pdf/r8_ra01-brasow.pdf  accessed 
January 5, 2013. 
United States Environmental Protection Agency (1994b) Method 3051: Microwave assisted 
acid digestion of sediments sludges, soils and oils. Available at URL:   
http://www.caslab.com/EPA-Methods/PDF/EPA-Method-3051.pdf  Accessed November 20, 
2012. 
236 
 
United States Environmental Protection Agency (1994c) Guidance manual for the Integrated 
Exposure Uptake Biokinetic model for lead in children: EPA/540/R-93/081. Available at URL:  
http://nepis.epa.gov/Exe/ZyPURL.cgi?Dockey=2000WN4R.txt  accessed November 20, 2012 
United States Environmental Protection Agency (1996a) Method 3050B: Acid digestion of 
sediments sludges and soils. Available at URL:  
http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/3050b.pdf  accessed November 20, 
2012. 
United States Environmental Protection Agency (1996b) Method 3052: Microwave assisted 
acid digestion of siliceous and organically based matrices. Available at URL:  
http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/3052.pdf  accessed November 12, 
2012. 
United States Environmental Protection Agency (1999) Short sheet: IEUBK mode mass 
fraction of soil in indoor dust (MSD) variable. Office of Solid Waste and Emergency 
Response: EPA540-F-00-008. Available at URL: 
http://epa.gov/superfund/lead/products/ssmsdcol.pdf   accessed November 20, 2012. 
United States Environmental Protection Agency (2000) Short sheet: TRW recommendations 
for sampling and analysis of soil at lead (Pb) sites – EPA 540-F-00-010. Available at URL: 
http://epa.gov/superfund/lead/products/sssiev.pdf  accessed November 12, 2012. 
United States Environmental Protection Agency (2002) Reference manual for the Integrated 
Exposure Uptake Biokinetic model for lead in children (IEUBK) Windows version-32-Bit 
version: OSWER 9285.7-44. Available at URL: 
http://www.epa.gov/superfund/lead/products/rmieubk32.pdf   accessed November 29, 2012. 
United States Environmental Protection Agency (2005) Human health risk assessment 
protocol (HHRAP) – Chapter 7: characterizing risk and hazard. Available at URL: 
http://www.epa.gov/osw/hazard/tsd/td/combust/finalmact/ssra/05hhrap7.pdf  accessed 
January 5, 2013. 
United States Environmental Protection Agency (2006) Approaches for the application of 
physiologically based pharmacokinetic (PBPK) models and supporting data in risk 
assessment. National Centre for Environmental Assessment, Washington D.C: EPA/600/R-
05/043F. Available at URL:  http://epa.gov/ncea.   Accessed November 20, 2012. 
United States Environmental Protection Agency (2007a) Method 3051a: Microwave assisted 
acid digestion of sediments sludges, soils and oils. Available at URL: 
237 
 
http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/3051a.pdf   accessed January 5, 
2013. 
United States Environmental Protection Agency (2007b) Method 6020A: Inductively Coupled 
Plasma-Mass Spectrometry. Available online at 
http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/6020a.pdf. 
United States Environmental Protection Agency (2007c). User’s guide for the Integrated 
Exposure Uptake Biokinetic model for lead in children. Office of Superfund Remediation and 
Technology Innovation: EPA 9285.7-42. Available at URL: 
http://www.epa.gov/superfund/lead/products/ugieubk32.pdf   accessed January 6, 2013. 
United States Environmental Protection Agency (2007d). System requirements and design 
for the Integrated Exposure Uptake Biokinetic model for lead in children. Office of Superfund 
Remediation and Technology Innovation: EPA 9285.7-42. Available at URL: 
http://www.epa.gov/superfund/lead/products/srdieubk32.pdf   accessed January 5, 2013. 
United States Environmental Protection Agency (2007e) Estimation of relative bioavailability 
of lead in soil and soil like materials using in vivo and in vitro methods. Office of Solid Waste 
and Emergency Response: OSWER 9285.7-77. Available at URL: 
http://epa.gov/superfund/bioavailability/lead_tsd_main.pdf   accessed January 6, 2013. 
United States Environmental Protection Agency (2008a) Standard operating procedure for an 
in vitro bioaccessibility assay for lead in soil – EPA 9200.1-86. Available at URL: 
http://epa.gov/superfund/bioavailability/pb_ivba_sop_final.pdf  accessed January 4, 2013. 
United States Environmental Protection Agency (2008b) National ambient air quality 
standards for lead, Final rule. EPA-HQ-OAR-2006-0735; FRL-8732-9. Available at URL:  
http://www.epa.gov/leaddesignations/2008standards/documents/Pb_NAAQS_Rule.pdf   
accessed January 10, 2013 
United States Environmental Protection Agency (2011) Science Advisory Board review of 
EPA’s approach for developing lead dust hazard standard for residences (November, 2010 
draft) and approach for developing lead dust hazard standards for public and commercial 
buildings (November, 2010 draft). Office of The Administrator Science Advisory Board. 
Available at URL: 
http://yosemite.epa.gov/sab/sabproduct.nsf/CD05EA314294B683852578C60060FB08/$File/
EPA-SAB-11-008-unsigned-revised.pdf  accessed January 10, 2013.  
238 
 
Vaga, E., Mugica, V., Reyes, E., Sanchez, G., Chow, J.C., and Watson, J.G., (2001) The 
chemical composition of fugitive dust emitters in Mexico city. Atmospheric Environment 35, 
4033-4039. 
Vamerali, T., Bandiera, M., and Mosca, G., (2011) In situ phytoremediation of arsenic- and 
metal-polluted pyrite waste with field crops: Effects of soil management. Chemosphere 83, 
1241-1248. 
Vanbever, R., Mintzes, J.D., Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R., and 
Edwards, D.A., (1999) Formation and physical characterisation of large porous particles for 
inhalation. Pharmaceutical Research 16, 1735-1742. 
Vanthanouvong, V., and Roomans, G.M., (2004) Methods for determining the composition of 
nasal fluid by X-ray microanalysis. Microscopy Research and Technique 63, 122-128. 
Vaziri, N.D., (2008) Mechanisms of lead-induced hypertension and cardiovascular disease. 
American Journal of Physiology – Heart and Circulatory Physiology 295, H454-H465. 
Veneis, P., Forastiere, F., Hoek, G., and Lipsett, M., (2004) Outdoor air pollution and lung 
cancer: recent epidemiologic evidence. International Journal of Cancer 111, 647-652. 
Viridor Waste Ltd, New England EFW (2009) Technical data for HHRA generic assessment 
criteria. Available at URL:  http://www.viridor.co.uk/assets/Uploads/Consultation/New-
England/Planning-
application/Volume%203c%20Environmental%20Statement/Section%2016%20Human%20H
ealth/Human%20Health%20Risk%20Assessment%20Appendices%20A%20to%20C.pdf  
accessed January 10, 2013. 
Vitorino, R., Lobo, M.J.C., Ferrer-Correira, A.J., Dubin, J.R., Tomer, K.B., Domingues, P.M., 
and Amodo, F.M.L., (2004) Identification of human whole saliva protein components using 
proteomics. Proteomics 4, 1109-1115. 
Vliet, A.V.D., O’Neill, C.A., Cross, C.E., Koosta, J.M., Volz, W.G., Halliwell, B., and Louie, S., 
(1999) Determination of low-molecular-mass antioxidant concentrations in human respiratory 
tract lining fluids. American Journal of Physiology – Lung Cellular and Molecular Physiology 
276, L289-L296. 
Voutsa, D., and Samara, C., (2002) Labile and bioaccessible fractions of heavy metals in the 
airborne particulate matter from urban and industrial areas. Atmospheric Environment 36, 
3583-3590. 
239 
 
Vupputuri, S., He, J., Munter, P., Bazzano, L.A., Whellon, P.K., and Batuman, V., (2003) 
Blood lead level is associated with elevated blood pressure in blacks. Hypertension 41, 463-
468. 
Wang, E.X., Bormann, F.H., and Benoit, G., (1995) Evidence of complete retention of 
atmospheric lead in soils of northern hardwood forested ecosystems. Environmental Science 
& Technology 29, 735-739. 
Wang, Z-M., Pierson Jr, R.N., and Heymsfield, S.D., (1992) The five-level model: a new 
approach to organizing body-composition research. The American Journal of Clinical 
Nutrition 56, 19-28. 
Wasserman, G.A., Liu, X., Lolacono, N.J., Factor-Litvak, P., Kline, J.K., Popova, D., Morina, 
N., Musabegovic, A., Vrenezi, N., Capuni-Paracka, S., Lekic, V., Preteni-Pedjepi, E., 
Hadzialjevic, S., Slavkovich, V., and Graziano, J.N., (1997) Lead exposure and intelligence in 
7 –year-old children: the Yugoslavia Perspective study. Environmental Health Perspectives 
105, 956-962. 
Wasserman, G.A., Liu, X., Popovac, D., Factor-Litvak, P., Kline, J., Waternaux, C., LoIacono, 
N., and Graziano, J.H., (2000) The Yugoslavia prospective lead study: contributions of 
prenatal and postnatal lead exposure to early intelligence. Neurotoxicology and Teratology 
22, 811-818. 
Wcislo, E., Ioven, D., Kucharski, R., and Szdzuj, J., (2002) Human health risk assessment 
case study: an abandoned metal smelter site in Poland. Chemosphere 47, 507-515. 
Wei, M-C., Wey, M-Y., Hwang, J-H., and Chen, J-C., (1998) Stability of heavy metal in 
bottom ash and fly ash under various incinerating conditions. Journal of Hazardous Materials 
57, 145-154. 
Weinmayr, G., Remeo, E., Sario, M.D., Weiland, S.K., and Forastiere, F., (2010) Short-term 
effect of PM10 and NO2 on respiratory health among children with asthma or asthma-like 
symtoms: a systemic review and meta-analysis. Environmental Health Perspectives 118, 
449-457. 
Weiss, D., Shtyk, W., Appleby, P.G., Kramers, J.D., and Cheburkin, A.K., (1999) 
Atmospheric Pb deposition since the industrial revolution recorded by five Swiss peat 
profiles: enrichment factors, fluxes, isotopic composition and sources. Environmental 
Science & Technology 33, 1340-1352. 
Wen, Y.H., Kalff, J., Peters, R.H., (1999) Pharmacokinetic modelling: a critical perspective. 
Environmental Review 7, 1-18. 
240 
 
Western Balkans Environmental Programme (WBEP) (2010) Case studies on remediation of 
environmental hot spots in Western Balkans. Available at URL:  
http://westernbalkansenvironment.net/documents/case_studies.pdf  accessed November 20, 
2012. 
White, P.D., Leeuwen, P.V., Davis, B.D., Maddaloni, M., Hogan, K.A., Marcus, A.H.,Elias, 
R.W., (1998) The conceptual structure of the Integrated Exposure Uptake biokinetic model 
for lead in children. Environmental Health Perspectives 106, 1513-1529. 
White, R.F., Diamond, R., Proctor, S., Morey, C., and Hu, H., (1993) Residual cognitive 
deficits 50 years after lead poisoning during childhood. British Journal of Industrial Medicine 
50, 613-622.  
Widdecombe, J.H., and Widdecombe, J.G., (1995) Regulation of human airway surface 
liquid. Respiration Physiology 99, 3-12. 
Widdicombe, J.G., (1997) Airway liquid: a barrier to drug diffusion. European Respiratory 
Journal 10, 2194-2197. 
Widory, D., Roy, S., Moullec, Y.L., Goupil, G., Coccherie, A., and Guerrot, C., (2004) The 
origin of atmospheric particles in Paris: a view through carbon and lead isotopes. 
Atmospheric Environment 38, 953-961. 
Wilkinson J.M., Hill J. and Philips C.J.C. (2003) ‘The accumulation of potentially-toxic metals 
by grazing ruminants,’ Proceedings of the Nutrition Society 62, 267-277. 
Williamson, B.J., Udachin, V., Purvis, O.W., Spiro, B., Cressey, G., and Jones, G.C., (2004) 
Characterisation of airborne particulate pollution in the Cu smelter and former mining town of 
Karabash, south Ural mountains of Russia. Environmental Monitoring and Assessment 98, 
235-259. 
Wilson, M.J., and Bell, N., (1996) Acid deposition and heavy metal mobilization. Applied 
Geochemistry 11, 1333-137. 
Wixson. B.G., and Davies, B.E., (1994) Guidelines for lead in soil, proposal of the Society for 
Environmental Geochemistry and Health. Environmental Science & Technology 28, 26 – 31. 
Wolf, M., Naftali, S., Schroter, R.C., and Elad, D., (2004) Air-conditioning characteristics of 
the human nose. The Journal of Laryngology & Otology 118, 87-92. 
Woodward, H., Horsey, B., Bhavanandan, V.P., and Davidson, E.A., (1982) Isolation, 
purification, and properties of respiratory mucus glycoproteins. Biochemistry 21, 694-701. 
241 
 
World Bank Group (1998). Pollution Prevention and Abatement Handbook, 
http://smap.ew.eea.europa.eu/media_server/files/1/v/poll_abatement_handbook.pdf. 
World Health Organisation (2005) WHO air quality guidelines for particulate matter, ozone, 
nitrogen dioxide and sulphur dioxide. Global update 2005: summary of risk assessment. 
Available at URL: http://www.euro.who.int/document/e90038.pdf  accessed November 20, 
2012. 
World Health Organisation (2006) Air quality guidelines global update 2005. Particulate 
matter, ozone, nitrogen dioxide and sulphur dioxide. Available at URL: 
http://www.euro.who.int/__data/assets/pdf_file/0005/78638/E90038.pdf   accessed January 
10, 2013. 
World Health Organisation (2009a) Environmental Health Criteria (EHC) 239: Principles for 
modelling dose-response for the risk assessment of chemicals. Available at URL:   
http://www.inchem.org/documents/ehc/ehc/ehc239.pdf  accessed January 6, 2013. 
World Health Organisation (2009b) DMSA therapy protocol - Mitrovica, UN administered 
province of Kosovo. DMSA WHO treatment protocol 26072009doc. Available at URL: 
https://docs.google.com/viewer?a=v&q=cache:F4drGlJw-
t4J:www.toxicwastekills.com/downloads/DMSA%2520WHO%2520Treatment_Protocol_26%
252007%25202009.doc+DMSA+THERAPY+PROTOCOL+MITROVICA,+UN+ADMINISTER
ED+PROVINCE+OF+KOSOVO&hl=en&gl=uk&pid=bl&srcid=ADGEESg93ft_3hAshj08eO7p
mMDq-
25j22YGjz9U1Qo_ux3x9yW5QnNT5Q6IkEVzogMGnrUAbwOpwn1R9l8r0Kk5hRwCYgRnMh
QOYXPmS1MCOVxhlCdPEELgdLyLCMvkOOyj9kVZgH2s&sig=AHIEtbSgHSmiGr46CBgWJ
0-7ogXmHWnBxg   accessed November 12, 2012. 
World Health Organisation (2010a) Childhood lead poisoning. Available at URL: 
http://www.who.int/ceh/publications/leadguidance.pdf  accessed January 10, 2013.  
World Health Organisation (2010b) Characterization and application of physiologically based 
pharmacokinetic  models in risk assessment; International Programme on Chemical Safety. 
Harmonization project No. 9. Available at URL: 
http://www.inchem.org/documents/harmproj/harmproj/harmproj9.pdf  accessed January 4, 
2013. 
Wragg, J., and Cave, M.R., (2003) In-vitro methods for measurement of oral bioaccessibility 
of selected metals and metalloids in soils: A critical review. R&D Technical Report P5-
062/TR/01. Environment Agency, Bristol, UK. 
242 
 
Wragg, J., and Klinck, B., (2007) The bioaccessibility of lead from Welsh mine waste using a 
respiratory uptake test. Journal of Environmental Science and Health - Part A, 
Toxic/Hazardous Substances & Environmental Engineering   42, 1223-1231. 
Wragg, J., Cave, M.,  Taylor, H., Basta, N., Brandon, E., Casteel, S., Gron, C., Oomem, A., 
and Van De Wiele, T., (2009) Inter-laboratory trial of a unified bioaccessibility procedure. 
Chemical & Biological Hazard Programme Open Report (OR/07/027), Natural Enviroment 
Research Council, Swindon, UK. 
Wragg, J., Cave, M., Basta, N., Braudon, E., Casteel, S., Denys, S., and Wiele, T.V.D., 
(2011) An inter-laboratory trial of the unified BARGE bioaccessibility method for arsenic, 
cadmium and lead in soil. Science of the Total Environment 409, 4016-4030. 
Yakovleva, E., and Hopke, P.K., (1999) Receptor modelling assessment of particle total 
exposure assessment methodology data. Environmental Science & Technology 33, 3645-
3652. 
Yang, W., Peters, J.I., and Williams III, R.O., (2008) Inhaled nanoparticles – a current review. 
International Journal of Pharmaceutics 365, 239-247. 
Yankel, A.J., von Lindern, I.H., and Walter, S.D., (1977) The Silver Valley lead study: The 
relationship between childhood blood lead levels and environmental exposure. Journal of Air 
Pollution Control Association 27, 763-767. 
Yeh, H.C., Phalen, R.F., and Raabe, O.G., (1976) Factors influencing the deposition of 
inhaled particles. Environmental Health Perspectives 15, 147-156. 
Young, T.M., Heeraman, D.A., Sirin, G., Ashbaugh, L.L., (2002) Resuspension of soil as a 
source of airborne lead near industrial facilities and highways. Environmental Science & 
Technology 36, 2484-2490. 
Young, T.M., Heerman, D.A., Sirin, G., Ashbaugh, L., (2001) Resuspension of contaminated 
soil as a source of airborne lead. California Air Resources Board. Available at URL: 
http://arb.ca.gov/research/apr/past/97-325.pdf  accessed January 10, 2013. 
Yu, C.H., Yiin, L-M., and Lioy, P.J., (2006) The bioaccessibility of lead (Pb) from vacuumed 
house dust on carpets in urban residences. Risk Analysis 26, 125-134. 
Zakrzewski, S.F., (2002) Environmental Toxicology 3rd edition Oxford University Press, New 
York. 
243 
 
Zaman, M.S., and Zereen, F., (1998) Growth responses of radish plants to soil cadmium and 
lead contamination. Bulletin of Environmental Contamination and Toxicology 61, 44-50. 
Zeka, A., Zanobetti, A., and Schwartz, J., (2006) Individual-level modifiers of the effects of 
particulate matter on daily mortality. American Journal of Epidemiology 163, 849-859. 
Zhang, L., Zhao, L., Yu, Y., Chen, and C., (1998) Removal of lead from aqueous solution by 
non-living rizopus nigracan. Water Research 32, 1437-1444. 
Zhang, Y., and Engelhardt, J.F., (1999) Airway surface volume and Cl content in cystic 
fibrosis and normal bronchial xenografts. Cell Physiology 276, C469-C476. 
Zhang, Y., Sun, C., Kohler, N., and Zhang, M., (2004) Self-assembled coatings on individual 
monodisperse magnetite nanoparticles for efficient intracellular uptake. Biomedical 
Microdeivices 6, 33-40. 
Zhao, P., Feng, Y., Zhu, T., Wu, J., (2006) characterisation of resuspended dust in six cities 
of north China. Atmospheric Environment 40, 5807-5814. 
Zheng, N., Liu, J., Wang, Q., and Liang, Z., (2010) Health risk assessment of heavy metal 
exposure to street dust in the zinc smelting district, northeast of China. Science of the Total 
Environment 408, 726-733. 
Zia, M.H., Codling, E.C., Scheckel, K.G., and Chaney, R.L., (2011) In vitro and in vivo 
approaches for measurement of oral bioavailability of lead (Pb) in contaminated soils: a 
review. Environmental Pollution 159, 2320-2327. 
Zielinski, H., Mudway, I.S., Berube, K.A., Murphy, S., Richards, R., and Kelly, F.J., (1999) 
Modeling the interactions of particulates with epithelial lining fluid antioxidants. American 
Journal of Physiology – Lung Cellular and Molecular Physiology 277, L719-L726. 
 
 
 
 
 
 
 
244 
 
APPENDICES 
Appendix A: Details of samples selected for bioaccessibility study. Sample ID, sample 
matrix, sample depth and location are given for the 63 samples 
SAMPLE ID SAMPLE MATRIX SAMPLE DEPTH (cm) Location 
RM 2 Soil 0-10 Roma Mahalla 
RM 3 Soil 0-10 Roma Mahalla 
RM 4 Soil 0-10 Roma Mahalla 
RM 6 Soil 0-10 Roma Mahalla 
RM 8 Soil 0-10 Roma Mahalla 
RM 11 Soil 0-10 Roma Mahalla 
RM 12 Soil 0-10 Roma Mahalla 
RM 18 Soil 0-10 Roma Mahalla 
RM 19 Soil 0-10 Roma Mahalla 
RM 20 Soil 0-10 Roma Mahalla 
RM 21 Soil 0-10 Roma Mahalla 
RM 23 Soil 0-10 Roma Mahalla 
RM 24 Soil 0-10 Roma Mahalla 
RM 27 Soil 0-10 Roma Mahalla 
RM 28 Soil 0-10 Roma Mahalla 
RM 30 Soil 0-10 Roma Mahalla 
RM 35 Soil 0-10 Roma Mahalla 
RM 37 Soil 0-10 Roma Mahalla 
RM 40 Soil 0-10 Roma Mahalla 
RM 42 Soil 0-10 Roma Mahalla 
RM 45 Soil 0-10 Roma Mahalla 
RM 49 Soil 0-10 Roma Mahalla 
RM 54 Soil 0-10 Roma Mahalla 
RM 59 Soil 0-10 Roma Mahalla 
RM 62 Soil 0-10 Roma Mahalla 
BM 1 Soil 0-10 Bosniak Mahalla 
BM 3 Soil 0-10 Bosniak Mahalla 
BM 5 Soil 0-10 Bosniak Mahalla 
BM 7 Soil 0-10 Bosniak Mahalla 
BM 9 Soil 0-10 Bosniak Mahalla 
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BM 11 Soil 0-10 Bosniak Mahalla 
BM 13 Soil 0-10 Bosniak Mahalla 
BM 15 Soil 0-10 Bosniak Mahalla 
BM 17 Soil 0-10 Bosniak Mahalla 
BM 19 Soil 0-10 Bosniak Mahalla 
RM 69 Soil 0-10 Osterode 
RM 67 Soil 0-10 Osterode 
RM 70 Soil 0-10 Cesmin lug 
RM 71 Soil 0-10 Cesmin lug 
RM 72 Soil 0-10 Cesmin lug 
RM 73 Soil 0-10 Cesmin lug 
RM 74 Soil 0-10 Cesmin lug 
BM 20 Soil 0-10 Seating Area 
BM 21 River sediment 0-10 River Bank 
BM 23 Soil 0-10 Mitrovica City 
BM 26 Soil 0-10 Mitrovica City  
BM 40 Soil 0-10 City park 
BM 41 Soil 0-10 City park 
BM 45 Garden Soil 0-10 Roadside Garden 
BM 46 Soil 0-10 City park 
BM 47 Soil 0-10 Riverbank Garden 
BM 49 Waste ground 0-10 Public waste ground 
BM 50 soil 0-10 City park 
RM 66 Tailing 3  Zharkov Potok 
RM 66 Tailing 2  Zharkov Potok 
RM 66 Tailing 1  Zharkov Potok 
BM 32 Tailing pond  Zharkov Potok 
BM 36 Yellow Tailings   
RM 76 Smelt. Red  Zvecan 
BM 39 Smelter waste  Zvecan Floodplain 
RM 77 Slag/Tails (Zn electrol)  Zn Smelter plant 
RM 77 Waste (Zn electrol)  Zn Smelter plant 
BM 35 Smelter waste  Black smelter fine 
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Appendix B: Stokes’ Law 
Theory of the Extraction Process (Jackson, 1979) 
George Gabriel Stoke developed a mathematical description of the force needed to move a 
sphere through a viscous fluid at a stated velocity. The equation (Stokes’ law) describing the 
motion is written as, 
Fd = 6πµVd                                                                                     (1) 
Where   Fd is drag force of the fluid on a suspended sphere 
               µ is the fluid viscosity 
                V is the velocity of the suspended sphere through the fluid 
                 d is the diameter of the suspended sphere 
In a suspension three forces are acting on the suspended sphere (Buoyancy effect of 
displacing the fluid, viscous drag on the sphere by the fluid and gravitational attraction). The 
buoyancy and drag forces are resisting the downward force due to gravitational attraction. 
Inputting the relationship between the drag force and the other forces influencing the 
suspended sphere and rearrangement of the resulting equations yields the equation relating 
sedimentation velocity to diameter of suspended sphere. 
 
V = g.d2 (Pp - Pm) /18µ                                                                                (2) 
Where      V is the velocity of the suspended sphere through the fluid (unit- cm.s-1)                   
                    g is acceleration of gravity (unit- cm.s-2) 
                   d is particle diameter (unit- cm) 
                  Pp is average particle density for mineral soils (unit- g.cm-3) (freeze and Cherry, 
1979) 
                  Pm is density of water at a given temperature (g.cm-3) (Lide, 1988) 
                   µ is viscosity of water at stated temperature (g.cm-1.s-1) (Lide, 1988)  
Substituting velocity of sedimentation with distance travelled (D) and time required (T) by 
PM10 to reach a designated point in the medium and rearrangement of equation 2 yields; 
T = (18D. µ) / [g.d2 (Pp - Pm)]                                                                (3) 
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The times 1044 and 3198 seconds were derived from equation 3 based on the default soil 
particle density (2.650 g.cm-3) and the < 63 µm fraction density (1.538 g.cm-3 determined in 
this work) as the time required for particulate matter >10 µm in suspension to pass the 50 ml 
mark (see fig.1); 
                    g =980.665 cm.s-2 
                   d = 0.001 cm 
                  Pp = default: 2.650 g.cm-3 (measured and applied: 1.538 g.cm-3)  
                  Pm at 20 oC = 0.998 g.cm-3 
                   µ at 20 oC = 0.010 g.cm-1.s-1 
                   D = 9.400 cm (see fig.1) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
248 
 
Appendix C: Total, gastric phase, gastrointestinal phase and residual concentrations of As and calculated % bioaccessibility of As in the 
gastric and gastrointestinal phases. Recovered Pb content, expressed as % total mass recovery is given. 
Sample Total (mg/kg) In-vitro oral bioaccessibility (mg/kg) 
  
Stage I Stage II Stage III Total recovered As content 
  
Gastric Phase Gastrointestinal Phase (Residual digest) (Stage II + III) 
 
Mean ± SD Mean ± SD 
% 
BAF Mean ± SD 
% 
BAF Mean ± SD Total % Total Recovery 
 
(n = 3) (n = 3) 
 
(n = 3) 
 
(n = 3) 
  RM2 26.0 ± 1.56 4.08 ± 0.26 15.7 5.04 ± 0.10 19.4 23.6 ± 0.14 28.6 110 
RM3 29.4 ± 0.87 5.11 ± 0.14 17.4 9.11 ± 0.12 31 22.7 ± 0.63 31.8 108 
RM4 19.4 ±  0.77 4.32 ± 0.56 22.3 3.89 ± 0.07 20 18.5 ± 1.84 22.1 114 
RM6 22.1 ± 0.76 3.97 ± 0.10 18.0 6.06 ± 0.56 27.4 21.4 ± 0.95 27.5 124 
RM11 25.4 ± 1.48 6.22 ± 0.21 24.5 4.87 ± 0.11 19.2 24.6 ± 2.87 29.5 116 
RM12 25.2 ± 0.30 5.89 ± 0.21 23.4 5.23 ± 0.14 20.7 24.6 ± 1.10 29.8 118 
RM20 19.2 ± 0.41 4.40 ± 0.17 22.9 4.24 ± 0.36 22.1 17.7  ± 2.34 21.9 114 
RM24 20.2 ± 0.47 4.02 ± 0.16 19.9 4.00 ± 0.12 19.8 19.5 ± 0.14 20.0 99 
RM42 20.6 ± 0.76 3.88 ± 0.14 18.8 4.09 ± 0.26 19.8 20.6 ± 2.53 21.0 102 
RM45 17.9 ± 0.70 5.11 ± 0.15 28.5 4.41 ± 0.20 24.6 15.5 ± 1.42 19.9 111 
RM49 15.4 ± 1.05 4.00 ± 0.16 26.0 3.51 ± 0.18 22.8 14.6 ± 0.28 18.1 117 
RM66T1 2,700 ± 20.9 200 ± 31.8 7.40 150 ± 12.6 5.55 2,360 ± 162 2,510 93.0 
RM66T2 2,700 ± 26.9 72.6 ± 4.46 2.70 50.8  ± 0.72  1.88 2,540 ± 246 2,590 95.9 
RM66T3 1,070 ± 61.3 35.2 ± 4.81 3.30 44.2 ± 4.57 4.13 1,120 ± 334 1,120 105 
RM67 23.0 ± 0.88 4.89 ± 0.20 21.3 3.89 ± 0.36 16.9 22.6 ± 2.48 26.5 115 
RM69 112 ± 4.65 28.0 ± 6.75 25.0 21.5 ± 0.44 19.2 90.9 ± 0.41 112 100 
RM70 44.4 ± 2.08 9.44 ± 1.15 21.3 8.04 ± 0.22 18.1 45.5 ± 3.23 53.5 120 
RM71 101 ± 2.17 19.0 ± 2.46 18.8 16.0 ± 0.34 15.8 107 ± 10.2 123 122 
RM72 148 ± 7.50 7.78 ± 0.12 5.26 15.6 ± 0.70 10.5 123 ± 16.8 139 93.9 
RM73 86.1 ± 3.19 22.2 ± 2.77 25.8 21.4 ± 0.41 24.8 76.7 ± 9.4 98.1 113 
RM74 140 ± 1.04 12.0 ± 0.76 8.57 21.2 ± 0.88 15.1 156 ± 13.8 177 126 
RM76 4,340 ± 59.0 43.7 ± 4.58 1.01 58.7 ± 4.37 1.35 5,230 ± 361 5,290 121 
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RM77(S/T) 1,910 ± 104 296 ± 36.5 15.5 46.9 ± 0.92 2.45 1,950 ± 52.0 2000 104 
RM77(W) 3,810 ± 220 1,270 ± 96.8 33.3 305 ± 60.5 8 3,470 ± 189 3,770 98.9 
RM8 13.1 ± 0.76 2.20 ± 0.06 16.8 3.22 ± 0.10 24.6 9.23 ± 1.08 12.4 94.6 
RM18 20.1 ± 0.87 3.28 ± 0.08 16.3 4.13 ± 0.17 20.54 17.8 ± 0.67 21.9 109 
RM19 20.7 ± 0.22 3.90 ± 0.09 18.8 5.77 ± 0.28 27.9 16.8 ± 0.17 22.6 109 
RM21 23.8 ± 0.88 5.10 ± 0.10 21.4 6.28 ± 0.29 26.4 16.2 ± 0.85 22.5 94.5 
RM23 22.2 ± 1.01 4.42 ± 0.08 20.0 6.32 ± 0.14 28.5 15.8 ± 0.62 22.1 99.5 
RM27 21.4 ± 0.48 3.83 ± 0.07 17.9 5.31 ± 0.12 24.8 14.8 ± 0.59 20.1 93.9 
RM28 18.7 ± 0.46 3.09 ± 0.08 16.5 4.24 ± 0.11 22.7 15.1 ± 0.10 19.3 103 
RM30 21.5 ± 0.41 4.61 ± 0.06 21.4 6.07 ± 0.10 28.2 15.2 ± 0.38 21.3 99.1 
RM35 19.1 ± 0.26 3.14 ± 0.05 16.4 4.30 ± 0.16 22.5 14.4 ± 0.16 18.7 97.9 
RM37 16.7 ± 0.75 3.56 ± 0.26 21.3 3.04 ± 0.16 18.2 14.4 ± 0.56 17.4 104 
RM40 26.3 ± 1.04 10.4 ± 0.47 39.5 6.91 ± 0.38 26.3 21.3 ± 1.71 28.2 107 
RM54 19.6 ± 0.99 3.30 ± 0.06 16.8 4.48 ± 0.21 22.9 14.3 ± 0.59 18.8 95.9 
RM59 27.5 ± 2.70 7.89 ± 0.37 28.7 7.84 ± 0.15 28.5 18.1 ± 0.77 25.9 94.2 
RM62 26.5 ± 1.10 5.72 ± 0.18 21.6 6.23 ± 0.12 23.5 19.4 ± 1.11 25.6 96.6 
BM1 200 ± 8.66 26.0 ± 1.01 13.0 47.0 ± 1.19 23.5 102 ± 6.66 149 74.5 
BM3 144 ± 6.76 34.8 ± 1.66 24.2 48.7 ± 2.75 33.8 78.0 ± 3.77 127 88.2 
BM5 140 ± 3.81 29.4 ± 0.78 21.0 42.1 ± 2.02 30.1 87.7 ± 2.27 130 92.8 
BM7 79.0 ± 2.07 17.0 ± 0.08 21.5 20.6 ± 0.75 26.1 55.4 ± 3.04 76.0 96.2 
BM9 123 ± 7.56 22.2 ± 1.79 18.0 40.8 ± 2.56 33.2 70.3 ± 1.10 111 90.2 
BM11 80.4 ± 1.12 20.0 ± 0.55 24.9 23.3 ± 1.03 29 54.6 ± 2.17 77.9 96.9 
BM13 168 ± 3.71 33.2 ± 1.67 19.8 43.9 ± 2.88 26.1 114 ± 7.19 158 94.0 
BM15 270 ± 13.8 46.7 ± 1.81 17.3 46.0 ± 1.71 17 203 ± 10.1 249 92.2 
BM17 134 ± 1.07 30.4 ± 0.91 22.7 65.6 ± 1.11 48.9 65.5 ± 3.83 131 97.8 
BM19 60.2 ± 2.91 15.1 ± 0.77 25.1 19.2 ± 0.88 31.9 38.2 ± 3.94 57.4 95.3 
BM20 10.0 ±0.01 1.43 ± 0.06 14.3 2.63 ± 0.06 26.3 4.92 ± 0.31 7.55 75.5 
BM21 11.7 ± 0.68 2.09 ± 0.06 17.9 3.42 ± 0.07 29.2 8.79 ± 1.54 12.2 104 
BM23 74.8 ± 0.71 24.2 ± 1.61 32.3 19.2 ± 0.86 25.7 54.0 ± 2.38 73.2 97.9 
BM26 6.03 ± 0.10 2.18 ± 0.07 36.1 1.44 ± 0.07 23.9 5.03 ± 0.14 6.47 107 
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BM32 3,310 ± 34.3 90.0 ± 3.76 2.72 119 ± 3.06 3.59 3,230 ± 120 3,350 101 
BM35 22,600 ± 300 260 ± 7.74 1.15 99.8 ± 4.78 0.44 22,100 ± 480 22,200 98.2 
BM36 1730 ± 63.0 285 ± 8.08 16.5 162 ± 2.12 9.36 1,640 ± 48.0 1800 104 
BM39 83.7 ± 3.00 29.4 ± 0.61 35.1 19.2 ± 0.08 22.9 61.6 ± 2.45 80.8 96.5 
BM40 32.0 ± 1.66 12.0 ± 0.67 37.5 10.2 ± 0.47 31.9 22.8 ± 1.29 33.0 103 
BM41 38.4 ± 1.87 12.3 ± 0.56 32.0 9.4 ± 0.58 24.5 30.3 ± 0.85 39.7 103 
BM45 114 ± 9.76 33.0 ± 1.71 28.9 39.0 ± 1.78 34.2 69.7 ± 2.51 109 95.6 
BM46 54.8 ± 0.89 12.9 ± 0.68 23.5 10.8 ± 0.47 19.7 43.4 ± 3.58 54.2 98.9 
BM47 33.3 ± 2.55 7.77 ± 0.69 23.3 10.3 ± 0.27 30.9 22.3 ± 1.34 32.6 97.9 
BM49 512 ± 15.0 90.2 ± 4.65 17.6 55.0 ± 1.88 10.7 433 ± 14.7 488 95.3 
BM50 46.0 ± 0.88 14.4 ± 0.81 31.3 13.3 ± 0.41 28.9 33.1 ± 1.19 46.4 101 
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Appendix D: Total, gastric phase, gastrointestinal phase and residual concentrations of Cd and calculated % bioaccessibility of Cd in the 
gastric and gastrointestinal phases. Recovered Cd content, expressed as % total mass recovery is given. 
.Sample Total (mg/kg) In-vitro oral bioaccessibility (mg/kg) 
  
Stage I Stage II Stage III Total recovered Cd content 
  
Gastric Phase 
Gastrointestinal 
Phase (Residual digest) (Stage II + III) 
 
Mean ± SD Mean ± SD 
% 
BAF Mean ± SD 
% 
BAF Mean ± SD Total % Total Recovery 
 
(n = 3) (n = 3) 
 
(n = 3) 
 
(n = 3) 
  RM2 1.62 ± 0.04 1.21 ± 0.06 74.7 bd NA 1.45 ± 0.04 1.45 89.5 
RM3 2.19 ± 0.05 1.50 ± 0.07 68.5 bd NA 1.95 ± 0.05 1.95 89.0 
RM4 1.22 ± 0.03 0.63 ± 0.03 51.6 bd NA 0.99 ± 0.04 0.99 81.1 
RM6 1.24 ± 0.04 0.60 ± 0.03 48.4 bd NA 1.11 ± 0.04 1.11 89.5 
RM11 2.35 ± 0.05 1.52 ± 0.07 64.7 bd NA 2.18 ± 0.10 2.18 92.8 
RM12 2.10 ± 0.04 1.49 ± 0.07 70.9 bd NA 1.81 ± 0.05 1.81 86.2 
RM20 1.41 ± 0.03 0.81 ± 0.04 57.4 bd NA 1.38 ± 0.04 1.38 97.9 
RM24 1.54 ± 0.03 0.75 ± 0.04 48.7 bd NA 1.29 ± 0.06 1.29 83.8 
RM42 1.68 ± 0.04 0.90 ± 0.04 53.6 bd NA 1.46 ± 0.03 1.46 86.9 
RM45 1.65 ± 0.03 0.91 ± 0.03 55.1 bd NA 1.41 ± 0.09 1.41 85.4 
RM49 1.19 ± 0.02 0.62 ± 0.03 52.1 bd NA 1.28 ± 0.07 1.28 107 
RM66T1 1.03 ± 0.02 bd NA bd NA 1.14 ± 0.03 1.14 110 
RM66T2 1.12 ± 0.03 bd NA bd NA 1.27 ± 0.05 1.27 113 
RM66T3 6.47 ± 0.11 0.81 ± 0.03 12.5 bd NA 6.41 ± 0.09 6.14 94.9 
RM67 2.35  ± 0.04 1.05 ± 0.04 44.1 0.55 ± 0.04 23.4 1.65 ± 0.12 2.20 93.6 
RM69 5.90 ± 0.10 3.58 ± 0.10 60.7 4.04 ± 0.16 68.5 1.31 ± 0.14 5.35 90.7 
RM70 1.64 ± 0.04 0.88 ± 0.04 53.7 bd NA 1.40 ± 0.06 1.40 85.3 
RM71 3.81 ± 0.08 2.50 ± 0.08 65.6 bd NA 3.80 ± 0.12 3.80 99.7 
RM72 2.47 ± 0.07 1.67 ± 0.07 67.6 bd NA 2.80 ± 0.11 2.80 113 
RM73 2.78 ± 0.07 1.63 ± 0.06 58.6 1.91 ± 0.15 68.7 0.60 ± 0.14 2.51 90.3 
RM74 4.53 ± 0.36 2.88 ± 0.09 63.6 3.42 ± 0.08 75.5 0.94 ± 0.09 4.36 96.2 
RM76 1.00 ± 0.16 0.12 ± 0.01 12.0 bd NA 0.80 ± 0.08 0.80 80.0 
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RM77(S/T) 1,430 ± 79.8 618 ± 2.04 43.2 527 ± 4.23 36.8 858 ± 2.03 1,380 96.5 
RM77(W) 1,440 ± 4.55 650 ± 1.12 45.1 41.8 ± 1.10 2.9 1,160 ± 37.0 1,200 83.3 
RM8 0.42 ± 0.01 0.25 ± 0.01 59.5 bd NA 0.35 ± 0.24 0.35 83.3 
RM18 0.95 ± 0.02 0.40 ± 0.01 42.1 bd NA 0.91 ± 0.03 0.91 95.8 
RM19 1.04 ± 0.05 0.57 ± 0.01 54.8 bd NA 1.00 ± 0.01 1.00 96.1 
RM21 0.72 ± 0.02 0.37 ± 0.01 51.4 bd NA 0.77 ± 0.06 0.77 106 
RM23 1.05 ± 0.06 0.58 ± 0.01 55.2 bd NA 0.92 ± 0.05 0.92 87.6 
RM27 1.38 ± 0.02 0.81 ± 0.01 58.7 bd NA 1.32 ± 0.07 1.32 95.6 
RM28 1.00 ± 0.02 0.40 ± 0.01 40.0 bd NA 0.95 ± 0.11 0.95 95.0 
RM30 1.93 ± 0.02 1.07 ± 0.01 55.4 bd NA 1.86 ± 0.01 1.86 96.4 
RM35 0.90 ± 0.03 0.46 ± 0.01 51.1 bd NA 0.84 ± 0.07 0.84 93.3 
RM37 1.11 ± 0.05 0.50 ± 0.01 45.0 bd NA 1.10 ± 0.05 1.10 99.1 
RM40 0.83 ± 0.03 0.42 ± 0.01 50.6 bd NA 0.74 ± 0.02 0.74 89.1 
RM54 0.90 ± 0.02 0.48 ± 0.04 53.3 bd NA 0.81 ± 0.07 0.81 90.0 
RM59 22.2 ± 0.40 14.9 ± 0.20 67.1 3.69 ± 0.08 16.6 16.9 ± 0.14 20.6 92.8 
RM62 bd bd NA bd NA bd NA NA 
BM1 12.3 ± 0.02 6.72 ± 0.15 54.6 0.86 ± 0.07 7.00 11.3 ± 0.31 12.2 99.2 
BM3 12.5 ± 0.41 6.50 ± 0.26 52.0 0.84 ± 0.02 6.72 11.6 ± 0.62 12.4 99.2 
BM5 13.2 ± 0.63 6.47 ± 0.09 49.0 1.03 ± 0.02 7.80 11.2 ± 0.24 12.2 92.4 
BM7 9.64 ± 0.28 5.40 ± 0.25 56.0 0.56 ± 0.03 5.81 8.80 ± 0.14 9.36 97.1 
BM9 13.3 ± 0.65 8.00 ± 0.13 60.1 0.85 ± 0.05 6.39 12.9 ± 0.52 13.7 103 
BM11 5.52 ± 0.09 3.22 ± 0.12 58.3 0.92 ± 05 16.7 4.15 ± 0.12 5.07 91.8 
BM13 15.4 ± 0.07 7.74 ± 0.18  50.3 1.16 ± 0.03 7.50 14.3 ± 0.49 15.5 101 
BM15 14.3 ± 0.30 8.70 ± 0.25 60.8 1.56 ± 0.09 10.9 13.5 ± 0.34 15.1 106 
BM17 9.51 ± 0.10 5.67 ± 0.18 59.6 1.06 ± 0.03 11.1 8.25 ± 0.40 9.31 97.9 
BM19 6.14 ± 0.04 2.53 ± 0.04 41.2 0.19 ± 0.01 3.09 5.55 ± 0.24 5.74 93.5 
BM20 bd bd NA bd NA bd NA NA 
BM21 1.10 ± 0.01 0.59 ± 0.03 53.6 bd NA 0.92 ± 0.12 0.92 83.6 
BM23 4.62 ± 0.09 2.42 ± 0.20 52.4 0.32 ± 0.01 6.92 4.39 ± 0.18 4.71 102 
BM26 bd bd NA bd NA bd NA NA 
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BM32 2.20 ± 0.08 0.39 ± 0.02 17.7 bd NA 2.12 ± 0.14 2.12 96.4 
BM35 1.38 ± 0.01 0.60 ± 0.03 43.5 bd NA 1.25 ± 0.04 1.25 90.6 
BM36 350 ± 15.9 45.8 ± 1.34 13.1 7.62 ± 0.28 2.18 332 ± 11.4 340 97.1 
BM39 8.49 ± 0.41 4.51 ± 0.07 53.1 0.34 ± 0.01 4.00 7.35 ± 0.09 7.69 90.6 
BM40 2.50 ± 0.12 1.33 ± 0.04 53.2 bd NA 2.33 ± 0.11 2.33 93.2 
BM41 2.69 ± 0.07 1.41 ± 0.02 52.4 0.27 ± 0.01 10.0 2.14 ± 0.06 2.41 89.6 
BM45 5.07 ± 0.04 2.39 ± 0.02 47.1 0.54 ± 0.02 10.6 4.42 ± 0.18 4.96 97.8 
BM46 1.52 ± 0.07 0.60 ± 0.01 39.5 bd NA 1.42 ± 0.01 1.42 93.4 
BM47 2.51 ± 0.07 1.23 ± 0.02 49.0 bd NA 2.50 ± 0.03 2.50 99.6 
BM49 51.3 ± 1.48 21.3 ± 0.05 41.5 4.34 ± 0.13 8.46 46.8 ± 2.38 51.1 99.6 
BM50 3.50 ± 0.04 1.60 ± 0.03 45.7 0.26 ± 0.01 7.43 3.34 ± 0.16 3.60 103 
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Appendix E: Total, gastric phase, gastrointestinal phase and residual concentrations of Cu and calculated % bioaccessibility of Cu in the 
gastric and gastrointestinal phases. Recovered Cu content, expressed as % total mass recovery is given. 
Sample Total (mg/kg) In-vitro oral bioaccessibility (mg/kg) 
  
Stage I Stage II Stage III Total recovered Cu content 
  
Gastric Phase 
Gastrointestinal 
Phase (Residual digest) (Stage II + III) 
 
Mean ± SD Mean ± SD 
% 
BAF Mean ± SD 
% 
BAF Mean ± SD Total % Total Recovery 
 
(n = 3) (n = 3) 
 
(n = 3) 
 
(n = 3) 
  RM2 29.0 ± 2.03 6.77 ± 0.31 23.3 7.22 ± 0.23 24.9 20.0 ± 2.67 27.2 93.8 
RM3 33.5 ± 1.60 8.88 ± 0.27 26.5 8.09 ± 0.30 24.1 27.6 ± 2.05 35.7 106 
RM4 23.5 ± 1.71 6.10 ± 0.19 25.9 5.07 ± 0.17 21.6 18.7 ± 0.91 23.8 101 
RM6 24.9 ± 0.83 bd NA bd NA 24.8 ± 1.19 24.8 99.6 
RM11 35.2 ± 1.07 bd NA bd NA 34.2 ± 0.76 34.2 97.2 
RM12 32.5 ± 0.58 bd NA bd NA 31.8 ± 0.84 31.8 97.8 
RM20 26.1 ± 0.42 bd NA bd NA 28.5 ± 0.65 28.5 109 
RM24 33.3 ± 1.69 7.91 ± 0.32 23.7 6.52 ± 0.32 19.6 28.7 ± 1.63 35.2 106 
RM42 34.1 ± 0.81 7.58 ± 0.33 22.2 bd NA 36.5 ± 2.40 36.5 107 
RM45 32.5 ± 1.86 6.93 ± 0.29 21.3 bd NA 32.1 ± 0.56 32.1 98.8 
RM49 28.0 ± 0.66 5.68 ± 0.16 20.3 5.28 ± 0.27 18.9 25.6 ± 1.33 30.9 110 
RM66T1 626 ± 14.8 24.0 ± 2.65 3.83 81.1 ± 3.91 12.9 564 ± 18.4 645 103 
RM66T2 503 ± 30.9 17.5 ± 2.15 3.48 46.4 ± 2.09 9.22 475 ± 11.0 521 103 
RM66T3 237 ± 2.50 bd NA bd NA 243 ± 18.6 243 102 
RM67 39.3 ± 0.62 7.89 ± 0.31 20.1 5.36 ± 0.21 13.6 33.7 ± 2.21 39.1 99.5 
RM69 136 ± 1.78 31.0 ± 1.42 22.8 27.6 ± 1.14 20.3 127 ± 4.65 155 114 
RM70 36.6 ± 1.47 7.54 ± 0.33 20.6 5.66 ± 0.18 15.5 33.5 ± 0.83 39.2 107 
RM71 96.2 ± 2.56 15.7 ± 0.56 16.3 bd NA 106 ± 6.40 106 110 
RM72 91.9 ± 1.38 bd NA bd NA 97.0 ± 6.77 97.0 105 
RM73 193 ± 2.84 47.7 ± 0.51 24.7 36.0 ± 1.07 18.6 166 ± 3.78 202 104 
RM74 204 ± 1.99 70.8 ± 2.77 34.7 36.2 ± 1.62 17.7 197 ± 4.54 233 114 
RM76 323 ± 7.04 9.82 ± 0.38 3.04 10.3 ± 0.36 3.19 309 ± 5.91 319 98.8 
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RM77(S/T) 3,790 ± 74.0 1,650 ± 56.6 43.5 1210 ± 40.0 31.9 2,600 ± 117 3,810 100 
RM77(W) 7,150 ± 79.8 5,200 ± 184 72.7 2120 ± 111 29.6 4,880 ± 177 7,000 97.9 
RM8 61.3 ± 1.71 15.1 ± 0.34 24.6 22.3 ± 0.48 36.4 39.8 ± 8.3 62.1 101 
RM18 75.3 ± 3.88 18.1 ± 0.38 24.0 24.4 ± 0.71 32.4 53.2 ± 2.58 77.6 103 
RM19 76.1 ± 4.16 18.8 ± 0.30 24.7 28.4 ± 0.88 37.3 56.6 ± 2.37 85.0 111 
RM21 70.2 ± 2.11 17.4 ± 0.73 24.8 22.8 ± 0.68 32.5 48.5 ± 0.87 71.3 101 
RM23 80.2 ± 0.90 21.3 ± 0.60 26.5 24.7 ± 0.91 30.8 60.7 ± 1.30 85.4 106 
RM27 81.5 ± 2.85 16.6 ± 1.26 NA 25.0 ± 1.75 30.7 59.6 ± 1.35 84.6 104 
RM28 73.1 ± 2.59 16.8 ± 0.67 23.0 21.3 ± 1.56 29.1 54.0 ± 2.39 78.3 107 
RM30 92.1 ± 4.26 20.2 ± 0.57 21.9 24.8 ± 1.66 26.9 68.9 ± 0.62 93.7 101 
RM35 69.9 ± 3.31 15.6 ± 0.56 22.3 19.3 ± 1.28 27.6 52.7 ± 3.05 72.0 103 
RM37 80.8 ± 4.28 15.5 ± 1.15 19.2 21.7 ± 1.09 26.9 60.9 ± 2.78 82.6 102 
RM40 78.9 ± 1.30 12.1 ± 0.18 15.3 15.3 ± 0.71 19.4 64.5 ± 2.87 79.8 101 
RM54 66.3 ± 0.66 15.0 ± 0.76 22.6 18.5 ± 0.84 27.9 50.2 ± 1.12 68.7 104 
RM59 113 ± 2.72 27.9 ± 0.92 24.7 36.5 ± 1.65 32.3 85.4 ± 5.56 122 107 
RM62 67.3 ± 3.18 14.3 ± 0.32 21.2 17.8 ± 0.20 26.4 52.1 ± 0.74 69.9 103 
BM1 201 ± 1.64 31.3 ± 1.75 15.6 52.1 ± 0.94 25.9 136 ± 6.90 188 93.5 
BM3 224 ± 6.13 37.3 ± 1.30 16.6 67.1 ± 3.09 29.9 135 ± 6.48 202 90.2 
BM5 207 ± 2.20 47.9 ± 1.24 23.1 80.6 ± 2.46 38.9 127 ± 1.93 208 100 
BM7 138 ± 6.61 20.6 ± 1.66 14.9 48.9 ± 0.51 35.4 90.2 ± 1.09 139 101 
BM9 171 ± 4.76 31.0 ± 2.41 18.1 62.9 ± 2.88 36.8 127 ± 2.80 190 111 
BM11 84.6 ± 0.72 26.3 ± 1.60 31.1 34.6 ± 1.69 40.9 44.7 ± 2.58 79.3 93.7 
BM13 195 ± 10.2 26.5 ± 1.18 13.6 38.2 ± 1.70 19.6 166 ± 8.78 204 104 
BM15 235 ± 8.29 46.7 ± 2.88 19.9 65.9 ± 2.87 28.0 184 ± 7.41 250 106 
BM17 168 ± 6.88 23.7 ± 1.45 14.1 37.3 ± 1.91 22.2 124 ± 4.46 161 95.8 
BM19 115 ± 4.65 27.8 ± 0.19 24.2 30.2 ± 3.30 26.3 81.0 ± 2.84 111 96.5 
BM20 32.2 ± 0.43 6.42 ± 0.07 19.9 7.61 ± 0.30 23.6 24.3 ± 1.35 31.9 99.1 
BM21 35.6 ±  0.78 9.89 ± 0.20 27.8 11.9 ± 0.42 33.4 21.6 ± 1.26 33.5 94.1 
BM23 146 ± 5.90 31.5 ± 1.22 21.6 32.1 ± 1.66 22.0 97.0 ± 2.33 129 88.3 
BM26 42.1 ± 2.00 4.60 ± 0.20 10.9 6.3 ± 0.29 15.0 38.2 ± 1.50 44.5 106 
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BM32 180 ± 4.85 13.1 ± 0.43 7.28 20.7 ± 1.85 11.5 159 ± 2.88 180 100 
BM35 4,660 ± 59.1 48.2 ± 3.85 1.03 75.0 ± 4.51 1.61 4,500 ± 243 4,570 98.1 
BM36 2,090 ± 38.4 473 ± 14.5 22.6 664 ± 19.2 31.8 1,510 ± 48.9 2,170 103 
BM39 82.7 ± 6.25 25.4 ± 1.46 30.7 31.8 ± 2.07 38.4 43.8 ± 1.40 75.6 91.4 
BM40 58.6 ± 1.27 18.7 ± 0.87 31.9 21.2 ± 0.80 36.2 41.1 ± 2.04 62.3 106 
BM41 60.5 ± 0.81 19.4 ± 0.73 32.1 27.9 ± 0.56 46.1 38.4 ± 3.07 66.3 110 
BM45 106 ± 5.77 27.2 ± 1.06 25.7 41.5 ± 3.69 39.1 63.1 ± 1.32 105 99.1 
BM46 51.6 ± 2.59 12.5 ± 0.33 24.2 16.3 ± 0.88 31.6 33.7 ± 1.20 50.0 96.9 
BM47 76.1 ± 2.26 21.8 ± 1.57 28.6 25.4 ± 0.71 33.4 53.0 ± 1.41 78.4 103 
BM49 444 ± 22.0 64.6 ± 1.70 14.5 62.2 ± 0.86 14.0 382 ± 4.27 444 100 
BM50 74.6 ± 2.79 18.6 ± 1.11 24.9 24.3 ± 0.78 32.6 56.1 ± 1.31 80.4 108 
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Appendix F: Total, gastric phase, gastrointestinal phase and residual concentrations of Mn and calculated % bioaccessibility of Mn in the 
gastric and gastrointestinal phases. Recovered Mn content, expressed as % total mass recovery is given. 
.Sample Total (mg/kg) In-vitro oral bioaccessibility (mg/kg) 
  
Stage I Stage II Stage III Total recovered Mn content 
  
Gastric Phase 
Gastrointestinal 
Phase (Residual digest) (Stage II + III) 
 
Mean ± SD Mean ± SD % BAF Mean ± SD % BAF Mean ± SD Total % Total Recovery 
 
(n = 3) (n = 3) 
 
(n = 3) 
 
(n = 3) 
  RM2 753 ± 3.04 434 ± 8.87 57.6 145 ± 1.04 19.3 644 ± 36.4 789 105 
RM3 788 ± 13.3 466 ± 12.7 59.1 174 ± 3.11 22.1 671 ± 3.03 845 107 
RM4 615 ± 14.7 433 ± 31.0 70.3 167 ± 4.10 27.1 481 ± 6.68 648 105 
RM6 665 ± 10.3 470 ± 25.3 70.7 163 ± 6.22 24.5 516 ± 39.1 679 102 
RM11 742 ± 12.7 598 ± 27.8 80.6 192 ± 10.4 25.9 554 ± 32.2 746 100 
RM12 686 ± 12.8 500 ± 14.7 72.9 169 ± 2.31 24.6 571 ± 35.1 740 108 
RM20 654 ± 9.78 443 ± 21.2 67.7 159 ± 7.80 24.3 543 ± 31.8 702 107 
RM24 710 ± 20.9 451 ± 18.3 63.5 160  ± 4.04 22.5 560 ± 11.6 720 101 
RM42 704 ± 22.8 519 ± 10.0 73.7 169 ± 10.2 24.0 537 ± 16.0 706 100 
RM45 617 ± 6.24 563 ± 13.3 91.2 165 ± 5.30 26.7 461 ± 32.2 626 101 
RM49 575 ± 26.0 549 ± 14.2 95.4 158 ± 10.1 27.4 473 ± 26.7 631 110 
RM66T1 2,810  ± 220 122 ± 5.56 4.30 15.0 ± 2.30 0.50 3,470 ± 260 3,480 124 
RM66T2 5,310 ± 38.8 26.0 ± 1.01 0.40 2.3 ± 0.33 0.10 5,560 ± 320 5,560 105 
RM66T3 
111,000 ± 
1800 
8550 ± 190 
7.70 500 ± 34.0 0.40 101,000 ± 290 101,500 91.7 
RM67 679 ± 6.82 472 ± 21.4 69.5 138 ± 7.88 20.3 512 ± 6.79 650 95.7 
RM69 927 ± 19.0 567 ± 35.6 61.2 192 ± 8.87 20.7 709 ± 9.06 901 97.2 
RM70 870 ± 27.8 508 ± 24.1 58.4 165 ± 13.1 19.0 742 ± 21.1 907 104 
RM71 834 ± 50.2 527 ± 29.1 63.2 157 ± 3.68 18.8 675 ± 33.6 832 99.8 
RM72 1,400 ± 65.7 476 ± 13.9 34.0 250 ± 15.4 17.9 1,160 ± 96.4 1,410 101 
RM73 1,220 ± 79.3 679 ± 11.5 55.8 182 ± 18.2 14.9 1,070 ± 42.4 1,250 103 
RM74 1,080 ± 45.3 620 ± 20.9 57.2 174 ± 12.2 16.0 860 ± 45.6 1,030 95.3 
RM76 2,290 ± 130 43 ± 1.88 1.90 4.00 ± 0.30 0.20 2,260 ± 110 2,260 98.9 
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RM77(S/T) 39,700 ± 1900 1,440 ± 16.7 3.60 1,280 ± 120 3.20 38,400 ± 1400 39,700 99.9 
RM77(W) 14,200 ± 630 110 ± 5.04 0.80 5.00 ± 0.11 0.10 13,500 ± 270 13,500 95.1 
RM8 577 ± 26.5 367 ± 19.2 63.6 216 ± 11.1 37.4 360 ± 14.2 576 99.8 
RM18 850 ± 27.9 312 ± 3.97 36.7 192 ± 7.79 22.6 654 ± 11.9 846 99.5 
RM19 950 ± 15.0 370 ± 13.1 38.9 172 ± 10.4 18.1 740 ± 14.1 912 96.0 
RM21 884 ± 34.4 284 ± 1.81 32.1 158 ± 6.62 17.9 751 ± 13.1 909 103 
RM23 941 ± 11.3 335 ± 7.03 35.6 170 ± 8.07 18.1 767 ± 19.6 937 99.6 
RM27 906  ± 14.0 375 ± 4.11 41.4 209 ± 6.15 23.1 725 ± 30.7 934 103 
RM28 850 ± 22.6 272 ± 4.24 32.0 175 ± 5.02 20.6 708 ± 22.2 883 104 
RM30 829 ± 22.0 346 ± 3.89 41.7 195 ± 10.0 23.5 640 ± 18.1 835 101 
RM35 827 ± 10.8 376 ± 11.0 45.5 329 ± 2.21 39.8 476 ± 6.06 805 97.3 
RM37 843 ± 17.2 385 ± 20.3 45.7 218 ± 10.4 25.9 602 ± 23.1 820 97.3 
RM40 879 ± 15.1 479 ± 14.6 54.5 168 ± 5.24 19.1 713 ± 29.8 881 100 
RM54 816 ± 181 408 ± 4.14 50.0 269 ± 14.0 33.0 546 ± 21.2 815 99.9 
RM59 808 ± 34.2 454 ± 25.2 56.2 226 ± 11.3 28.0 622 ± 31.3 848 105 
RM62 1,220 ± 34.0 549 ± 38.1 44.8 377 ± 20.2 30.8 869 ± 17.0 1250 102 
BM1 1,140 ± 33.3 393 ± 20.6 34.5 249 ± 11.3 21.9 644 ± 15.4 893 78.5 
BM3 829 ± 33.2 360 ± 20.1 43.4 223 ± 10.4 26.9 564 ± 25.8 787 94.9 
BM5 894 ± 40.8 324 ± 14.4 36.2 213 ± 8.68 23.8 570 ± 19.2 783 87.6 
BM7 584 ± 27.5 311 ± 18.7 53.2 151 ± 7.98 25.9 384 ± 16.2 535 91.6 
BM9 834 ± 43.4 332 ± 13.2 39.8 243 ± 12.7 29.1 572 ± 33.3 815 97.7 
BM11 964 ± 20.7 395 ± 8.12 41.0 190 ± 9.94 19.7 777 ± 32.3 967 100 
BM13 1,200 ± 47.0 439 ± 21.2 36.6 218 ± 9.02 18.2 941 ± 40.6 1,160 96.6 
BM15 1,630 ± 107 539 ± 19.4 33.1 334 ± 9.88 20.5 1,230 ± 19.5 1,360 83.9 
BM17 711 ± 33.1 322 ± 15.8 45.3 151 ± 8.02 21.2 550 ± 19.7 701 98.6 
BM19 679 ± 11.6 275 ± 7.85 40.5 208 ± 7.87 30.6 458 ± 21.3 666 98.1 
BM20 469 ± 10.4 340 ± 4.43 72.5 174 ± 10.1 37.1 277 ± 11.1 451 96.2 
BM21 704 ± 9.03 434 ± 6.31 61.6 273 ± 8.10 38.8 453 ± 5.12 726 103 
BM23 871 ± 35.0 435 ± 5.02 49.9 216 ± 11.0 24.8 645 ± 16.4 861 98.8 
BM26 396 ± 12.8 330 ± 10.0 83.3 206 ± 9.91 52.0 188 ± 9.05 394 99.5 
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BM32 16,100 ± 290 2550 ± 18.2 15.8 2590 ± 11.4 16.1 14,900 ± 830 17,500 109 
BM35 71,600 ± 120 2440 ± 60.3 3.40 1360 ± 90.0 1.90 70,400 ± 800 71,800 100 
BM36 3,430 ± 200 497 ± 13.4 14.5 226 ± 5.05 6.60 3,230 ± 110 3,460 101 
BM39 1,480 ± 42.4 730 ± 12.0 49.2 436 ± 22.2 29.4 1,070 ± 8.82 1,510 101 
BM40 907 ± 17.4 522 ± 6.20 57.5 267 ± 10.3 29.4 644 ± 17.3 911 100 
BM41 682 ± 17.1 460 ± 22.2 67.4 222 ± 8.30 32.5 441 ± 22.2 663 97.2 
BM45 935 ± 37.5 563 ± 28.2 60.2 280 ± 13.3 29.9 584 ± 19.0 864 92.4 
BM46 984 ± 17.0 487 ± 3.35 49.5 326 ± 13.2 33.1 643 ± 32.7 969 98.5 
BM47 713 ± 15.2 432 ± 18.1 60.6 251 ± 13.8 35.2 451 ± 6.13 702 98.5 
BM49 2,940 ± 150 666 ± 17.5 22.6 483 ± 24.1 16.4 2,380 ± 100 2,860 97.5 
BM50 950 ± 12.4 610 ± 18.4 64.2 360 ± 20.5 37.9 664 ± 30.4 1,020 108 
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Appendix G: Total, gastric phase, gastrointestinal phase and residual concentrations of Pb and calculated % bioaccessibility of Pb in the 
gastric and gastrointestinal phases. Recovered Pb content, expressed as % total mass recovery is given. 
Sample Total (mg/kg) In-vitro oral bioaccessibility (mg/kg) 
  
Stage I Stage II Stage III Total recovered Pb content 
  
Gastric Phase 
Gastrointestinal 
Phase (Residual digest) (Stage II + III) 
 
Mean ± SD Mean ± SD 
% 
BAF Mean ± SD 
% 
BAF Mean ± SD Total % Total Recovery 
 
(n = 3) (n = 3) 
 
(n = 3) 
 
(n = 3) 
  RM2 943 ± 3.10 632 ± 36.2 67.0 10.2 ± 0.30 1.08 964 ± 9.97 974 103 
RM3 1,030 ± 3.97 795 ± 8.87 77.2 82.3 ± 18.6 7.99 1,040 ± 11.1 1,120 109 
RM4 529 ± 10.6 387 ± 27.1 73.2 bd NA 538 ± 74.4 538 102 
RM6 441 ± 3.62 364 ± 11.0 82.5 bd NA 399 ± 65.2 399 90.5 
RM11 1040 ± 6.38 845 ± 46.1 81.2 51.7 ± 8.04 4.9 1220 ± 178 1220 117 
RM12 915 ± 2.29 828 ± 17.6 90.5 13.4 ± 1.66 1.46 979 ± 100 992 108 
RM20 618 ± 18.4 462 ± 18.9 74.8 bd NA 638 ± 15.7 638 103 
RM24 617 ± 18.4 477 ± 13.1 77.3 bd NA 640 ± 16.5 640 104 
RM42 709 ± 4.83 500 ± 1.89 70.5 57.8 ± 5.88 8.15 648 ± 23.8 706 99.6 
RM45 624 ± 25.7 557 ± 2.01 89.3 67.3 ± 5.61 10.8 533 ± 47.8 600 96.1 
RM49 410 ± 2.66 378 ± 6.78 92.2 16.5 ± 2.81 4.02 403 ± 29.3 419 102 
RM66T1 2,080 ± 28.8 bd NA bd NA 1,940 ± 264 1,940 93.3 
RM66T2 1,650 ± 25.0 bd NA bd NA 1,460 ± 150  1,460 88.5 
RM66T3 1,510 ± 8.88 88.0 ± 9.56 5.83 bd NA 1,230  ± 88.6 1,230 81.4 
RM67 571 ± 3.71 349 ± 7.77 61.1 23.0 ± 0.59 4.03 559 ± 5.40 582 102 
RM69 4,400 ± 210 3,350 ± 527 76.1 783 ± 17.4 17.8 3,460 ± 357 4,240 96.4 
RM70 1,810 ± 9.96 1,350 ± 112 74.6 39.1 ± 5.56 2.16 1,880 ± 110 1,920 106 
RM71 3,210 ± 24.0 2,810 ± 224 87.5 191 ± 6.04 5.95 2,820 ± 290 3,010 93.8 
RM72 2,140 ± 8.50 286 ± 1.01 13.3 bd NA 2,020 ± 243 2,020 94.4 
RM73 2,600 ± 136 1,260 ± 95.6 48.5 bd NA 2,680 ± 129 2,680 103 
RM74 2,600 ± 16.2 1,050 ± 23.8 40.4 bd NA 2,500 ± 228 2,500 96.1 
RM76 12,500 ± 132 154 ± 17.6 1.23 bd NA 13,300 ± 931 13,300 106 
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RM77(S/T) 47,300 ± 116 1,800 ± 151 3.80 470 ± 69.8 0.99 48,100 ± 2970 48,100 102 
RM77(W) 46,900 ± 1200 1,558 ± 28.9 3.32 1,100 ± 109 2.34 45,200 ± 1650 45,200 96.4 
RM8 351 ± 17.0 202 ± 7.76 57.5 43.4 ± 3.72 12.4 277 ± 9.77 320 91.2 
RM18 548 ± 20.1 311 ± 6.04 56.7 14.5 ± 0.94 2.65 526 ± 2.91 540 98.5 
RM19 655 ± 28.0 395 ± 19.7 60.3 10.0 ± 0.91 1.53 618 ± 10.1 628 95.8 
RM21 499 ± 26.8 320 ± 2.24 64.1 9.98 ± 0.56 2.00 488 ± 8.06 498 99.8 
RM23 598 ± 8.97 384 ± 5.19 64.2 16.5 ± 0.66 2.76 596 ± 2.11 612 102 
RM27 571 ± 15.0 379 ± 15.8 66.4 16.3 ± 0.74 2.85 564 ± 11.56 580 102 
RM28 471 ± 21.2 270 ± 2.11 57.3 15.8 ± 0.49 3.35 470 ± 10.7 486 103 
RM30 709 ± 29.9 350 ± 1.78 49.4 39.2 ± 1.59 5.53 661 ± 9.09 700 98.7 
RM35 434 ± 3.01 274 ± 5.87 63.1 28.6 ± 1.01 6.59 402 ± 17.8 430 99.1 
RM37 365 ± 7.88 243 ± 3.96 66.6 39.5 ± 1.04 10.8 333 ± 15.5 372 102 
RM40 329 ± 6.03 150 ± 10.2 45.6 bd NA 355 ± 15.6 355 108 
RM54 579 ± 10.0 373 ± 15.6 64.4 158 ± 4.86 27.3 385 ± 8.44 543 93.8 
RM59 895 ± 38.2 625 ± 20.0 69.8 107 ± 2.91 11.9 760 ± 21.3 867 96.9 
RM62 1,220 ± 66.2 485 ± 9.98 39.7 36.6 ± 1.58 3.00 1,190 ± 49.9 1,230 101 
BM1 10,200 ± 145 4,340 ± 276 42.5 3,220 ± 200 31.6 6,140 ± 154 9,360 91.8 
BM3 9,210 ± 220 3,230 ± 229 35.1 3,090 ± 163 33.5 5,470 ± 258 8,560 92.9 
BM5 8,670 ± 183 2,580 ± 279 29.7 2,370 ± 109 27.3 5,980 ± 77.3 8,350 96.3 
BM7 4,430 ± 523 2,100 ± 112 47.4 1,120 ± 77.6 25.3 3,220 ± 187 4,340 97.7 
BM9 6,200 ± 148 2,290 ± 176 36.9 1,220 ± 108 19.7 4,770 ± 333 5,990 96.6 
BM11 2,810 ± 69.0 2,060 ± 76.6 73.3 55.5 ± 2.61 NA 2,820 ± 125 2,870 102 
BM13 9,320 ± 31.4 4,680 ± 576 50.2 1,280 ± 92.2 13.7 8,100 ± 737 9,380 101 
BM15 16,500 ± 1200 8,370 ± 122 50.7 2,070 ± 118 12.5 12,900 ± 400 14,500 90.7 
BM17 6,360 ± 66.0 2,830 ± 155 44.5 3,250 ± 21.6 51.1 2,380 ± 18.6 5,630 88.5 
BM19 2,930 ± 57.7 1,970 ± 57.7 67.2 586 ± 22.2 20.0 2,240 ± 140 2,830 96.4 
BM20 71.0 ± 4.77 41.3 ± 1.07 58.2 18.3 ± 0.77 25.8 47.4 ± 2.03 66.0 93.0 
BM21 167 ± 3.03 106 ± 5.96 63.5 19.9 ± 1.05 11.9 148 ± 2.66 168 101 
BM23 4,440 ± 63.8 3,380 ± 161 76.1 1,040 ± 53.7 23.4 3,440 ± 130 4,480 101 
BM26 54.1 ± 2.98 27.4 ± 1.03 50.6 22.0 ± 0.58 40.7 36.0 ± 2.02 58.0 107 
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BM32 1,330 ± 30.0 70.0 ± 0.95 5.26 19.8 ± 0.88 1.48 1,340 ± 44.2 1,360 102 
BM35 160,000 ± 10,000 53,300 ± 4000 33.3 25,700 ± 998 16.1 149,000 ± 6,500 152,000 94.7 
BM36 24,800 ± 116 3,750 ± 83.6 15.1 1,720 ± 33.2 6.93 23,600 ± 705 25,300 102 
BM39 973 ± 28.0 694 ± 2.77 71.3 65.6 ± 4.58 6.74 1,010 ± 52.4 1,076 111 
BM40 1,100 ± 23.1 834 ± 22.0 75.8 126 ± 2.43 11.4 968 ± 23.8 1,094 99.4 
BM41 1,550 ± 97.0 1,340 ± 113 86.4 695 ± 20.1 44.8 870 ± 23.1 1,560 101 
BM45 3,240 ± 306 2,550 ± 120 78.7 1,810 ± 59.0 55.9 1,430 ± 64.6 3,240 100 
BM46 429 ± 10.0 237 ± 3.18 55.2 87.6 ± 4.88 20.4 328 ± 32.6 416 97 
BM47 1,430 ± 21.8 1,140 ± 50.6 79.7 595 ± 20.4 41.6 778 ± 33.9 1,370 96 
BM49 20,500 ± 338 9,300 ± 381 45.4 9,570 ± 824 46.7 10,900 ± 659 20,500 99.8 
BM50 1,340 ± 7.04 1,030 ± 16.8 76.9 312 ± 13.3 23.3 1,130 ± 82.7 1,440 108 
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Appendix H: Total, gastric phase, gastrointestinal phase and residual concentrations of Zn and calculated % bioaccessibility of Zn in the 
gastric and gastrointestinal phases. Recovered Pb content, expressed as % total mass recovery is given. 
.Sample Total (mg/kg) In-vitro oral bioaccessibility (mg/kg) 
  
Stage I Stage II Stage III Total content 
  
Gastric Phase Gastrointestinal Phase (Residual digest) (Stage II + III) 
 
Mean ± SD Mean ± SD 
% 
BAF Mean ± SD 
% 
BAF Mean ± SD Total % Total Recovery 
 
(n = 3) (n = 3) 
 
(n = 3) 
 
(n = 3) 
  RM2 231 + 1.02 73.0 ± 5.60 31.5 bd NA 278 ± 25.4 278 120 
RM3 276 ± 0.08 78.8 ± 18.6 28.5 bd NA 297 ± 15.6 297 108 
RM4 173 ±  0.48 65.3 ± 8.56 37.7 bd NA 190 ± 2.85 190 110 
RM6 216 ± 0.82 91.7 ± 4.59 42.4 bd NA 246 ± 39.2 246 114 
RM11 374 ± 1.31 150 ± 6.01 40.1 bd NA 441 ± 39.9 441 118 
RM12 313 ± 0.69 159 ± 22.8 50.8 bd NA 345 ± 6.03 345 110 
RM20 185 ±  0.14 71.4 ± 5.67 38.6 bd NA 205 ± 11.7 205 111 
RM24 208 ± 0.79 53.0 ± 2.59 25.5 bd NA 237 ± 28.5 237 114 
RM42 212 ± 0.80 61.3 ± 1.11 28.8 bd NA 237 ± 3.91 237 111 
RM45 191   0.63 74.1 ± 0.96 37.2 bd NA 227 ± 10.8 227 119 
RM49 155 ± 10.2 58.4 ± 4.88 37.6 bd NA 199 ± 11.1 199 128 
RM66T1 289 ± 1.19 bd NA bd NA 263 ± 40.0 263 91.1 
RM66T2 214 ± 9.24 bd NA bd NA 213 ± 25.6 213 99.7 
RM66T3 1,660 ± 17.0 bd NA bd NA 1,590 ± 130 1,590 95.8 
RM67 272 ± 1.00 122 ± 6.78 44.8 bd NA 313 ± 9.57 313 115 
RM69 3,110 ± 59 1,600 ± 49.0 51.4 314 ± 31.6 10.1 2,890 ± 115 3,204 103 
RM70 491 ± 13.3 242 ± 3.30 49.3 bd NA 546 ± 52.6 456 92.9 
RM71 746 ± 15.7 519 ± 37.6 69.6 21.7 ± 0.56 2.91 668 ± 59.6 690 92.5 
RM72 1,390 ± 1.11 513 ± 14.3 36.9 43.4 ± 4.98 3.12 1,260 ± 188 1,300 93.7 
RM73 3,100 ± 70.5 2,670 ± 163 86.1 132 ± 3.04 4.26 3,300 ± 214 3,430 111 
RM74 2,570 ± 1.26  1,500 ± 48.7 58.4 183 ± 4.08 7.12 2,340 ± 345 2,520 98.2 
RM76 3,000 ± 82.0 151 ± 44.2 5.02 bd NA 3,420 ± 120 3,420 114 
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RM77(S/T) 
166,000 ± 
5,020 
45,200 ± 
2,190 27.2 19,500 ± 2,380 11.7 164,000 ± 14800 183,500 110 
RM77(W) 
250,000 ± 
6,840 
58,500 ± 
1,590 23.4 23,200 ± 1970 9.28 216,000 ± 8,170 239,200 95.7 
RM8 125 ± 8.79 60.0 ± 3.59 48.0 bd NA 112 ± 5.69 112 89.5 
RM18 100 ± 2.19 bd NA bd NA 96.0 ± 4.02 96.6 96.5 
RM19 112 ± 5.78 15.5 ± 0.55 13.8 bd NA 107 ± 5.11 107 95.5 
RM21 100 ± 7.08 3.43 ± 0.10 3.43 bd NA 94.7 ± 5.87 94.7 94.7 
RM23 196 ± 10.2 21.4 ± 0.88 10.9 bd NA 186 ± 8.19 186 94.9 
RM27 149 ± 5.00 70.8 ± 1.78 47.5 bd NA 152 ± 4.24 152 102 
RM28 120 ± 4.43 bd NA bd NA 114 ± 3.77 114 95 
RM30 332 ± 15.7 115 ± 6.58 34.6 bd NA 325 ± 12.0 325 97.9 
RM35 148 ± 3.96 67.7 ± 3.33 45.7 bd NA 124 ± 5.88 124 83.8 
RM37 205 ± 5.07 64.2 ± 1.59 31.3 12.0 5.85 198 ± 2.14 210 102 
RM40 148 ± 3.77 50.2 ± 2.57 33.9 bd NA 160 ± 9.81 160 108 
RM54 135 ± 6.59 46.3 ± 1.71 34.3 bd NA 130 ± 6.06 130 96.3 
RM59 762 ± 36.6 543 ± 24.4 71.3 75.3 ± 2.77 9.88 729 ± 30.7 804 105 
RM62 297 ± 3.45 193 ± 4.78 65.0 16.1 ± 0.61 5.42 303 ± 7.91 319 107 
BM1 1,500 ± 139 673 ± 34.7 44.9 458 ± 8.79 30.5 773 ± 53.0 1,230 82 
BM3 1,980 ±  47.0 900 ± 52.6 45.4 480 ± 25.2 24.2 1,410 ± 66.6 1,890 95.4 
BM5 1,790 ± 47.8 769 ± 59.7 43.0 370 ± 14.7 20.7 1,320 ± 57.0 1,690 94.4 
BM7 767 ± 34.9 286 ± 22.0 37.3 72.8 ± 3.73 9.49 654 ± 27.8 727 94.8 
BM9 1,290 ± 17.2 648 ± 51.6 50.2 236 ± 11.9 18.3 1,050 ± 17.3 1,290 99.7 
BM11 1,040  ± 27.7 517 ± 199.7 49.7 29 .4 ± 0.65 2.83 997 ± 50.0 1,030 98.7 
BM13 2,000 ± 88.4 970 ± 52.8 48.4 262 ± 14.1 13.1 1,700 ± 116 1,960 98 
BM15 720 ± 34.8 491 ± 22.1 68.2 234 ± 17.8 32.5 486 ± 14.8 720 100 
BM17 1,140 ± 48.0 612 ± 50.0 53.7 480 ± 26.0 42.1 790 ± 29.6 1,270 111 
BM19 841 ± 22.7 247 ± 12.2 29.4 83.4 ± 4.65 9.92 711 ± 22.7 794 94.4 
BM20 55.0 ± 0.88 21.9 ± 0.54 39.8 12.2 ± 1.83 22.2 45.5 ± 2.04 57.7 105 
BM21 30.0 ± 0.65 8.88 ± 0.49 29.6 4.80 ± 0.22 16 23.8 ± 1.04 28.6 95.3 
BM23 636 ± 12.9 160 ± 3.57 25.2 37.4  ± 1.77 5.88 602 ± 24.8 639 100 
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BM26 74.4 ± 1.69 38.0 ± 1.63 51.3 bd NA 62.2 ± 5.58 62.2 84 
BM32 527 ± 28.0 bd NA bd NA 516 ± 20.0 516 97.9 
BM35 
190,000 ± 
5,900 40,800 ± 200 21.5 20,700 ± 771 10.9 173,000 ± 4000 194,000 102 
BM36 47,800 ± 2210 11,800 ± 818 24.7 3,170 ± 130 6.63 47,900 ± 3000 51,070 107 
BM39 1250 ± 46.6 490 ± 2.76 39.2 89.1 ± 3.68 7.13 1160 ±24.4 1250 99.9 
BM40 217 ± 10.2 46.4 ± 4.57 21.4 7.03 ± 0.48 3.24 229 ± 12.7 236 109 
BM41 342 ± 9.89 152 ± 11.0 44.4 49.0 ± 2.57 14.3 308 ± 16.6 357 104 
BM45 367 ± 17.7 245 ± 15.7 66.8 40.4 ± 1.79 11 320 ± 10.0 360 98.1 
BM46 191 ± 9.98 93.8 ± 3.66 49.1 13.2 ± 0.78 6.81 185 ± 15.8 198 104 
BM47 317 ± 14.1 115 ± 3.93 36.3 45.9 ± 2.07 14.5 284 ± 7.03 330 104 
BM49 11,700 ± 1080 7,830 ± 145 66.9 5,350 ± 70.8 45.7 5,560 ± 361 10,900 93.2 
BM50 614 ± 22.7 346 ± 13.89 56.3 88.3 ± 4.01 14.4 544 ±22.9 632 103 
 
 
 
 
 
 
 
 
 
 
 
266 
 
Appendix I: Predicted daily intake (DI), tolerable daily intake (TDIoral) and the required ingestion to exceed the TDIoral based on total, gastric (G) and 
Gastrointestinal (GI) concentration, and corresponding hazard quotient for As. 
  PTE DI (µg kg-1 BW d-1) 
TDI   
(µg kg-1 BW d-1) 
Required ingestion  
(mg  d-1) to exceed TDI oral Hazard Quotient (Unitless) 
SAMPLE 
ID Total G GI   Total G GI Total G GI 
Soil  
RM2 0.14 0.02 0.03 0.3 215 1370 1110 4.7E - 01 6.7E - 02 1.0E - 01 
RM3 0.16 0.03 0.05 0.3 190 1090 613 5.3E - 01 1.0E - 01 1.7E - 01 
RM4 0.10 0.02 0.02 0.3 288 1290 1430 3.3E - 01 6.7E - 02 6.7E - 02 
RM6 0.12 0.02 0.03 0.3 252 1410 921 4.0E - 01 6.7E - 02 1.0E - 01 
RM11 0.14 0.03 0.03 0.3 220 897 1150 4.7E - 01 1.0E - 01 1.0E - 01 
RM12 0.14 0.03 0.03 0.3 221 947 1067 4.7E - 01 1.0E - 01 1.0E - 01 
RM20 0.10 0.02 0.02 0.3 291 1270 1320 3.3E - 01 6.7E - 02 6.7E - 02 
RM24 0.11 0.02 0.02 0.3 276 1390 1390 3.7E - 01 6.7E - 02 6.7E - 02 
RM42 0.11 0.02 0.02 0.3 271 1450 1360 3.7E - 01 6.7E - 02 6.7E - 02 
RM45 0.10 0.03 0.02 0.3 312 1090 1260 3.3E - 01 1.0E - 01 6.7E - 02 
RM49 0.08 0.02 0.02 0.3 362 1390 1590 2.7E - 01 6.7E - 02 6.7E - 02 
RM67 0.12 0.03 0.02 0.3 243 1140 1430 4.0E - 01 1.0E - 01 6.7E - 02 
RM69 0.60 0.15 0.12 0.3 50.0 199 260 2.0E + 00 5.0E - 01 4.0E - 01 
RM70 0.24 0.05 0.04 0.3 126 591 694 8.0E - 01 1.7E - 01 1.3E - 01 
RM71 0.54 0.10 0.09 0.3 55.0 294 349 1.8E + 00 3.3E - 01 3.0E - 01 
RM72 0.80 0.04 0.08 0.3 38.0 717 358 2.7E + 00 1.3E - 01 2.7E - 01 
RM73 0.46 0.12 0.12 0.3 65.0 251 261 1.5E + 00 4.0E - 01 4.0E - 01 
RM74 0.75 0.06 0.11 0.3 40.0 465 263 2.5E + 00 2.0E - 01 3.7E - 01 
RM8 0.07 0.01 0.02 0.3 426 2540 1730 2.3E - 01 3.3E - 02 6.7E - 02 
RM18 0.11 0.02 0.02 0.3 278 1700 1350 3.7E - 01 6.7E - 02 6.7E - 02 
RM19 0.11 0.02 0.03 0.3 270 1430` 967 3.7E - 01 6.7E - 02 1.0E - 01 
RM21 0.13 0.03 0.03 0.3 234 1090 889 4.3E - 01 1.0E - 01 1.0E - 01 
RM23 0.12 0.02 0.03 0.3 251 1260 883 4.0E - 01 6.7E - 02 1.0E - 01 
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RM27 0.12 0.02 0.03 0.3 261 1460 1050 4.0E - 01 6.7E - 02 1.0E - 01 
RM28 0.10 0.02 0.02 0.3 298 1810 1320 3.3E - 01 6.7E - 02 6.7E - 02 
RM30 0.12 0.02 0.03 0.3 260 1210 910 4.0E - 01 6.7E - 02 1.0E - 01 
RM35 0.10 0.02 0.02 0.3 292 1780 1300 3.3E - 01 6.7E - 02 6.7E - 02 
RM37 0.09 0.02 0.02 0.3 334 1560 1840 3.0E - 01 6.7E - 02 6.7E - 02 
RM40 0.14 0.06 0.04 0.3 212 537 808 4.7E - 01 2.0E - 01 1.3E - 01 
RM54 0.11 0.02 0.02 0.3 285 1690 1250 3.7E - 01 6.7E - 02 6.7E - 02 
RM59 0.15 0.04 0.04 0.3 203 707 712 5.0E - 01 1.3E - 01 1.3E - 01 
RM62 0.14 0.03 0.03 0.3 211 976 896 4.7E - 01 1.0E - 01 1.0E - 01 
BM1 1.08 0.14 0.25 0.3 28.0 215 119 3.6E + 00 4.7E - 01 8.3E - 01 
BM3 0.77 0.19 0.26 0.3 39.0 160 115 2.6E + 00 6.3E - 01 8.6E - 01 
BM5 0.75 0.16 0.23 0.3 40.0 190 133 2.5E + 00 5.3E - 01 7.7E - 01 
BM7 0.42 0.09 0.11 0.3 71.0 328 271 1.4E + 00 3.0E - 01 3.7E - 01 
BM9 0.66 0.12 0.22 0.3 45.0 251 137 2.2E + 00 4.0E - 01 7.3E - 01 
BM11 0.43 0.11 0.13 0.3 69.0 279 239 1.4E + 00 3.7E - 01 4.3E - 01 
BM13 0.90 0.18 0.24 0.3 33.0 168 127 3.0E + 00 6.0E - 01 8.0E - 01 
BM15 1.45 0.25 0.25 0.3 21.0 119 121 4.8E + 00 8.3E - 01 8.3E - 01 
BM17 0.72 0.16 0.35 0.3 42.0 184 85.0 2.4E + 00 5.3E - 01 1.2E + 00 
BM19 0.32 0.08 0.10 0.3 93.0 370 291 1.1E + 00 2.7E - 01 3.3E - 01 
BM20 0.05 0.01 0.02 0.3 558 3900 2120 1.7E - 01 3.3E - 02 6.7E - 02 
BM21 0.06 0.01 0.02 0.3 477 2670 1630 2.0E - 01 3.3E - 02 6.7E - 02 
BM23 0.40 0.13 0.10 0.3 75.0 231 291 1.3E + 00 4.3E - 01 3.3E - 01 
BM26 0.03 0.01 0.01 0.3 925 2560 3870 1.0E - 01 3.3E - 02 3.3E - 01 
BM40 0.17 0.06 0.05 0.3 174 465 547 5.7E - 01 2.0E - 01 1.7E - 01 
BM41 0.21 0.07 0.05 0.3 145 454 594 7.0E - 01 2.3E - 01 1.7E - 01 
BM45 0.61 0.18 0.21 0.3 49.0 169 143 2.0E + 00 6.0E - 01 7.0E - 01 
BM46 0.29 0.07 0.06 0.3 102 433 517 9.7E -  01 2.3E - 01 2.0E - 01 
BM47 0.18 0.04 0.06 0.3 168 718 542 6.0E - 01 1.3E - 01 2.0E - 01 
BM50 0.25 0.08 0.07 0.3 121 388 420 8.3E - 01 2.7E - 01 2.3E - 01 
 metallurgic waste  
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RM66T1 14.5 1.08 0.81 0.3 2.00 28.0 37.0 4.8E + 01 3.6E + 00 2.7E + 00 
RM66T2 14.5 0.39 0.27 0.3 2.00 77.0 110 4.8E + 01 1.3E + 00 9.0E - 01 
RM66T3 5.75 0.19 0.24 0.3 5.00 159 126 1.9E +  01 6.3E - 01 8.0E - 01 
RM76 23.3 0.23 0.32 0.3 1.00 128 95.0 7.8E + 01 7.7E - 01 1.1E + 00 
RM77(S/T) 10.3 1.59 0.25 0.3 3.00 19 119 3.4E + 01 5.3E + 00 8.3E - 01 
RM77(W) 20.5 6.83 1.64 0.3 1.00 4.00 18.0 6.8E + 01 2.3E + 01 5.5E + 00 
BM32 17.8 0.48 0.64 0.3 2.00 62.0 47.0 5.9E + 01 1.6E + 00 2.1E + 00 
BM35 121 1.4 0.54 0.3 NA 21.0 56.0 4.0E + 02 4.7E + 00 1.8E + 00 
BM36 9.30 1.53 0.87 0.3 3.00 20.0 34.0 3.1E + 01 5.1E + 00 2.9E + 00 
BM39 0.45 0.16 0.10 0.3 67.0 190 291 1.5E + 00 5.3E - 01 3.3E - 01 
BM49 2.75 0.48 0.30 0.3 11.0 62.0 101 9.2E + 00 1.6E + 00 1.0E + 00 
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Appendix J: Predicted daily intake (DI), tolerable daily intake (TDIoral) and the required ingestion to exceed the TDIoral based on total, gastric (G) and 
Gastrointestinal (GI) concentration, and corresponding hazard quotient for Cd. 
  
PTE  DI  
(µg kg-1 BW d-1) 
TDI   
(µg kg-1 BW d-1) 
Required ingestion  
(mg  d-1) to exceed TDI oral Hazard Quotient (Unitless) 
SAMPLE 
ID Total G GI   Total G GI Total G GI 
        Soil             
RM2 0.01 0.01 NA 0.36 4130 5530 NA 2.8E - 02 2.8E - 02 NA 
RM3 0.01 0.01 NA 0.36 3060 4460 NA 2.8E - 02 2.8E - 02 NA 
RM4 0.01 0 NA 0.36 5490 10600 NA 2.8E - 02 0 NA 
RM6 0.01 0 NA 0.36 5400 11200 NA 2.8E - 02 0 NA 
RM11 0.01 0.01 NA 0.36 2850 4400 NA 2.8E - 02 2.8E - 02 NA 
RM12 0.01 0.01 NA 0.36 3190 4490 NA 2.8E - 02 2.8E - 02 NA 
RM20 0.01 0 NA 0.36 4750 8270 NA 2.8E - 02 0 NA 
RM24 0.01 0 NA 0.36 4350 8920 NA 2.8E - 02 0 NA 
RM42 0.01 0 NA 0.36 3990 7440 NA 2.8E - 02 0 NA 
RM45 0.01 0 NA 0.36 4060 7360 NA 2.8E - 02 0 NA 
RM49 0.01 0 NA 0.36 5630 10800 NA 2.8E - 02 0 NA 
RM67 0.01 0.01 0 0.36 2850 6380 12200 2.8E - 02 2.8E - 02 0 
RM69 0.03 0.02 0.02 0.36 1130 1870 1660 8.3E - 02 5.5E - 02 5.5E - 02 
RM70 0.01 0 NA 0.36 4080 7610 NA 2.8E - 02 0 NA 
RM71 0.02 0.01 NA 0.36 1760 2680 NA 5.5E - 02 2.8E - 02 NA 
RM72 0.01 0.01 NA 0.36 2710 4010 NA 2.8E - 02 2.8E - 02 NA 
RM73 0.01 0.01 0.01 0.36 2410 4110 3510 2.8E - 02 2.8E - 02 2.8E - 02 
RM74 0.02 0.02 0.02 0.36 1480 2320 1960 5.5E - 02 5.5E - 02 5.5E - 02 
RM8 0 0 NA 0.36 15900 26800 NA 0 0 NA 
RM18 0.01 0 NA 0.36 7050 16700 NA 2.8E - 02 0 NA 
RM19 0.01 0 NA 0.36 6440 11750 NA 2.8E - 02 0 NA 
RM21 0 0 NA 0.36 9300 18100 NA 0 0 NA 
RM23 0.01 0 NA 0.36 6380 11500 NA 2.8E - 02 0 NA 
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RM27 0.01 0 NA 0.36 4850 8270 NA 2.8E - 02 0 NA 
RM28 0.01 0 NA 0.36 6700 16700 NA 2.8E - 02 0 NA 
RM30 0.01 0.01 NA 0.36 3470 6260 NA 2.8E - 02 2.8E - 02 NA 
RM35 0 0 NA 0.36 7440 14600 NA 0 0 NA 
RM37 0.01 0 NA 0.36 6030 13400 NA 2.8E - 02 0 NA 
RM40 0 0 NA 0.36 8070 15900 NA 0 0 NA 
RM54 0 0 NA 0.36 7440 13900 NA 0 0 NA 
RM59 0.12 0.08 0.02 0.36 302 449 1810 3.3E - 01 2.2E - 01 5.5E - 02 
RM62 0 0 NA 0.36 83700 167000 NA 0 0 NA 
BM1 0.07 0.04 0 0.36 544 996 7790 1.9E - 01 1.1E - 01 0 
BM3 0.07 0.03 0 0.36 536 1030 7970 1.9E - 01 8.3E - 02 0 
BM5 0.07 0.03 0.01 0.36 507 1030 6500 1.9E - 01 8.3E - 02 2.8E - 02 
BM7 0.05 0.03 0 0.36 695 1240 12000 1.4E - 01 8.3E - 02 0 
BM9 0.07 0.04 0 0.36 503 837 7880 1.9E - 01 1.1E - 01 0 
BM11 0.03 0.02 0 0.36 1210 2080 7280 8.3E - 02 5.5E - 02 0 
BM13 0.08 0.04 0.01 0.36 435 865 5770 2.2E - 01 1.1E - 01 2.8E - 02 
BM15 0.08 0.05 0.01 0.36 468 770 4290 2.2E - 01 1.3E - 01 2.8E - 02 
BM17 0.05 0.03 0.01 0.36 704 1180 6320 1.4E - 01 8.3E - 02 2.8E - 02 
BM19 0.03 0.01 0 0.36 1090 2650 35200 8.3E - 02 2.8E - 02 0 
BM20 NA NA NA 0.36 NA NA NA NA NA NA 
BM21 0.01 0 NA 0.36 6090 11300 NA 2.8E - 02 0 NA 
BM23 0.02 0.01 0 0.36 1450 2770 20900 5.5E - 02 2.8E - 02 0 
BM26 NA NA NA 0.36 NA NA NA NA NA NA 
BM40 0.01 0.01 NA 0.36 2670 5030 NA 2.8E - 02 2.8E - 02 NA 
BM41 0.01 0.01 0 0.36 2490 4750 24800 2.8E - 02 2.8E - 02 0 
BM45 0.03 0.01 0 0.36 1320 2800 12400 8.3E - 02 2.8E - 02 0 
BM46 0.01 0 NA 0.36 4400 11200 NA 2.8E - 02 0 NA 
BM47 0.01 0.01 NA 0.36 2670 5440 NA 2.8E - 02 2.8E - 02 NA 
BM50 0.02 0.01 0 0.36 1910 4180 25700 5.5E - 02 2.8E - 02 0 
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Metallurgic waste 
RM66T1 0.01 NA NA 0.36 6500 NA NA 2.8E - 02 NA NA 
RM66T2 0.01 NA NA 0.36 5980 NA NA 2.8E - 02 NA NA 
RM66T3 0.03 0 NA 0.36 1030 8270 NA 8.3E - 02 0 NA 
RM76 0.01 0 NA 0.36 6700 55800 NA 2.8E - 02 0 NA 
RM77(S/T) 7.69 3.32 2.83 0.36 5.00 11.0 13.0 2.1E + 01 9.2E + 00 7.9E + 00 
RM77(W) 7.74 3.49 0.22 0.36 5.00 10.0 160 2.1E + 01 9.7E + 00 6.1E - 01 
BM32 0.01 0 NA 0.36 3040 17200 NA 2.8E - 02 0 NA 
BM35 0.01 0 NA 0.36 4850 11200 NA 2.8E - 02 0 NA 
BM36 1.88 0.25 0.04 0.36 19.0 146 879 5.2 + 00 6.9E - 01 1.1E - 01 
BM39 0.05 0.02 0 0.36 789 1480 19700 1.4E - 01 5.5E - 02 0 
BM49 0.28 0.11 0.02 0.36 131 314 1540 7.8E - 01 3.0E - 01 5.5E - 02 
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Appendix K: Predicted daily intake (DI), tolerable daily intake (TDIoral) and the required ingestion to exceed the TDIoral based on total, gastric (G) and 
Gastrointestinal (GI) concentration, and corresponding hazard quotient for Cu. 
  
 DI  
(µg kg-1 BW d-1) 
TDI   
(µg kg-1 BW d-1) 
Required ingestion  
(mg  d-1) to exceed TDI oral 
(x1000) Hazard Quotient (Unitless) 
SAMPLE 
ID Total G GI   Total G GI Total G GI 
        Soil             
RM2 0.16 0.04 0.04 160 103 440 412 1.0E - 03 2.5E - 04 2.5E - 04 
RM3 0.18 0.05 0.04 160 88.8 335 368 1.1E - 03 3.1E - 04 2.5E - 04 
RM4 0.13 0.03 0.03 160 127 489 587 8.1E - 04 1.9E - 04 1.9E - 04 
RM6 0.13 NA NA 160 119 NA NA 8.1E - 04 NA NA 
RM11 0.19 NA NA 160 84.5 NA NA 1.2E - 03 NA NA 
RM12 0.17 NA NA 160 91.5 NA NA 1.1E - 03 NA NA 
RM20 0.14 NA NA 160 114 NA NA 8.7E - 04 NA NA 
RM24 0.18 0.04 0.04 160 89.4 376 456 1.1E - 03 2.5E - 04 2.5E - 04 
RM42 0.18 0.04 NA 160 87.3 393 NA 1.1E - 03 1.9E - 04 NA 
RM45 0.17 0.03 NA 160 91.5 429 NA 1.1E - 03 1.9E - 04 NA 
RM49 0.15 0.03 0.03 160 106 524 564 9.4E - 04 1.9E - 04 1.9E - 04 
RM67 0.21 0.04 0.03 160 75.7 377 555 1.3E - 03 2.5E - 04 1.9E - 04 
RM69 0.73 0.17 0.15 160 21.9 96 108 4.6E - 03 1.1E - 04 9.4E - 04 
RM70 0.20 0.04 0.03 160 81.3 395 525 1.2E - 03 2.5E - 04 1.9E - 04 
RM71 0.52 0.08 NA 160 30.9 189 NA 3.2E - 03 5.0E - 04 NA 
RM72 0.49 NA NA 160 32.4 NA NA 3.1E - 03 NA NA 
RM73 1.04 0.26 0.19 160 14.4 62.4 82.6 6.5E - 03 1.6E - 03 1.2E - 03 
RM74 1.10 0.38 0.19 160 14.6 42 82.2 6.9E - 03 2.4E - 03 1.2E - 03 
RM8 0.33 0.08 0.12 160 48.5 197 133 2.1E - 03 5.0E - 04 7.5E - 04 
RM18 0.40 0.10 0.13 160 39.5 146 122 2.5E - 03 6.5E - 04 8.1E - 04 
RM19 0.41 0.10 0.15 160 39.1 158 105 2.6E - 03 6.2E - 04 9.4E - 04 
RM21 0.38 0.09 0.12 160 42.4 171 130 2.4E - 03 5.6E - 04 7.4E - 04 
RM23 0.43 0.11 0.13 160 37.1 140 120 2.7E - 03 6.9E - 04 8.1E - 04 
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RM27 0.44 NA 0.13 160 36.5 NA 119 2.7E - 03 NA 8.1E - 04 
RM28 0.39 0.09 0.11 160 40.7 177 140 2.4E - 03 5.6E - 04 6.7E - 04 
RM30 0.50 0.11 0.13 160 32.3 147 120 3.1E - 03 6.9E - 04 8.1E - 04 
RM35 0.38 0.08 0.10 160 42.6 191 154 2.4E - 03 5.0E - 04 6.2E - 04 
RM37 0.43 0.08 0.12 160 36.8 192 137 2.7E - 03 5.0E - 04 7.5E - 04 
RM40 0.42 0.07 0.08 160 37.7 246 194 2.6E - 03 4.4E - 04 5.0E - 04 
RM54 0.36 0.08 0.10 160 44.9 198 161 2.2E - 03 5.0E - 04 6.2E - 04 
RM59 0.61 0.15 0.20 160 26.3 107 81.5 3.8E - 03 9.4E - 04 1.2E - 03 
RM62 0.36 0.08 0.10 160 44.2 208 167 2.2E - 03 5.0E - 04 6.2E - 04 
BM1 1.08 0.17 0.28 160 14.8 95.1 57.1 6.7E - 03 1.1E - 03 1.7E - 03 
BM3 1.20 0.20 0.36 160 13.3 79.8 44.3 7.5E - 03 1.2E - 03 2.2E - 03 
BM5 1.11 0.26 0.43 160 14.8 62.1 36.9 6.9E - 03 1.6E - 03 2.7E - 03 
BM7 0.74 0.11 0.26 160 21.6 144 60.9 4.6E - 03 6.9E - 04 1.6E - 03 
BM9 0.92 0.17 0.34 160 17.4 96 47.3 5.7E - 03 1.1E - 03 2.1E - 03 
BM11 0.45 0.14 0.19 160 35.2 113 86.0 2.8E - 03 8.7E - 04 1.2E - 03 
BM13 1.05 0.14 0.21 160 15.3 112 77.9 6.6E - 03 8.7E - 04 1.3E - 03 
BM15 1.26 0.25 0.35 160 12.7 63.7 45.2 7.9E - 03 1.6E - 03 2.2E - 03 
BM17 0.90 0.13 0.20 160 17.7 125 79.8 5.6E - 03 8.1E - 04 1.2E - 03 
BM19 0.60 0.15 0.16 160 25.9 107 98.5 3.7E - 03 9.4E - 04 1.0E - 03 
BM20 0.17 0.03 0.04 160 92.4 463 39.0 1.2E - 03 1.9E - 04 2.5E - 04 
BM21 0.19 0.05 0.06 160 83.6 301 250 1.2E - 03 3.1E - 04 3.7E - 04 
BM23 0.78 0.17 0.17 160 20.4 94.5 92.7 4.9E - 03 1.1E - 03 1.1E - 03 
BM26 0.23 0.02 0.03 160 70.7 647 472 1.4E - 03 1.2E - 04 1.9E - 04 
BM40 0.32 0.10 0.11 160 50.8 159 140 2.0E - 03 6.2E - 04 6.7E - 04 
BM41 0.33 0.10 0.15 160 49.2 153 107 2.1E - 03 6.2E - 04 9.4E - 04 
BM45 0.57 0.15 0.22 160 28.1 109 71.7 3.6E - 03 9.4E - 04 1.4E - 03 
BM46 0.28 0.07 0.09 160 57.7 238 183 1.7E - 03 4.4E - 04 5.6E - 04 
BM47 0.41 0.12 0.14 160 39.1 136 117 2.6E - 03 7.5E - 04 8.7E - 04 
BM50 0.40 0.10 0.13 160 39.9 160 122 2.5E - 03 6.2E - 04 8.1E - 04 
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metallurgic waste 
RM66T1 3.37 0.13 0.44 160 4.75 124 36.7 2.1E - 02 8.1E - 04 2.7E - 03 
RM66T2 2.70 0.09 0.25 160 5.92 170 64.1 1.7E - 02 5.6E - 04 1.6E - 03 
RM66T3 1.27 NA NA 160 12.6 NA NA 7.9E - 03 NA NA 
RM76 1.74 0.05 0.06 160 9.21 303 289 1.1E - 02 3.1E - 04 3.7E - 04 
RM77(S/T) 20.4 8.87 6.51 160 0.78 1.80 2.46 1.3E - 01 5.5E - 02 4.1E - 02 
RM77(W) 38.4 28.0 11.4 160 0.42 0.57 1.40 2.4E - 01 1.7E - 01 7.1E - 02 
BM32 0.97 0.07 0.11 160 16.5 227 144 6.1E - 03 4.4E - 04 6.7E - 04 
BM35 25.0 0.26 0.40 160 0.64 61.7 37.9 1.6E - 01 1.6E - 03 2.5E - 03 
BM36 11.2 2.54 3.57 160 1.42 6.29 4.48 7.0E - 02 1.6E - 02 2.2E - 02 
BM39 0.44 0.14 0.17 160 36.0 117 93.6 2.7E - 03 8.7E - 04 1.1E - 03 
BM49 2.39 0.35 0.33 160 6.70 46.1 47.8 1.5E - 02 2.2E - 03 2.1E - 03 
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Appendix L: Predicted daily intake (DI), tolerable daily intake (TDIoral) and the required ingestion to exceed the TDIoral based on total, gastric (G) and 
Gastrointestinal (GI) concentration, and corresponding hazard quotient for Mn. 
   DI (µg kg-1 BW d-1) 
TDI   
(µg kg-1 BW d-1) 
Required ingestion  
(mg  d-1) to exceed TDI oral Hazard Quotient (Unitless) 
SAMPLE 
ID Total G GI   Total G GI Total G GI 
        Soil             
RM2 4.05 2.33 0.78 140 3460 6000 18000 2.9E - 02 1.7E - 02 5.6E - 03 
RM3 4.24 2.51 0.94 140 3300 5590 15000 3.0E - 02 1.8E - 02 6.7E - 03 
RM4 3.31 2.33 0.90 140 4230 6010 15600 2.3E - 02 1.7E - 02 6.3E - 03 
RM6 3.58 2.53 0.88 140 3920 5540 16000 2.6E - 02 1.8E - 02 6.3E - 03 
RM11 3.99 3.22 1.03 140 3510 4350 13600 2.8E - 02 2.3E - 02 7.4E - 03 
RM12 3.69 2.69 0.91 140 3800 5210 15400 2.6E - 02 1.9E - 02 6.5E - 03 
RM20 3.52 2.38 0.85 140 3980 5880 16400 2.5E - 02 1.7E - 02 6.1E - 03 
RM24 3.82 2.42 0.86 140 3670 5770 16300 2.7E - 02 1.7E - 02 6.1E - 03 
RM42 3.78 2.79 0.91 140 3700 5020 15400 2.7E - 02 2.0E - 02 6.5E - 03 
RM45 3.32 3.03 0.89 140 4220 4620 15800 3.4E - 02 2.2E - 02 6.4E - 03 
RM49 3.09 2.95 0.85 140 4530 4740 16500 2.2E - 02 2.1E - 02 6.1E - 03 
RM67 3.65 2.54 0.74 140 3830 5520 18900 2.6E - 02 1.8E - 02 5.3E - 03 
RM69 4.88 3.05 1.03 140 2810 4590 13600 3.5E - 02 2.2E - 02 7.4E - 03 
RM70 4.68 2.73 0.89 140 2990 5130 15800 3.3E - 02 1.9E - 02 6.4E - 03 
RM71 4.48 2.83 0.84 140 3120 4940 16700 3.2E - 02 2.0E - 02 6.0E - 03 
RM72 7.53 2.56 1.34 140 1860 5170 10400 5.4E - 02 1.8E - 02 9.6E - 03 
RM73 6.56 3.65 0.98 140 2130 3830 14300 4.7E - 02 2.6E - 02 7.0E - 03 
RM74 5.81 3.33 0.94 140 2410 4200 15000 4.1E - 02 2.6E - 02 6.7E - 03 
RM8 3.10 1.97 1.16 140 4510 7090 12100 2.2E - 02 1.4E - 02 8.3E - 03 
RM18 4.57 1.68 1.03 140 3060 8350 13600 3.3E - 02 1.2E - 02 7.4E - 03 
RM19 5.11 1.99 0.92 140 2740 7040 15100 3.6E - 02 1.4E - 02 6.6E - 03 
RM21 4.75 1.53 0.85 140 2950 9170 16500 3.4E - 02 1.1E - 02 6.1E - 03 
RM23 5.06 1.80 0.91 140 2770 7770 15300 3.6E - 02 1.3E - 03 6.5E - 03 
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RM27 4.87 2.02 1.12 140 2870 6940 12500 3.5E - 02 1.4E - 02 8.0E - 03 
RM28 4.57 1.46 0.94 140 3060 9570 14900 3.3E - 02 1.0E - 02 6.7E - 03 
RM30 4.46 1.86 1.05 140 3140 7530 13300 3.2E - 02 1.3E - 02 7.5E - 03 
RM35 4.45 2.02 1.77 140 3150 6930 7910 3.2E - 02 1.4E - 02 1.3E - 02 
RM37 4.53 2.07 1.17 140 3090 6760 11900 3.2E - 02 1.5E - 02 8.4E - 03 
RM40 4.73 2.58 0.90 140 2960 5440 15500 3.4E - 02 1.8E - 02 6.4E - 03 
RM54 4.39 2.19 1.45 140 3190 6380 9680 3.1E - 02 1.6E - 02 1.0E - 02 
RM59 4.34 2.44 1.22 140 3220 5740 11500 3.1E - 02 1.7E - 02 8.7E - 03 
RM62 6.56 2.95 2.03 140 2130 4740 6910 4.7E - 02 2.1E - 02 1.4E - 02 
BM1 6.13 2.11 1.34 140 2280 6630 10500 4.4E - 02 1.5E - 02 9.6E - 03 
BM3 4.46 1.94 1.20 140 3140 7230 11700 3.2E - 02 1.4E - 02 8.6E - 03 
BM5 4.81 1.74 1.15 140 2910 8040 12200 3.4E - 02 1.2E - 02 8.2E - 03 
BM7 3.14 1.67 0.81 140 4460 8370 17200 2.2E - 02 1.2E - 02 5.9E - 03 
BM9 4.48 1.78 1.31 140 3120 7840 10700 3.2E - 02 1.3E - 02 9.4E - 03 
BM11 5.18 2.12 1.02 140 2700 6590 13700 3.7E - 02 1.5E - 02 7.3E - 03 
BM13 6.45 2.36 1.17 140 2170 5930 11900 4.6E - 02 1.7E - 02 8.4E - 03 
BM15 8.76 2.90 1.80 140 1600 4830 7800 6.3E - 02 2.1E - 02 1.3E - 02 
BM17 3.82 1.73 0.81 140 3660 8090 17200 2.7E - 02 1.2E - 02 5.8E - 03 
BM19 3.65 1.48 1.12 140 3830 9470 12500 2.6E - 02 1.1E - 02 8.0E - 03 
BM20 2.52 1.83 0.94 140 5550 7660 15000 1.8E - 02 1.3E - 02 6.7E - 03 
BM21 3.78 2.33 1.47 140 3700 6000 9540 2.7E - 02 1.7E - 02 1.0E - 02 
BM23 4.68 2.34 1.16 140 2990 5990 12100 3.3E - 02 1.7E - 02 8.3E - 03 
BM26 2.13 1.77 1.11 140 6580 7890 12600 1.5E - 02 1.3E - 02 7.9E - 03 
BM40 4.88 2.81 1.44 140 2870 4990 9750 3.5E - 02 2.0E - 02 1.0E - 02 
BM41 3.67 2.47 1.19 140 3820 5660 11700 2.6E - 02 1.8E - 02 8.5E - 03 
BM45 5.03 3.03 1.51 140 2780 4620 9300 3.6E - 02 2.2E - 02 1.1E - 02 
BM46 5.29 2.62 1.75 140 2650 5350 7990 3.7E - 02 1.9E - 02 1.2E - 02 
BM47 3.83 2.32 1.35 140 3650 6030 10400 2.7E - 02 1.6E - 02 9.6E - 03 
BM50 5.11 3.28 1.94 140 2740 4270 7230 3.6E - 02 2.3E - 02 1.4E - 02 
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metallurgic waste 
RM66T1 15.1 0.66 0.08 140 927 21300 174000 1.1E - 01 4.7E - 03 5.7E - 03 
RM66T2 28.5 0.14 0.01 140 490 100000 1130000 2.0E - 01 1.0E - 03 7.1E - 05 
RM66T3 597 46.0 2.69 140 23.0 305 5210 4.3E + 00 3.3E - 01 1.9E - 02 
RM76 12.3 0.23 0.02 140 1140 60600 651000 8.8E - 02 1.6E - 02 1.4E - 04 
RM77(S/T) 213 7.74 6.88 140 66.0 1810 2030 1.5E + 00 5.5E - 02 4.9E - 02 
RM77(W) 76.3 0.59 0.03 140 183 23700 521000 5.4E - 01 4.2E - 02 2.1E - 04 
BM32 86.6 13.7 13.9 140 162 1020 1000 6.2E - 01 9.9E - 02 9.9E - 02 
BM35 385 13.1 7.31 140 36.0 1070 1910 2.7E + 00 9.4E - 02 5.2E - 02 
BM36 18.4 2.67 1.22 140 759 5240 11500 1.3E - 01 1.9E - 02 8.7E - 03 
BM39 7.96 3.92 2.34 140 1760 3570 5970 5.7E - 02 2.8E - 02 1.6E - 02 
BM49 15.8 3.58 2.60 140 886 3910 5390 1.1E - 01 2.6E - 02 1.9E - 02 
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Appendix M: Predicted daily intake (DI), tolerable daily intake (TDIoral) and the required ingestion to exceed the TDIoral based on total, gastric (G) and 
Gastrointestinal (GI) concentration, and corresponding hazard quotient for Pb. 
  
 DI  
(µg kg-1 BW d-1) 
TDI   
(µg kg-1 BW d-1) 
Required ingestion  
(mg  d-1) to exceed TDI oral Hazard Quotient (Unitless) 
SAMPLE 
ID Total G GI   Total G GI Total G GI 
        soil             
RM2 5.07 3.40 0.05 3.6 71.0 106 6560 1.4E + 00 9.4E -01 1.4E - 02 
RM3 5.54 4.27 0.44 3.6 65.0 84.0 814 1.5E + 00 1.2E + 00 1.2E - 01 
RM4 2.84 2.08 NA 3.6 127 173 NA 7.9E - 01 5.8E - 01 NA 
RM6 2.37 1.96 NA 3.6 152 184 NA 6.6E - 01 5.4E - 01 NA 
RM11 5.59 4.54 0.28 3.6 64.0 79.0 1290 1.5E + 00 1.3E - 01 7.7E - 02 
RM12 4.92 4.45 0.07 3.6 73.0 81.0 5000 1.3E + 00 1.2E + 00 1.9E - 02 
RM20 3.32 2.48 NA 3.6 108 145 NA 9.2E - 01 6.9E - 01 NA 
RM24 3.32 2.56 NA 3.6 109 140 NA 9.2E - 01 7.1E - 01 NA 
RM42 3.81 2.69 0.31 3.6 94.0 134 1160 1.1E + 00 7.4E - 01 8.6E - 02 
RM45 3.35 2.99 0.36 3.6 107 120 995 9.3E - 01 8.3E - 01 1.0E -01 
RM49 2.20 2.03 0.09 3.6 163 177 4060 6.1E - 01 5.6E - 01 2.5E - 02 
RM67 3.07 1.88 0.12 3.6 117 192 2910 8.5E - 01 5.2E - 01 3.3E - 02 
RM69 23.6 18.0 4.21 3.6 15.0 20.0 86 6.5E + 00 5.0E + 00 1.2E + 00 
RM70 9.73 7.26 0.21 3.6 37.0 50.0 1710 2.7E + 00 2.0E + 00 5.8E - 02 
RM71 17.3 15.1 1.03 3.6 21.0 24.0 351 4.8E + 00 4.2E + 00 2.8E - 01 
RM72 11.5 1.54 NA 3.6 31.0 234 NA 3.2E + 00 4.2E - 01 NA 
RM73 14.0 6.77 NA 3.6 26.0 54.0 NA 3.9E + 00 1.9E + 00 NA 
RM74 14.0 5.65 NA 3.6 26.0 64.0 NA 3.9E + 00 1.6E + 00 NA 
RM8 1.89 1.09 0.23 3.6 191 331 1540 5.2E -01 3.3E - 01 6.4E - 02 
RM18 2.95 1.67 0.08 3.6 122 215 4620 8.2E - 01 4.6E - 01 2.2E - 02 
RM19 3.52 2.12 0.05 3.6 102 170 6700 9.8E - 01 5.9E - 01 1.4E - 02 
RM21 2.68 1.72 0.05 3.6 134 209 6710 7.4E - 01 4.8E - 01 1.4E - 02 
RM23 3.22 2.06 0.09 3.6 112 174 4060 8.9E - 01 5.7E - 01 2.5E - 02 
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RM27 3.07 2.04 0.09 3.6 117 177 4110 8.5E - 01 5.6E - 01 2.5E - 02 
RM28 2.53 1.45 0.08 3.6 142 248 4240 7.0E - 01 4.0E - 01 2.2E - 02 
RM30 3.18 1.88 0.21 3.6 94 191 1710 8.8E - 01 5.2E - 01 5.8E - 02 
RM35 2.33 1.47 0.15 3.6 154 244 2340 6.4E - 01 4.1E - 01 4.2E - 02 
RM37 1.96 1.31 0.21 3.6 183 276 1690 5.4E - 01 3.6E - 01 5.8E - 02 
RM40 1.77 0.81 NA 3.6 204 446 NA 4.9E - 01 2.2E - 01 NA 
RM54 3.11 2.01 0.85 3.6 116 180 424 8.6E - 01 5.6E - 01 2.4E - 01 
RM59 4.81 3.36 0.58 3.6 75.0 107 626 1.3E + 00 9.3E - 01 1.6E -01 
RM62 6.56 2.61 0.20 3.6 55.0 138 1830 1.8E + 00 7.2E - 01 5.6E - 02 
BM1 54.8 23.3 17.3 3.6 7.00 15.0 21.0 1.5E + 01 6.5E + 00 4.8E + 00 
BM3 49.5 17.4 16.6 3.6 7.00 21.0 22.0 1.3E + 01 4.8E + 00 4.6E + 00 
BM5 46.6 13.9 12.7 3.6 8.00 26.0 28.0 1.2E + 01 3.9E + 00 3.5E + 00 
BM7 23.8 11.3 6.02 3.6 15.0 32.0 60.0 6.6E - 01 3.1E + 00 1.7E + 00 
BM9 33.3 12.3 6.56 3.6 11.0 29.0 55 9.2E + 00 3.4E + 00 1.8E + 00 
BM11 15.1 11.1 0.30 3.6 24.0 33.0 1210 4.2E + 00 3.1E + 00 8.3E - 02 
BM13 50.1 25.2 6.88 3.6 7.00 14.0 52.0 1.4E + 01 7.0E + 00 1.9E + 00 
BM15 88.7 45.0 11.1 3.6 4.00 8.00 32.0 2.4E + 01 1.2E + 01 3.1E + 00 
BM17 34.2 15.2 17.5 3.6 11.0 24.0 21.0 9.5E + 00 4.2E + 00 4.9E + 00 
BM19 15.7 10.6 3.15 3.6 23.0 34.0 114 4.4E + 00 2.9E + 00 8.7E - 01 
BM20 0.38 0.22 0.10 3.6 943 1620 3660 1.0E - 01 6.1E - 02 2.8E - 02 
BM21 0.90 0.57 0.11 3.6 401 632 3360 2.5E - 01 1.5E - 01 3.1E - 02 
BM23 23.9 18.2 5.59 3.6 15.0 20.0 64.0 6.6E + 00 5.1E + 00 1.5E + 00 
BM26 0.29 0.15 0.12 3.6 1238 2444 3040 8.1E - 02 4.2E - 02 3.3E - 02 
BM40 5.91 4.48 0.68 3.6 61.0 80.0 531 1.6E + 00 1.2E + 00 1.9E - 01 
BM41 8.33 7.20 3.74 3.6 43.0 50.0 96.0 2.3E + 00 2.0E + 00 1.0E + 00 
BM45 17.4 13.7 9.73 3.6 21.0 26.0 37.0 4.8E + 00 3.8E + 00 2.7E + 00 
BM46 2.31 1.27 0.47 3.6 156 283 764 6.4E - 01 3.5E - 01 1.3E - 01 
BM47 7.69 6.13 3.20 3.6 47.0 59.0 113 2.1E - 01 1.7E + 00 8.9E - 01 
BM50 7.20 5.54 1.68 3.6 50.0 65.0 215 2.0E + 00 1.5E + 00 4.7E - 01 
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Metallurgic waste 
RM66T1 11.2 NA NA 3.6 32.0 NA NA 3.1E + 00 NA NA 
RM66T2 8.87 NA NA 3.6 41.0 NA NA 2.5E + 00 NA NA 
RM66T3 8.12 0.47 NA 3.6 44.0 761 NA 2.2E + 00 1.3E - 01 NA 
RM76 67.2 0.83 NA 3.6 5.00 435 NA 1.8E + 01 2.3E - 00 NA 
RM77(S/T) 254 9.68 2.53 3.6 1.00 37.0 142 7.0E + 01 2.7E - 00 7.0E - 01 
RM77(W) 252 8.38 5.91 3.6 1.00 43.0 61.0 7.0E + 01 2.3E + 00 1.6E + 00 
BM32 7.15 0.38 0.11 3.6 50 957 3380 2.0E + 00 1.1E - 01 3.1E - 02 
BM35 8600 286.6 138 3.6 0 1.00 3.00 2.3E + 03 8.0E + 01 3.8E + 01 
BM36 133 20.2 9.25 3.6 3.00 18.0 39.0 3.6E + 01 5.6E + 00 2.6E + 00 
BM39 5.23 3.73 0.35 3.6 69 96.0 1020 1.4E + 00 1.0E + 00 9.7E - 02 
BM49 110 50.0 51.4 3.6 3.00 7.00 7.00 3.0E + 01 1.3E + 01 1.4E + 01 
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Appendix N: Predicted daily intake (DI), tolerable daily intake (TDIoral) and the required ingestion to exceed the TDIoral based on total, gastric (G) and 
Gastrointestinal (GI) concentration, and corresponding hazard quotient for Zn. 
  
 DI  
(µg kg-1 BW d-1) 
TDI   
(µg kg-1 BW d-1) 
Required ingestion  
(mg  d-1) to exceed TDI oral 
X 1000 Hazard Quotient (Unitless) 
SAMPLE 
ID Total G GI   Total G GI Total G GI 
        Soil             
RM2 1.24 0.39 NA 600 48.2 153 NA 2.1E - 03 6.5E - 04 NA 
RM3 1.48 0.42 NA 600 40.4 141 NA 2.5E - 03 7.0E - 04 NA 
RM4 0.93 0.35 NA 600 64.5 171 NA 1.5E - 03 5.8E - 04 NA 
RM6 1.16 0.49 NA 600 51.7 121 NA 1.9E - 03 8.2E - 04 NA 
RM11 2.01 0.81 NA 600 29.8 74.4 NA 3.3E - 03 1.3E - 03 NA 
RM12 1.68 0.85 NA 600 35.6 70.2 NA 2.8E - 03 1.4E - 03 NA 
RM20 0.99 0.38 NA 600 60.3 156 NA 1.6E - 03 6.3E - 04 NA 
RM24 1.12 0.28 NA 600 53.6 211 NA 1.9E - 03 4.7E - 04 NA 
RM42 1.14 0.33 NA 600 52.5 182 NA 1.9E - 03 5.5E - 04 NA 
RM45 1.03 0.38 NA 600 58.4 157 NA 1.7E - 03 6.3E - 04 NA 
RM49 0.83 0.31 NA 600 71.9 191 NA 1.4E - 03 5.2E - 04 NA 
RM67 1.46 0.66 NA 600 41.0 91.5 NA 2.4E - 03 1.1E - 03 NA 
RM69 16.7 8.60 1.69 600 3.60 6.97 35.5 2.8E - 02 1.4E - 02 2.8E - 03 
RM70 2.64 1.30 NA 600 22.7 46.1 NA 4.4E - 03 2.2 - 03 NA 
RM71 4.01 2.79 0.12 600 15.0 21.5 514 6.7E - 03 4.6E - 03 2.0E - 04 
RM72 7.47 2.76 0.23 600 8.03 21.7 257 1.2E - 02 4.6E - 03 3.8E - 04 
RM73 16.7 14.3 0.71 600 3.60 4.18 84.5 2.8E - 02 2.4E - 02 1.2E - 03 
RM74 13.8 8.06 0.98 600 4.32 7.44 61 2.3E - 02 1.3E - 02 1.6E - 03 
RM8 0.67 0.32 NA 600 89.3 186 NA 1.1E - 03 5.3E - 04 NA 
RM18 0.54 NA NA 600 112 NA NA 9.0E - 04 NA NA 
RM19 0.60 0.08 NA 600 99.6 720 NA 1.0E - 03 1.3E - 04 NA 
RM21 0.54 0.02 NA 600 112 3250 NA 9.0E - 04 3.3E - 05 NA 
RM23 1.05 0.12 NA 600 56.9 521 NA 1.7E - 03 2.0E - 04 NA 
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RM27 0.08 0.38 NA 600 74.9 158 NA 1.3E - 04 6.3E - 04 NA 
RM28 0.65 NA NA 600 93.0 NA NA 1.1E - 03 NA NA 
RM30 1.78 0.62 NA 600 33.6 97 NA 3.0E - 03 1.0E - 03 NA 
RM35 0.80 0.36 NA 600 75.4 165 NA 1.3E - 03 6.0E - 04 NA 
RM37 1.10 0.35 0.06 600 54.4 174 930 1.8E - 03 5.8E - 04 1.0E - 04 
RM40 0.80 0.27 NA 600 75.4 222 NA 1.3E - 03 4.5E - 04 NA 
RM54 0.73 0.25 NA 600 82.7 241 NA 1.2E - 03 4.2E - 04 NA 
RM59 4.10 2.92 0.40 600 14.6 20.5 148 6.8E - 03 4.9E - 03 6.7E - 04 
RM62 1.60 1.04 0.09 600 37.6 57.8 693 2.7E - 03 1.7E - 03 1.5E - 04 
BM1 8.06 3.62 2.46 600 7.44 16.6 24.4 1.3E - 02 6.0E - 03 4.1E - 03 
BM3 10.6 4.84 2.58 600 5.64 12.4 23.2 1.8E - 02 8.1E - 03 4.3E - 03 
BM5 9.62 4.13 1.99 600 6.23 14.5 30.2 1.6E - 02 6.9E - 03 3.3E - 03 
BM7 4.12 1.54 0.39 600 1.45 39.0 153 6.8E - 03 2.6E - 03 6.5E - 04 
BM9 6.94 3.48 1.27 600 8.65 17.2 47.3 1.1E - 02 5.8E - 03 2.1E - 03 
BM11 5.59 2.78 0.16 600 10.7 21.6 380 9.3E - 03 4.6E - 03 2.7E - 04 
BM13 10.8 5.22 1.41 600 55.7 11.5 42.6 1.8E - 02 8.7E - 03 2.3E - 03 
BM15 3.87 2.64 1.26 600 15.5 22.7 47.7 6.4E - 03 4.4E - 03 2.1E - 03 
BM17 6.13 3.29 2.58 600 9.80 18.2 23.2 1.0E - 02 5.4E - 03 4.3E - 03 
BM19 4.52 1.33 0.45 600 13.3 45.2 134 7.5E - 03 2.2E - 03 7.5E - 04 
BM20 0.30 0.12 0.07 600 203 510 915 5.0E - 04 2.0E - 04 1.1E - 04 
BM21 0.16 0.05 0.03 600 372 1260 2320 2.7E - 04 8.3E - 05 5.0E - 05 
BM23 3.42 0.86 0.20 600 17.5 69.7 298 5.7E - 03 1.4E - 03 3.3E - 04 
BM26 0.40 0.20 NA 600 151 294 NA 6.7E - 04 3.3E - 04 NA 
BM40 1.17 0.25 0.04 600 51.4 240 1590 1.9E - 03 4.2E - 04 6.7E - 05 
BM41 1.84 0.41 0.26 600 32.6 147 228 3.1E - 03 6.8E - 04 4.3E - 04 
BM45 1.97 1.32 0.22 600 30.4 45.5 276 3.3E - 03 2.2E - 03 3.7E -04 
BM46 1.03 0.50 0.07 600 58.4 119 858 1.7E - 03 8.3E - 04 1.2E - 04 
BM47 1.70 0.62 0.25 600 35.2 97.0 243 2.8E - 03 1.0E - 03 4.2E - 04 
BM50 3.30 1.86 0.47 600 18.2 32.2 126 5.5E - 03 3.1E - 03 7.8E - 04 
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metallurgic waste 
RM66T1 1.55 NA NA 600 38.7 NA NA 2.6E - 03 NA NA 
RM66T2 1.15 NA NA 600 52.2 NA NA 1.9E - 03 NA NA 
RM66T3 8.92 NA NA 600 6.72 NA NA 1.5E - 02 NA NA 
RM76 16.1 0.81 NA 600 3.72 73.9 NA 2.6E - 02 1.3E - 03 1.6E - 03 
RM77(S/T) 892 243 105 600 0.07 0.25 0.57 1.5E + 00 4.0E - 01 1.7E - 01 
RM77(W) 1340 314 125 600 0.04 0.19 0.48 2.2E + 00 5.2E - 01 2.1E - 01 
BM32 2.84 NA NA 600 21.2 NA NA 4.7E - 03 NA NA 
BM35 1020 219 111 600 0.06 0.27 0.54 1.7E - 03 3.6E - 01 1.8E - 01 
BM36 257 63.4 17.0 600 0.23 0.95 3.52 4.3E - 01 1.1E - 01 2.8E - 02 
BM39 6.72 2.63 0.48 600 8.93 22.8 125 1.1E - 02 4.4E - 03 8.0E - 04 
BM49 62.9 42.1 14.3 600 0.95 1.42 4.18 1.0E - 01 7.0E - 02 2.4E - 02 
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APPENDIX O: Preparation of Simulated Epithelial Lung Fluids (1000 mL) 
The recipe of the chemicals required to prepare 1000 ml of SELF are given in Tables 1, 2 
and 3 respectively. To prepare 500 ml of the inorganic and organic phases, add the 
chemicals as specified in Tables 1 and 2 into separate 1 litre HDPE screw top bottles and 
make up to 500 ml with de-ionised water. Simultaneously pour the separate 500ml volume 
of the inorganic and organic phases into a 1 litre bottle containing the solids listed in Table 
3. mix thoroughly and add 0.4 mL of HCl. Check the pH of the resulting fluids which 
should be at 7.4 ± 0.2. If necessary adjust the fluid to the correct pH with either 1.0 M 
NaOH or 37 % HCl. 
Table 1 Inorganic Phase Reagent (500 ml) 
Reagent Final Concentration in 
1000ml 
(mg l-1) 
Volume/Weight made up to 
500 
ml 
NaCl 6020 6020 
CaCl2 256 256 
Na2HPO4 150 150 
NaHCO3 2700 2700 
KCl 298 298 
MgCl2 200 200 
Na2SO4 72 72 
 
Table 2 Organic Phase Reagent (500 ml) 
Reagent Final Concentration in 
1000ml 
(mg l-1) 
Volume/Weight made up to 
500 
ml 
Ascorbic acid 18 18 
Uric acid 16 16 
Glutathione 30 30 
 
Table 3 Additional Constituents Phase Reagents 
Reagent Final Concentration in 
1000ml 
(mg l-1) 
Volume/Weight made up to 
1000 
ml 
Albumin 260 260 
Cysteine 122 122 
DPPC 100 100 
Glycine 376 376 
Mucin 500 500 
 
 
285 
 
APPENDIX P: Bioaccesibility extraction protocol 
1. Switch on the extractor 2 hours prior to the commencement of the bioaccessibility 
extraction and set the temperature to 37 ± 2 0C. 
2. Warm the simulated epithelial lung fluids to 37 0C ± 2 prior to use in the 
bioaccessiblilty extraction method. 
3. Check that the temperature is maintained at 37 ± 2 0C. . 
4. Using a pipette add 20 ml of the prepared fluids into each extraction vessel 
5. Place the extraction tubes in the extractor and leach the samples using end-over 
rotation at 37 ± 2 0C for the required  time 
6. Switch off the incubator and remove the resulting suspensions. 
7. Measure the pH of the resulting suspensions; the pH should 7.4 ± 0.2  
8. Collect the supernatant by centrifuging the suspension at 3000 g for 10 mins. 
9. Remove 1 ml of the supernatant using a pipette and transfer into 10 ml tube 
previously holding 9 ml of 0.1 M HNO3. 
10. Store the sample at < 4 0C prior to analysis. 
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Appendix Q:  Aqua regia total, inhalation bioaccessibility, residual digest, mass balance of the inhalation bioaccessibility, mass lost to PM extraction 
process 
Sample 
Pseudo-Total 
(mg/kg)  In-vitro simulated tracheobronchial fluid (mg/kg) 
PM10 Extraction 
(mg/kg) 
    Stage I Stage II Mass balance     
    
(inhalation 
bioaccessibility) (Residual digest) (Stage I + II) Water extractable 
  Mean ± SD Mean ± SD % IBAF Mean ± SD Mean  %Total mass Recovery Mean ± SD % WEF 
  n = 3 n = 3   n = 3 n = 3   n = 3   
RM6 535 ± 25.3 33.6 ± 3.0 6.28 497 ± 20.5 530 99.1 0.8 ± 0.01 0.14 
RM19 814 ± 27.4 50.8 ± 3.2 6.24 775 ± 10.6 825 101 1.2 ± 0.01 0.15 
RM27 838 ± 17.8 60.4 ± 3.6 7.20 746 ± 38.2 806 96.2 1.4 ± 0.07 0.17 
RM28 628 ± 31.1 38.7 ± 1.8 6.16 611 ± 19.1 649 103 0.7 ± 0.01 0.11 
RM42 904 ± 23.1 53.5 ± 4.5 5.92 872 ± 8.60 926 102 1.0 ±  0.01 0.11 
RM45 825 ± 33.8 54.4 ± 3.5 6.60 791 ± 38.7 845 102 1.6 ± 0.05 0.19 
RM49 488 ± 26.3 23.9 ± 1.8 4.90 450 ± 19.7 474 97.1 1.0 ± 0.05 0.20 
RM54 722 ± 21.3 31.4 ± 1.4 4.35 688 ± 30.1 719 99.6 1.2. ± 0.10 0.17 
RM66T1 4,720 ± 217 0.80 ± 0.05 0.02 4,800 ± 93.9 4,800 102 4.3  ± 0.06 0.09 
RM66T2 5,380 ± 226 10.2 ± 0.4 0.19 5,410 ± 256 5,420 101 0.6 ± 0.02 0.01 
RM66T3 3,900 ± 99.1 49.2 ± 0.3 1.26 3,950 ± 18.2 4,000 102 0.1 ± 0.01 0.01 
RM67 576 ± 19.1 21.0 ± 0.5 3.64 549 ± 15.4 570 98.8 1.0 ± 0.02 0.17 
RM69 5,770 ± 336 301 ± 9.8 5.23 5,370 ± 285 5,670 98.3 21 ± 0.72 0.36 
RM70 2,160 ± 12.8 102 ± 6.0 4.71 2,070 ± 81.7 2170 100 6.6 ± 0.04 0.30 
RM71 4,690 ± 72.7 145 ± 3.1 3.10 4,520 ± 170 4,660 99.4 7.7 ± 0.02 0.16 
RM72 2,510 ± 56.7 13.4 ± 0.7 0.53 2510 ± 130 2,520 100 1.7 ± 0.04 0.07 
RM74 4,660 ± 56.7 47.2 ± 1.4 1.01 4,660 ± 185 4,710 101 3.6 ± 0.07 0.08 
RM76 21,400 ± 792 7.20 ± 0.2 0.03 21,400 ± 384 21,400 99.7 6.3 ± 0.08 0.03 
RM77(S/T) 72,800 ± 185 64.4 ± 3.4 0.09 72,300 ± 4119 72,400 99.3 52 ± 1.85 0.07 
RM77(W) 56,900 ± 2488 51.9 ± 0.9 0.09 57,200 ± 1232 57,200 100 200 ± 2.99 0.35 
BM3 13,700 ± 676 529 ± 1.8 3.86 13,200 ± 97.1 13,700 100 36 ± 1.15 0.26 
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BM5 11,000 ± 441 1,060 ± 27 9.62 9,580 ± 386 10,600 96.8 18 ± 0.04 0.16 
BM9 9,350 ± 450 1,030 ± 53 11.0 8,270 ± 465 9,300 99.4 17 ± 0.07 0.18 
BM11 4,100 ± 217 352 ± 15 8.58 3,930 ± 181 4,280 104 4 .0 ± 0.04 0.09 
BM21 274 ± 3.80 9.80 ± 0.5 3.58 267 ± 4.60 277 101 0.3 ± 0.01 0.11 
BM32 2,990 ± 143 0.70 ± 0.02 0.02 3,020 ± 166 3,020 101 1.1 ± 0.01 0.04 
BM36 25,300 ± 963 14.0 ± 0.7 0.05 24,800 ± 273 24,800 98.3 240 ± 12.7 0.94 
BM41 2,390 ± 51.6 186 ± 5.9 7.78 2,180 ± 97.4 2,370 99.0 5.2 ± 0.11 0.21 
BM45 5,390 ± 18.7 355 ± 16 6.60 4,970 ± 266 5,320 98.8 8.4 ± 0.07 0.16 
BM46 620 ± 18.3 18.1 ± 0.5 2.92 613 ± 9.50 631 102 2.3 ± 0.06 0.37 
BM47 2,480 ± 115 198 ± 2.1 7.97 2,220 ± 153 2,410 97.4 2.7 ± 0.05 0.11 
BM49 20,900 ± 350 964 ± 22 4.60 20,900 ± 669 21,900 104 43 ± 1.93 0.20 
BM50 2,450 ± 35.8 135 ± 5.2 5.51 2,290 ± 55.3 2,420 98.8 3.3 ± 0.02 0.13 
 
% IBAF = (CIBM / Ctotal) x 100 
Where CIBM is the concentration of the Pb in the tracheobronchial fluid and Ctotal is the pseudo total concentration of Pb 
% total mass recovery = (residual digest / pseudototal) x 100 
% WEF = (CWEF / Ctotal) x 100 
Where CWEF is the concentration of Pb lost to the PM10 extraction and is Ctotal the pseudo total concentration of Pb   
 
 
 
 
